SMILES,TITLE,Hybrid2,fragments,site
c1cc(cnc1)C2=[NH+]OC[C@@H](N2)C[NH+]3CCCCC3,Iroxanadine,-13.762961,x0678,active-noncovalent
CC(=O)Nc1cn[nH]c1C(=O)Nc2ccc(cc2)F,4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide,-13.079412,x0678,active-noncovalent
c1ccc2c(c1)c3c4c(c5c6ccccc6[nH]c5c3[nH]2)C(=O)NC4,"6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one",-12.704174,x0678,active-noncovalent
c1ccc2c(c1)c3c4c(c5c6ccccc6[nH]c5c3[nH]2)c([nH]c4C(=O)[O-])O,"7-carboxy-5-hydroxy-12,13-dihydro-6H-indolo[2,3-a]pyrrolo[3,4-c]carbazole",-12.467003,x0678,active-noncovalent
c1ccc2c(c1)c([nH]n2)C(=O)N[C@@H]3C[NH+]4CCC3CC4,Facinicline,-12.401834,x0678,active-noncovalent
c1ccc2cc(ccc2c1)c3cc4c(c[nH]c4nc3)c5ccc(cc5)CC(=O)[O-],"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",-12.315027,x0161,active-noncovalent
CCCCc1c2c([nH]c1c3ccc(cc3)O)nccn2,"6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE",-12.273432,x0678,active-noncovalent
c1ccc(cc1)c2ccc(cc2)C[C@@H](C(=O)[O-])[NH3+],Biphenylalanine,-12.168997,x0678,active-noncovalent
c1cc(cc2c1cc(cc2C#N)c3ccc(c(c3)F)O)O,3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE,-12.129187,x0749,active-covalent
c1conc1c2[nH]c3c(n2)cnc4c3COCC4,S-8510,-11.731334,x0678,active-noncovalent
c1ccc2c(c1)cc(cn2)c3cc(ccn3)c4cc5c([nH]4)CCNC5=O,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ON",-11.718282,x0104,active-noncovalent
c1cc(c(=O)[nH]c1)c2[nH]c3cc(ccc3n2)C(=[NH2+])N,"Imino[2-(2-oxo-1,2-dihydro-3-pyridinyl)-1H-benzimidazol-5-yl]methanaminium",-11.711179,x0678,active-noncovalent
c1ccc2c(c1)-c3ccccc3C2[NH+]4CCN(CC4)C(=O)c5ccc6c(c5)cc[nH]6,Genz-10850,-11.636246,x0104,active-noncovalent
c1cc(ccc1[C@@H]2Cc3ccc(cc3OC2)O)O,Equol,-11.620012,x0749,active-covalent
Cc1c([nH]cn1)CN2CCc3c(c4ccccc4n3C)C2=O,Alosetron,-11.610959,x0195,active-noncovalent
c1ccc(cc1)CCn2c(=O)c3ccccc3c(=O)[nH]2,"2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione",-11.491937,x0678,active-noncovalent
c1cc2c(cc(cn2)c3ccc(cc3)O)c4c1ccnc4,"9-(4-Hydroxyphenyl)-2,7-Phenanthroline",-11.480380,x0678,active-noncovalent
CCCC[NH+](CCCC)C[C@@H](c1cc(cc\2c1-c3ccc(cc3/C2=C/c4ccc(cc4)Cl)Cl)Cl)O,Lumefantrine,-11.434649,x0161,active-noncovalent
c1cc2c(cc1C(=[NH2+])N)nc([nH]2)Cc3[nH]c4ccc(cc4n3)C(=[NH2+])N,Bis(5-Amidino-Benzimidazolyl)Methane,-11.427685,x1077,active-noncovalent
c1ccc-2c(c1)Cc3c2[nH]nc3c4ccncc4,"3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole",-11.392682,x0749,active-covalent
c1cc(ccc1c2ccc3c(c2)ccc(c3Cl)O)O,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,-11.376515,x0749,active-covalent
C[N@H+](CC=C)Cc1ccc(cc1)c2ccc(cc2)C(=O)c3ccc(cc3)Br,"(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone",-11.371954,x0104,active-noncovalent
c1ccc(cc1)NC(=O)c2ccn[nH]2,N-phenyl-1H-pyrazole-3-carboxamide,-11.371179,x0678,active-noncovalent
c1ccc(cc1)C(=O)c2ccc(cc2)C[C@@H](C(=O)[O-])[NH3+],PARA-(BENZOYL)-PHENYLALANINE,-11.360617,x0678,active-noncovalent
C[C@H](c1ccc(c(c1)F)c2ccccc2)C(=O)[O-],Tarenflurbil,-11.357160,x0678,active-noncovalent
c1ccc2c(c1)ncc(n2)NS(=O)(=O)c3ccc(cc3)N,Sulfaquinoxaline,-11.320952,x0678,active-noncovalent
c1cc(ccc1C2=Cc3ccc(cc3OC2)O)O,Idronoxil,-11.288698,x0749,active-covalent
c1cc(ccc1c2cc3ccc(cc3s2)O)O,2-(4-hydroxyphenyl)benzo[b]thiophen-6-ol,-11.269278,x0749,active-covalent
Cc1ccn(c(=O)c1c2ccc3c(c2)cnc(n3)N)c4ccc5c(c4)NCC5(C)C,"3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-on",-11.266127,x0161,active-noncovalent
c1ccc2c(c1)C3=[NH+]c4ccc(cc4CN3C2=O)N,Daniquidone,-11.263820,x0678,active-noncovalent
c1ccc2c(c1)c([nH]n2)c3[nH]c4ccccc4n3,3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE,-11.232033,x0678,active-noncovalent
CC(C)(c1cccnc1)C(=O)c2cccnc2,Metyrapone,-11.216053,x0678,active-noncovalent
c1ccc(cc1)NCc2cccnc2,N-(pyridin-3-ylmethyl)aniline,-11.209691,x0678,active-noncovalent
c1ccc(c(c1)c2[nH]c3cc(ccc3n2)C(=[NH2+])N)O,CRA_1144,-11.192276,x0678,active-noncovalent
c1ccc(c(c1)c2[nH]c3cc(ccc3n2)C(=[NH2+])N)O,2-(2-Hydroxy-Phenyl)-3h-Benzoimidazole-5-Carboxamidine,-11.192276,x0678,active-noncovalent
c1cc2c3c(c1)[C@H]4CCC[C@H]4C[N@]3CC[NH2+]C2,Vabicaserin,-11.190751,x0195,active-noncovalent
Cc1c2c(nc(n1)N)C[C@@H](C[C@H]2N=O)c3ccc(cc3c4cccnc4)F,"(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin",-11.147985,x0749,active-covalent
C[NH+]1CCC(=C2c3ccccc3CCc4c2ccs4)CC1,Pizotifen,-11.140948,x0195,active-noncovalent
c1ccc(cc1)CCc2c3c(cc4c2nc[nH]4)c(=O)[nH]c(n3)N,"6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",-11.125434,x0967,active-noncovalent
c1ccc2c(c1)C=Cc3ccccc3N2Cc4cnc5c(n4)c(nc(n5)N)N,"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",-11.118546,x0107,active-noncovalent
C[C@]12CCc3c4ccc(cc4ccc3[C@@H]1CCC2=O)O,Equilenin,-11.084661,x0749,active-covalent
c1ccc(cc1)c2ccc3c(c2)c(n[nH]3)N,5-phenyl-1H-indazol-3-amine,-11.072072,x0749,active-covalent
Cc1cccc(n1)[C@H]2[C@@H](CN=N2)c3ccc4c(n3)cccn4,Naphthyridine Inhibitor,-11.059591,x0397,active-noncovalent
c1cc2c(cc1C(=[NH2+])N)nc([nH]2)C(=O)c3[nH]c4ccc(cc4n3)C(=[NH2+])N,Bis(5-Amidino-2-Benzimidazolyl)Methanone,-11.054985,x1077,active-noncovalent
c1cc2c(cc1C(=[NH2+])N)nc([nH]2)C(=O)c3[nH]c4ccc(cc4n3)C(=[NH2+])N,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,-11.054985,x1077,active-noncovalent
c1cc(cc2c1cc(cc2)O)c3c4ccc(cc4on3)O,3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL,-11.038447,x0678,active-noncovalent
C[N@@H+]1CCc2cccc-3c2[C@H]1Cc4c3c(c(cc4)O)O,Apomorphine,-11.037971,x0195,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1C[C@H]([C@@H]2O)O)O,Estriol,-11.030424,x0749,active-covalent
c1ccc2c(c1)/C(=N/c3ccc(cc3)O)/C(=O)N2,(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One,-11.021921,x0749,active-covalent
c1cc2ccc3cc4c(c5c3c2c(c1)cc5)C[C@H]([C@H]([C@@H]4O)O)O,"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",-11.008533,x0749,active-covalent
C[C@]12CC[C@@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C)O,"17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane",-11.001923,x0749,active-covalent
CC1(CCC(c2c1ccc(c2)[C@H](c3ccc4cc(ccc4c3)C(=O)[O-])O)(C)C)C,BMS184394,-10.989280,x0161,active-noncovalent
c1cc(ccc1[C@H]2[C@H]3CC(C[C@H]3c4cc(ccc4O2)O)(F)F)O,"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[",-10.982422,x0195,active-noncovalent
c1ccc2c(c1)C(=C(C(=O)C2=O)C3CCC(CC3)c4ccc(cc4)Cl)[O-],"2-[4-(4-Chlorophenyl)Cyclohexylidene]-3,4-Dihydroxy-1(2h)-Naphthalenone",-10.958655,x0161,active-noncovalent
CC1=C(C(=O)C(=C(C1=O)[NH+]2CC2)CO)[NH+]3CC3,RH-1,-10.949577,x0195,active-noncovalent
C/C(=C/1\c2cc(ccc2NC1=O)NC(=O)N)/c3ccc[nH]3,1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA,-10.941818,x0749,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@H]4[C@@H]3CCC(=O)C4=O,17alpha-methyl-4-hydroxynandrolone,-10.933439,x0749,active-covalent
Cc1c(c(nc(n1)N)N)C#C[C@H](C)c2cc(cc(c2)OC)c3ccccc3,"5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",-10.926559,x0678,active-noncovalent
Cc1c(=O)c2cc(ccc2oc1c3cc(c(c(c3)Br)[O-])Br)O,"6,4'-Dihydroxy-3-Methyl-3',5'-Dibromoflavone",-10.916977,x0749,active-covalent
c1cc(c(cc1C(F)(F)F)Cl)Oc2ccc(c(c2)C(=O)[O-])N(=O)=O,Acifluorfen,-10.915106,x1093,active-noncovalent
c1cc2c(cc1Cl)n(c(=O)n(c2=O)Cc3ccc(cc3F)Br)CC(=O)[O-],Zenarestat,-10.890029,x0830,active-covalent
C[C@]12CCC(=O)C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4O)C,5beta-dihydrotestosterone,-10.882597,x0749,active-covalent
C[C@]12CC[C@@H]3c4cc(c(cc4CC[C@H]3[C@@H]1CC[C@@H]2O)O)O,2-Hydroxyestradiol,-10.873961,x0749,active-covalent
c1ccc2c(c1)c(c[nH]2)Cc3c[nH]c4c3cccc4,"3,3'-diindolylmethane",-10.868416,x1093,active-noncovalent
C[NH+](C)CCCN1c2ccccc2CCc3c1cccc3,Imipramine,-10.859057,x0195,active-noncovalent
Cn1c2c(c(n1)c3ccc4ccccc4c3)c(ncn2)N,"1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",-10.850032,x0678,active-noncovalent
CC1(CCC(c2c1ccc(c2)C(=O)c3ccc4cc(ccc4c3)C(=O)[O-])(C)C)C,CD564,-10.829392,x0161,active-noncovalent
c1ccc2c(c1)c(c([nH]2)O)c3c(c4ccccc4[nH]3)N=O,Indirubin-3'-monoxime,-10.825436,x0678,active-noncovalent
C[C@@H](c1cccc2c1occ2c3ccccc3)C(=O)[O-],Furaprofen,-10.824141,x0678,active-noncovalent
Cc1ccc(cc1)CCc2c3c(cc4c2nc[nH]4)c(=O)[nH]c(n3)N,"6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ON",-10.818161,x0107,active-noncovalent
c1cc(c(cc1/C=C/c2cc(cc(c2)O)O)O)O,PICEATANNOL,-10.811160,x0749,active-covalent
c1ccc2c(c1)c(=O)c3cc(ccc3o2)S(=O)(=O)[N-]c4n[n-]nn4,"N-(1,4-dihydro-5H-tetrazol-5-ylidene)-9-oxo-9H-xanthene-2-sulfonamide",-10.809532,x0678,active-noncovalent
COc1ccc2c(c1)/C(=C/c3cnc[nH]3)/C(=O)N2,SU9516,-10.803868,x0195,active-noncovalent
Cc1ccccc1c2cc3ccc(cc3[nH]2)C(=[NH2+])N,2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE,-10.802519,x0678,active-noncovalent
CCn1c2ccccc2c3c1ccc(c3)C[NH2+]C,1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine,-10.797463,x0195,active-noncovalent
c1ccc2cc(ccc2c1)C[C@@H](C(=O)[O-])[NH3+],Beta-(2-Naphthyl)-Alanine,-10.797232,x0830,active-covalent
c1ccc2c(c1)CCN(C2)C(=[NH2+])N,Debrisoquine,-10.796881,x0195,active-noncovalent
C/C(=C/1\c2cc(ccc2NC1=O)O)/c3ccc[nH]3,5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE,-10.796027,x0195,active-noncovalent
c1ccc(cc1)c2cc(c3[nH+]cc(n3c2)Br)NCc4cncnc4,"3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine",-10.788913,x0678,active-noncovalent
CCN1c2cc3c(cc2C(C1=O)(C)C)[nH]c-4c3CCCc5c4n[nH]c5C,"8-ethyl-3,10,10-trimethyl-4,5,6,8,10,12-hexahydropyrazolo[4',3':6,7]cyclohepta[1",-10.785570,x0749,active-covalent
CC(C)[C@H]1c2cc(ccc2CC[NH2+]1)NC(=O)c3ccc4cc(ccc4c3)C(=[NH2+])N,"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarb",-10.780117,x0104,active-noncovalent
c1cc(ccc1c2ccc(o2)/C=C\3/C(=O)NC(=[NH2+])S3)C(=O)[O-],"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACI",-10.776232,x0107,active-noncovalent
CCS/C(=[NH+]/c1ccc(cc1)C(F)(F)F)/N,S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea,-10.765605,x0195,active-noncovalent
c1ccc2c(c1)c(ccc2O)/N=N/c3ccccc3C(=O)[O-],2-((4'-HYDROXYNAPHTHYL)-AZO)BENZOIC ACID,-10.749926,x0195,active-noncovalent
C[C@]12CC[C@@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4O)C)O,"5-Alpha-Androstane-3-Beta,17beta-Diol",-10.740103,x0749,active-covalent
CC1=C2C(=Cc3cccc(c3C2=O)[O-])C[C@H](O1)CC(=O)[O-],"[(3S)-9-hydroxy-1-methyl-10-oxo-4,10-dihydro-3H-benzo[g]isochromen-3-yl]acetic a",-10.739415,x0749,active-covalent
CCC1=C[C@@H]2Cc3c(c(c4ccc(cc4[nH+]3)Cl)N)[C@@H](C2)C1,"3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Ami",-10.738072,x0749,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC=C4[C@@]3(CC[C@@H](C4)O)C,Prasterone,-10.734205,x0749,active-covalent
C[C@]12CCc3c4ccc(cc4ccc3[C@@H]1CC[C@@]2(C)O)O,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,-10.732480,x0749,active-covalent
c1cc(c(cc1c2ccc(cc2F)F)C(=O)[O-])O,Diflunisal,-10.732103,x0749,active-covalent
c1cc(ccc1Cn2c(c3c(c2O)[C@@H]([N@@H+]4[C@H]3CCC4)c5ccc(cc5)C(=[NH2+])N)O)F,"(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYR",-10.723947,x0434,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(Cc5c(non5)C4)C,Furazabol,-10.722659,x0749,active-covalent
c1cc2c(cc1O)sc(n2)C3=NC(=O)CS3,"2-(6-HYDROXY-1,3-BENZOTHIAZOL-2-YL)-1,3-THIAZOL-4(5H)-ONE",-10.700084,x0749,active-covalent
C[C@]12CC[C@@H]3[C@H]4CC[C@@H](CC4=CC[C@H]3[C@@H]1CC[C@@H]2O)O,19-Nor-5-androstenediol,-10.695486,x0749,active-covalent
c1cc(ccc1c2cc(=O)c3c(cc(cc3o2)O)[O-])O,Apigenin,-10.685080,x0749,active-covalent
c1ccc2cc3c(cccc3N)cc2c1,Aminoanthracene,-10.685076,x0195,active-noncovalent
C[C@@H](c1ccc(c(c1)F)c2ccccc2)C(=O)[O-],Flurbiprofen,-10.678944,x0830,active-covalent
C[NH2+]CCCC1c2ccccc2C=Cc3c1cccc3,Protriptyline,-10.678865,x0195,active-noncovalent
c1ccc(cc1)C(c2ccccc2)(c3ccccc3)OC[C@@H]4[C@H](C[C@@H](O4)n5ccc(=O)[nH]c5=O)F,"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,",-10.667377,x0195,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC[C@@H]4[C@@H]3CCC(=O)C4,"(13S)-13-METHYLDODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17(2H,4H)-DIONE",-10.659962,x0749,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(Cc5cn[nH]c5C4)C,Stanozolol,-10.635459,x0749,active-covalent
C[C@]12CC[C@@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@H]4O)C)O,"5-Alpha-Androstane-3-Beta,17-Alpha-Diol",-10.632685,x0749,active-covalent
C[N@@H+]1CCC2=C(C1)c3ccccc3Cc4c2cccc4,Setiptiline,-10.631288,x0072,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C[C@H](CC[C@]34C)O,4-Androstenediol,-10.628994,x0749,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@@H]4[C@@]3(C=C[C@@H](C4)O)C,1-Androstenediol,-10.614017,x0749,active-covalent
CC[C@@]1(Cc2ccc(cc2C1)F)c3cnc[nH]3,Fipamezole,-10.610895,x0161,active-noncovalent
c1ccc(cc1)c2cc(on2)c3ccn[nH]3,3-phenyl-5-(1H-pyrazol-3-yl)isoxazole,-10.603693,x0678,active-noncovalent
CC\1=C(c2cc(ccc2/C1=C\c3ccc(cc3)[S@@](=O)C)F)CC(=O)[O-],Sulindac,-10.595797,x0830,active-covalent
c1ccc(cc1)c2ccc(n2CC(=O)NC(=[NH2+])N)c3ccccc3,"N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide",-10.592916,x0967,active-noncovalent
Cc1nnc2n1-c3ccc(cc3[C@@H](N=C2)c4ccccc4Cl)Cl,Triazolam,-10.587616,x1077,active-noncovalent
CC1(Cc2c(c(c(n2C1)CC(=O)[O-])c3ccc(cc3)Cl)c4ccccc4)C,Licofelone,-10.586469,x1418,active-covalent
C/C(=C\C(=O)[O-])/C=C/C=C(/C)\C=C\1/CCCc2c1cccc2,9CUAB30,-10.581276,x0831,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,Norethynodrel,-10.580162,x0749,active-covalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CCC2=O)O,Estrone,-10.575466,x0749,active-covalent
c1cc(cc(c1)N2c3cccc(c3Oc4c2cccc4C(=O)[O-])C(=O)[O-])C(F)(F)F,"N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid",-10.561419,x0830,active-covalent
c1cc2c(cc1C(=[NH2+])N)[nH]c(n2)c3cc(ccc3O)F,CRA_1802,-10.557934,x0678,active-noncovalent
c1cncc2c1n3c(n2)C[C@@H]([C@H](C3)[NH3+])c4cc(c(cc4F)F)F,"(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyrid",-10.556579,x0749,active-covalent
c1cc(ccc1/C=c\2/c(=O)n(/c(=C\[NH3+])/[nH]2)CC(=O)[O-])O,"[2-(Methyleneamine)-4-(4-Hydroxy-Benzylidine)-5-Oxo-4,5-Dihydro-Imidazol-1-Yl]-A",-10.538618,x0678,active-noncovalent
CNc1ccc(cc1[18F])c2nc3ccc(cc3s2)O,Flutemetamol (18F),-10.536270,x0749,active-covalent
C[C@@H](c1ccc2c3cc(ccc3[nH]c2c1)Cl)C(=O)[O-],Carprofen,-10.533113,x0749,active-covalent
c1ccc2c(c1)c3c([nH]2)[C@@H]4CCCC[N@H+]4CC3=O,"(7as,12ar,12bs)-1,2,3,4,7a,12,12a,12b-Octahydroindolo[2,3-a]Quinolizin-7(6h)-One",-10.528099,x0195,active-noncovalent
C[C@]12CC[C@@H]3[C@H]4CCC(=O)CC4=CC[C@H]3[C@@H]1CCC2=O,19-Nor-5-androstenedione,-10.515950,x0749,active-covalent
c1cc(cc(c1)I)C[NH+]=C(N)N,Iobenguane,-10.515469,x0195,active-noncovalent
c1cc(cc(c1)[123I])C[NH+]=C(N)N,Iobenguane sulfate I-123,-10.515469,x0195,active-noncovalent
c1cnc(nc1)[N-]S(=O)(=O)c2ccc(cc2)N,Sulfadiazine,-10.514614,x0072,active-noncovalent
c1cnc(nc1)[N-]S(=O)(=O)c2ccc(cc2)N,Silver sulfadiazine,-10.514614,x0072,active-noncovalent
CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@H]34,18-methyl-19-nortestosterone,-10.513809,x0749,active-covalent
COc1ccc(c(c1)c2[nH]c3cc(ccc3n2)C(=[NH2+])N)O,2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine,-10.503323,x0107,active-noncovalent
COc1ccc(c(c1)OC)/C=C/2\CCCN=C2c3cccnc3,GTS-21,-10.501475,x0107,active-noncovalent
c1cc(cc2c1cc[nH]2)CCc3cc(=O)[nH]c(n3)N,2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one,-10.495667,x0678,active-noncovalent
C[NH+]1CCC(=C2c3ccccc3C=Cc4c2cccc4)CC1,Cyproheptadine,-10.486872,x0195,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC=C3[C@@H]1CCC2=O)O,Equilin,-10.479601,x0749,active-covalent
c1cc2c(c(c1)Sc3ccc(cc3)N4CCOCC4)c(nc(n2)N)N,"5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine",-10.478854,x0749,active-covalent
c1cc(ccc1/C=C/c2cc(cc(c2)O)O)O,Resveratrol,-10.467901,x0749,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(C/C(=C/[O-])/C(=O)C4)C,Oxymetholone,-10.464322,x0749,active-covalent
Cc1nccn1C[C@H]2CCc3c(c4cccc5c4n3CCC5)C2=O,Cilansetron,-10.463753,x0749,active-covalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1[C@H]([C@H]([C@@H]2O)O)O)O,Estetrol,-10.461740,x0749,active-covalent
COC(=O)[C@H](c1ccccc1Cl)[N@H+]2CCc3c(ccs3)C2,Clopidogrel,-10.458050,x0749,active-covalent
C[NH+](C)C/C=C(/c1ccc(cc1)Br)\c2cccnc2,Zimelidine,-10.456805,x0107,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1C[C@H]([C@H]2O)O)O,17alpha-Estriol,-10.455505,x0749,active-covalent
C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C,Cholecalciferol,-10.450566,x0104,active-noncovalent
c1cc2c(cc1F)cc([nH]2)C(=O)NCCS,Fica,-10.450373,x0678,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CC[C@@H]2O)O,Estradiol,-10.439062,x0749,active-covalent
c1ccc2c(c1)[nH]c(n2)Cc3[nH]c4cc(ccc4n3)C(=[NH2+])N,Hemi-Babim,-10.431572,x0104,active-noncovalent
COc1ccc2c(c1)occ(c2=O)c3ccc(cc3)O,Isoformononetin,-10.425697,x0749,active-covalent
C[C@@H](c1ccccc1F)/[NH+]=C\2/NC(=O)[C@@](S2)(C)C(F)(F)F,"(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-th",-10.417786,x0678,active-noncovalent
C[NH+](C)C[C@@H](Cn1c2ccc(cc2c3c1ccc(c3)Br)Br)O,(S)-wiskostatin,-10.416639,x0195,active-noncovalent
C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O,Trenbolone,-10.413925,x0749,active-covalent
C[C@]12CC[C@@H]3c4cc(c(cc4CC[C@H]3[C@@H]1CC[C@@H]2O)O)OC,2-Methoxyestradiol,-10.411283,x0749,active-covalent
c1cc(ccc1c2cc3cc(ccc3o2)O)O,2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL,-10.409985,x0749,active-covalent
c1ccc(cc1)CSC[C@@H](C(=O)[O-])[NH3+],Benzylcysteine,-10.406841,x0678,active-noncovalent
C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@@H]3[C@@H]1[C@@H]4CC[C@]([C@]4(CC3)C)(C)O,Mibolerone,-10.404454,x0749,active-covalent
CN1CC[NH+](CC1)CCCN2c3ccccc3Sc4c2cc(cc4)C(F)(F)F,Trifluoperazine,-10.390505,x0195,active-noncovalent
C[NH+](C)CC/C=C/1\c2ccccc2CSc3c1cccc3,Dosulepin,-10.388539,x0104,active-noncovalent
C[N@H+](C/C=C/c1ccccc1)Cc2cccc3c2cccc3,Naftifine,-10.381157,x0161,active-noncovalent
CC1=CC(=O)C=C2[C@]1([C@H]3CC[C@]4([C@H]([C@@H]3CC2)CCC4=O)C)C,Atamestane,-10.381104,x0749,active-covalent
CC[C@H]1C[NH2+]Cc2c1cc(cc2)NC(=O)c3ccc4cc(ccc4c3)C(=[NH2+])N,"6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxam",-10.379058,x0104,active-noncovalent
C[C@@]12[C@@H]([C@@H](C[C@@H](O1)n3c4ccccc4c5c3c6n2c7ccccc7c6c8c5C(=O)NC8)N(C)C(=O)c9ccccc9)OC,Midostaurin,-10.378401,x0161,active-noncovalent
C/C=C(/C(=C/C)/c1ccc(cc1)O)\c2ccc(cc2)O,Dienestrol,-10.377300,x0749,active-covalent
c1ccc2c(c1)cccc2CC3=[NH+]CCN3,Naphazoline,-10.375788,x0195,active-noncovalent
Cc1ccnc(n1)[N-]S(=O)(=O)c2ccc(cc2)N,Sulfamerazine,-10.372015,x0072,active-noncovalent
c1ccc(cc1)c2ncc(s2)c3ccn[nH]3,"PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE",-10.365655,x0678,active-noncovalent
Cc1c2cc(ccc2oc1S(=O)(=O)c3ccc(=O)[nH]n3)Cl,6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE,-10.362899,x1093,active-noncovalent
Cc1cc(cc(c1O)C)/C=C/c2ccccc2,"2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol",-10.359794,x0749,active-covalent
Cc1cc(c2cc(ccc2[nH+]1)NC(=O)Nc3ccc4c(c3)c(cc([nH+]4)C)N)N,Aminoquinuride,-10.346724,x0161,active-noncovalent
c1cc(ccc1c2cc([nH]n2)C3CC[NH2+]CC3)Cl,4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE,-10.342799,x0749,active-covalent
CCc1c2cc(ccc2nc-3c1Cn4c3cc5c(c4=O)COC(=O)[C@@]5(CC)O)O,7-ethyl-10-hydroxycamptothecin,-10.330955,x0161,active-noncovalent
c1cc(c(c(c1)C(=O)c2ccc(cc2)Br)N)CC(=O)[O-],Bromfenac,-10.330639,x0830,active-covalent
c1ccc(cc1)Oc2c(cc(cc2S(=O)(=O)N)C(=O)[O-])N3CCCC3,Piretanide,-10.329835,x0831,active-covalent
c1ccc2c(c1)cccc2C[C@@H](C(=O)N)[NH3+],NAM NAPTHYLAMINOALANINE,-10.329604,x0195,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@H]4[C@@H]3CCC(=O)C4=O,Oxabolone,-10.329434,x0749,active-covalent
C[NH+](C)C[C@@H]1CCn2cc(c3c2cccc3)C4=C(c5cn(c6c5cccc6)CCO1)C(=O)NC4=O,Ruboxistaurin,-10.322952,x0195,active-noncovalent
Cc1nnc(s1)NS(=O)(=O)c2ccc(cc2)N,Sulfamethizole,-10.322209,x0678,active-noncovalent
C[N@H+]1CC[N@@]2c3ccccc3Cn4cccc4[C@H]2C1,Aptazapine,-10.315897,x0195,active-noncovalent
c1ccc2cc(c(cc2c1)c3nc(nc(n3)N)N)Br,"6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE",-10.310462,x0749,active-covalent
C[C@]12CCC(=O)C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C,"5-BETA-ANDROSTANE-3,17-DIONE",-10.307767,x0749,active-covalent
C[C@@H](c1cccc(c1)Cl)Oc2cccc3c2c(nc(n3)N)N,"5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine",-10.306492,x0678,active-noncovalent
CCCCc1[nH]c2c(n1)c(=O)[nH][nH]c2=O,"2-Butyl-5,6-Dihydro-1h-Imidazo[4,5-D]Pyridazine-4,7-Dione",-10.303450,x0678,active-noncovalent
C[C@]12CC[C@@H](C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C)O,"17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene",-10.297828,x0749,active-covalent
c1cc(ccc1c2coc3cc(cc(c3c2=O)[O-])O)O,Genistein,-10.293783,x0749,active-covalent
C[C@]12CC[C@@H](C[C@@H]1C[C@@H]([C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C)O)O,7-beta-Hydroxyepiandrosterone,-10.289455,x0749,active-covalent
C[N@@H+]1CC[C@@H](C1)CN2c3ccccc3Sc4c2cccc4,Methdilazine,-10.289266,x0874,active-noncovalent
Cc1c(c[nH]n1)c2ccc(cc2)CC[NH3+],2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE,-10.283529,x0749,active-covalent
c1ccc(cc1)c2cccc3c2oc(cc3=O)N4CCOCC4,LY-294002,-10.283077,x0195,active-noncovalent
c1cc2c(cc1F)[C@@]3(C[C@H](O2)C(=O)N)C(=O)NC(=O)N3,Fidarestat,-10.279768,x0195,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,Norethisterone,-10.277848,x0749,active-covalent
c1cc2c(cc1O)C=CC3=CCC=C[C@@H]3[N@@]2Cc4cnc5c(n4)c(nc(n5)N)N,"(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-",-10.276102,x0107,active-noncovalent
c1ccc(cc1)c2ccc(cc2)[C@@H](c3ccccc3)n4ccnc4,Bifonazole,-10.270142,x0195,active-noncovalent
Cc1[nH+]c(cn1Cc2c(cccc2Cl)Cl)c3ccnc(n3)N,"4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine",-10.267672,x0830,active-covalent
Cn1cc(nc1)C[C@@H](C(=O)[O-])[NH3+],4-Methyl-Histidine,-10.263056,x0397,active-noncovalent
c1ccc(cc1)c2cc3c(c4cc(ccc4n3CCC(=O)[O-])O)c5c2C(=O)NC5=O,"3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPA",-10.261752,x0195,active-noncovalent
C[C@@]1(CC[C@@H]2[C@@]1(C[C@H]([C@H]3[C@H]2CCC4=CC(=O)C(=C[C@]34C)C=O)O)C)O,Formebolone,-10.260154,x0749,active-covalent
c1cc2c3c(c1)C(=O)N(C[C@H]3CCC2)[C@@H]4C[NH+]5CCC4CC5,Palonosetron,-10.253355,x0195,active-noncovalent
c1ccc(cc1)[C@@H]2C[C@H]2c3ccc4cc(ccc4c3)C(=[NH2+])N,Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine,-10.251935,x1093,active-noncovalent
c1ccc2c(c1)c(nn2Cc3ccc(cc3Cl)Cl)C(=O)[O-],Lonidamine,-10.246520,x0678,active-noncovalent
c1ccc(cc1)C[NH+]2CCC(CC2)[C@@]3(CCC(=O)NC3=O)c4ccccc4,Dexetimide,-10.236910,x1077,active-noncovalent
C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C,Alfacalcidol,-10.218488,x0104,active-noncovalent
Cc1c(ccc2c1c(nc(n2)N)N)c3ccccc3,"5-methyl-6-phenylquinazoline-2,4-diamine",-10.217152,x1418,active-covalent
Cc1cccc(c1Nc2c3cncn3c(cn2)c4ccccc4)C,"N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",-10.217003,x0161,active-noncovalent
C[N@H+]1CC[C@@H]([C@@H](C1)O)c2c(cc(c3c2oc(cc3=O)c4ccccc4Cl)[O-])O,Alvocidib,-10.214050,x0195,active-noncovalent
C[C@]12CC[C@@H](CC1=C[C@@H]([C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C#C)O)C)O)O,HE3286,-10.213523,x0749,active-covalent
c1ccc(cc1)c2coc3ccccc3c2=O,Isoflavone,-10.211707,x0749,active-covalent
c1cc(ccc1C[C@@H](C(=O)[O-])[NH3+])CC(F)(F)F,"4-(2,2,2-TRIFLUOROETHYL)-L-PHENYLALANINE",-10.207756,x0830,active-covalent
C[C@@H](C(c1ccccc1)c2ccccc2)Nc3c4cc(c(cc4ncn3)F)F,"(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine",-10.205979,x0678,active-noncovalent
C[C@@H](CON=C1c2ccccc2-c3c1cccc3)C(=O)[O-],(2S)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methylpropanoic acid,-10.201475,x0678,active-noncovalent
Cn1cnc2c1c(c(c(c2)C#N)c3ccccc3Cl)C[NH3+],7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrile,-10.197589,x0195,active-noncovalent
Cc1[nH+]cc2n1-c3ccc(cc3C(=NC2)c4ccccc4F)Cl,Midazolam,-10.197142,x0161,active-noncovalent
Cc1ccc(cc1)C(=O)c2ccc(n2C)CC(=O)[O-],Tolmetin,-10.196149,x0749,active-covalent
c1ccc2c(c1)c(c3c([nH+]2)CCCC3)NCc4cccc(c4)I,"9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE",-10.189380,x0195,active-noncovalent
c1ccc(cc1)[C@@H]2[C@H]3CC[C@H](C3)[C@@]2(C(=O)c4ccccc4)[NH3+],(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE,-10.179537,x0434,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC=C4[C@@]3(CC[C@@H](C4)O)C,Androstenediol,-10.178667,x0749,active-covalent
c1ccc2c(c1)c(c[nH]2)CCC3CC[NH2+]CC3,Indalpine,-10.172886,x0072,active-noncovalent
c1cc2c(cccc2O)c(c1)c3nc4ccc(cc4o3)O,"2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL",-10.163948,x0749,active-covalent
CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)O)C)[C@@H]4C1=CC(=O)CC4,Nomegestrol,-10.160978,x0104,active-noncovalent
c1ccc2c(c1)c3c([nH]2)CN(CC3)C(=O)CCS,"3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One",-10.160679,x0749,active-covalent
C[NH2+][C@H]1Cc2ccccc2[C@@H](C1)c3ccccc3,"CP-39,332",-10.160624,x0072,active-noncovalent
c1ccc2c(c1)c(c[nH]2)[C@H]3[C@@H](C(=O)NC3=O)c4cn5c6c4cccc6CCC5,Tivantinib,-10.158295,x0195,active-noncovalent
C[C@@H]1C[C@]2([C@@H](CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4O)C)CC1=O)C,Drostanolone,-10.157775,x0749,active-covalent
C[C@@H](c1cccc(c1)Oc2ccccc2)C(=O)[O-],Fenoprofen,-10.157457,x0678,active-noncovalent
Cc1cc2c(c(c3cc(c[n+](c3c2nc1)C)C)C)C,"3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium",-10.156841,x0195,active-noncovalent
C[NH+](C)CCN(Cc1ccccc1)c2ccccn2,Tripelennamine,-10.154097,x0749,active-covalent
C1CC[C@H]([C@H](C1)c2[nH]c(=S)[nH]n2)C(=O)[O-],"(1R,2S)-2-(5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)cyclohexanecarboxylic acid",-10.153746,x0397,active-noncovalent
[2H]C([2H])([2H])Oc1cc2c(cc1OC([2H])([2H])[2H])[C@@H]3CC(=O)[C@H](C[N@H+]3CC2)CC(C)C,Deutetrabenazine,-10.153470,x0104,active-noncovalent
c1ccc2c(c1)c(c[nH]2)CCCC(=O)[O-],3-Indolebutyric Acid,-10.152559,x0072,active-noncovalent
c1ccc2c(c1)C(=O)C(=N2)c3c4cc(ccc4[nH]c3O)Br,5-Bromoindirubin,-10.152431,x0195,active-noncovalent
CC(=O)NCCc1c[nH]c2c1cc(cc2)O,N-acetylserotonin,-10.148422,x0678,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CCCC[C@H]34,Lynestrenol,-10.147342,x0749,active-covalent
c1ccc2c(c1)c(c3ccccc3[nH+]2)N,Aminacrine,-10.145630,x0749,active-covalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CC[C@]2(C#C)O)O,Ethinylestradiol,-10.145099,x0749,active-covalent
c1cnccc1c2[nH]c(nn2)c3ccnc(c3)C#N,Topiroxostat,-10.140364,x0749,active-covalent
COC(=O)[C@H]1[C@H](CC[C@@H]2[C@@H]1C[C@H]3c4c(c5ccccc5[nH]4)CC[N@@H+]3C2)O,Yohimbine,-10.129053,x0104,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=CC(=O)CC[C@H]34,19-norandrostenedione,-10.128485,x0749,active-covalent
C[NH+](C)CC/C=C\1/c2ccccc2COc3c1cccc3,Doxepin,-10.125546,x0104,active-noncovalent
CCCc1cc(c2c(c1)OC([C@H]3[C@H]2C=C(CC3)C)(C)C)O,Tetrahydrocannabivarin,-10.125142,x0195,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@H](C=C4[C@@]3(CC[C@@H](C4)O)C)O,HE-2200,-10.121007,x0749,active-covalent
c1cc2c(cc1C(=[NH2+])N)[nH]c(n2)C(c3[nH]c4cc(ccc4n3)C(=[NH2+])N)(O)O,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,-10.119225,x0395,active-noncovalent
c1ccc(cc1)c2ccc(cc2)Cn3ccnc3,1-(biphenyl-4-ylmethyl)-1H-imidazole,-10.117471,x0678,active-noncovalent
c1ccc2c(c1)c(ccc2N(=O)=O)N3C(=O)[C@@H]4[C@H](C3=O)C5CCC4CC5,"(3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)",-10.116779,x0749,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@@H]4[C@@]3(C=CC(=O)C4)C,1-Testosterone,-10.116395,x0749,active-covalent
[H]/N=c\1/cc2cccc3c(=O)n(c(=O)c(c1)[C@@H]23)CC[NH+](C)C,Amonafide,-10.097839,x0195,active-noncovalent
C[C@]12CCC(=O)C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4O)C,Stanolone,-10.097753,x0749,active-covalent
c1ccc(cc1)[C@@H](c2ccc(cc2)c3c4c([nH]cn4)ncn3)[NH3+],(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,-10.090278,x0161,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC=C4[C@@]3(CCC(=O)C4)C,5-androstenedione,-10.089784,x0749,active-covalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CC[C@]2(C#C)O)OC,Mestranol,-10.084953,x0749,active-covalent
Cc1cc(c(c(c1)Br)O)c2[nH]c3cc(ccc3n2)C(=[NH2+])N,CRA_9334,-10.084724,x0107,active-noncovalent
C[C@]12CCC(=O)C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C,Androstanedione,-10.084422,x0749,active-covalent
C[C@@]1(CC[C@@H]2[C@@]1(C=CC3=C4CCC(=O)C=C4CC[C@@H]23)C)O,Metribolone,-10.076726,x0749,active-covalent
Cc1c(c2cc(ccc2n1Cc3ccccc3)OC)CC(=O)[O-],(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid,-10.071774,x0830,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(CC=C)O)CCC4=CCCC[C@H]34,Allylestrenol,-10.066011,x0749,active-covalent
Cn1c2ccccc2c(n/c(=N\C(=O)[C@@H]3Cc4cccc5c4[N@@]3CCC5)/c1=O)c6ccccc6,Tarazepide,-10.065496,x0195,active-noncovalent
c1cc(ccc1N)S(=O)(=O)Nc2ccc(nn2)Cl,Sulfachlorpyridazine,-10.063926,x0678,active-noncovalent
c1ccc(cc1)c2cc(=O)c3c4ccccc4ccc3o2,beta-Naphthoflavone,-10.063298,x0195,active-noncovalent
Cn1cc(c2c1cccc2)C(=O)[C@@H]3CCc4c(nc[nH]4)C3,Ramosetron,-10.062973,x0678,active-noncovalent
Cc1c(ccc2c1nc(c3c2c4cc(c(cc4nc3)OC)OC)N)N,"10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine",-10.062973,x0195,active-noncovalent
Cc1c(noc1NS(=O)(=O)c2ccc(cc2)N)C,Sulfisoxazole,-10.062277,x0678,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC=C2)CC[C@@H]4[C@@]3(CC[C@H](C4)O)C,"16,17-Androstene-3-Ol",-10.061821,x0749,active-covalent
c1cc(ccc1C[NH3+])NC(=O)c2ccc3cc(ccc3c2)C(=[NH2+])N,6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine,-10.058638,x0161,active-noncovalent
Cc1cccc2c1C(=O)N(C2=O)c3ccnc(c3)Cl,"2-(2-chloropyridin-4-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",-10.051485,x0749,active-covalent
CC/C=C\c1cc2c(cc1O)CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4O)C,"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",-10.049177,x0946,active-noncovalent
C[C@@]1(c2ccccc2N(C1=O)c3ccccc3)CCC[NH2+]C,Amedalin,-10.040892,x0749,active-covalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C,Methyltestosterone,-10.039907,x0749,active-covalent
CCN(CC)C(=O)C1=C[C@H]2c3cccc4c3c(c[nH]4)C[C@H]2[N@H+](C1)C,Lysergic acid diethylamide,-10.039042,x0831,active-covalent
c1cc2c(cc1F)c(=O)c3cc(c(nc3o2)N)C(=O)N,"2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide",-10.038277,x0749,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(COC(=O)C4)C,Oxandrolone,-10.027637,x0749,active-covalent
c1cc2c(cc1F)c(c[nH]2)CCCOP(=O)([O-])[O-],5-FLUOROINDOLE PROPANOL PHOSPHATE,-10.026001,x0831,active-covalent
Cc1ccc2c(c1)c3c4n2CC[NH2+][C@H]4CCC3,Pirlindole,-10.021654,x0195,active-noncovalent
c1cc(c(nc1)c2[nH]c3cc(ccc3n2)C(=[NH2+])N)O,CRA_1801,-10.018373,x0678,active-noncovalent
c1ccc2c(c1)c(c([nH]2)O)C3=Nc4ccccc4C3=O,Indirubin,-10.012036,x0195,active-noncovalent
C1[C@@H]2C[C@@H]2N([C@@H]1C#N)C(=O)[C@H](C34C[C@H]5C[C@@H](C3)CC(C5)(C4)O)[NH3+],"(1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1",-10.010939,x0749,active-covalent
c1cc2c(nc1)O[C@@]3(C2)C[NH+]4CCC3CC4,AZD-0328,-10.009050,x0195,active-noncovalent
C[C@@]12CC[N@H+]([C@@H]1[N@@](c3c2cc(cc3)OC(=O)Nc4ccccc4)C)C,Phenserine,-10.007851,x0946,active-noncovalent
c1cc(cc(c1)Cl)c2nc(on2)SCC(=O)[O-],"Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol",-10.003502,x0678,active-noncovalent
Cc1ccccc1c2cc3cc(ccc3[nH]2)C(=[NH2+])N,2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,-10.002663,x0749,active-covalent
c1cc2c(c(c1)[O-])C(=O)c3c(ccc(c3[O-])CC(=O)[O-])C2,Acetyl Dithranol,-10.000976,x0749,active-covalent
CC(C)(C)c1[nH]c2c3cc[nH]c(=O)c3c4cc(ccc4c2n1)F,"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-",-9.996657,x0749,active-covalent
C[N@H+]1Cc2c(cccc2N)[C@@H](C1)c3ccccc3,Nomifensine,-9.995811,x0104,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C[C@H](CC[C@H]34)O,Bolandiol,-9.994949,x0749,active-covalent
C[NH+](C)CCCNC(=O)c1cccc2c1[nH+]c3ccccc3c2N,9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide,-9.992680,x0104,active-noncovalent
COc1ccc(cc1)CCc2c3c(cc4c2nc[nH]4)c(=O)[nH]c(n3)N,"6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-O",-9.990961,x0967,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)c4ccc(cc4)O)CC=C5[C@@]3(CCC(=C5)C(=O)[O-])C,"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene",-9.990626,x0104,active-noncovalent
c1c(c2c([nH]1)ncnc2[N@]3CCc4c([nH]cn4)C3)Cl,"5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c",-9.987360,x1334,active-covalent
C[C@]12CC[C@@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3C[C@H](C4=O)Br)C)O,16-Bromoepiandrosterone,-9.986480,x0749,active-covalent
c1cc(ccc1[C@H]2[C@H]3CCC[C@H]3c4cc(ccc4O2)O)O,Erteberel,-9.984001,x0749,active-covalent
C[C@]12CCC(=O)C(=O)[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C,Formestane,-9.982073,x0749,active-covalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C,Androstenedione,-9.974551,x0749,active-covalent
C[NH2+][C@@H]1CCc2c(c3cc(ccc3[nH]2)C(=O)N)C1,Frovatriptan,-9.971147,x0749,active-covalent
CC/[NH+]=C\1/Nc2ccc(cc2[C@@](O1)(C)c3ccccc3)Cl,Etifoxine,-9.962926,x0305,active-noncovalent
c1ccc2c(c1)[nH]c(n2)c3cscn3,Thiabendazole,-9.962716,x0678,active-noncovalent
CC[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C)O,Norethandrolone,-9.962214,x0749,active-covalent
C[NH+](C)CCC=C1c2ccccc2C=Cc3c1cccc3,Cyclobenzaprine,-9.961802,x0195,active-noncovalent
CC(=O)c1ccc2c(c1)N(c3ccccc3S2)CCC[NH+](C)C,Acepromazine,-9.957523,x0161,active-noncovalent
c1ccc2c(c1)c(nnc2Nc3ccc(cc3)Cl)Cc4ccncc4,Vatalanib,-9.954937,x0195,active-noncovalent
CC1(CCC(c2c1ccc(c2)C(=O)/C=C/c3ccc(cc3)C(=O)[O-])(C)C)C,"4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Be",-9.951847,x0161,active-noncovalent
C[NH2+]CCCC12CCC(c3c1cccc3)c4c2cccc4,Maprotiline,-9.946642,x0195,active-noncovalent
c1cc(ccc1C2=C(c3ccc(cc3C2=O)O)Br)O,3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE,-9.944729,x0749,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C,Testosterone,-9.943193,x0749,active-covalent
Cc1cccc2c1C(=O)N(C2=O)c3cc(ccc3O)c4ccccc4,"2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",-9.941304,x0195,active-noncovalent
c1ccc(c(c1)c2cc3cc(ccc3[nH]2)C(=[NH2+])N)O,2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,-9.938999,x0749,active-covalent
Cc1cc(n2c(n1)ncn2)Nc3ccc4cc5ccccc5cc4c3,"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",-9.937044,x0104,active-noncovalent
C[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C)O,BA-2664,-9.936911,x0749,active-covalent
C[C@@H](c1ccc(c(c1)F)c2ccccc2)C(=O)OC,Flurbiprofen Methyl Ester,-9.935732,x0161,active-noncovalent
c1cc2ccc3cc2c(c1)N4CC[C@H](C4=O)[NH2+]Cc5cncn5Cc6ccc(c(c6)O3)C#N,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18",-9.933512,x0195,active-noncovalent
c1ccc2c(c1)c(c3n2c4ccccc4c(=O)[nH]3)CC(=O)[O-],"(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid",-9.933271,x1392,active-covalent
c1ccn(c1)CCOc2ccc3c(c2)cc[nH]3,5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole,-9.930014,x0678,active-noncovalent
c1ccc(cc1)c2c3cccc(c3[nH]c2c4ccccc4)C(=O)[O-],"2,3-diphenyl-1H-indole-7-carboxylic acid",-9.926270,x1418,active-covalent
c1ccc2c(c1)c(c[nH]2)c3c(c([nH]c3C(=O)[O-])C(=O)[O-])c4c[nH]c5c4cccc5,"3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID",-9.925931,x1392,active-covalent
C[C@]12CCCCC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3C[C@H](C4=O)F)C,Fluasterone,-9.924752,x0749,active-covalent
c1cc(cc2c1cc(cc2)C(F)(F)P(=O)([O-])[O-])C(=O)[O-],6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID,-9.922787,x0749,active-covalent
C[C@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]([C@]4(CC3)C)(C)O)C,Calusterone,-9.921382,x0749,active-covalent
c1ccc(cc1)C(=O)Nc2cn[nH]c2c3[nH]c4ccccc4n3,N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE,-9.920585,x0749,active-covalent
COc1ccc(cc1)Oc2cccc3c2c(nc(n3)N)N,"5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine",-9.919506,x0678,active-noncovalent
c1ccc(cc1)c2cc(=O)c3ccc4ccccc4c3o2,2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE,-9.917702,x0195,active-noncovalent
C[C@@H](c1ccc(cc1)c2ccccc2)C(=O)[O-],"2-(1,1'-Biphenyl-4-Yl)Propanoic Acid",-9.916240,x0678,active-noncovalent
C[C@@H]1CC(=O)N=N[C@H]1c2ccc(cc2)/N=N/C(C#N)C#N,Levosimendan,-9.912669,x0749,active-covalent
C[C@@]1(CCC[N@@H+]2[C@@H]1c3c(c4ccccc4o3)CC2)COC,ORM-12741,-9.912396,x0104,active-noncovalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)OC(=O)c3c[nH]c4c3cccn4,"(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOX",-9.911579,x0072,active-noncovalent
c1ccc(c(c1)[C@@H]2c3cc(ccc3N(C(=S)C=N2)CC(F)(F)F)Cl)F,Quazepam,-9.911168,x0434,active-noncovalent
C[C@@H]1C[N@@H+]1C2=CC(=O)c3c(c(c(n3C)c4ccccc4)CO)C2=O,"3-(HYDROXYMETHYL)-1-METHYL-5-(2-METHYLAZIRIDIN-1-YL)-2-PHENYL-1H-INDOLE-4,7-DION",-9.909996,x0195,active-noncovalent
c1cc(c(c(c1)F)c2ccc(cc2)C(=O)[O-])F,"2',6'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID",-9.909955,x0749,active-covalent
c1ccc(cc1)CNc2c3ccccc3[nH+]c4c2CCCC4,9-N-Phenylmethylamino-Tacrine,-9.908722,x0195,active-noncovalent
c1ccc2c(c1)[nH]c(n2)c3cc[nH]n3,2-(1H-pyrazol-3-yl)-1H-benzimidazole,-9.903585,x0195,active-noncovalent
c1ccc(cc1)CNc2cccnc2N,"N~3~-BENZYLPYRIDINE-2,3-DIAMINE",-9.902380,x0195,active-noncovalent
Cc1cccc(n1)c2c(c3n(n2)CCC3)c4ccc(cc4)F,"3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazol",-9.901592,x0434,active-noncovalent
c1ccc(cc1)c2cc3c(c4cc(ccc4[nH]3)O)c5c2C(=O)NC5=O,"9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE",-9.895704,x0195,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(C=CC(=O)C4)C,Methyl-1-testosterone,-9.895525,x0749,active-covalent
Cc1ccccc1O[C@H](CC[NH2+]C)c2ccccc2,Atomoxetine,-9.891411,x0434,active-noncovalent
CC(=O)c1ccc(cc1)N2C[C@H](CC2=O)C(=O)[O-],(3S)-1-(4-acetylphenyl)-5-oxopyrrolidine-3-carboxylic acid,-9.884806,x0678,active-noncovalent
c1ccc(c(c1)C(=O)[O-])Nc2cccc(c2)C(F)(F)F,Flufenamic acid,-9.884418,x1093,active-noncovalent
Cc1cccc(n1)c2nc3ccccc3c(n2)Nc4ccncc4,2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine,-9.884365,x0195,active-noncovalent
CC[C@]12CC[C@H]3[C@H]([C@@H]1C=C[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,Gestodene,-9.883617,x0749,active-covalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CCC(=O)C4)C)C,"(5BETA)-PREGNANE-3,20-DIONE",-9.882681,x0749,active-covalent
COc1ccc(cc1C23CC4CC(C2)CC(C4)C3)c5ccc6cc(ccc6c5)C(=O)[O-],Adapalene,-9.871438,x0104,active-noncovalent
C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2C[C@H]([C@]4([C@@]3(CC[C@@H]4C5=CC(=O)OC5)O)C)O)O,Digoxigenin,-9.870768,x0678,active-noncovalent
CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CC[C@@H]4[C@@H]3CCC(=C4)N=O,Norelgestromin,-9.870210,x0749,active-covalent
Cc1[nH]c2cc3c(cc2n1)nc([nH]c3=O)N,"6-amino-2-methyl-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",-9.869997,x0107,active-noncovalent
c1c2c(cc(c1F)N3CC[NH2+]CC3)n(cc(c2=O)C(=O)[O-])C4CC4,Ciprofloxacin,-9.866356,x0749,active-covalent
C[C@H]1C2=C([C@@H]3[C@@H](O1)CC(=O)O3)C(=O)c4cccc(c4C2=O)[O-],Nanaomycin D,-9.864988,x0749,active-covalent
c1ccc(c(c1)c2cc(ccn2)c3cc4c([nH]3)CCNC4=O)F,"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4",-9.864575,x0107,active-noncovalent
c1ccc(cc1)c2cccc(c2O)c3cc4cc(c(cc4[nH]3)Cl)C(=[NH2+])N,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,-9.861497,x0161,active-noncovalent
C[N@@H+]1CC[N@]2c3ccccc3Cc4ccccc4[C@@H]2C1,Mianserin,-9.861363,x0072,active-noncovalent
c1c/2[n-]c(c1)/cc/3\nc(/cc/4\[n-]/c(c\c5n/c(c2)/C=C5)/cc4)C=C3,Porphyrin Fe(III),-9.853448,x0195,active-noncovalent
c1cc2c(cnn2nc1)c3ccnc(n3)NC4CC4,"N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",-9.852198,x0749,active-covalent
CC[C@@]1(CC[C@@H]2[C@@]1(C=CC3=C4CCC(=O)C=C4CC[C@@H]23)CC)O,"17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE",-9.847711,x0749,active-covalent
C[NH+](C)CCCN1c2ccccc2Sc3c1cccc3,Promazine,-9.841721,x0874,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C\C=C\C(=C\C(=O)[O-])\C)/C,Alitretinoin,-9.841584,x0678,active-noncovalent
CC[C@]12CC[C@H]3[C@H]([C@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,Norgestrel,-9.838452,x0749,active-covalent
C[N@H+]1CCC2=C(C1)[C@@H](c3c2cccc3)c4ccccc4,Phenindamine,-9.834886,x1418,active-covalent
Cc1nnc2n1-c3ccc(cc3[C@@H](N=C2)c4ccccc4)Cl,Alprazolam,-9.834808,x1077,active-noncovalent
c1c(nc[nH]1)C[C@@H](C(=O)[O-])[NH3+],Histidine,-9.834416,x0397,active-noncovalent
CC[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CCCC[C@H]34)C)O,Ethylestrenol,-9.829795,x0749,active-covalent
c1cc(ccc1[C@@H]2CC(=O)c3c(cc(cc3O2)O)[O-])O,Naringenin,-9.825522,x0749,active-covalent
c1cc(ccc1CN(Cc2ccc(cc2)Cl)c3n[n-]nn3)Cl,"N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine",-9.822378,x0678,active-noncovalent
CC1(CCC(c2c1ccc(c2)[C@H](c3ccc4cc(ccc4c3)C(=O)[O-])N=O)(C)C)C,SR11254,-9.815429,x0161,active-noncovalent
c1cc2ccc3ccc(nc3c2nc1)C[C@@H](C(=O)[O-])[NH3+],"3-(1,10-Phenanthrol-2-Yl)-L-Alanine",-9.815008,x0195,active-noncovalent
Cc1cccc(c1C)Nc2ccccc2C(=O)[O-],Mefenamic acid,-9.810359,x0749,active-covalent
CC[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(C#C)O,Gestrinone,-9.808918,x0749,active-covalent
C[NH+](C)CC/C=C\1/c2ccccc2Sc3c1cc(cc3)Cl,Chlorprothixene,-9.799965,x0104,active-noncovalent
c1ccc(cc1)C(=O)NC[C@@H](C(=O)[O-])[NH3+],3-(Benzoylamino)-L-Alanine,-9.795436,x0678,active-noncovalent
c1ccc2c(c1)N(c3cc(ccc3S2)C#N)CCC[NH+]4CCC(CC4)O,Periciazine,-9.791709,x0104,active-noncovalent
CC(C)(C(=O)[O-])Sc1ccncc1c2ccc(c3c2cccc3)C#N,Verinurad,-9.784450,x0830,active-covalent
c1ccc(cc1)c2cnc(c3n2cnc3)Nc4ccccc4Cl,"N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",-9.784328,x0195,active-noncovalent
Cc1cc2c(s1)c3cnn(c(=O)c3n2C)Cc4ccccc4F,"6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]py",-9.781904,x0104,active-noncovalent
Cc1ccc2c(c1)c3c(n2CCc4ccc(nc4)C)CC[N@H+](C3)C,Latrepirdine,-9.780933,x0678,active-noncovalent
c1cc(ccc1c2c[nH]nc2)[C@@H](C[NH3+])c3ccc(cc3)Cl,(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,-9.776078,x0107,active-noncovalent
c1cn(cn1)CC(=O)C23CC4CC(C2)CC(C4)C3,1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone,-9.775269,x0678,active-noncovalent
C[NH+](C)CC/C=C\1/c2ccccc2COc3c1cc(cc3)CC(=O)[O-],Olopatadine,-9.771244,x0678,active-noncovalent
Cc1ccnc2c1ccc3c2nccc3C,"4,7-Dimethyl-[1,10]Phenanthroline",-9.769610,x0749,active-covalent
c1ccc2c(c1)c3c(n(c2=O)CCCC(=O)[O-])-c4ccccc4C3=O,"4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE",-9.769316,x0195,active-noncovalent
c1ccc(cc1)c2cccc(c2O)c3[nH]c4cc(c(cc4n3)C(=[NH2+])N)Cl,CRA_10762,-9.765903,x0161,active-noncovalent
C[C@]12CCC(=O)C(=O)[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4O)C,4-Hydroxytestosterone,-9.763376,x0749,active-covalent
c1ccc(cc1)[C@](CC[NH+]2CCCCC2)([C@H]3C[C@@H]4C[C@H]3C=C4)O,Biperiden,-9.761608,x0678,active-noncovalent
CC(C)(C)c1cc(c(cc1O)C(C)(C)C)O,"2,5-DI-(TERT-BUTYL)-1,4,BENZOHYDROQUINONE",-9.760643,x0749,active-covalent
c1ccc2c(c1)CCC[C@H]2C3=[NH+]CCN3,Tetryzoline,-9.759826,x0195,active-noncovalent
c1cc(c(cc1CC[NH3+])C2CCCCC2)O,4-(2-aminoethyl)-2-cyclohexylphenol,-9.756968,x0072,active-noncovalent
c1ccc(cc1)COc2cccnc2N,3-(Benzyloxy)Pyridin-2-Amine,-9.754707,x0678,active-noncovalent
C[C@@H](c1ccc(s1)C(=O)c2ccccc2)C(=O)[O-],Tiaprofenic acid,-9.752036,x0678,active-noncovalent
c1cc2c(cc1O)Oc3cc(ccc3C2CCC(=O)[O-])O,"3,6-dihydroxy-xanthene-9-propionic acid",-9.747395,x1392,active-covalent
c1ccc2c(c1)c(c[nH]2)C[C@@H](C(=O)N)[NH3+],L-Tryptophanamide,-9.744668,x0195,active-noncovalent
Cc1cc(ccc1O)c2cc(nc(=O)[nH]2)c3ccccc3,4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one,-9.741743,x1093,active-noncovalent
c1ccc(cc1)CC[NH+]2CCC3(CC2)CNC(=O)O3,Fenspiride,-9.741241,x0678,active-noncovalent
CC[C@H](c1ccc(cc1)O)[C@@H](CC)c2ccc(cc2)O,Hexestrol,-9.736449,x0749,active-covalent
c1cc(ccc1/N=N/c2c([nH]nc2N)N)O,"4-[(E)-(3,5-DIAMINO-1H-PYRAZOL-4-YL)DIAZENYL]PHENOL",-9.735858,x0749,active-covalent
Cc1ccc(cc1)N(CC2=[NH+]CCN2)c3cccc(c3)O,Phentolamine,-9.731118,x0104,active-noncovalent
c1ccc(cc1)[C@@H]2CC(=O)c3ccc(cc3O2)O,"5,4'-Dideoxyflavanone",-9.725934,x0749,active-covalent
c1cnccc1SSc2ccncc2,"4,4'-DIPYRIDYL DISULFIDE",-9.725857,x0072,active-noncovalent
Cn1c2cc(cnc2nc1N)c3ccc(cc3)O,"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",-9.716659,x0749,active-covalent
C[C@@]1([C@@H](Nc2c(=O)[nH]c(nc2N1)N)C=O)CCc3ccccc3,"7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin",-9.714854,x0678,active-noncovalent
C[C@@H](c1ccc2cc(ccc2c1)OC)C(=O)[O-],Naproxen,-9.712101,x0749,active-covalent
c1ccc2c(c1)c(c3c([nH+]2)CCCC3)N,Tacrine,-9.708664,x0749,active-covalent
c1cc(sc1)c2ccc(cc2)C[NH3+],1-(4-thiophen-2-ylphenyl)methanamine,-9.708050,x0161,active-noncovalent
COc1ccc2c(c1)c3c(s2)C(=O)N[C@@H](CN3)C[NH3+],"(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]d",-9.705943,x0749,active-covalent
c1ccnc(c1)C#CCCc2cn3cc(ccc3[nH+]2)F,Dipraglurant,-9.704144,x1093,active-noncovalent
c1ccc2c(c1)CN(C(=O)O2)CC(=O)N,Caroxazone,-9.703465,x0195,active-noncovalent
c1cc2cn(nc2c(c1)N(=O)=O)C(=[NH2+])N,7-Nitroindazole-2-Carboxamidine,-9.702150,x0195,active-noncovalent
C[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4O)C)O,"5alpha-androstane-3alpha,17beta-diol",-9.701172,x0749,active-covalent
c1ccc(cc1)c2cccc(c2O)O,"Biphenyl-2,3-Diol",-9.699683,x0195,active-noncovalent
C[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]([C@]4(CC3)C)(C)O)C,Bolasterone,-9.697890,x0749,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=Cc5c(cno5)C[C@]34C,Danazol,-9.696914,x0749,active-covalent
c1ccc(cc1)c2cc3c(c[nH]c3nc2)c4ccc(cc4)C(=O)[O-],"4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",-9.694307,x0104,active-noncovalent
c1ccc(cc1)c2ccc(cc2)CC(=O)[O-],Felbinac,-9.689272,x0749,active-covalent
COc1ccc(cc1)n2cnc3c2cc(cc3)c4n[nH]c(=S)o4,"5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione",-9.688055,x0749,active-covalent
c1ccc2c(c1)[C@]3(COc4c3cc5c(c4)OCO5)C(=O)N2Cc6ccc(o6)C(F)(F)F,Funapide,-9.686974,x0434,active-noncovalent
Cc1cc(n(c1C(=O)c2ccc(cc2)Cl)C)CC(=O)[O-],Zomepirac,-9.684780,x0830,active-covalent
CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@]4([C@H]([C@@H]3CCC2=C1)CC[C@]4(C#C)OC(=O)C)C,Ethynodiol diacetate,-9.683345,x0104,active-noncovalent
c1ccc2c(c1)c(c([nH]2)c3c4ccc(cc4[nH]c3O)Br)N=O,6-bromoindirubin-3'-oxime,-9.681839,x0195,active-noncovalent
c1ccc2c(c1)c(c[nH]2)CCc3ccncc3,Inhibitor of P38 Kinase,-9.679056,x0195,active-noncovalent
c1ccc(cc1)c2c(c(cs2)[N@@]3CC(=O)NS3(=O)=O)Cl,"5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",-9.678338,x0749,active-covalent
B(c1ccc(cc1)/C=C/C(=O)[O-])(O)O,4-(Carboxyvin-2-Yl)Phenylboronic Acid,-9.678303,x0678,active-noncovalent
c1ccc2c(c1)Nc3ccccc3S2,Phenothiazine,-9.673660,x0749,active-covalent
Cc1ccc2c(=O)c3cccc(c3oc2c1C)CC(=O)[O-],Vadimezan,-9.673493,x0195,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC[C@@H]4[C@@]3(C=CC(=O)C4)C,1-Androstenedione,-9.671797,x0749,active-covalent
CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)[C@@H]5C[C@@H]5[C@]34C)Cl)C)OC(=O)C,Cyproterone acetate,-9.666415,x0874,active-noncovalent
C[C@H]1CCc2cc(cc3c2n1cc(c3=O)C(=O)[O-])F,Flumequine,-9.666282,x0195,active-noncovalent
C[C@@H](c1cc2ccccc2s1)N(C(=O)N)O,Zileuton,-9.663414,x0749,active-covalent
C[NH+]1CCC(=C2c3ccccc3CCn4c2[nH+]cc4C=O)CC1,Alcaftadine,-9.661277,x0195,active-noncovalent
c1ccc2c(c1)NC(=O)C(O2)(c3ccc(cc3)O)c4ccc(cc4)O,Bisoxatin,-9.661194,x1093,active-noncovalent
c1cc(ccc1N)S(=O)(=O)c2ccc(cc2)NCC(=O)[O-],Acediasulfone,-9.660825,x0072,active-noncovalent
c1ccc(cc1)C2=C(c3ccccc3C2=O)[O-],Phenindione,-9.660164,x0749,active-covalent
C[C@H](C[C@@H]1CCCC[N@H+]1C)C[C@@H](C)c2ccccc2,"(2S)-1-methyl-2-[(2S,4R)-2-methyl-4-phenylpentyl]piperidine",-9.658806,x0195,active-noncovalent
CCC1(Cc2ccccc2C1)c3cnc[nH]3,Atipamezole,-9.654212,x0161,active-noncovalent
c1cc(ccc1c2ccc(cc2)OC[C@@H]3C[C@H](C(=O)N3)CC(=O)[O-])C(=[NH2+])N,Fradafiban,-9.654033,x0104,active-noncovalent
c1cc(ccc1CC2CC[NH2+]CC2)F,4-(4-FLUOROBENZYL)PIPERIDINE,-9.653991,x0195,active-noncovalent
Cc1ccc2c(c1)c3c(n2CCC[NH3+])cc(c4c3C(=O)NC4=O)C,"6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",-9.652295,x0195,active-noncovalent
c1csc(n1)NC(=O)C(=O)NC2CCCC2,N1-CYCLOPENTYL-N2-(THIAZOL-2-YL)OXALAMIDE,-9.648842,x0678,active-noncovalent
c1ccc(cc1)c2cccc(c2O)c3[nH]c4ccc(cc4n3)C(=[NH2+])N,"2-{2-hydroxy-[1,1'-biphenyl]-3-yl}-1H-1,3-benzodiazole-5-carboximidamide",-9.645448,x0161,active-noncovalent
C1CSCc2c1c(c(s2)NC(=O)C(=O)[O-])C(=O)[O-],"2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Thiopyran-3-Carboxylic Acid",-9.644593,x1478,active-covalent
Cc1cc(cc(c1O)C)/N=N/c2ccccc2C(=O)[O-],"2-((3',5'-DIMETHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID",-9.644226,x0749,active-covalent
Cc1ccc(c(c1)Cc2c3c(ncnc3n(n2)C(C)(C)C)N)C,"1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE",-9.643802,x0161,active-noncovalent
CNC1=[NH+]c2ccc(cc2C(=N(=O)C1)c3ccccc3)Cl,Chlordiazepoxide,-9.643092,x0161,active-noncovalent
CCC[N@@H+]1C[C@@H](C[C@H]2[C@H]1Cc3c[nH]c4c3c2ccc4)CSC,Pergolide,-9.642730,x0104,active-noncovalent
c1ccc(cc1)c2ccc(c(c2)O)O,"1,1'-BIPHENYL-3,4-DIOL",-9.640567,x0195,active-noncovalent
CCC(=O)O[C@@]1(CC[N@@H+](C[C@@H]1CC=C)C)c2ccccc2,Allylprodine,-9.639481,x0678,active-noncovalent
CCC[C@]1(C(=O)N/C(=[NH+]/C2CCCCCCC2)/S1)C,"(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one",-9.638379,x0749,active-covalent
c1cc(ccc1c2cc3cc(cc(c3o2)CC#N)O)O,[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,-9.635464,x0749,active-covalent
c1cc(cc(c1)Nc2c(cccn2)C(=O)[O-])C(F)(F)F,Niflumic acid,-9.634744,x0195,active-noncovalent
COc1cccc(c1)c2[nH]c3cccc(c3n2)C(=O)N,2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,-9.633945,x0749,active-covalent
C[C@]12CC[C@@H]3c4cc(c(cc4CC[C@H]3[C@@H]1CC=C2)C(=O)N)OC,ENMD-1198,-9.633458,x0749,active-covalent
c1cc2c(cc1C(=[NH2+])N)cc([nH]2)c3cc(cc(c3O)Br)CC(=O)[O-],CRA_9678,-9.632359,x0749,active-covalent
C[C@H]1[C@H]2Cc3ccc(cc3[C@@]1(CC[N@@H+]2CC=C(C)C)C)O,Pentazocine,-9.632236,x0678,active-noncovalent
Cc1cc([n+](c(c1)C)CCc2ccc(cc2)S(=O)(=O)N)C,"1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM",-9.632211,x0161,active-noncovalent
CC[NH+](CC)CCNc1ccc(c2c1c(=O)c3ccccc3s2)C,Lucanthone,-9.628585,x0195,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CC[C@]2(C#C)O)OC5CCCC5,Quinestrol,-9.620751,x0104,active-noncovalent
CCCCCCCc1ccc(cc1)O,Heptanyl-P-Phenol,-9.620426,x0749,active-covalent
C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4n5cnc6c5cccc6)C)O,Galeterone,-9.616874,x0161,active-noncovalent
C[NH+](C)CCC=C1c2ccccc2CCc3c1cccc3,Amitriptyline,-9.616800,x0874,active-noncovalent
c1ccc(cc1)/N=N/c2ccc(nc2N)N,Phenazopyridine,-9.614861,x0749,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=CC(=O)C=C[C@]34C,"ANDROSTA-1,4-DIENE-3,17-DIONE",-9.612382,x0749,active-covalent
c1ccc(cc1)Cn2c3c(c4c2c(ccc4)C(=O)[O-])CCCC3,"9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid",-9.611747,x0195,active-noncovalent
c1ccc2c(c1)c(c[nH]2)C[C@@H]([NH3+])O,(1S)-1-AMINO-2-(1H-INDOL-3-YL)ETHANOL,-9.611294,x0195,active-noncovalent
CN1c2ccc(cc2[C@@H](N=CC1=O)c3ccccc3)Cl,Diazepam,-9.608867,x1077,active-noncovalent
c1cc(ccc1c2c(c(=O)c3c(cc(cc3o2)O)[O-])[O-])O,Kaempherol,-9.605663,x0749,active-covalent
c1ccc(cc1)c2cccc(c2O)c3cc4cc(ccc4[nH]3)C(=[NH2+])N,CRA_8696,-9.604443,x0874,active-noncovalent
C1CC[C@H]2[C@H](C1)CC[N@@H+]2C[C@H]3CC[C@H]4[C@@H](C3)[C@@H]([NH2+][C@@H](N4)N)N,"6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine",-9.604060,x1093,active-noncovalent
CC[NH+](CC)[C@@H](C)CN1c2ccccc2Sc3c1cccc3,Profenamine,-9.603622,x0195,active-noncovalent
c1ccc2c(c1)[C@@H](CC[C@H]2[NH3+])c3ccc(c(c3)Cl)Cl,Dasotraline,-9.601754,x0104,active-noncovalent
CC(C)n1c2c(c(n1)c3ccc4c(c3)cccn4)c(ncn2)N,"1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",-9.601428,x0678,active-noncovalent
c1ccc(cc1)COc2ccc(cc2)NC(=O)C[NH3+],N-[4-(benzyloxy)phenyl]glycinamide,-9.600570,x1093,active-noncovalent
Cc1c2ccccc2c(c3c1cccc3)CCC(=O)[O-],3-(10-methyl-9-anthryl)propanoic acid,-9.596895,x1418,active-covalent
CC/C(=C(/CC)\c1ccc(cc1)O)/c2ccc(cc2)O,Diethylstilbestrol,-9.595503,x0678,active-noncovalent
C1C[NH2+]Cc2c1c(c(s2)NC(=O)C(=O)[O-])C(=O)[O-],"2-(Oxalyl-Amino)-4,5,6,7-Tetrahydro-Thieno[2,3-C]Pyridine-3-Carboxylic Acid",-9.594749,x1478,active-covalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C,Sepranolone,-9.593403,x0749,active-covalent
c1ccc2c(c1)c(ccc2c3ccc(cc3)O)CN=O,4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME,-9.591529,x0830,active-covalent
c1cc(ccc1c2ccc(cc2)F)C(=O)[O-],"4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID",-9.590690,x0749,active-covalent
C[NH2+]Cc1ccc(cc1)c2c3c([nH]cn3)ncn2,N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,-9.586765,x0749,active-covalent
c1ccc2c(c1)c(c(nc2Cl)C(=O)NCC(=O)[O-])O,FG-2216,-9.583687,x0830,active-covalent
c1ccc(cc1)c2c3c(ncnc3oc2c4ccccc4)NCC(=O)[O-],"N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE",-9.583276,x0830,active-covalent
CCc1c2cc(ccc2nn1c3ccc(cc3)O)O,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,-9.583135,x0749,active-covalent
c1ccc(cc1)C(=O)c2cccc(c2N)CC(=O)N,Nepafenac,-9.576254,x0749,active-covalent
c1ccc2c(c1)CCn3c(c[nH+]c3C24CC[NH2+]CC4)C(=O)N,Vapitadine,-9.574443,x1386,active-covalent
c1ccc(cc1)c2ccc3nnc(n3n2)Cc4ccc(cc4)O,"4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol",-9.572967,x0104,active-noncovalent
c1ccc(cc1)COc2ccc(cc2)O,Monobenzone,-9.571682,x0072,active-noncovalent
c1ccc(cc1)C2=NCc3nncn3-c4c2cc(cc4)Cl,Estazolam,-9.570478,x0708,active-covalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,Pregnenolone,-9.569349,x0749,active-covalent
c1cc2c(c(c(n2O)c3ccncc3)c4ccc(cc4)F)nc1,"3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine",-9.567225,x0195,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@H]2O)CCC4=CC(=O)CC[C@]34C,Epitestosterone,-9.564961,x0749,active-covalent
c1ccc(c(c1)c2nc(no2)c3cccc(c3)C(=O)[O-])F,Ataluren,-9.564470,x0749,active-covalent
Cc1cccc(c1)c2cc3cc(ccc3[nH]2)C(=[NH2+])N,2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,-9.563510,x0678,active-noncovalent
c1cc(ccc1n2c(c3cc(ccc3n2)O)Cl)O,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,-9.560147,x0749,active-covalent
c1cc(cc2c1ccc(c2)C(F)(F)P(=O)([O-])[O-])C(F)(F)P(=O)([O-])[O-],{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Aci,-9.552279,x0749,active-covalent
CCc1ccsc1c2ccc(c(c2)O)O,"4-(3-ethylthiophen-2-yl)benzene-1,2-diol",-9.550874,x0195,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)C=C[C@]34C,Boldenone,-9.548451,x0749,active-covalent
c1cc(c2c(c1)ncc(n2)c3ccc(cc3)Cl)C(=O)N,2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,-9.545990,x0678,active-noncovalent
CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,Levonorgestrel,-9.541877,x0749,active-covalent
c1ccc(cc1)C(=O)Nc2cc(n[nH]2)C3CC3,N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide,-9.540628,x0678,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CCC(=O)O2)CCC4=CC(=O)C=C[C@]34C,Testolactone,-9.537466,x0749,active-covalent
Cc1ccc(cc1c2ccc3c(c2)cnc(n3)N)C(=O)Nc4cccc(c4)C(F)(F)F,3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,-9.536749,x0161,active-noncovalent
c1ccc2c(c1)cccc2C[C@@H](C(=O)[O-])[NH3+],NAPHTHALEN-2-YL-3-ALANINE,-9.534020,x0830,active-covalent
c1cc(c(cc1/N=N/c2ccc(c(c2)C(=O)[O-])O)C(=O)[O-])O,Olsalazine,-9.531301,x0749,active-covalent
C[C@]12CCC(=O)C=C1[C@@H]3C[C@@H]3[C@@H]4[C@@H]2CC[C@]5([C@H]4[C@@H]6C[C@@H]6[C@@]57CCC(=O)O7)C,Drospirenone,-9.531165,x0749,active-covalent
c1ccc(cc1)c2cc(n3c(n2)c(cn3)Br)NCc4ccncc4,"3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",-9.529728,x0107,active-noncovalent
Cc1nnc2n1-c3c(cc(s3)Br)C(=NC2)c4ccccc4Cl,Brotizolam,-9.528973,x0831,active-covalent
CC[C@H]1C[N@H+](CC[C@@]1(c2ccccc2)OC(=O)CC)C,Alphameprodine,-9.528659,x0678,active-noncovalent
c1ccc(cc1)c2cc(=O)c3ccccc3o2,Flavone,-9.527216,x0749,active-covalent
c1cc([nH]c1)c2cc(c3c(ccc4nc(=O)c2[C@H]43)F)NCC[NH3+],5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE,-9.527086,x0104,active-noncovalent
Cc1cc(c(c(c1CC2=[NH+]CCN2)C)O)C(C)(C)C,Oxymetazoline,-9.523150,x0161,active-noncovalent
c1cc(c2c(c1NCC[NH3+])C(=O)c3ccncc3C2=O)NCC[NH3+],Pixantrone,-9.517454,x1392,active-covalent
c1cc2c(ccc3c2c(c1)C(=O)OC3(c4ccc(cc4)O)c5ccc(cc5)O)N(=O)=O,3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE,-9.514108,x0830,active-covalent
c1ccc2c(c1)c3ccccc3n2CCCC(=O)[O-],Carbazole Butanoic Acid,-9.513207,x0195,active-noncovalent
CCC[C@@H](c1c[nH]c2c1cccc2)C(=O)[O-],(2S)-2-(1H-indol-3-yl)pentanoic acid,-9.511976,x0195,active-noncovalent
c1cc2c(c(c1)[O-])C(=O)c3c(ccc(c3[O-])CC(=O)[O-])C2=O,Oxidized Acetyl Dithranol,-9.510326,x0749,active-covalent
c1ccc(c(c1)Cc2ccc(o2)C(=O)[O-])Cl,5-(2-CHLOROBENZYL)-2-FUROIC ACID,-9.508364,x0830,active-covalent
C[C@]12C[C@@H](C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(COC)OC)c5ccc(cc5)CN=O,Asoprisnil,-9.508085,x1077,active-noncovalent
c1cc(ccc1[C@H](CC(=O)[O-])C[NH3+])Cl,L-Baclofen,-9.506580,x0107,active-noncovalent
c1ccc(cc1)C[C@H](CC(=O)[O-])C(=O)[O-],L-BENZYLSUCCINIC ACID,-9.500868,x0397,active-noncovalent
c1ccc2c(c1)cc(c3c2cccc3)N,9-Aminophenanthrene,-9.498992,x0195,active-noncovalent
Cc1c2c(ccn1)c3ccc(cc3[nH]2)OC,7-METHOXY-1-METHYL-9H-BETA-CARBOLINE,-9.496728,x0749,active-covalent
c1ccc(cc1)[C@H]2c3ccccc3CCN2C(=O)O[C@H]4C[NH+]5CCC4CC5,Solifenacin,-9.496224,x0072,active-noncovalent
c1ccc2c(c1)c(n[nH]2)c3ccncc3,3-pyridin-4-yl-1H-indazole,-9.495156,x0195,active-noncovalent
Cc1cc(c(cc1Cl)N)S(=O)(=O)[N@]2CCC[C@H]2C(=O)[O-],1-[(2-AMINO-4-CHLORO-5-METHYLPHENYL)SULFONYL]-L-PROLINE,-9.494630,x0749,active-covalent
C[N+]1(CCCC1)CCCCC[N+]2(CCCC2)C,Pentolinium,-9.493567,x0749,active-covalent
C=Cc1cc(cc2c1oc(n2)c3ccc(c(c3)F)O)O,"2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL",-9.493013,x0749,active-covalent
C[C@H](CN1c2ccccc2Sc3c1cccc3)C[NH+](C)C,Alimemazine,-9.491579,x0195,active-noncovalent
Cc1cc(c(cc1N)C(C)(C)C)SC2=C(C[C@@](OC2=O)(CCc3ccc(cc3)O)C4CCCC4)[O-],3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4,-9.490135,x0161,active-noncovalent
c1cc(c(cc1N(=O)=O)Cl)c2ccc(o2)C(=O)[O-],5-(2-CHLORO-4-NITROPHENYL)-2-FUROIC ACID,-9.489832,x0749,active-covalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5cc(c(c6c5c4[C@H](CC6)[NH3+])C)F)O,Exatecan,-9.485881,x0104,active-noncovalent
C[NH+](C)CCCN1c2ccccc2Sc3c1cc(cc3)Cl,Chlorpromazine,-9.484500,x0072,active-noncovalent
Cc1cccc(c1c2cc(cc(c2)OC)[C@@H](C)C#Cc3c(nc(nc3N)N)C)C,"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidi",-9.484292,x0072,active-noncovalent
C[N@@H+]1CC[N@]2c3c(cccn3)Cc4ccccc4[C@@H]2C1,Mirtazapine,-9.484286,x0072,active-noncovalent
c1c[nH]c2c1cc(cn2)c3c4c(ncnc4n(n3)C5CCCC5)N,"1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-am",-9.483578,x0678,active-noncovalent
CC(=O)NCCc1c[nH]c2c1cc(cc2)OC,Melatonin,-9.483315,x0678,active-noncovalent
c1c(cc(c(c1O)O)O)c2c(c(=O)c3c(cc(cc3o2)O)[O-])[O-],Myricetin,-9.482223,x0749,active-covalent
c1cc(ccc1C[C@@H]2CCCC[C@H](C2=O)Cc3ccc(cc3)C(=[NH2+])N)C(=[NH2+])N,Bis-Benzamidine,-9.475630,x0874,active-noncovalent
CN1CC(=O)N2[C@@H](C1=O)Cc3c4ccccc4[nH]c3[C@H]2c5ccc6c(c5)OCO6,Tadalafil,-9.475203,x0678,active-noncovalent
CC(=O)C[C@H](c1ccc(cc1)N(=O)=O)c2c(c3ccccc3oc2=O)[O-],Acenocoumarol,-9.470320,x0678,active-noncovalent
Cc1cc(cc(c1)c2cc(cc(c2)OC)[C@@H](C)C#Cc3c(nc(nc3N)N)C)C,"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidi",-9.467371,x0072,active-noncovalent
c1cc(ncc1Br)NC(=O)CCC(=O)[O-],4-[(5-bromopyridin-2-yl)amino]-4-oxobutanoic acid,-9.465168,x0678,active-noncovalent
Cc1nc2cnccc2n1c3ccc(cc3)Cn4c5ccccc5sc4=O,"3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE",-9.463634,x0072,active-noncovalent
c1ccc2c(c1)ccn3c2[nH+]c(c3)C(=O)NN,"IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE",-9.462347,x0749,active-covalent
CCCC[C@@H](c1c[nH]c2c1cccc2)C(=O)[O-],(2S)-2-(1H-indol-3-yl)hexanoic acid,-9.461685,x1392,active-covalent
COc1ccc(cc1)C2=C(c3ccccc3C2=O)[O-],Anisindione,-9.457760,x0749,active-covalent
c1cc(c(cc1F)F)n2cc(c(=O)c3c2nc(c(c3)F)N4C[C@@H]5[C@H](C4)C5[NH3+])C(=O)[O-],Trovafloxacin,-9.455624,x0434,active-noncovalent
c1c(nc[nH]1)C[C@H]2C(=O)N3CCC[C@H]3C(=O)N2,Cyclo(his-pro),-9.453528,x0195,active-noncovalent
CCCc1cc(=O)oc2c1c3c(c4c2[C@H]([C@@H]([C@H](O4)C)C)O)C=CC(O3)(C)C,Calanolide A,-9.447371,x0195,active-noncovalent
c1ccc2c(c1)cc(s2)C(=[NH2+])N,Benzo[B]Thiophene-2-Carboxamidine,-9.447006,x0195,active-noncovalent
CC(=O)c1cc2c(o1)C(=O)c3ccccc3C2=O,Napabucasin,-9.445909,x0195,active-noncovalent
C[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2[C@H](C=C[C@H]3[C@H]1C5)O)OCc6ccccc6,Benzylmorphine,-9.445313,x0678,active-noncovalent
CCN1C[C@H](C(C1=O)(c2ccccc2)c3ccccc3)CC[NH+]4CCOCC4,Doxapram,-9.440405,x0678,active-noncovalent
C[C@@H](Cc1c[nH]c2c1cccc2)[NH3+],Indopan,-9.435568,x0195,active-noncovalent
Cc1cc2c(s1)Nc3ccccc3[NH+]=C2N4CC[NH+](CC4)C,Olanzapine,-9.434286,x0195,active-noncovalent
CC(C)(c1ccccc1)c2ccc(cc2)O,4-(1-methyl-1-phenylethyl)phenol,-9.430995,x0072,active-noncovalent
Cc1nccn1C[C@H]2CCc3c(c4ccccc4n3C)C2=O,Ondansetron,-9.429194,x0104,active-noncovalent
c1ccnc(c1)NC(=O)Nc2cccc3c2[C@H]4CCCN4C3=O,"N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea",-9.427494,x0678,active-noncovalent
C[C@H](Cc1ccccc1)NCCC#N,Fenproporex,-9.425476,x0678,active-noncovalent
c1ccc2c(c1)cc(cn2)CC3CCN(CC3)C(=O)[O-],4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid,-9.420111,x0749,active-covalent
COc1cccc(c1)Cc2c[nH]c3c2cccn3,"3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine",-9.419450,x0749,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C(C(=O)CC[C@]34C)Cl,Clostebol,-9.418159,x0749,active-covalent
CCn1cc(c(=O)c2c1c(c(c(c2)F)[N@]3CC[NH2+][C@@H](C3)C)F)C(=O)[O-],Lomefloxacin,-9.416935,x0749,active-covalent
c1cc2c(cc1F)c(c(n2Cc3cc(cc4c3OCOC4)F)O)N=O,"(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3",-9.415816,x0831,active-covalent
c1c(cc(c(c1O)O)O)[C@@H]2[C@@H](Cc3c(cc(cc3O2)O)O)O,Epigallocatechin,-9.412716,x0749,active-covalent
C[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C#C)O)C)O,Apoptone,-9.411007,x0749,active-covalent
c1ccc(cc1)[C@H]2c3cc(ccc3N(C(=O)C=N2)CC4CC4)Cl,Prazepam,-9.410961,x1077,active-noncovalent
c1ccc(cc1)[C@H]2CN3CCSC3=[NH+]2,Levamisole,-9.408648,x1093,active-noncovalent
C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(CC#N)O,Dienogest,-9.407588,x0749,active-covalent
c1ccc2c(c1)C[NH2+][C@@H]3[C@@H]2c4cc(c(cc4CC3)O)O,Dihydrexidine,-9.406582,x0749,active-covalent
C[N@@H+]1CCc2cc3c(cc2[C@H]1[C@H]4c5ccc6c(c5C(=O)O4)OCO6)OCO3,Bicuculline,-9.402954,x0072,active-noncovalent
c1ccc(cc1)c2ccc(cc2)CC[N@H+]3CCC(=CC3)c4cccc(c4)C(F)(F)F,Paliroden,-9.402541,x0161,active-noncovalent
c1ccc2c(c1)CC[C@@H]([C@H]2O)[NH3+],"TRANS-(1S,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL",-9.401395,x0195,active-noncovalent
c1ccc(cc1)c2cc([nH]c(=O)c2C#N)c3cc(ccc3O)Br,"6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE",-9.396533,x0072,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@]45[C@@]3(C[C@H](C(=O)[C@H]4O5)C#N)C,Trilostane,-9.396224,x0749,active-covalent
C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@@H]3[C@@H]1[C@@H]4CC[C@]([C@]4(CC3)C)(C#C)O,Tibolone,-9.392832,x0749,active-covalent
c1ccc(cc1)NC(=O)Nc2ccccc2,"1,3-DIPHENYLUREA",-9.392790,x0678,active-noncovalent
c1ccc2c(c1)-c3ccccc3C2=NOCCC(=O)[O-],3-[(9H-fluoren-9-ylideneamino)oxy]propanoic acid,-9.391680,x0195,active-noncovalent
c1cc(ccc1Nc2cc(ncn2)N)S(=O)(=O)N,4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide,-9.389877,x0749,active-covalent
CC(C)(c1ccc(cc1)O)c2ccc(cc2)O,"4,4'-PROPANE-2,2-DIYLDIPHENOL",-9.388649,x0072,active-noncovalent
Cc1cc(c2c(c1C(=O)OC)cc3c(c2[O-])C(=O)c4c(cccc4[O-])C3=O)O,Nogalaviketone,-9.387328,x0749,active-covalent
c1cc(cc(c1)N(=O)=O)c2c3c(cccn3)cc(n2)c4ccc(cc4)C(=O)[O-],"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",-9.385926,x0434,active-noncovalent
Cc1ccc(cc1)Sc2cccc3c2c(nc(n3)N)N,"5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine",-9.379839,x0107,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5cccc(c5c4)N)O,9-aminocamptothecin,-9.378341,x0195,active-noncovalent
c1c2c(cc3c1OCCO3)O[C@@H]4CCCN4C2=O,"2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-O",-9.377535,x0749,active-covalent
c1ccc(cc1)c2c(c([nH]n2)c3[nH]c4cc(ccc4n3)C(=[NH2+])N)O,2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,-9.377332,x0678,active-noncovalent
c1ccc(cc1)c2[nH]c(c[nH+]2)C(=O)[O-],2-phenyl-1H-imidazole-4-carboxylic acid,-9.374901,x0678,active-noncovalent
c1ccc2c(c1)/C(=C/CCN3CC[NH+](CC3)CCO)/c4cc(ccc4S2)C(F)(F)F,Flupentixol,-9.374624,x0434,active-noncovalent
COc1cc(c(c(c1)c2cc3cc(ccc3[nH]2)C(=[NH2+])N)O)c4ccccc4,"3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE",-9.374249,x1093,active-noncovalent
c1ccc2c(c1)C(=O)C[C@H](O2)c3ccc(cc3)O,4'-Hydroxyflavanone,-9.369635,x0749,active-covalent
B1(OCCO1)OCc2ccc(cc2)C(=[NH2+])N,"[4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine",-9.368467,x0749,active-covalent
C[NH2+]CCC=C1c2ccccc2CCc3c1cccc3,Nortriptyline,-9.365887,x0072,active-noncovalent
c1ccc(cc1)[C@H](Cc2ccccn2)[NH3+],Lanicemine,-9.362711,x0749,active-covalent
c1cc(ccc1c2c[nH]nc2c3ccnc(c3)F)F,2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine,-9.360613,x0195,active-noncovalent
Cc1c([nH]c(=O)[nH]1)C(=O)c2ccc(cc2)SC,Enoximone,-9.360544,x0104,active-noncovalent
Cc1ccn(c(=O)c1c2ccc3c(c2)cnc(n3)N)c4cccc(c4)C(F)(F)F,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-o,-9.360229,x0104,active-noncovalent
Cc1cc(nc(n1)[N-]S(=O)(=O)c2ccc(cc2)N)C,Sulfamethazine,-9.358548,x0072,active-noncovalent
C[C@@]12[C@](C[C@@H](O1)n3c4ccccc4c5c3c6n2c7ccccc7c6c8c5C(=O)NC8)(CO)O,Lestaurtinib,-9.358193,x0195,active-noncovalent
c1cc2c(cc1Cl)c3c(o2)c(=O)[nH]c(n3)[C@@H]4CCC[NH2+]4,BMS-863233,-9.357981,x0195,active-noncovalent
C[C@@H](c1ccc2c(c1)CC(=O)c3ccccc3S2)C(=O)[O-],Zaltoprofen,-9.357831,x0072,active-noncovalent
c1cc(nnc1C(=O)N)NN,Hydracarbazine,-9.356958,x0397,active-noncovalent
c1ccc(cc1)[C@@H]2C(=O)NC(=[NH2+])O2,Pemoline,-9.356454,x0195,active-noncovalent
c1ccc(cc1)C(=O)c2ccccc2,Benzophenone,-9.352918,x0749,active-covalent
c1cc(c2c(c1C(=O)N)C[C@H](CO2)[NH+](C3CCC3)C4CCC4)F,Robalzotan,-9.348658,x0434,active-noncovalent
c1ccc(cc1)c2c(c2=O)c3ccccc3,Diphencyprone,-9.345084,x0749,active-covalent
CN1c2ccc(cc2[C@@H](N=CC1=O)c3ccccc3F)Cl,Fludiazepam,-9.344943,x1077,active-noncovalent
Cc1ccc2c(c1)C(=O)[C@@]3(CCN(C3=[NH+]2)c4ccccc4)O,(S)-blebbistatin,-9.344901,x0195,active-noncovalent
c1cc(ccc1C(=[NH2+])N)N/N=N/c2ccc(cc2)C(=[NH2+])N,Diminazene,-9.344325,x0395,active-noncovalent
c1ccc(cc1)CCCCC(=O)[O-],5-Phenylvaleric Acid,-9.342169,x0678,active-noncovalent
c1ccc(cc1)OC(=O)c2ccc(cc2O)N,Phenyl aminosalicylate,-9.341426,x0749,active-covalent
Cc\1cc(=C)[nH]/c1=C\c2c3ccccc3[nH]c2O,Semaxanib,-9.340160,x0749,active-covalent
c1cc(c(cc1Cl)Cl)[C@@H]2CS/C(=C(/C#N)\n3ccnc3)/S2,Luliconazole,-9.338475,x0678,active-noncovalent
CC(=O)N1[C@@H](CC(=N1)c2ccccc2Cl)c3cccc(c3)O,"3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol",-9.338289,x1392,active-covalent
c1cc(cc(c1)Cl)N2CC[NH2+]CC2,m-Chlorophenylpiperazine,-9.335801,x0195,active-noncovalent
c1c2c(cc3c1[nH]cn3)nc([nH]c2=O)N,"6-AMINO-3,7-DIHYDRO-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",-9.330733,x0107,active-noncovalent
CC(C)[C@@]1(C(=O)NC(=[NH+]1)c2c(cc3ccccc3n2)C(=O)[O-])C,IMAZAQUIN,-9.330585,x0195,active-noncovalent
C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C,Medroxyprogesterone acetate,-9.328434,x0749,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C,Exemestane,-9.327736,x0749,active-covalent
Cc1ccc(cc1)C(=O)c2cc(c(c(c2)O)[O-])N(=O)=O,Tolcapone,-9.327284,x0749,active-covalent
c1ccc(cc1)COC(=O)c2ccccc2,Benzyl benzoate,-9.326831,x0749,active-covalent
c1ccc(cc1)[C@H]2c3cc(ccc3N(C(=O)C=N2)CC(F)(F)F)Cl,Halazepam,-9.326532,x0195,active-noncovalent
c1cc(c(c(c1)F)Cn2cc(nn2)C(=O)N)F,Rufinamide,-9.326454,x0678,active-noncovalent
CCOC(=O)c1cc2ccc(cc2oc1=O)O,7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester,-9.323027,x0749,active-covalent
C[NH+]1CCN(CC1)c2cccc3c2oc(=O)[nH]3,Pardoprunox,-9.319084,x0104,active-noncovalent
c1cc(ccc1C[C@@H]2C(=O)[N-]C(=S)S2)C(F)(F)F,"(5R)-2-sulfanyl-5-[4-(trifluoromethyl)benzyl]-1,3-thiazol-4(5H)-one",-9.317893,x0749,active-covalent
Cc1ccc(cc1)[C@]23C[C@H]2C[NH2+]C3,Bicifadine,-9.315760,x0161,active-noncovalent
c1ccc(cc1)C(=O)c2ccc3n2CC[C@@H]3C(=O)[O-],Ketorolac,-9.314570,x0749,active-covalent
CC(C)c1c(nc(s1)[C@@H]2Cc3ccccc3C[NH2+]2)C(=O)[O-],2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,-9.310791,x0830,active-covalent
CN1(=O)CCC(CC1)[Si](C)(C)c2ccccc2,TRANS-2-(DIMETHYLPHENYLSILYL)-PIPERIDINE-N-OXIDE,-9.309852,x0072,active-noncovalent
c1cc(ccc1C2(CCCCC2)c3ccc(cc3)O)O,"4,4'-cyclohexane-1,1-diyldiphenol",-9.306413,x0072,active-noncovalent
c1ccc2c(c1)C(=O)OC23c4ccc(cc4Oc5c3ccc(c5)O)O,Fluorescein,-9.304455,x0831,active-covalent
c1ccc(cc1)c2ccc(cc2)N(=O)=O,P-nitrobiphenyl,-9.296867,x0749,active-covalent
CCCCCc1cc(c2c(c1)OC([C@H]3[C@H]2C=C(CC3)C)(C)C)O,Dronabinol,-9.296268,x0104,active-noncovalent
C[N@@H+]1CCCC[C@H]1CCN2c3ccccc3Sc4c2cc(cc4)SC,Thioridazine,-9.295393,x0104,active-noncovalent
c1cc(ccc1c2c[nH]nc2)[C@H](C[NH3+])c3ccc(cc3)Cl,(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine,-9.292952,x0107,active-noncovalent
c1cc(ccc1C[NH3+])C[NH2+]CCC(=O)[O-],1-Carboxyethylaminomethyl-4-Aminomethylbenzene,-9.290071,x0678,active-noncovalent
c1cc2cccc3c2c(c1)C(=O)N(C3=O)CC(=O)[O-],Alrestatin,-9.288126,x0195,active-noncovalent
c1ccc(cc1)N2CC[C@@]3(C2=[NH+]c4ccccc4C3=O)O,"(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",-9.287693,x1093,active-noncovalent
C[C@@H]1c2ccc(cc2C[NH2+]1)c3ccc4c(c3OC(F)F)n(cc(c4=O)C(=O)[O-])C5CC5,Garenoxacin,-9.286920,x0874,active-noncovalent
Cc1cc(c(n1c2ccccc2)C)/C=C/c3ccc4cc(ccc4[n+]3C)N(C)C,Pyrvinium,-9.286083,x0104,active-noncovalent
c1cc(cc(c1)O[C@@H]2CO[C@H]3[C@@H]2OC[C@@H]3Oc4cccc(c4)C(=[NH2+])N)C(=[NH2+])N,"2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol",-9.285383,x0161,active-noncovalent
Cc1c(cccc1O)C(=O)Nc2cccc3c2cc(cc3)C(=[NH2+])N,N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE,-9.284214,x1093,active-noncovalent
CC(=[NH2+])NCc1cccc(c1)C[NH3+],N-[3-(aminomethyl)benzyl]acetamidine,-9.283804,x0104,active-noncovalent
C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4c5cccnc5)C)O,Abiraterone,-9.283616,x1077,active-noncovalent
c1cc(cc(c1)Cl)COc2ccc3c(cc(=O)oc3c2)C=O,7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE,-9.282849,x0195,active-noncovalent
C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1([C@H](C=O)O)O)C)O)F)C)F,Flumethasone,-9.280256,x0749,active-covalent
Cn1c(c(c(n1)c2cc(c(cc2F)Cl)C(=O)[O-])Br)C(F)(F)F,4-Bromo-3-(5'-Carboxy-4'-Chloro-2'-Fluorophenyl)-1-Methyl-5-Trifluoromethyl-Pyra,-9.279454,x0749,active-covalent
CC(C)(C)n1c2c(c(n1)c3ccc(cc3)Cl)c(ncn2)N,"1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",-9.278509,x0678,active-noncovalent
CC(C)(C)c1ccc(cc1)C[N@H+](C)Cc2cccc3c2cccc3,Butenafine,-9.272779,x0072,active-noncovalent
c1cc2c3cccc(c3oc2c(c1)C(=O)[O-])C(=O)[O-],"Dibenzofuran-4,6-Dicarboxylic Acid",-9.268975,x0749,active-covalent
C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@@H]3[C@@H]1[C@@H]4CC[C@@H]([C@]4(CC3)C)O,Trestolone,-9.267095,x0749,active-covalent
c1ccc2cc(ccc2c1)CC[N@H+]3CCC(=CC3)c4cccc(c4)C(F)(F)F,Xaliproden,-9.264948,x0195,active-noncovalent
Cc1ccccc1n2c(nc3ccccc3c2=O)C,Methaqualone,-9.264595,x0749,active-covalent
c1ccc(cc1)/N=N/c2cnc(nc2c3ccc(cc3Cl)Cl)N,"4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine",-9.264237,x0678,active-noncovalent
c1cnccc1c2cc(c(=O)[nH]c2)N,Amrinone,-9.258416,x1077,active-noncovalent
c1ccc(cc1)[C@@H](C[NH3+])c2ccc(cc2)Cl,(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE,-9.257401,x0749,active-covalent
C[N@@]1CC[N@](c2c1ccc(c2)C[NH3+])C,"1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine",-9.256259,x1334,active-covalent
c1ccc2c(c1)c(c[nH]2)CCCOP(=O)([O-])[O-],Indole-3-Propanol Phosphate,-9.254682,x0072,active-noncovalent
C[NH+](C)CCNC(=O)c1cccc2c1[nH+]c3c(c2N)cccc3Br,5-Bromo-N[2-(Dimethylamino)Ethyl]-9-Aminoacridine-4-Carboxamide,-9.252184,x0195,active-noncovalent
c1ccc(cc1)C(=O)c2c(nc3n2cc(cc3)C(=O)c4c(cccc4F)F)N,"[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone",-9.250391,x0831,active-covalent
Cn1c2c(c(=O)n(c1=O)C)n(c(n2)[N@@]3CCC[C@H](C3)[NH3+])Cc4ccccc4C#N,"2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-",-9.247791,x0874,active-noncovalent
c1cc(cc(c1)O[C@@H]2CO[C@H]3[C@@H]2OC[C@@H]3Oc4ccc(cc4)C(=[NH2+])N)C(=[NH2+])N,"2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL",-9.242170,x0874,active-noncovalent
c1cc2c(cc1N(CC(F)(F)F)CC(F)(F)F)c(cc(=O)[nH]2)C(F)(F)F,LGD-2226,-9.240721,x0195,active-noncovalent
c1ccc(cc1)/C=C/C[NH+]2CCN(CC2)C(c3ccc(cc3)F)c4ccc(cc4)F,Flunarizine,-9.239660,x0395,active-noncovalent
CCc1cc2c(s1)-n3c(nnc3C=N[C@@H]2c4ccccc4Cl)C,Etizolam,-9.238684,x1093,active-noncovalent
c1cc(ccc1c2c(c[nH]n2)c3ccncc3)F,4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE,-9.237774,x0195,active-noncovalent
c1cc(c2c(c1)O[C@H]([C@@H]3[C@H]2CCC3)c4ccc(cc4)O)O,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-O",-9.235160,x0195,active-noncovalent
Cn1cc(c2c1cc(c3c2C(=O)NC3=O)c4ccccc4Cl)CCO,"4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-di",-9.233765,x1392,active-covalent
CN1Cc2ccccc2N[C@H](C1=O)CC(=O)[O-],"[(2S)-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-2-yl]acetic acid",-9.232681,x0678,active-noncovalent
c1cc(ccc1/C=c\2/c(=O)n(/c(=C(\CC(=O)[O-])/[NH3+])/[nH]2)CC(=O)[O-])O,CHROMOPHORE (ASP-TYR-GLY),-9.231709,x0749,active-covalent
CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C,Megestrol acetate,-9.230185,x0749,active-covalent
Cc1cc2c(c(c1)[O-])C(=O)c3c(cc(cc3[O-])O)C2=O,Emodin,-9.229018,x0749,active-covalent
c1cc(nc(c1)N)CCc2ccc3cc[nH]c3c2,6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE,-9.228477,x0678,active-noncovalent
CC(C)c1cc2c(cc1S(=O)(=O)[O-])[C@]3(CCC[C@@]([C@@H]3CC2)(C)C(=O)[O-])C,Ecabet,-9.226086,x0749,active-covalent
CC(=O)c1c(c2n(c1O)C([C@H]3[C@@H]2c4c[nH]c5c4c(ccc5)C3)(C)C)O,"(6AR,11AS,11BR)-10-ACETYL-9-HYDROXY-7,7-DIMETHYL-2,6,6A,7,11A,11B-HEXAHYDRO-11H-",-9.225728,x0830,active-covalent
c1cc(cnc1)c2ccc(o2)C[NH3+],(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE,-9.225658,x1334,active-covalent
CCn1c2ccccc2c3c(c1=O)c([nH]n3)C,"5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE",-9.225077,x0195,active-noncovalent
CCn1c2c(cc(c1=O)c3ccn[nH]3)c(nc(n2)N)C,Voxtalisib,-9.223606,x0678,active-noncovalent
C[C@@H](c1cccc(c1)C(=O)c2ccccc2)C(=O)[O-],Ketoprofen,-9.223348,x0830,active-covalent
c1ccc(cc1)c2cc(=O)oc3c2ccc(c3O)O,"7,8-dihydroxy-4-phenyl-2H-chromen-2-one",-9.222348,x1418,active-covalent
CC(C)[C@@H](c1ccc(cc1)Br)c2c(=O)c3ccccc3oc2[O-],3-[1-(4-BROMO-PHENYL)-2-METHYL-PROPYL]-4-HYDROXY-CHROMEN-2-ONE,-9.221236,x0195,active-noncovalent
c1ccc(cc1)CCCC(=O)C(=O)[O-],5-phenyl-2-keto-valeric acid,-9.220507,x0678,active-noncovalent
Cc1ccc2c(c1)[NH+]=C3[C@](C2=O)(CCN3c4ccccc4)O,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin",-9.218321,x0195,active-noncovalent
COc1cc(c(cc1NC(=O)Nc2cnc(cn2)C#N)Cl)OC,"1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA",-9.213976,x0678,active-noncovalent
c1ccc(cc1)C[C@@H](C(=O)N)[NH3+],Phenylalanine Amide,-9.213627,x0195,active-noncovalent
c1cc(ccc1c2cc(cc(c2)F)F)C(=O)[O-],"3',5'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID",-9.212149,x0749,active-covalent
c1cc(ccc1c2cc3cc(cc(c3o2)C#N)O)O,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,-9.212136,x0749,active-covalent
Cn1c2c(ccc(c2Cl)Cl)c3c1C(=O)NC4([C@@H]3C#N)CC[NH+](CC4)C,"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4",-9.210411,x0749,active-covalent
Cc1cc(cc(c1)c2nc3ccccc3o2)C,"2-(3,5-DIMETHYLPHENYL)-1,3-BENZOXAZOLE",-9.209198,x0749,active-covalent
c1c2c(c(c(c1F)[N@@]3CCCC[C@H](C3)[NH3+])Cl)n(cc(c2=O)C(=O)[O-])C4CC4,Besifloxacin,-9.208812,x1334,active-covalent
Cc1c2c(ccc(c2Oc3cc(cc(c3)C#N)C#N)F)n[nH]1,"5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile",-9.208042,x0104,active-noncovalent
c1ccc2c(c1)Cc3ccccc3N4[C@H]2C[NH+]=C4N,Epinastine,-9.204981,x0072,active-noncovalent
C[NH+](C)Cc1ccc(o1)c2cccnc2,"N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE",-9.204436,x0678,active-noncovalent
c1cc(c(cc1c2c(c(=O)c3ccc(cc3o2)O)[O-])O)O,Fisetin,-9.203892,x0195,active-noncovalent
Cc1cccc(c1NC(=O)[C@@H]2CCCC[N@H+]2C)C,Mepivacaine,-9.203002,x0195,active-noncovalent
c1ccc(c(c1)C[N@H+]2CCc3c(ccs3)C2)Cl,Ticlopidine,-9.201123,x0104,active-noncovalent
c1cc(ccc1CO)NC(=[NH2+])N,1-[4-(hydroxymethyl)phenyl]guanidine,-9.194180,x0195,active-noncovalent
C[NH+](C)CC[C@@H](c1ccc(cc1)Br)c2ccccn2,Dexbrompheniramine,-9.193460,x0195,active-noncovalent
Cc1cc(cc(c1O)C)c2nc3ccccc3o2,"4-(1,3-BENZOXAZOL-2-YL)-2,6-DIMETHYLPHENOL",-9.191895,x0749,active-covalent
c1cc(ccc1CNC(=O)c2ccc(cc2)S(=O)(=O)N)F,4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide,-9.190118,x0072,active-noncovalent
c1ccc(cc1)c2c(c(c(s2)C(=O)[O-])OCC(=O)[O-])Br,4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID,-9.188826,x0678,active-noncovalent
c1cc(ccc1N)S(=O)(=O)Nc2nccs2,Sulfathiazole,-9.188683,x0678,active-noncovalent
c1cc(ccc1[C@@H]2C[NH2+]CCc3c2cc(c(c3Cl)O)O)O,Fenoldopam,-9.188109,x1385,active-covalent
c1cc2c(c(c1)[O-])C(=O)[C@@H]3[C@@H](C2)C[C@H]4CC(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-],Incyclinide,-9.185708,x0749,active-covalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CC[C@@]25CCC(C(=O)O5)(C)C)C(=O)N,"3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDR",-9.185682,x0104,active-noncovalent
Cc1ccc(cn1)c2ccc3c(n2)ccc4c3c5c(s4)C(=O)N[C@@H](CN5)C,"(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino",-9.185480,x0104,active-noncovalent
c1cnc2cc3c(cc2n1)[C@@H]4C[C@H]3C[NH2+]C4,Varenicline,-9.185208,x0195,active-noncovalent
c1cc2cc(sc2c(c1)Cl)C(=O)N[C@H]3C[NH+]4CCC3CC4,Encenicline,-9.184338,x0749,active-covalent
C[n+]1c2ccc(cc2sc1c3ccc(cc3)N(C)C)[O-],"2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM",-9.183519,x0749,active-covalent
c1ccc2c(c1)[NH+]=C(c3cc(ccc3O2)Cl)N4CC[NH2+]CC4,Amoxapine,-9.183174,x0749,active-covalent
C[NH+](C)CCC[C@]1(c2ccc(cc2CO1)C#N)c3ccc(cc3)F,Citalopram,-9.182612,x0195,active-noncovalent
c1ccc2c(c1)c(=O)c(c(o2)[O-])Cc3c(=O)c4ccccc4oc3[O-],"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",-9.181915,x1093,active-noncovalent
c1ccc2c(c1)c(=O)c(c(o2)[O-])Cc3c(=O)c4ccccc4oc3[O-],Dicoumarol,-9.181915,x1093,active-noncovalent
c1ccc(cc1)C[C@@]2(CC[N@@]3CC[C@H](N3C2=O)C=O)[NH3+],"3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",-9.178607,x0104,active-noncovalent
CC(C)(C)c1ccc(cc1)Sc2cccc3c2c(nc(n3)N)N,"5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine",-9.177116,x0708,active-covalent
C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,Cholesterol,-9.176235,x0104,active-noncovalent
c1ccc2c(c1)c3ccccc3[nH]2,9H-CARBAZOLE,-9.175595,x0749,active-covalent
C[C@@H](CN1c2ccccc2Sc3c1cccc3)[NH+](C)C,Promethazine,-9.174159,x0874,active-noncovalent
C[C@H](C1=[NH+]CCN1)Oc2c(cccc2Cl)Cl,Lofexidine,-9.172547,x0678,active-noncovalent
C[C@H](CN1c2ccccc2CCc3c1cccc3)C[NH+](C)C,Trimipramine,-9.171801,x0072,active-noncovalent
c1cc2c(c(c1)[O-])C(=O)c3c(ccc(c3C2=O)N(=O)=O)[O-],"1,8-Di-Hydroxy-4-Nitro-Anthraquinone",-9.171643,x0749,active-covalent
C[NH+](C)CCc1c[nH]c2c1cccc2,Dimethyltryptamine,-9.166842,x0195,active-noncovalent
C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@@]3(CC[C@@H]4C5=CC(=O)OC5)O)C)O,"4-(3,14-Dihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5",-9.165751,x0678,active-noncovalent
C[C@@H]([C@H](Cc1ccccc1)[NH3+])O,3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL,-9.162723,x0195,active-noncovalent
c1ccc2c(c1)C(=O)OC2(c3ccc(cc3)O)c4ccc(cc4)O,Phenolphthalein,-9.162469,x0692,active-covalent
C[C@@]12CC[N@H+]([C@@H]1[N@@](c3c2cc(cc3)OC(=O)NC)C)C,Physostigmine,-9.161679,x0104,active-noncovalent
Cc1cc(nc(n1)N)C#Cc2ccccc2CNn3ccoc3=O,"3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ON",-9.161633,x0749,active-covalent
c1ccc(c(c1)c2cccc(c2O)O)Cl,"2'-Chloro-Biphenyl-2,3-Diol",-9.160531,x0195,active-noncovalent
C[N@@H+](CC#C)[C@@H]1CCc2c1cccc2,N-Methyl-N-Propargyl-1(R)-Aminoindan,-9.158055,x0104,active-noncovalent
COc1cc2c(cc1Cl)C(=NCC2)c3cccc(c3)Br,"1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline",-9.157446,x0195,active-noncovalent
Cn1cncc1[C@@](c2ccc(cc2)Cl)(c3ccc4c(c3)c(cc(=O)n4C)c5cccc(c5)Cl)[NH3+],Tipifarnib,-9.151299,x0678,active-noncovalent
c1cc(c(cc1C[C@@H](C(=O)[O-])[NH3+])I)O,3-Iodo-Tyrosine,-9.146530,x0107,active-noncovalent
c1ccc(cc1)C[C@@H]([C@H](CCl)O)[NH3+],3-Amino-1-Chloro-4-Phenyl-Butanol-2-Yl,-9.146114,x0104,active-noncovalent
c1ccc2c(c1)[nH]c(n2)c3c(c4cc(ccc4[nH]c3=O)Cl)N[C@@H]5C[NH+]6CCC5CC6,4-[(3S)-1-AZABICYCLO[2.2.2]OCT-3-YLAMINO]-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINO,-9.145432,x0104,active-noncovalent
c1ccc2c(c1)ccc(c2O)O,"NAPHTHALENE-1,2-DIOL",-9.143034,x0195,active-noncovalent
CCOc1ccc(cc1)c2c(c(nc3c2c(c(s3)C(=O)N)N)N)C#N,"3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE",-9.141431,x0195,active-noncovalent
C[NH2+][C@@H]1Cc2cccc3c2n(c(=O)[nH]3)C1,Sumanirole,-9.137506,x0195,active-noncovalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)OC(c3ccccc3)c4ccccc4,Benzatropine,-9.134780,x0072,active-noncovalent
C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(CC=C)O,Altrenogest,-9.133274,x0749,active-covalent
c1ccc2c(c1)-c3c(c4cc(ccc4[nH]3)N(=O)=O)CC(=O)N2,Alsterpaullone,-9.132438,x0678,active-noncovalent
CC(=O)C[C@H](c1ccccc1)c2c(=O)c3ccccc3oc2[O-],Warfarin,-9.132425,x0195,active-noncovalent
CCc1cc2c(s1)N(C(=O)CN=C2c3ccccc3Cl)C,Clotiazepam,-9.130610,x0434,active-noncovalent
CS(=O)(=O)c1ccc2c(c1)nc3n2C[C@@H]([C@H](C3)c4cc(c(cc4F)F)F)[NH3+],"(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,",-9.129974,x0161,active-noncovalent
CCOC(=O)c1c(nn(c1C)c2ccccc2Cl)C,"1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",-9.128606,x0195,active-noncovalent
COc1ccc(cc1)[C@H]2c3ccc(cc3OC[C@H]2c4ccc(cc4)O)O,Triphendiol,-9.127517,x1392,active-covalent
C[C@@H](c1ccc(cc1)N2Cc3ccccc3C2=O)C(=O)[O-],Indoprofen,-9.125704,x0678,active-noncovalent
c1ccc2c(c1)c(c[nH]2)[C@@H]([C@@H](C(=O)[O-])[NH3+])O,Beta-Hydroxytryptophane,-9.123577,x0678,active-noncovalent
CN(C)c1cccc2c1ccc(c2)S(=O)(=O)[O-],5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID,-9.120770,x0195,active-noncovalent
c1ccc(cc1)c2c(c3ccccn3n2)c4cc5c(n[nH]c5nn4)N,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",-9.116975,x0434,active-noncovalent
c1cc(c2c(c1N)C(=O)c3c(ccc(c3C2=O)[O-])[O-])N,"5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone",-9.115044,x0195,active-noncovalent
CCC(=O)NCC[C@@H]1CCc2c1c3c(cc2)OCC3,Ramelteon,-9.112935,x0104,active-noncovalent
C[N@H+]1[C@H]2CC[C@@H]1[C@@H]([C@H](C2)c3ccc(c(c3)Cl)Cl)/C=N/OC,Brasofensine,-9.107718,x0749,active-covalent
CC(C)[NH2+]CCCC1(c2ccccc2-c3c1cccc3)C(=O)N,Indecainide,-9.105799,x0072,active-noncovalent
CCC(CC)n1c2c([nH]c1=O)ncc(n2)C#C,Tirasemtiv,-9.104708,x0195,active-noncovalent
c1cc(sc1)c2ccc(s2)C[NH3+],"1-(2,2'-bithiophen-5-yl)methanamine",-9.104526,x0161,active-noncovalent
c1cc(c2ccncc2c1S(=O)(=O)NCC[NH3+])Cl,N-(2-Aminoethyl)-5-Chloroisoquinoline-8-Sulfonamide,-9.104425,x0678,active-noncovalent
c1cc(c(cc1c2ccc(cc2Cl)Cl)C(=O)[O-])O,"2',4'-DICHLORO-4-HYDROXY-1,1'-BIPHENYL-3-CARBOXYLIC ACID",-9.102478,x0749,active-covalent
Cc1c(c2cc(ccc2nc1c3ccc(cc3)c4ccccc4)F)C(=O)[O-],Brequinar Analog,-9.102465,x0104,active-noncovalent
c1ccc2c(c1)[nH]c(=O)n2CCC[NH+]3CCC(CC3)n4c5ccc(cc5[nH]c4=O)Cl,Domperidone,-9.099450,x0161,active-noncovalent
c1cc2c(cc1/C=C\3/C(=O)[N-]C(=O)S3)OC(O2)(F)F,"(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE",-9.096585,x0749,active-covalent
Cc1c(c2cc(ccc2n1C(=O)c3ccc(cc3)Cl)OC)CC(=O)[O-],Indomethacin,-9.092182,x0831,active-covalent
CC[C@H]1[C@@H]2C[C@H]3[C@H]4[C@@]5(C[C@@H]([C@H]2[C@H]5O)[N@H+]3[C@@H]1O)c6ccccc6[N@@]4C,Ajmaline,-9.090511,x0749,active-covalent
c1ccc(c(c1)C(=O)Nc2c(c3c(s2)CCCC3)C#N)F,"N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide",-9.090214,x0195,active-noncovalent
C[NH+]1CCC(CC1)OC(c2ccccc2)c3ccccc3,Diphenylpyraline,-9.089118,x0195,active-noncovalent
c1cc2c(cc1O)onc2c3cc(c(cc3O)O)Br,"4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol",-9.085079,x0749,active-covalent
C[N@@H+]1CCC[C@H]1c2cccnc2,Nicotine,-9.081602,x0678,active-noncovalent
c1ccc(c(c1)[C@@H](c2ccc(cc2)Cl)C(Cl)Cl)Cl,Mitotane,-9.080888,x0072,active-noncovalent
c1ccc2c(c1)CC[C@@H](O2)C[NH2+]Cc3cc(cnc3)c4ccc(cc4)F,Sarizotan,-9.080109,x0397,active-noncovalent
Cc1c(c(nc(c1F)Oc2cccc(c2)C(=[NH2+])N)Oc3cccc(c3)C(=[NH2+])N)F,ZK-805623,-9.078842,x0434,active-noncovalent
CCn1cc(c(=O)c2c1cc(c(c2)F)N3CC[NH2+]CC3)C(=O)[O-],Norfloxacin,-9.077718,x0749,active-covalent
CC1(C(=O)N(C(=O)N1)c2ccc(c(c2)C(F)(F)F)N(=O)=O)C,Nilutamide,-9.077441,x0195,active-noncovalent
c1ccc2c(c1)c3c4c(c5c6ccccc6n7c5c3n2[C@H]8CC[C@@H]7O8)C(=O)NC4=O,"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]P",-9.077034,x0195,active-noncovalent
c1ccc(cc1)c2[nH]c3cc(ccc3n2)S(=O)(=O)[O-],Ensulizole,-9.076019,x0678,active-noncovalent
c1cc(ccc1OS(=O)(=O)c2ccc(cc2)Cl)Cl,Chlorfenson,-9.074696,x0195,active-noncovalent
CN(C)c1ccc(cc1)/N=N/c2ccccc2C(=O)[O-],2-(4-DIMETHYLAMINOPHENYL)DIAZENYLBENZOIC ACID,-9.072773,x0749,active-covalent
c1ccc(c(c1)c2ccc(o2)C(=O)[O-])Cl,5-(2-Chlorophenyl)Furan-2-Carboxylic Acid,-9.072553,x0749,active-covalent
c1ccc2c(c1)CC3(C2)C(=O)[NH+]=C4N3C=CC=C4,ST-101,-9.071997,x0749,active-covalent
c1cc(ccc1N)S(=O)(=O)c2ccc(cc2)N,Dapsone,-9.071971,x0072,active-noncovalent
c1ccc2c(c1)c(c[nH]2)C[C@@H](C(=O)[O-])O,3-(INDOL-3-YL) LACTATE,-9.070028,x0072,active-noncovalent
c1cc(ccc1c2ccc(o2)/C=N/N3CC(=O)NC3=O)N(=O)=O,Dantrolene,-9.066478,x1077,active-noncovalent
c1cc(ccc1C(=O)c2ccncc2)F,(4-fluorophenyl)(pyridin-4-yl)methanone,-9.066327,x0749,active-covalent
CCN(CC)C(=O)[C@@]1(C[C@@H]1C[NH3+])c2ccccc2,Milnacipran,-9.065971,x0678,active-noncovalent
Cc1cc2c(nc(nc2s1)N3CC[NH2+]CC3)c4ccccc4F,DDP-225,-9.064019,x0072,active-noncovalent
C[C@@H](COc1ccccc1)[N@H+](CCCl)Cc2ccccc2,Phenoxybenzamine,-9.063204,x1093,active-noncovalent
CCC[NH+](CCC)CCc1cccc2c1CC(=O)N2,Ropinirole,-9.060728,x0749,active-covalent
CSc1nc2ccccc2c(=O)n1c3c(cccc3F)F,"3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one",-9.060269,x0749,active-covalent
c1cc2cc(sc2nc1)C(=[NH2+])N,"Thieno[2,3-B]Pyridine-2-Carboxamidine",-9.060172,x0195,active-noncovalent
c1cc(oc1/C=N/N2CCOC2=O)N(=O)=O,Furazolidone,-9.059069,x0749,active-covalent
CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC(=C)[C@@]3(C(=O)C)O)C)[C@@]4(C1=CC(=O)CC4)C,Melengestrol,-9.058436,x0104,active-noncovalent
c1ccc2c(c1)C(=O)C(=N2)c3c4cc(ccc4[nH]c3O)S(=O)(=O)[O-],Indirubin-5-sulphonate,-9.058376,x0678,active-noncovalent
C[NH2+]CCCN1c2ccccc2CCc3c1cccc3,Desipramine,-9.058245,x0072,active-noncovalent
C[C@]12CCC(=O)C=C1C=C[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(CCC(=O)[O-])O)C,Canrenoic acid,-9.058157,x0967,active-noncovalent
c1cc(ccc1C(=O)NCc2cc(c(c(c2)F)F)F)S(=O)(=O)N,"4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide",-9.056854,x0072,active-noncovalent
c1cc(c(cc1N(=O)=O)Cl)NC(=O)c2cc(ccc2O)Cl,Niclosamide,-9.055682,x0678,active-noncovalent
c1cc(ccc1N/C(=[NH+]\O)/N)Cl,N-(Chlorophenyl)-N'-Hydroxyguanidine,-9.054607,x0195,active-noncovalent
CC(=O)n1c2ccccc2c3c1C(=O)CCC3,"9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE",-9.054573,x0195,active-noncovalent
C[C@@H]([NH3+])[C@H]1CC[C@@H](CC1)C(=O)Nc2ccncc2,(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE,-9.054545,x0749,active-covalent
C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@H]3[C@H](C[C@@]2([C@H]1C(=O)CO)C)O)C)F,Fluocortolone,-9.054537,x0749,active-covalent
c1cc(ccc1C(=O)[O-])NC(=[NH2+])N,4-guanidinobenzoic acid,-9.052281,x0195,active-noncovalent
Cc1c(c(nc(n1)N)N)C#C[C@@H](C)c2ccc(c(c2)OC)c3ccccc3,"5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",-9.052001,x0104,active-noncovalent
C[NH+]1CCN(CC1)C2=[NH+]c3cc(ccc3Nc4c2cccc4)Cl,Clozapine,-9.049873,x0749,active-covalent
CC\1=CCCC(/C1=C\C=C(/C)\C=C\C=C(/C)\C=C)(C)C,"(6e)-6-[(2e,4e,6e)-3,7-Dimethylnona-2,4,6,8-Tetraenylidene]-1,5,5-Trimethylcyclo",-9.049681,x0104,active-noncovalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@H](C4)O)C)C,Alfaxalone,-9.049335,x0749,active-covalent
C#CC[NH2+][C@@H]1CCc2c1cccc2,Rasagiline,-9.048687,x1382,active-covalent
C([C@H](C(=O)[O-])[NH3+])P(=O)([O-])[O-],3-Phosphono-D-alanine,-9.048206,x0397,active-noncovalent
Cc1c[nH+]c2n1ccnc2NCc3ccncc3,"3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",-9.047623,x0107,active-noncovalent
c1c(c2c([nH]1)nc([nH]c2=O)N)C[NH3+],7-Deaza-7-Aminomethyl-Guanine,-9.047290,x0195,active-noncovalent
c1c(cc(c2c1C[C@H](CC2)n3c(c[nH]c3=S)C[NH3+])F)F,Nepicastat,-9.044143,x0107,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCc4ccccc4)CCC5=CC(=O)CC[C@H]35,Nandrolone phenpropionate,-9.042923,x0104,active-noncovalent
c1cc2ccc3cccnc3c2nc1,"1,10-Phenanthroline",-9.042077,x1382,active-covalent
Cc1cc(=O)oc2c1cc3cc(oc3c2C)C,Trioxsalen,-9.041206,x0749,active-covalent
c1ccc2c(c1)cc(c3c2C(=O)N(S3(=O)=O)CC(=O)[O-])C(=O)[O-],"2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3",-9.040524,x0749,active-covalent
C1CCC(CC1)NC(=O)NCC(=O)[O-],N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE,-9.037539,x0678,active-noncovalent
c1ccc2c(c1)c(c[nH]2)CC[NH3+],2-(1H-INDOL-3-YL)ETHANAMINE,-9.031832,x0678,active-noncovalent
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C,Betamethasone,-9.030954,x0749,active-covalent
c1cc2c(c(c1)N)CN(C2=O)[C@H]3CCC(=O)NC3=O,Lenalidomide,-9.030118,x0195,active-noncovalent
C[C@H]1COc2c(c(cc3c2n1cc(c3=O)C(=O)[O-])F)C4(CC4)[NH3+],Pazufloxacin,-9.029604,x1334,active-covalent
c1ccc2c(c1)N(c3ccccc3S2)C[C@H]4C[NH+]5CCC4CC5,Mequitazine,-9.027774,x0072,active-noncovalent
c1cc2c(cc1O)nc([nH]2)N,2-Amino-1H-benzimidazol-5-ol,-9.026856,x0678,active-noncovalent
C[C@]12CCC(=O)C=C1C=C[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@]45CCC(=O)O5)C,Canrenone,-9.025975,x0104,active-noncovalent
CC1(CCC2=C(O1)c3ccccc3C(=O)C2=O)C,Lapachone,-9.025756,x0195,active-noncovalent
c1cc(c(cc1F)NC(=O)[C@@H]2C[C@@H]2C(=O)[O-])F,"(1S,2R)-2-[(2,5-difluorophenyl)carbamoyl]cyclopropanecarboxylic acid",-9.024098,x0678,active-noncovalent
CCOC(=O)c1c(nn(c1C)c2ccccc2)C,"3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER",-9.021263,x0195,active-noncovalent
C[C@@]1(C(=O)N(C(=O)O1)Nc2ccccc2)c3ccc(cc3F)F,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",-9.020964,x0678,active-noncovalent
CN(C)c1ccc(cc1)C(=C2C=CC(=[N+](C)C)C=C2)c3ccccc3,Malachite Green,-9.020826,x0434,active-noncovalent
Cc1cccc2c1C(=O)N(C2=O)c3ccc(cc3)C#N,"4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzonitrile",-9.018719,x0749,active-covalent
C[NH+](C)CCCN1c2ccccc2CCc3c1cc(cc3)Cl,Clomipramine,-9.016691,x0072,active-noncovalent
c1cc(c(c(c1)Cl)C/N=N/C(=[NH2+])N)Cl,Guanabenz,-9.014619,x0195,active-noncovalent
CCCc1c(c2cc(ccc2[nH]c1=O)Cl)OC3CCCCC3,6-CHLORO-4-(CYCLOHEXYLOXY)-3-PROPYLQUINOLIN-2(1H)-ONE,-9.013094,x0831,active-covalent
c1ccc(cc1)c2[nH]nc(n2)c3ccc(cc3)F,"3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole",-9.012434,x0161,active-noncovalent
CC([C@H](c1ccc(cc1)Cl)c2ccccc2Cl)(Cl)Cl,Mitometh,-9.010462,x0072,active-noncovalent
c1ccc(c(c1)N(=O)=O)S(=O)(=O)n2ccc3c2cc(cn3)C(=O)N,"1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE",-9.009446,x0678,active-noncovalent
CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,Testosterone propionate,-9.008215,x0946,active-noncovalent
c1cc2c(cc1C(=O)N3CCCCC3)nccn2,CX516,-9.008186,x0678,active-noncovalent
C[C@H]1Cc2c3cc(c(cc3[nH]c2[C@]4([NH2+]1)c5cc(ccc5NC4=O)Cl)Cl)F,Cipargamin,-9.007626,x1093,active-noncovalent
CC(=O)NCCc1cccc2c1cc(cc2)OC,Agomelatine,-9.007483,x0195,active-noncovalent
c1ccc2c(c1)C(C(=O)N2)(c3ccc(cc3)O)c4ccc(cc4)O,Oxyphenisatin,-9.003879,x1418,active-covalent
B1(c2ccc(cc2CO1)Oc3ccc(cc3)C#N)O,Crisaborole,-9.002372,x1093,active-noncovalent
C[NH+](C)CCCN1c2ccccc2Sc3c1cc(cc3)C(F)(F)F,Triflupromazine,-9.002316,x0195,active-noncovalent
C(C(=O)[O-])[NH2+]CP(=O)([O-])[O-],Glyphosate,-8.998384,x0397,active-noncovalent
c1ccc(cc1)Nc2c[nH]c3c2cccn3,"N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine",-8.998302,x0107,active-noncovalent
c1ccc2c(c1)cc(o2)C(=O)N[C@H]3[C@@H]([NH+]4CCC3CC4)Cc5cccnc5,Bradanicline,-8.996147,x0107,active-noncovalent
CCS/C(=[NH+]/c1ccccc1)/N,S-Ethyl-N-Phenyl-Isothiourea,-8.993024,x0195,active-noncovalent
c1cc(c(c(c1)Cl)c2nc3ccc(cc3o2)C(=O)[O-])Cl,"2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID",-8.992853,x0749,active-covalent
c1ccc2c(c1)c(c[nH]2)C(=O)OC3C[C@H]4CC5C[C@@H](C3)[NH+]4CC5=O,Dolasetron,-8.991913,x0161,active-noncovalent
c1cc(c(nc1)Nc2ccc(cc2)Cl)C(=O)[O-],2-(4-CHLORO-PHENYLAMINO)-NICOTINIC ACID,-8.989126,x0749,active-covalent
c1ccc2c(c1)nc(n2Cc3ccc(cc3)F)NC4CC[NH2+]CC4,Tecastemizole,-8.989010,x0195,active-noncovalent
CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)c5ccc6c(c5)OCO6)C)O,ORG-34517,-8.987616,x0874,active-noncovalent
c1cc(ccc1c2c(n(cn2)CC3CC3)c4ccnc(n4)N)F,4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole,-8.986018,x1386,active-covalent
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@H]1C(=O)CO)C)O)F)C,Desoximetasone,-8.985964,x0749,active-covalent
c1ccc(cc1)C[C@@H](C(=O)CCl)[NH3+],Phenylalanylmethylchloride,-8.985691,x0678,active-noncovalent
COc1ccc2cc-3[n+](cc2c1OC)CCc4c3cc5c(c4)OCO5,Berberine,-8.984882,x0749,active-covalent
CC1(c2ccccc2N(c3c1cccc3)CCC[NH+](C)C)C,Dimetacrine,-8.984730,x1392,active-covalent
c1ccc(cc1)[C@](CC[NH+]2CCCCC2)(C3CCCC3)O,Cycrimine,-8.984573,x0072,active-noncovalent
COC(=O)[C@@H](c1ccccc1)[C@H]2CCCC[NH2+]2,Methylphenidate,-8.984003,x0195,active-noncovalent
C1CCC(CC1)C(C[C@H]2CCCC[NH2+]2)C3CCCCC3,Perhexiline,-8.983480,x0434,active-noncovalent
c1nc2c(c3c(s2)CCCC3)c(=O)n1Cc4n[n-]nn4,"3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H",-8.981087,x0397,active-noncovalent
c1cc2cc(c1)S(=O)(=O)NCCCNc3c(cnc(n3)N2)Br,"6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),",-8.980571,x0195,active-noncovalent
COC(=O)[C@@H]1[C@H]2CC[C@H]([N@@H+]2C/C=C/I)C[C@@H]1c3ccc(cc3)F,Altropane,-8.979902,x0195,active-noncovalent
CC(=O)C[C@@H](c1ccccc1)c2c(=O)c3ccccc3oc2[O-],4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One,-8.976754,x0749,active-covalent
C#C[C@H]1CC[C@H](N1C(=O)[C@H](C2CCCC2)[NH3+])C[NH3+],"(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETH",-8.974972,x0195,active-noncovalent
CC[NH+](CC)CCc1c[nH]c2c1cccc2,Diethyltryptamine,-8.973318,x0195,active-noncovalent
C[C@]12C[C@@H]([C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CC[C@@H]2O)O)COC,"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-",-8.971619,x0749,active-covalent
Cc1c(cnc2c1c(nc(n2)N)N)CNc3cccc4c3cccn4,Sri-9439,-8.969899,x0072,active-noncovalent
CN(CC(=O)[O-])C(=S)c1cccc2c1ccc(c2C(F)(F)F)OC,Tolrestat,-8.968763,x0830,active-covalent
c1cc2c(c[nH]c2c(c1)Cl)c3c(c([nH]c3C(=O)[O-])C(=O)[O-])c4c[nH]c5c4cccc5Cl,"3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid",-8.967058,x0072,active-noncovalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@H](C4)O)C)C,Brexanolone,-8.965098,x0749,active-covalent
c1ccc2c(c1)[C@H](C(=O)N2)Cc3ccc(cc3)N4CCN(CC4)C=O,3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone,-8.965074,x0072,active-noncovalent
c1ccc(cc1)SCc2cc(cc3c2nc([nH]c3=O)N)C[NH3+],2-Amino-6-Aminomethyl-8-Phenylsulfanylmethyl-3h-Quinazolin-4-One,-8.964978,x0749,active-covalent
C[C@H]1C[C@@H](CN(C1)c2ccc3c(c2OC)n(cc(c3=O)C(=O)[O-])C4CC4)[NH3+],Nemonoxacin,-8.964596,x0072,active-noncovalent
C1C[C@H](N2C[C@@H]1N(C2=O)OS(=O)(=O)[O-])C(=O)N,Avibactam,-8.962753,x0397,active-noncovalent
Cc1c(cnc2c1c(nc(n2)N)N)/C=C\c3cc(ccc3OC)OC,Sri-9662,-8.961369,x0967,active-noncovalent
COc1cc(c2c(c1)O[C@@H](CC2=O)c3ccc(cc3)O)[O-],"(2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydro-4H-chromen-4-one",-8.960837,x0749,active-covalent
C[C@@H](Cc1ccccc1)[N@@H+](C)Cc2ccccc2,Benzphetamine,-8.960630,x0946,active-noncovalent
CCn1cc(c(=O)c2c1cc(c(c2)F)N3CC[NH+](CC3)C)C(=O)[O-],Pefloxacin,-8.958783,x0749,active-covalent
CCCCc1c(n(n(c1=O)c2ccccc2)c3ccccc3)[O-],Phenylbutazone,-8.958724,x0678,active-noncovalent
c1cc(ccc1c2c[nH]cn2)Cl,4-(4-Chlorophenyl)Imidazole,-8.958656,x0749,active-covalent
Cc1ccc(c(c1)[C@H](CC[NH+](C(C)C)C(C)C)c2ccccc2)O,Tolterodine,-8.958519,x0195,active-noncovalent
COc1ccccc1c2ccc(o2)C(=O)[O-],5-(2-METHOXYPHENYL)-2-FUROIC ACID,-8.957792,x0749,active-covalent
Cn1c(cc(c1O)c2ccccc2)O,Phensuximide,-8.956554,x0195,active-noncovalent
CN1c2ccc(cc2[C@@H](N=C(C1=O)OC(=O)N(C)C)c3ccccc3)Cl,Camazepam,-8.956079,x0678,active-noncovalent
Cc1/c(=C/c2c3cc(ccc3[nH]c2O)Cl)/[nH]c(=C)c1C(=O)NC,"5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H",-8.955953,x0104,active-noncovalent
C(CC(=O)[O-])[C@H](C(=O)[O-])[NH3+],D-Glutamic Acid,-8.955894,x0397,active-noncovalent
c1ccc2c(c1)ccc3c2c4c(cc3)[C@H]([C@@H]([C@@H](C4)O)O)O,"(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL",-8.955287,x0195,active-noncovalent
C[NH2+]CC12CCC(c3c1cccc3)c4c2cccc4,Benzoctamine,-8.954339,x0072,active-noncovalent
C[N@H+]1CC[C@]23CCCC[C@H]2[C@H]1Cc4c3cc(cc4)O,Levorphanol,-8.953556,x1311,active-covalent
C[NH+](C)CCC[C@@]1(c2ccc(cc2CO1)C#N)c3ccc(cc3)F,Escitalopram,-8.952180,x0072,active-noncovalent
c1c2c(cc3c1[nH]c(n3)N)nc([nH]c2=O)N,"2,6-diamino-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",-8.951109,x0107,active-noncovalent
c1cc2c(cnc(c2O)C(=O)NCC(=O)[O-])c(c1)I,N-[(4-HYDROXY-8-IODOISOQUINOLIN-3-YL)CARBONYL]GLYCINE,-8.950841,x0195,active-noncovalent
CN(C)C(=O)N1CC(=C[C@H]1c2ccccc2)c3cc(ccc3F)F,"(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBO",-8.949821,x0434,active-noncovalent
CC(=O)Nc1cc2cccnc2c3c1cccn3,"N-1,10-phenanthrolin-5-ylacetamide",-8.949649,x0195,active-noncovalent
Cc1c(cnc2c1c(nc(n2)N)N)Cc3cc(ccc3OC)OC,Piritrexim,-8.947220,x0967,active-noncovalent
c1ccc2c(c1)ccc(n2)C(=O)[O-],Quinaldic Acid,-8.946893,x1382,active-covalent
c1cc2c(cc1N)c(nc(n2)N)N,"2,4,6-Triaminoquinazoline",-8.946316,x1077,active-noncovalent
CC[C@H]([C@@H](C(=O)[O-])NS(=O)(=O)c1ccc(cc1)C)C(=O)[O-],(3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid,-8.945287,x0678,active-noncovalent
C[C@H]1[C@@H](OCC[N@@H+]1C)c2ccccc2,Phendimetrazine,-8.944763,x0161,active-noncovalent
Cc1c(c2cc(ccc2n1C(=O)c3ccc(cc3)I)OC)CC(=O)[O-],1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID,-8.943621,x0831,active-covalent
c1cc2c(nc1)C[C@]34CC[N@H+](C3)CC[C@@H]4O2,Dianicline,-8.941437,x0195,active-noncovalent
C1=CC(C=C[C@H]1CC[C@H]([NH3+])C(=O)[O-])[NH3+],"2-Amino-4-(4-Amino-Cyclohexa-2,5-Dienyl)-Butyric Acid",-8.940307,x0678,active-noncovalent
c1ccc(cc1)[C@](CC[NH+]2CCCCC2)(C3CCCCC3)O,Trihexyphenidyl,-8.939350,x0104,active-noncovalent
c1cc(cc(c1)CCSC(=[NH2+])N)CCSC(=[NH2+])N,"S,S'-(1,3-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea",-8.939226,x1392,active-covalent
CCn1cc(c(=O)c2c1cc(cc2)c3ccncc3)C(=O)[O-],Rosoxacin,-8.938631,x0195,active-noncovalent
c1cc2c(c(c1)F)c(c[nH]2)C[C@@H](C(=O)[O-])[NH3+],4-Fluorotryptophane,-8.937800,x0749,active-covalent
CC(=O)[C@H](CCc1ccccc1)[NH3+],HOMOPHENYLALANINYLMETHANE,-8.931318,x0161,active-noncovalent
Cc1ccc(cn1)c2c(cc(cn2)Cl)c3ccc(cc3)S(=O)(=O)C,Etoricoxib,-8.930543,x0678,active-noncovalent
Cc1cccc(c1/[NH+]=C\2/NCCCS2)C,Xylazine,-8.929581,x0434,active-noncovalent
c1ccc(cc1)N(c2ccccc2)C(=O)N[NH+]=C(N)N,"3-Carbamimidamido-1,1-diphenylurea",-8.929390,x0195,active-noncovalent
c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)N[C@@H](N2)[C@H]3C[C@@H]4C[C@H]3C=C4,Cyclothiazide,-8.927109,x0195,active-noncovalent
COc1ccc2c(c1OC)C[N@H+]3CCc4cc(c(cc4[C@@H]3C2)OC)OC,Tetrahydropalmatine,-8.922980,x0104,active-noncovalent
CC1(c2ccccc2[C@](S1)(CCC[NH2+]C)c3ccccc3)C,Talsupram,-8.921137,x0749,active-covalent
c1c2c3c4c(cc(c(=O)c4oc2O)[O-])c(oc3c(=O)c1[O-])O,Ellagic acid,-8.920332,x0749,active-covalent
c1ccn(c1)C(=O)c2c(cc(cc2O)O)O,"2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol",-8.918880,x0678,active-noncovalent
c1cc(cnc1)Cc2c[nH]c3c2nc([nH]c3=O)N,Peldesine,-8.918018,x0749,active-covalent
c1ccc(cc1)c2cc3cnc(nc3nc2N4CC=CC4)N,"7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine",-8.917163,x1385,active-covalent
C[NH+]1CCC(=C2c3ccccc3CCc4c2nccc4)CC1,Azatadine,-8.916715,x0195,active-noncovalent
Cc1cccc2c1C(=O)[C@@]3(CCN(C3=[NH+]2)c4ccccc4)O,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin",-8.912935,x1093,active-noncovalent
CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@]3(C)C(=O)C)C)[C@@]4(C1=CC(=O)CC4)C,Medrogestone,-8.912298,x0749,active-covalent
c1cc(oc1)CNc2c3c([nH]cn3)ncn2,Kinetin,-8.910966,x0749,active-covalent
c1cc(c(cc1Cl)Cc2cc(ccc2O)Cl)O,Dichlorophen,-8.910726,x0161,active-noncovalent
c1c(c(c2cn[nH]c2[nH+]1)[N@]3CCO[C@H](C3)C[NH3+])Br,"1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE",-8.910646,x0107,active-noncovalent
Cn1cc(c2c1cccc2)C3=C(C(=O)NC3=O)c4cn(c5c4ccc(c5)N(=O)=O)C,MKC-1,-8.910169,x0830,active-covalent
C[N@@]1CCn2c1nc3c2c(c(c(c3Br)Br)Br)Br,"N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE",-8.909936,x0749,active-covalent
CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)N(=O)=O,Nitazoxanide,-8.909885,x0678,active-noncovalent
c1ccc(cc1)n2c(ccn2)NS(=O)(=O)c3ccc(cc3)N,Sulfaphenazole,-8.909131,x0749,active-covalent
c1cnc([nH]1)SCc2cc(cc3c2nc([nH]c3=O)N)N,"2,6-Diamino-8-(1h-Imidazol-2-Ylsulfanylmethyl)-3h-Quinazoline-4-One",-8.908922,x1093,active-noncovalent
Cc1c(sc(n1)Nc2ccccc2)C(=O)C,2-PHENYLAMINO-4-METHYL-5-ACETYL THIAZOLE,-8.907822,x0749,active-covalent
CS(=O)(=O)c1cc(cc2c1n(c3c2CC[C@@H]3CC(=O)[O-])Cc4ccc(cc4)Cl)F,Laropiprant,-8.907263,x0195,active-noncovalent
c1cc(cc(c1)O[C@H]2CO[C@H]3[C@@H]2OC[C@H]3Oc4ccc(cc4)C(=[NH2+])N)C(=[NH2+])N,"1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-gluc",-8.907069,x0395,active-noncovalent
C1CCCCCNC(=O)[C@H](CCCC1)[NH3+],3-AMINO-AZACYCLOTRIDECAN-2-ONE,-8.906254,x0104,active-noncovalent
Cn1c2cc(cnc2nc1N)c3ccccc3,"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine",-8.905650,x0749,active-covalent
C[NH+](C)CCCOc1cc(=O)sc2c1cccc2,Thiocoumarin,-8.904337,x0104,active-noncovalent
C[N+]1([C@@H]2CC[C@H]1CC(C2)OC3c4ccccc4CCc5c3cccc5)C,"(3-EXO)-3-(10,11-DIHYDRO-5H-DIBENZO[A,D][7]ANNULEN-5-YLOXY)-8,8-DIMETHYL-8-AZONI",-8.900844,x0072,active-noncovalent
CCn1c(c([nH]c1=O)c2ccccc2)[O-],Ethotoin,-8.900129,x0195,active-noncovalent
C[C@H]1C=C([C@@H]2[C@@H]([C@]1(CO[C@@H]2c3ccc(cc3)O)CO)C)C,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL",-8.899755,x0749,active-covalent
c1cc2ccc(cc2c(c1)Nc3ncccn3)C(=[NH2+])N,8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide,-8.899223,x0434,active-noncovalent
c1ccc-2c(c1)CCc3c2nnc(c3)N,"5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine",-8.896029,x0195,active-noncovalent
c1cc(ccc1C(=O)[O-])OCCn2ccnc2,Dazoxiben,-8.894512,x0072,active-noncovalent
CC[C@@H](c1ccccc1)c2c(=O)c3c(oc2[O-])CCCCC3,"6,7,8,9-TETRAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOHEPTA[B]PYRAN-2-ONE",-8.892855,x0161,active-noncovalent
C[NH+](C)CC(=O)Nc1ccc2c(c1)c3ccccc3c(=O)[nH]2,"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",-8.891733,x0161,active-noncovalent
C[C@@]12[C@@H]([C@@H](C[C@@H](O1)n3c4ccccc4c5c3c6n2c7ccccc7c6c8c5C(=O)NC8)[NH2+]C)OC,Staurosporine,-8.891430,x0195,active-noncovalent
CCOCc1nc2c(n1CC(C)(C)O)c3ccccc3nc2N,Resiquimod,-8.891293,x1077,active-noncovalent
c1ccc2c(c1)nc(o2)c3cc(c(c(c3)Br)[O-])Br,"4-(1,3-BENZOXAZOL-2-YL)-2,6-DIBROMOPHENOL",-8.890933,x0749,active-covalent
CC(=O)/C=C/c1cn(c2c1cccc2)C,(3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE,-8.889580,x0195,active-noncovalent
CC1=C(C2=C(C3(CC3)[C@@](C(=O)C2=C1)(C)O)C)CO,Irofulven,-8.886318,x0195,active-noncovalent
CCN(c1cccc(c1)c2ccnc3n2ncc3C#N)C(=O)C,Zaleplon,-8.886124,x0195,active-noncovalent
C[NH+](C)CCO[C@@H](c1ccccc1)c2ccc(cc2)Br,Bromodiphenhydramine,-8.885732,x0195,active-noncovalent
c1ccc(c(c1)[C@]23c4cc(ccc4NC(=O)C[N@H+]2CCO3)Cl)Cl,Cloxazolam,-8.883878,x0830,active-covalent
c1cc(ccc1c2c(n(cn2)CC3CC3)c4ccncc4)F,4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE,-8.882900,x0195,active-noncovalent
c1ccc(cc1)Sc2cccc3c2c(nc(n3)N)N,"5-Phenylsulfanyl-2,4-Quinazolinediamine",-8.881219,x0107,active-noncovalent
C[NH+](C)CCOC(c1ccccc1)c2ccccc2,Diphenhydramine,-8.878661,x1093,active-noncovalent
C[NH+](C)CCOC(c1ccccc1)c2ccccc2,Dimenhydrinate,-8.878661,x1093,active-noncovalent
c1ccc(cc1)NC(=O)/C=C/c2c3c(cc(cc3Cl)Cl)[nH]c2C(=O)[O-],Gavestinel,-8.877934,x1093,active-noncovalent
c1ccc2c(c1)c(c[nH]2)C[C@H](C(=O)[O-])[NH3+],D-Tryptophan,-8.877129,x0749,active-covalent
c1ccc(c(c1)Cn2c(=O)c3ccccc3nc2N4CCC[C@H](C4)[NH3+])C#N,2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE,-8.875749,x1093,active-noncovalent
C[C@H]1COc2c3n1cc(c(=O)c3cc(c2N4CC[NH+](CC4)C)F)C(=O)[O-],Levofloxacin,-8.874720,x1385,active-covalent
CCC(CC)n1ccc2c1ccc3c2c(nc(n3)N)N,"7-(1-ETHYL-PROPYL)-7H-PYRROLO-[3,2-F]QUINAZOLINE-1,3-DIAMINE",-8.874576,x0749,active-covalent
c1cc(ccc1[C@@H]2CC[NH2+]C[C@H]2COc3ccc4c(c3)OCO4)F,Paroxetine,-8.871614,x0072,active-noncovalent
c1ccc2c(c1)c(ccn2)c3c[nH]nc3c4ccccn4,4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline,-8.871042,x1077,active-noncovalent
CN1CC[NH+](CC1)CC(=O)N2c3ccccc3C(=O)Nc4c2nccc4,Pirenzepine,-8.870657,x0104,active-noncovalent
C[C@H]1C[NH2+]CC[N@@]1S(=O)(=O)c2cccc3c2ccnc3,5-(2-methylpiperazine-1-sulfonyl)isoquinoline,-8.869709,x0749,active-covalent
CCC(=O)O[C@](Cc1ccccc1)(c2ccccc2)[C@H](C)C[NH+](C)C,Dextropropoxyphene,-8.865889,x0678,active-noncovalent
c1ccc(cc1)C[C@@H](C(O)O)[NH3+],"(2S)-2-amino-3-phenylpropane-1,1-diol",-8.865764,x0195,active-noncovalent
c1cc2c(cc1S(=O)(=O)N)C[NH2+]CC2,"1,2,3,4-Tetrahydro-Isoquinoline-7-Sulfonic Acid Amide",-8.865551,x0195,active-noncovalent
CC1(c2ccccc2[C@](O1)(CCC[NH2+]C)c3ccccc3)C,Talopram,-8.865288,x0195,active-noncovalent
CCC(=O)O[C@@](Cc1ccccc1)(c2ccccc2)[C@@H](C)C[NH+](C)C,Levopropoxyphene,-8.864452,x0678,active-noncovalent
B(c1cccc(c1)NC(=O)CI)(O)O,4-iodo-acetamido phenylboronic acid,-8.862325,x0195,active-noncovalent
c1cc(ccc1c2c3cc(ccc3no2)c4ccnc(n4)N)Cl,"4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine",-8.860837,x0195,active-noncovalent
C[C@](Cc1ccccc1)(c2ccccc2)NC(=O)C[NH3+],Remacemide,-8.859919,x0874,active-noncovalent
Cc1c2c(cc(c1F)[N@]3CC[NH2+][C@@H](C3)C)n(cc(c2=O)C(=O)[O-])C4CC4,Grepafloxacin,-8.857184,x0749,active-covalent
Cc1cc(c(c(c1)Br)O)c2cc3cc(ccc3[nH]2)C(=[NH2+])N,CRA_9076,-8.857115,x0678,active-noncovalent
COc1ccc2c(c1)c(c[nH]2)CCC(=O)[O-],3-(5-methoxy-1H-indol-3-yl)propanoic acid,-8.856071,x0749,active-covalent
c1ccc2c(c1)C3=[NH+]CCN3[C@@]2(c4ccc(cc4)Cl)O,Mazindol,-8.855818,x0195,active-noncovalent
C[C@@H]1CC[C@@H](N1c2ccc3c(c2)c(cc(=O)[nH]3)C(F)(F)F)[C@H](C(F)(F)F)O,LGD2941,-8.853800,x0749,active-covalent
CCN(CC)C(=O)N[C@@H]1C[N@H+]([C@@H]2Cc3c[nH]c4c3c(ccc4)C2=C1)C,Lisuride,-8.853628,x0104,active-noncovalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@@H]3[C@H]2C=CC4=CC(=O)CC[C@@]34C)C,Dydrogesterone,-8.851148,x0749,active-covalent
c1c(c(c(c(c1Cl)Cl)Cc2c(c(cc(c2Cl)Cl)Cl)O)O)Cl,Hexachlorophene,-8.850200,x0830,active-covalent
CC[C@]12CC(=C)[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CCCC[C@H]34,Desogestrel,-8.845607,x0749,active-covalent
Cc1ccc(cc1)c2c3c(ncnc3n(n2)C(C)(C)C)N,"1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",-8.840606,x0678,active-noncovalent
c1ccc(c(c1)c2cc3c(c4cc(ccc4[nH]3)NC=O)c5c2C(=O)NC5=O)Cl,"N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FO",-8.839449,x0749,active-covalent
c1ccc2c(c1)cccc2/C=C\3/C(=C(C(=O)O3)c4ccc(cc4)Cl)[O-],(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE,-8.839400,x0104,active-noncovalent
COc1ccc(c(c1)O)C(=O)c2ccccc2,Oxybenzone,-8.838999,x0749,active-covalent
c1ccc2c(c1)C(=O)N(C2=O)CCc3n[n-]nn3,"2-[2-(1H-tetrazol-5-yl)ethyl]-1H-isoindole-1,3(2H)-dione",-8.838402,x0678,active-noncovalent
c1cc(c(cc1c2c(c(=O)c3c(cc(cc3o2)O)[O-])[O-])O)O,Quercetin,-8.834005,x0749,active-covalent
Cc1cc2c(c(c1)OC(=O)C)C3=C(CC[C@@H](C3)C)C(O2)(C)C,Pirnabine,-8.833778,x0195,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5ccc(c(c5c4)C[NH+](C)C)O)O,Topotecan,-8.833655,x0161,active-noncovalent
c1cc(ccc1c2cc[nH]n2)N(=O)=O,3-(4-nitrophenyl)-1H-pyrazole,-8.832658,x0195,active-noncovalent
c1cc(ccc1c2c[nH]nc2)C3(CC[NH2+]CC3)c4ccc(cc4)Cl,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,-8.832039,x1077,active-noncovalent
Cc1ccc(cc1)Cn2cc(nc2)c3cccs3,4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole,-8.831050,x1093,active-noncovalent
Cc1cc2c(cc1C3(CC3)c4ccc(cn4)C(=O)[O-])C(CCC2(C)C)(C)C,"6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridi",-8.830045,x0072,active-noncovalent
CN1CC[NH+](CC1)CCCN2c3ccccc3Sc4c2cc(cc4)Cl,Prochlorperazine,-8.829357,x0195,active-noncovalent
C[C@H](Cc1ccccc1)[N@@H+](C)CC#C,Selegiline,-8.827469,x0161,active-noncovalent
c1cc2c(cc1N)c(=O)[nH]c(n2)N,"2,6-diaminoquinazolin-4-ol",-8.826744,x0678,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5ccccc5c4CC[Si](C)(C)C)O,Cositecan,-8.826438,x0161,active-noncovalent
Cc1cccc(c1)[C@@]23c4ccccc4C(=O)N2CCS3,"(R)-(+)9B-(3-METHYL)PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-5(9BH)-ONE",-8.825463,x0195,active-noncovalent
CC(=O)OCC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,Desoxycorticosterone acetate,-8.824808,x0749,active-covalent
C1[C@@H]2C[C@@H]2N([C@@H]1C#N)C(=O)[C@H](C34C[C@H]5C[C@@H](C3)CC(C5)(C4)O)[NH3+],Saxagliptin,-8.824578,x0749,active-covalent
CC[C@H](C(C[C@@H](C)[NH+](C)C)(c1ccccc1)c2ccccc2)O,Alphamethadol,-8.824572,x0195,active-noncovalent
C(CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-])C[NH3+],Alendronic acid,-8.822410,x0397,active-noncovalent
CCC[NH2+][C@H](C)C(=O)Nc1ccccc1C,Prilocaine,-8.821436,x0195,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C3(CCCCC3)[NH3+])C(=O)[O-])C,Cyclacillin,-8.818027,x0678,active-noncovalent
c1cc(ccc1CCSC(=[NH2+])N)CCSC(=[NH2+])N,"S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea",-8.816635,x0874,active-noncovalent
C[NH2+]Cc1ccc(o1)c2cccnc2,N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE,-8.816086,x0397,active-noncovalent
CC(C)c1cc(ccc1O)Sc2ccc(c(c2)C(C)C)O,4-(4-Hydroxy-3-Isopropylphenylthio)-2-Isopropylphenol,-8.813923,x0749,active-covalent
C[NH+](C)CC[C@H](c1ccc(cc1)Cl)c2ccccn2,Chlorpheniramine,-8.807839,x0072,active-noncovalent
CC(C)c1cc(ccc1O)Oc2c(cc(cc2Cl)CC(=O)[O-])Cl,KB-141,-8.807411,x0195,active-noncovalent
Cc1ccc2c(c1C)CN(C[C@@H]2c3cccc(c3)O)C(=O)N(C)C,"(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBO",-8.806817,x1418,active-covalent
Cc1cccc(c1C)Cc2c[nH]cn2,Detomidine,-8.805959,x0195,active-noncovalent
Cc1c(cccn1)OC[C@@H]2CCC[NH2+]2,Pozanicline,-8.804146,x0104,active-noncovalent
c1cc(ccc1CC(=O)NC[P@@H](=O)[O-])I,(P-Iodophenylacetylamino)Methylphosphinic Acid,-8.803741,x0749,active-covalent
CC[NH+](CC)CC(=O)Nc1c(cccc1C)C,Lidocaine,-8.802265,x0195,active-noncovalent
c1cc2c(cc1N(=O)=O)C[NH2+][C@H](C2)CO,"[(3R)-7-NITRO-1,2,3,4-TETRAHYDROISOQUINOLIN-3-YL]METHANOL",-8.801618,x0195,active-noncovalent
Cc1c(cccc1Cl)Nc2ccccc2C(=O)[O-],Tolfenamic acid,-8.798061,x0104,active-noncovalent
c1cc2c(c(c1)[O-])C(=O)c3c(cccc3[O-])C2,Anthralin,-8.798023,x0749,active-covalent
c1ccc(c(c1)c2ccc(o2)C(=O)[O-])C(F)(F)F,5-[2-(TRIFLUOROMETHYL)PHENYL]-2-FUROIC ACID,-8.797132,x0195,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@]4(C)O)C)O)F,Fluoxymesterone,-8.796730,x1077,active-noncovalent
c1ccc2c(c1)CC(C2)[C@H](C(=O)[O-])[NH3+],Alpha-Amino-2-Indanacetic Acid,-8.794549,x0195,active-noncovalent
c1cc2c(cc1O)[C@@]34CCCC[C@]3([C@@H](C2)[N@H+](CC4)CC5CCC5)O,Butorphanol,-8.793920,x0072,active-noncovalent
CSc1nc([nH]n1)c2ccc(cc2)Cl,"3-(4-CHLOROPHENYL)-5-(METHYLTHIO)-4H-1,2,4-TRIAZOLE",-8.793152,x0678,active-noncovalent
c1cc(cc(c1)NC(=O)Nc2ccc(cc2)Oc3ccncc3)C(F)(F)F,1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA,-8.791049,x0161,active-noncovalent
CC1=C(C(=O)c2ccccc2C1=O)C,"2,3-DIMETHYL-1,4-NAPHTHOQUINONE",-8.788751,x0195,active-noncovalent
Cn1c(=O)cc(n(c1=O)Cc2ccccc2C#N)N3CCC[C@H](C3)[NH3+],Alogliptin,-8.787475,x1392,active-covalent
c1cc(ccc1[C@@H](CC(=O)[O-])C[NH3+])Cl,Arbaclofen,-8.787353,x0678,active-noncovalent
c1cc(ccc1[C@@H](CC(=O)[O-])C[NH3+])Cl,Baclofen,-8.787353,x0678,active-noncovalent
CC(=O)CCc1ccc2cc(ccc2c1)OC,Nabumetone,-8.786806,x0195,active-noncovalent
c1c(cncc1Br)C(=O)N,5-Bromonicotinamide,-8.786503,x0397,active-noncovalent
C[N@H+]1[C@H]2CC[C@@H]1[C@H]([C@H](C2)OC(=O)c3ccccc3)C(=O)[O-],Benzoylecgonine,-8.786451,x0749,active-covalent
CC[C@@H](c1ccccc1)c2c(c3ccc(cc3oc2=O)OC)[O-],4-HYDROXY-7-METHOXY-3-(1-PHENYL-PROPYL)-CHROMEN-2-ONE,-8.786123,x0072,active-noncovalent
c1c(cc(cc1Cl)Cl)NC(=O)[C@H]2CC(=O)N(C2)C3CCCCC3,"(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE",-8.785215,x0749,active-covalent
Cc1c(ccc(c1Cl)C#N)/[NH+]=C\2/N3CC[C@@H]([C@H]3[C@@H](O2)C(F)(F)F)O,"2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1",-8.784797,x0678,active-noncovalent
c1c[nH]c2c1[C@H](CCNC2=O)C3=NC(=[NH2+])NC3=O,Debromohymenialdisine,-8.784710,x0104,active-noncovalent
C[C@@H]1C[C@@H](CN(C1)C(=O)c2cc(ccc2N)Br)C,"4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}aniline",-8.781930,x0195,active-noncovalent
c1c2c([nH]c(=O)[nH]c2=O)n[nH]1,Oxypurinol,-8.781333,x0678,active-noncovalent
Cc1cccc(c1)n2cnc3c2ccc(c3)N,1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE,-8.780076,x0195,active-noncovalent
C[NH+]1CCN(CC1)C2=[NH+]c3ccccc3Oc4c2cc(cc4)Cl,Loxapine,-8.779706,x0874,active-noncovalent
CNC(=[NH+]Cc1ccccc1)NC,Bethanidine,-8.779254,x0678,active-noncovalent
c1ccc2c(c1)ccc(=O)[nH]2,2-OXOQUINOLINE,-8.778525,x0678,active-noncovalent
CC[NH+](CC)[C@H](C)C(=O)c1ccccc1,Diethylpropion,-8.776320,x0195,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@H]4C(=O)CO)C)O,Corticosterone,-8.776215,x0967,active-noncovalent
c1ccc(c(c1)C(=O)[O-])/N=N/c2ccc(cc2)O,2-((4'-HYDROXYPHENYL)-AZO)BENZOIC ACID,-8.774345,x0749,active-covalent
Cc1c(cccc1Cl)Nc2c(cccn2)C(=O)[O-],Clonixin,-8.772776,x0749,active-covalent
C1Cc2c(n(c(=O)[nH]c2=O)C[C@@H](C(=O)[O-])[NH3+])C1,"(S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proioni",-8.771086,x1374,active-covalent
c1cn2cnc3c(c2n1)nc[nH]3,"1,N6-Ethenoadenine",-8.771063,x0397,active-noncovalent
c1ccc2c(c1)C[C@H]([C@@H]2O)NC(=O)c3cc4cc(sc4[nH]3)Cl,"2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE",-8.770727,x1077,active-noncovalent
Cn1c-2c(c(n1)C(=O)[O-])CCc3c2nc(nc3)Nc4ccccc4,"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic",-8.766799,x0072,active-noncovalent
c1ccc(cc1)Nc2cccc3c2c(ccc3)S(=O)(=O)[O-],1-Anilino-8-Naphthalene Sulfonate,-8.765585,x0161,active-noncovalent
c1cc(ccc1C#N)C(c2ccc(cc2)C#N)n3cncn3,Letrozole,-8.765322,x1392,active-covalent
C/C=C/1\[C@@H]2Cc3c(ccc(=O)[nH]3)[C@]1(CC(=C2)C)/N=C/c4cc(cc(c4O)OC)Cl,Mimopezil,-8.764030,x0749,active-covalent
Cc1ccc(cc1)c2cc(nn2c3ccc(cc3)S(=O)(=O)N)C(F)(F)F,Celecoxib,-8.763126,x1386,active-covalent
C#CC[NH2+][C@H]1CCc2c1cccc2,N-Propargyl-1(S)-Aminoindan,-8.761830,x0195,active-noncovalent
C[NH+](C)CC[C@H](c1ccccc1)c2ccccn2,Pheniramine,-8.760836,x0874,active-noncovalent
CN1CCn2c3ccc(cc3c4c2C1=[NH+]CC4)OC,Metralindole,-8.758816,x0749,active-covalent
C[NH2+]Cc1ccccc1c2cccs2,N-methyl-1-(2-thiophen-2-ylphenyl)methanamine,-8.757997,x0195,active-noncovalent
c1ccc2cc(c(cc2c1)C(=O)[O-])NC(=O)C(=O)[O-],3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid,-8.757351,x0749,active-covalent
c1cc(cc2c1cc3ccc(cc3n2)N)N,Proflavine,-8.755239,x0749,active-covalent
C[C@@H](CN1c2ccccc2Sc3c1nccc3)[NH+](C)C,Isothipendyl,-8.753884,x0195,active-noncovalent
Cc1cc(cc(c1)OC[C@H]2CNC(=O)O2)C,Metaxalone,-8.752860,x0874,active-noncovalent
CC(C)c1nnc2n1cc(cc2)c3c(nco3)c4ccc(cc4)F,Triazolopyridine,-8.751641,x0749,active-covalent
CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)[NH+]5CCOCC5)C)C)[N+]6(CCCC6)CC=C,Rocuronium,-8.751361,x0104,active-noncovalent
Cc1cc2c(cc1C(=C)c3ccc(cc3)C(=O)[O-])C(CCC2(C)C)(C)C,Bexarotene,-8.751095,x0072,active-noncovalent
Cc1ccc(c(c1Cl)Nc2ccccc2C(=O)[O-])Cl,Meclofenamic acid,-8.749172,x1093,active-noncovalent
c1ccc2c(c1)[nH]c(=S)s2,2-mercaptobenzothiazole,-8.748226,x0678,active-noncovalent
CN1CC[NH+](CC1)C(c2ccccc2)c3ccccc3,Cyclizine,-8.747169,x0831,active-covalent
c1cc(cc(c1)C(=O)N)Cn2c3c(c4c2c(ccc4)C(=O)[O-])CCCCC3,"5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic aci",-8.746214,x0195,active-noncovalent
CC[C@H](c1ccccc1)c2c(=O)c3ccccc3oc2[O-],Phenprocoumon,-8.745324,x1093,active-noncovalent
C[C@@]12[C@@H](CCO1)C(=O)N[C@]2(C=O)[C@H]([C@H]3CCCC=C3)O,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHY",-8.744459,x0749,active-covalent
c1ccc(cc1)CC2=[NH+]CCN2,Tolazoline,-8.743675,x0195,active-noncovalent
C[P@](=O)(C/C(=C/C(=O)[O-])/O)[O-],4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid,-8.743319,x0397,active-noncovalent
Cn1c2cccc(c2c(c(c1=O)C(=O)N(C)c3ccc(cc3)C(F)(F)F)[O-])OC,Tasquinimod,-8.741734,x0831,active-covalent
c1ccc(cc1)NC(=O)c2ccc3cc(ccc3c2)C(=[NH2+])N,6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine,-8.741552,x1077,active-noncovalent
CNC(=O)CC[C@@H](C(=O)[O-])[NH3+],N5-Methylglutamine,-8.740340,x0107,active-noncovalent
CS(=O)(=O)N1CCC(CC1)[C@H]2c3ccc(cc3C(=Cc4c2nccc4)N5CC[NH2+]CC5)Cl,(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[,-8.738490,x0195,active-noncovalent
CC(C)C[C@@H](C(=O)[O-])NC(=O)c1ccco1,Furoyl-Leucine,-8.736470,x0397,active-noncovalent
c1cc2c(cc1I)C[NH2+]CC2,"7-Iodo-1,2,3,4-Tetrahydro-Isoquinoline",-8.734660,x0195,active-noncovalent
C[N@H+]1[C@H]2CC[C@@H]1[C@@H]([C@H](C2)c3ccc(c(c3)Cl)Cl)COC,NS-2359,-8.734034,x0104,active-noncovalent
c1cnc(nc1c2cc(sc2Cl)Cl)N,"4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine",-8.731435,x0749,active-covalent
C[N@H+]1C[C@@H]2c3ccccc3Oc4ccc(cc4[C@H]2C1)Cl,Asenapine,-8.731202,x0195,active-noncovalent
C1[C@@H]2COC(=O)N2c3c(=O)[nH]c(nc3N1)N,"5,6-Cyclic-Tetrahydropteridine",-8.729576,x0195,active-noncovalent
CCCC[C@@H]1c2ccccc2C(=O)O1,Butylphthalide,-8.726678,x0195,active-noncovalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,Progesterone,-8.726217,x0749,active-covalent
COc1c2c(cc(c1N3C[C@@H]4CCC[NH2+][C@@H]4C3)F)c(=O)c(cn2C5CC5)C(=O)[O-],Moxifloxacin,-8.725466,x0195,active-noncovalent
c1cc(c2c(c1)oc3c(ccc(c3c2=O)[O-])N(=O)=O)[O-],"1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One",-8.724290,x0749,active-covalent
c1cc(cc(c1)Br)C(=O)c2cnc(o2)N,"(2-AMINO-1,3-OXAZOL-5-YL)-(3-BROMOPHENYL)METHANONE",-8.723484,x0749,active-covalent
c1cc(ccc1CCC(=O)N=O)Cl,(2E)-3-(4-CHLOROPHENYL)-N-HYDROXYACRYLAMIDE,-8.722711,x0749,active-covalent
C[N@@H+]1CCCC[C@H]1CCN2c3ccccc3Sc4c2cc(cc4)[S@@](=O)C,Mesoridazine,-8.721065,x0195,active-noncovalent
c1cc(c(cc1C(=O)[O-])C(=O)[O-])c2c3cc(c(cc3oc-4cc(=O)c(cc24)F)O)F,OREGON GREEN 488 CARBOXYLATE,-8.720537,x1418,active-covalent
Cc1ccc(cc1)c2cc(cc(c2)OC)[C@@H](C)C#Cc3c(nc(nc3N)N)C,"5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,",-8.719364,x0161,active-noncovalent
c1ccc(cc1)NC(=O)c2cc(ccc2Cl)N(=O)=O,2-chloro-5-nitro-N-phenylbenzamide,-8.718929,x0678,active-noncovalent
C[NH+](C)CCc1c[nH]c2c1cc(cc2)O,Bufotenine,-8.715672,x0831,active-covalent
C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@H]1[C@H](C=O)O)C)O)F)C)F,Difluocortolone,-8.715178,x0967,active-noncovalent
CCn1c2cc3c(cc2c(=O)c(n1)C(=O)[O-])OCO3,Cinoxacin,-8.714756,x0749,active-covalent
CCN(C(C)C)C(=O)c1cc(cc(c1)OC[C@H](C)Nc2cc[nH+]cc2)C,N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE,-8.714584,x0195,active-noncovalent
c1ccc(cc1)[C@@H]2C[NH+]=C(O2)N,Aminorex,-8.713026,x0104,active-noncovalent
CCC[N@H+](CCc1cccs1)[C@H]2CCc3c(cccc3O)C2,Rotigotine,-8.706867,x0104,active-noncovalent
CCn1ccc(nc1=O)NS(=O)(=O)c2ccc(cc2)N,Sulfacytine,-8.705966,x0749,active-covalent
c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)N[C@@H](N2)C(Cl)Cl,"6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE",-8.705724,x0195,active-noncovalent
c1cc(c(cc1C#N)F)[C@H]2CCc3n2cnc3,Osilodrostat,-8.704613,x0195,active-noncovalent
C[C@@]1(CCC[NH2+]1)c2[nH]c3c(cccc3n2)C(=O)N,Veliparib,-8.704514,x0104,active-noncovalent
COC(=O)Nc1[nH]c2ccccc2n1,Carbendazim,-8.704404,x0678,active-noncovalent
c1cc2c(cc1S(=O)(=O)N)nc([nH]2)c3cscn3,"2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide",-8.704337,x0678,active-noncovalent
CC(C)c1c(cc(cc1O)/C=C/c2ccccc2)O,Tapinarof,-8.702489,x0749,active-covalent
Cc1cccc(c1C(=O)Nc2cc(c(c(c2)Br)[O-])Br)C,"N-(3,5-dibromo-4-hydroxyphenyl)-2,6-dimethylbenzamide",-8.702322,x0830,active-covalent
C1CCC2(C1)C3C[NH+](CC2C[NH+](C3)CC4CC4)CC5CC5,Tedisamil,-8.701493,x0678,active-noncovalent
CS(=O)(=O)c1ccc(cc1)C2=C(C(=O)OC2)c3ccccc3,Rofecoxib,-8.700452,x0195,active-noncovalent
c1cc(ccc1C(=[NH2+])N)OCCCCCCOc2ccc(cc2)C(=[NH2+])N,Hexamidine,-8.699392,x0874,active-noncovalent
Cc1ccc(c(c1)C(=O)[O-])NS(=O)(=O)c2ccccc2,5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID,-8.699165,x0678,active-noncovalent
c1ccc(c(c1)C(=O)[O-])Nc2ccccc2C(F)(F)F,O-Trifluoromethylphenyl Anthranilic Acid,-8.699039,x0195,active-noncovalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5ccccc5C4=O)[O-])(C(=O)C)O)[NH3+])O,Idarubicin,-8.697884,x0161,active-noncovalent
[2H]C([2H])(C#C)[N@H+]([11CH3])[C@H](C)Cc1ccccc1,L-deprenyl-D2 C-11,-8.696830,x0678,active-noncovalent
CC1(C[N@H+](CC[N@]1C)[C@@H]2C[C@H](c3c2cc(cc3)Cl)c4ccccc4)C,Zicronapine,-8.696643,x0195,active-noncovalent
CC(=O)[C@H](COCc1ccccc1)[NH3+],3-Amino-4-Oxybenzyl-2-Butanone,-8.694608,x0749,active-covalent
c1ccc2c(c1)c(c[nH]2)CO,Indole-3-carbinol,-8.693953,x0195,active-noncovalent
COc1ccc2c(c1)c(ccn2)[C@H]([C@@H]3C[C@@H]4CC[N@H+]3C[C@H]4C=C)O,Quinidine barbiturate,-8.693700,x0195,active-noncovalent
c1cc(ccc1[C@@H]2CC(=O)c3ccc(cc3O2)O)O,5-deoxyflavanone,-8.692631,x0749,active-covalent
c1cc2c(cc1O)onc2c3ccc(cc3O)O,"4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL",-8.691811,x0749,active-covalent
C[N+]1(CC[C@]23c4c5ccc(c4O[C@H]2[C@H](C=C[C@H]3[C@H]1C5)O)OC)C,Codeine methylbromide,-8.690700,x1385,active-covalent
CN(C)/C=[NH+]/c1c(cc(c(c1I)CCC(=O)[O-])I)I,Iopodic acid,-8.690508,x0195,active-noncovalent
Cc1cc(on1)c2c(c3cc(ccc3[nH]c2=O)Cl)c4ccccc4,6-CHLORO-3-(3-METHYLISOXAZOL-5-YL)-4-PHENYLQUINOLIN-2(1H)-ONE,-8.688659,x1392,active-covalent
C(C(=O)[O-])(C(=O)[O-])[NH3+],2-Aminopropanedioic Acid,-8.688499,x0397,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4([C@H](C=O)O)O)C)O,Hydrocortisone,-8.688115,x0678,active-noncovalent
C([C@H](C(=O)[O-])[NH3+])C(=O)[O-],D-Aspartic Acid,-8.687477,x0397,active-noncovalent
C[NH+](C)CCOC1=Cc2ccccc2Sc3c1cc(cc3)Cl,Zotepine,-8.686658,x0678,active-noncovalent
c1ccc(cc1)C[NH2+][C@@H](c2ccccc2)P(=O)([O-])[O-],Alpha-Benzyl-Aminobenzyl-Phosphonic Acid,-8.686124,x0434,active-noncovalent
CCCOc1ccc(cc1Cl)CC(=O)[O-],(3-Chloro-4-Propoxy-Phenyl)-Acetic Acid,-8.684936,x0749,active-covalent
C/C(=C(\C#N)/C(=O)Nc1ccc(cc1)C(F)(F)F)/O,Teriflunomide,-8.682094,x0195,active-noncovalent
Cc1c(ccc(c1Cl)C#N)n2c(c3n(c2=O)CC[C@H]3O)[O-],BMS-564929,-8.679653,x1385,active-covalent
CCOC(=O)c1cncn1[C@H](C)c2ccccc2,Etomidate,-8.679118,x0161,active-noncovalent
c1cc(cc(c1)C(F)(F)F)[C@H](C[NH3+])O,(1R)-2-amino-1-[3-(trifluoromethyl)phenyl]ethanol,-8.677788,x0195,active-noncovalent
c1c(c2c([nH]1)nc([nH]c2=O)N)C#N,7-cyano-7-deazaguanine,-8.676987,x0195,active-noncovalent
CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)OC(=O)C)CC[C@@H]4[C@@H]3CC=C(C4)N=O,Norgestimate,-8.670858,x0749,active-covalent
C[C@H](c1ccc(cc1)Br)NC(=O)c2cc(ccc2O)F,N-[(1R)-1-(4-Bromophenyl)ethyl]-5-fluoro-2-hydroxybenzamide,-8.667340,x0434,active-noncovalent
c1cnc(cn1)C(=O)N,Pyrazinamide,-8.667175,x0397,active-noncovalent
C[NH2+][C@H]1CC[C@H](c2c1cccc2)c3ccc(c(c3)Cl)Cl,Sertraline,-8.662815,x0195,active-noncovalent
CCc1cccc2c1[nH]c3c2CCO[C@@]3(CC)CC(=O)[O-],Etodolac,-8.662307,x0195,active-noncovalent
COc1c(nccn1)NS(=O)(=O)c2ccc(cc2)N,Sulfametopyrazine,-8.661619,x0678,active-noncovalent
Cc1cncc2c1c(ccc2)S(=O)(=O)[N@@]3CCC[NH2+]C[C@@H]3C,(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,-8.661167,x0692,active-covalent
c1cc(ccc1C(=O)NCC[NH+]2CCOCC2)Cl,Moclobemide,-8.661036,x0161,active-noncovalent
C(CC(=O)[O-])[C@@H](C(=O)N)[NH3+],4-Amido-4-Carbamoyl-Butyric Acid,-8.660124,x0426,active-noncovalent
c1ccc(c(c1)c2c3c(n(c(=O)c(=O)n2)CCC#N)CC=C(C3)Cl)F,Cinolazepam,-8.660000,x0749,active-covalent
c1ccc2c(c1)c(c(oc2=O)Cl)Cl,"3,4-Dichloroisocoumarin",-8.658970,x0195,active-noncovalent
COc1c2c(ccc(=O)o2)cc3c1occ3,Methoxsalen,-8.658818,x0749,active-covalent
c1ccc2c(c1)CC(=O)c3ccccc3N2C(=O)N,Oxcarbazepine,-8.657276,x0104,active-noncovalent
B([C@H](Cc1ccccc1)[NH3+])(O)O,PHENYLALANINE BORONIC ACID,-8.657084,x0104,active-noncovalent
c1ccc(cc1)C2(CCCCC2)[NH+]3CCCC3,Rolicyclidine,-8.655874,x0830,active-covalent
c12c([nH]c(n1)I)nc([nH]c2=O)N,8-iodo-guanine,-8.655401,x0678,active-noncovalent
Cc1cc(n2c(n1)ncn2)Nc3ccc(cc3)C(F)(F)F,"5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine",-8.654149,x1386,active-covalent
c1cc(c(cc1Oc2c(cc(cc2I)CC(=O)[O-])I)I)O,Tiratricol,-8.653764,x0830,active-covalent
c1ccc2c(c1)c(=O)oc(=O)[nH]2,Isatoic anhydride,-8.652579,x0678,active-noncovalent
B([C@@H]1CCCN1C(=O)[C@H](C(C)C)[NH3+])(O)O,Talabostat,-8.651994,x0104,active-noncovalent
c1cc2c(c(c1)[O-])C(=O)c3c(cccc3[O-])C2=O,Dantron,-8.650962,x0749,active-covalent
Cn1c2ccccc2c(n1)C(=O)NC3C[C@H]4CCC[C@@H](C3)[NH+]4C,Granisetron,-8.650248,x0749,active-covalent
CC[C@]12CC(=C)[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,Etonogestrel,-8.650203,x0749,active-covalent
CC1=CC[C@H](CC1)[N@@H+](C)CCC=C(C)C,R-azabisabolene,-8.647064,x0678,active-noncovalent
COC1=CC(=O)O[C@@H](C1)/C=C/C2=CCCC=C2,Kava,-8.647023,x0749,active-covalent
c1ccc2cc(ccc2c1)C(=O)[C@@H](c3cccc4c3cccc4)P(=O)([O-])[O-],Bis-Napthyl Beta-Ketophosphonic Acid,-8.645821,x0831,active-covalent
CCC[N@H+](CC)[C@H](CC)C(=O)Nc1c(cccc1C)C,Etidocaine,-8.645063,x0104,active-noncovalent
C[N@H+]1[C@H]2CC[C@@H]1[C@H]([C@H](C2)OC(=O)c3ccccc3)C(=O)OC,Cocaine,-8.643191,x0161,active-noncovalent
c1ccc(c(c1)[C@]23c4cc(ccc4NC(=O)C[N@H+]2CCO3)Br)F,Haloxazolam,-8.639376,x0830,active-covalent
C[C@]([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CC[N@@H+]([C@@H]3Cc6c5c(c(cc6)O)O4)CC7CC7)OC)(C(C)(C)C)O,Buprenorphine,-8.637957,x0195,active-noncovalent
CC(C)C[C@@H](C(=O)[O-])n1cc(nn1)C[NH3+],"(S)-2-[4-(Aminomethyl)-1h-1,2,3-Triazol-1-Yl]-4-Methylpentanoic Acid",-8.634365,x0397,active-noncovalent
C[N+]1(CCN(CC1)C[C@](c2ccccc2)(C3CCCCC3)O)C,Hexocyclium,-8.634324,x0678,active-noncovalent
C[C@@H](C(=O)[O-])n1c(c2c(c1O)[C@H]3CC[C@@H]2C3)O,"(2S)-2-[(3aR,4R,7S,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl]propanoic",-8.632608,x0195,active-noncovalent
c1ccc(cc1)C[NH2+]C[C@H]2COc3ccc4c(c3O2)CC(=O)N4,Aplindore,-8.632162,x0104,active-noncovalent
CN1c2ccc(cc2N(C(=O)CC1=O)c3ccccc3)Cl,Clobazam,-8.632013,x0195,active-noncovalent
CC1(c2cc(ccc2NC(=S)O1)c3ccc(n3C)C#N)C,Tanaproget,-8.631413,x0749,active-covalent
c1ccc2c(c1)c(c[nH]2)CC(=O)N,2-(1H-INDOL-3-YL)ACETAMIDE,-8.630117,x0195,active-noncovalent
Cc1nc2c(n1CC(C)C)c3c(cccn3)nc2N,Sotirimod,-8.630054,x0195,active-noncovalent
C[C@]12CCC(=O)C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4O)CCOCc5cc(cc(c5)F)F,"(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-M",-8.628716,x0195,active-noncovalent
c1ccc(cc1)Oc2ccc(cc2)NC(=O)Nc3ccc(cc3)C(=[NH2+])N,1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea,-8.627699,x0161,active-noncovalent
c1c(n(cn1)CC[NH+]2CCOCC2)N(=O)=O,Nimorazole,-8.626919,x0104,active-noncovalent
CC(=O)O[C@H]1Cc2ccccc2N(c3c1cccc3)C(=O)N,Eslicarbazepine acetate,-8.626589,x0072,active-noncovalent
C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@H]1C(=O)CO)C)O)Cl)C)F,Clocortolone,-8.626530,x0749,active-covalent
Cc1ccc(c(c1)CC(=O)[O-])Nc2c(cccc2Cl)F,Lumiracoxib,-8.624336,x0749,active-covalent
C[N@@H+]1CCO[C@@H](c2ccccc2C1)c3ccccc3,Nefopam,-8.622624,x0195,active-noncovalent
CCCC[C@@]12CCC(=O)C(=C1c3ccc(cc3C2)O)Br,"(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one",-8.622558,x0749,active-covalent
C[N@H+]1CCc2cc3c(c(c2[C@@H]1[C@@H]4c5ccc(c(c5C(=O)O4)OC)OC)OC)OCO3,Noscapine,-8.622482,x0195,active-noncovalent
c1ccc2c(c1)c(ccc2n3c(c4n(c3=O)CC[C@H]4O)[O-])C#N,"4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-",-8.618741,x1385,active-covalent
C[C@@H]1C[C@H]2C[N@H+]1CCn3c(=O)c4cccc(c4[nH]3)-c5c(=O)[nH]c6cccc(c6n5)O2,"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,",-8.617660,x0195,active-noncovalent
[H]/N=C(\Cc1c[nH]c2c1cccc2)/C(=O)[O-],Imino-Tryptophan,-8.615948,x0749,active-covalent
C[NH2+]Cc1ccc(cc1)c2c3c4c(cc(cc4[nH]2)F)C(=O)NCC3,Rucaparib,-8.615771,x0104,active-noncovalent
COc1cc(ccc1O)c2ccc3c(c2)[nH]nc3c4[nH]c5ccccc5n4,4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL,-8.615508,x0161,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5ccccc5c4/C=N/OC(C)(C)C)O,Gimatecan,-8.615489,x0874,active-noncovalent
c1cc(ccc1C(=O)c2ccc(cc2)O)O,bis(4-hydroxyphenyl)methanone,-8.615445,x0072,active-noncovalent
CN1CCC[NH+]=C1/C=C/c2cccs2,Pyrantel,-8.614363,x0678,active-noncovalent
c1cc(ccc1/C=c\2/c(=O)n(/c(=C(\CO)/[NH3+])/[nH]2)CC(=O)[O-])O,[4-(4-Hydroxy-Benzyl)-2-(2-Hydroxy-1-Methyl-Ethyl)-5-Oxo-Imidazolidin-1-Yl]-Acet,-8.612837,x0397,active-noncovalent
c1cc(ccc1C(=O)[O-])NCc2cnc3c(n2)c(=O)[nH]c(n3)N,Pteroic Acid,-8.611973,x0749,active-covalent
c1cc(ccc1C(=O)[O-])NCc2cnc3c(n2)c(=O)[nH]c(n3)N,Pteric acid,-8.611973,x0749,active-covalent
c1c(c(cc(c1N)O)O)C[C@@H](C(=O)[O-])[NH3+],3-Amino-6-Hydroxy-Tyrosine,-8.607805,x0107,active-noncovalent
CC\1=C(c2cc(ccc2/C1=C\c3ccc(cc3)S(=O)(=O)C)F)CC(=O)[O-],Exisulind,-8.603947,x0830,active-covalent
c1ccc(cc1)C2(C(=O)NC(=O)N2)c3ccccc3,Phenytoin,-8.603527,x0195,active-noncovalent
C[N@H+]1CC[N@@]2c3c(cccn3)Cc4ccccc4[C@H]2C1,Esmirtazapine,-8.602228,x0195,active-noncovalent
CC(C)c1c(c2cc(ccc2[nH]c1=O)Cl)OC3CCCCC3,6-CHLORO-4-(CYCLOHEXYLOXY)-3-ISOPROPYLQUINOLIN-2(1H)-ONE,-8.601430,x0195,active-noncovalent
Cc1ccc(cc1c2ccc(cc2C)c3nnc(o3)C)C(=O)NC4CC4,"N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxa",-8.599949,x0161,active-noncovalent
C[C@@H]1COc2c3n1cc(c(=O)c3cc(c2N4CC[NH+](CC4)C)F)C(=O)[O-],Ofloxacin,-8.599224,x1385,active-covalent
c1ccc2c(c1)c(ns2)N3CC[NH+](CC3)CCc4cc5c(cc4Cl)NC(=O)C5,Ziprasidone,-8.598448,x0678,active-noncovalent
C[NH2+]CC/C=C/c1cccnc1,Rivanicline,-8.597290,x0107,active-noncovalent
c1ccc2c(c1)c(c[nH]2)CCC(=O)[O-],Indolylpropionic Acid,-8.596369,x0749,active-covalent
c1cc2c(cc1F)c(c[nH]2)C[C@@H](C(=O)[O-])[NH3+],5-fluorotryptophan,-8.595808,x0830,active-covalent
CC[N@@H+](C)Cc1cnc(nc1N)C,"5-{[Ethyl(Methyl)Amino]Methyl}-2-Methyl-5,6-Dihydropyrimidin-4-Amine",-8.595036,x0678,active-noncovalent
c1c[nH]nc1CC[NH3+],Betazole,-8.593248,x0397,active-noncovalent
Cc1c(cno1)C(=O)Nc2ccc(cc2)C(F)(F)F,Leflunomide,-8.592921,x0749,active-covalent
COC(=O)[C@H](Cc1ccccc1)[NH3+],methyl L-phenylalaninate,-8.592135,x0678,active-noncovalent
c1cc(c(cc1[C@@]23C[C@@H]2C[NH2+]C3)Cl)Cl,Amitifadine,-8.590970,x0195,active-noncovalent
c1cc2c(cc1/C=C\3/C(=O)[N-]C(=O)S3)c(ccn2)c4ccncc4,GSK-1059615,-8.590685,x0161,active-noncovalent
Cc1c(c2cc(ccc2nc1c3ccc(cc3)c4ccccc4F)F)C(=O)[O-],Brequinar,-8.590233,x0104,active-noncovalent
c1ccc(cc1)CCC[NH3+],3-Phenylpropylamine,-8.589304,x0195,active-noncovalent
CCN(CC)C(=O)[C@]1(C[C@H]1C[NH3+])c2ccccc2,Levomilnacipran,-8.588881,x0387,active-noncovalent
c1ccc2c(c1)c(c[nH]2)C[C@@H](C(=O)[O-])[NH3+],Tryptophan,-8.588454,x0195,active-noncovalent
Cc1cccc(c1)Cc2c3c(ncnc3n(n2)C(C)(C)C)N,"1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",-8.587972,x0161,active-noncovalent
c1ccc2c(c1)OC[C@H](O2)C3=[NH+]CCN3,Idazoxan,-8.587899,x0195,active-noncovalent
c1cc2c(ccc3c2c(c1)C(OC3=O)(c4ccc(c(c4)Br)O)c5ccc(c(c5)Br)O)Cl,"4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN",-8.584899,x0708,active-covalent
c1ccc2c(c1)NC(=O)[C@H](S2)CC(=O)NO,"2-(3,4-Dihydro-3-Oxo-2h-Benzo[B][1,4]Thiazin-2-Yl)-N-Hydroxyacetamide",-8.584510,x0195,active-noncovalent
c1cc2c(cc1C(=O)[O-])oc(n2)c3cc(cc(c3)Cl)Cl,Tafamidis,-8.581557,x0749,active-covalent
c1cc(c(c2c1C(=O)c3c(ccc(c3C2=O)[O-])[O-])[O-])O,"1,2,5,8-tetrahydroxyanthracene-9,10-dione",-8.581480,x0195,active-noncovalent
Cc1ccc(cc1)c2c(n3cc(ccc3n2)C)CC(=O)N(C)C,Zolpidem,-8.578808,x0195,active-noncovalent
CC[C@H](c1ccccc1)NC=O,N-(1-PHENYL-PROPYL)-FORMAMIDE,-8.576698,x0678,active-noncovalent
CC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)c5ccc(cc5)N(C)C)C)C(=O)COC,Telapristone acetate,-8.576076,x1077,active-noncovalent
C[C@@H](CN1c2ccccc2Sc3c1cc(cc3)C(=O)C)[NH+](C)C,Aceprometazine,-8.575106,x0161,active-noncovalent
CC(=O)N1c2cccc(c2N=C3CC(CC(=O)[C@H]3[C@@H]1c4ccc(cc4Cl)Cl)(C)C)O,"(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hex",-8.574265,x0161,active-noncovalent
CCOC(=O)C1(CC[NH+](CC1)C)c2ccccc2,Meperidine,-8.574247,x0104,active-noncovalent
[H]/N=C/C(=C)CCc1ccc(cc1)F,(1Z)-4-(4-FLUOROPHENYL)-2-METHYLIDENEBUTAN-1-IMINE,-8.571533,x0749,active-covalent
c1cc2c(cc1/C=C\3/C(=O)[N-]C(=O)S3)nccn2,"5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE",-8.569762,x0749,active-covalent
C[NH+](C)CCCCSC(=[NH2+])N,4-(DIMETHYLAMINO)BUTYL IMIDOTHIOCARBAMATE,-8.569202,x0195,active-noncovalent
Cc1ccc(cc1)/C=C/2\[C@@H]3CC[C@](C2=O)(C3(C)C)C,Enzacamene,-8.566621,x0749,active-covalent
Cc1c2c(=O)c3cc(ccc3n(c2n(n1)C)[O-])Cl,"6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE",-8.565640,x0749,active-covalent
Cc1cc2c(cc1C)n(c-3nc(=O)[nH]c(=O)c3n2)C,"7,8,10-TRIMETHYLBENZO[G]PTERIDINE-2,4(3H,10H)-DIONE",-8.564152,x0967,active-noncovalent
c1cc2cnccc2c(c1)N,5-Aminoisoquinoline,-8.562566,x0540,active-noncovalent
CCOC[C@H]1[C@H]2CC[C@H]([N@@H+]2C)C[C@@H]1c3ccc(c(c3)Cl)Cl,Tesofensine,-8.562256,x0104,active-noncovalent
c1ccc2c(c1)cccc2OCC(=O)[O-],NAPHTHYLOXYACETIC ACID,-8.562251,x1385,active-covalent
c1cc2c3c(c1)CCN3C(=O)CC2,Pyroquilon,-8.560533,x0195,active-noncovalent
c1cc(ccc1C[C@@H](C(=O)[O-])[NH3+])O,Tyrosine,-8.559490,x0107,active-noncovalent
Cc1ccc(=O)n(c1)c2ccccc2,Pirfenidone,-8.558218,x0195,active-noncovalent
c1ccc2c(c1)cccc2CC(=O)[O-],1-naphthaleneacetic acid,-8.556835,x1392,active-covalent
c1cc(ccc1[C@H](C#N)c2c(cc(cc2Cl)n3c(=O)[nH]c(=O)cn3)Cl)Cl,Diclazuril,-8.556479,x0161,active-noncovalent
c1c(cc2c(c1[O-])C(=O)/C(=C/c3cc(c(c(c3O)Br)[O-])Br)/O2)O,"3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE",-8.555655,x0749,active-covalent
c1cc(c(cc1[C@@H]2[C@H](C(=O)c3c(cc(cc3O2)O)[O-])O)O)O,Taxifolin,-8.554293,x0749,active-covalent
C[N@@H+](CC#C)Cc1ccccc1,Pargyline,-8.553005,x0678,active-noncovalent
CC[C@@](C)(C[NH+](C)C)OC(=O)c1ccccc1,Amylocaine,-8.552486,x0161,active-noncovalent
Cc1ccc(nc1)c2ccc(cn2)C,Abametapir,-8.550557,x0749,active-covalent
C(C[C@@](C(F)F)(C(=O)[O-])[NH3+])C[NH3+],Eflornithine,-8.548601,x0397,active-noncovalent
C(C[C@@](C(F)F)(C(=O)[O-])[NH3+])C[NH3+],L-Eflornithine,-8.548601,x0397,active-noncovalent
CC(C)c1ccc2c(c1)c(=O)c3cc(c(nc3o2)N)C(=O)[O-],Amlexanox,-8.547929,x0072,active-noncovalent
COc1ccnc2c1c(c[nH]2)c3ccnc(n3)N,"4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",-8.546545,x1077,active-noncovalent
CCn1cc(c(=O)c2c1nc(c(c2)F)N3CC[NH2+]CC3)C(=O)[O-],Enoxacin,-8.545741,x0749,active-covalent
c1cc2c(cc1Br)c(c([nH]2)C(=O)N)S(=O)(=O)N3CCCC3,5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide,-8.543896,x0749,active-covalent
Cc1c(c(no1)c2ccccc2)c3ccc(cc3)S(=O)(=O)N,Valdecoxib,-8.543512,x0161,active-noncovalent
Cc1c(nc(n1c2ccc(cc2)F)C)C#Cc3ccnc(c3)Cl,Basimglurant,-8.538751,x0104,active-noncovalent
CCOC(=O)c1c(nn(c1C)c2ccc(cc2)N)C,"1-(4-Aminophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",-8.538040,x0749,active-covalent
c1cc(ccc1C[C@@H](C(=O)N)[NH3+])O,L-tyrosinamide,-8.536988,x0195,active-noncovalent
CC(C)[C@@H]1C(=O)N/C(=[NH+]/c2ccccc2F)/S1,"(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one",-8.536366,x0749,active-covalent
Cc1cccc(c1C)[C@H](C)c2c[nH]c(=S)[nH]2,Rezatomidine,-8.535708,x0072,active-noncovalent
Cc1nc2ccccc2c(n1)N(C)c3ccc(cc3)OC,Verubulin,-8.535555,x0831,active-covalent
c1cc2cnccc2c(c1)S(=O)(=O)[N@]3CCC[NH2+]CC3,Fasudil,-8.533946,x0072,active-noncovalent
CC[C@H](Cc1c[nH]c2c1cccc2)[NH3+],Etryptamine,-8.530258,x0072,active-noncovalent
CN1c2ccc(cc2C(=NCC1=O)c3ccccc3F)N(=O)=O,Flunitrazepam,-8.530227,x0434,active-noncovalent
c1cc(ccc1[C@@H](C(=O)[O-])[NH3+])O,Oxfenicine,-8.528625,x1077,active-noncovalent
Cc1cc2c(cc1C)nc3c(n2)c4cc(ccc4n3CC(=O)NCC[NH+](C)C)Cl,Rabeximod,-8.526732,x0874,active-noncovalent
CC(=O)N1CCN(CC1)NC(=O)c2ccc(cc2)F,FK-960,-8.523940,x0749,active-covalent
CC1=CC(=O)c2ccccc2C1=O,Menadione,-8.520124,x0195,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)/N=C\2/NC(=O)/C(=C/c3ccc(o3)C)/S2,4-Methyl-N-[5-(5-methyl-furan-2-ylmethylene)-4-oxo-thiazolidin-2-ylidene]-benzen,-8.519338,x0161,active-noncovalent
CC1=CC[C@]2(C[C@@H]1[C@H](OC2)c3ccc(cc3)O)CO,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",-8.518875,x0749,active-covalent
c1ccc(cc1)C2(CCCCC2)[NH3+],1-Phenylcyclohexylamine,-8.517974,x0195,active-noncovalent
Cn1c2c(c(nc(=O)c1=O)c3ccccc3)C=C(CC2)Cl,Temazepam,-8.517952,x1380,active-covalent
CC(C)[C@@H](C(=O)[O-])NS(=O)(=O)c1ccc2c3ccccc3sc2c1,"N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine",-8.516657,x0104,active-noncovalent
CCCC[N@@H+]1CCCC[C@H]1C(=O)Nc2c(cccc2C)C,Levobupivacaine,-8.515640,x0874,active-noncovalent
C[C@@H]1COc2c3n1cc(c(=O)c3cc(c2N4CC[NH+](CC4)C)F)C(=O)[O-],D-Levofloxacin,-8.515532,x0749,active-covalent
c1cc(c(c(c1)Cl)Cl)c2c(nc(nn2)N)N,Lamotrigine,-8.514943,x0195,active-noncovalent
Cc1cccc(c1C)[C@H](C)c2cnc[nH]2,Dexmedetomidine,-8.513158,x0195,active-noncovalent
Cc1cccc(c1C)[C@H](C)c2cnc[nH]2,Medetomidine,-8.513158,x0195,active-noncovalent
CCC[C@](C)([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CC[N@@H+]([C@@H]3Cc6c5c(c(cc6)O)O4)C)OC)O,Dihydroetorphine,-8.513003,x0195,active-noncovalent
c1c(cc(c(c1Br)[O-])Br)C[C@@H](C(=O)[O-])[NH3+],Dibromotyrosine,-8.512824,x0830,active-covalent
Cc1ccccc1[C@H](c2ccccc2)OCC[NH+](C)C,Orphenadrine,-8.506549,x0195,active-noncovalent
Cc1ccc(=O)n(c1)c2ccc(cc2)O,Hydronidone,-8.506185,x0195,active-noncovalent
c1cc(c(cc1Cl)c2ccc(o2)C(=O)[O-])Cl,"5-(2,5-DICHLOROPHENYL)-2-FUROIC ACID",-8.506137,x0749,active-covalent
c1ccc2c(c1)c(c([nH]2)O)C[C@@H](C(=O)[O-])[NH3+],2-Hydroxy-Tryptophan,-8.505823,x0195,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])SP(=O)([O-])[O-],S-Phosphocysteine,-8.504059,x0397,active-noncovalent
c1ccc(cc1)c2cccc3c2c(c(n3Cc4cc(cc5c4OCOC5)F)O)N=O,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3",-8.503301,x0161,active-noncovalent
C[C@@]12[C@](C[C@@H](O1)n3c4ccccc4c5c3c6n2c7ccccc7c6c8c5C(=O)NC8)(C(=O)OC)O,K-252a,-8.500988,x0195,active-noncovalent
CCc1c([nH]c(=O)c(c1Oc2cccc(c2)/C=C/C#N)I)C,"(2E)-3-{3-[(5-ETHYL-3-IODO-6-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-4-YL)OXY]PHENYL}ACR",-8.500910,x0195,active-noncovalent
c1c(cnc(c1Cl)Cl)N2C[C@@H]3C[NH2+][C@@H]3C2,Sofinicline,-8.498679,x0749,active-covalent
c1ccc(cc1)Oc2cc(c(c(c2)Br)[O-])Br,"2,6-dibromo-4-phenoxyphenol",-8.494667,x1386,active-covalent
c1ccc(cc1)CNC(=O)c2ccc(cc2)S(=O)(=O)N,N-Benzyl-4-Sulfamoyl-Benzamide,-8.494147,x0072,active-noncovalent
c1cc(c(c(c1)Cl)[NH+]=C2NCCN2)Cl,Clonidine,-8.493985,x1385,active-covalent
Cc1c(c2c(n1C)C(=O)C=C(C2=O)OC)COc3ccccc3,"5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione",-8.492207,x0749,active-covalent
C1CCC[NH+](CCC1)CCNC(=[NH2+])N,Guanethidine,-8.490370,x0072,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5ccc(cc5c4)O)O,10-hydroxycamptothecin,-8.489619,x0104,active-noncovalent
c1ccc(cc1)/C=C/c2cc(c(c(c2)Br)[O-])Br,"2,6-dibromo-4-[(E)-2-phenylethenyl]phenol",-8.489545,x0749,active-covalent
c1cc(c2c(c1)[nH]cc2C[C@@H](C(=O)[O-])[NH3+])N,2-Amino-3-(4-Amino-1h-Indol-3-Yl)Propanoic Acid,-8.489252,x0830,active-covalent
CCn1c2ccccc2c3c1[C@](SCC3)(C)CC[NH+](C)C,Tandamine,-8.489201,x0195,active-noncovalent
B(c1cc2ccccc2s1)(O)O,Benzo[B]Thiophene-2-Boronic Acid,-8.488256,x0195,active-noncovalent
Cc1ccc(cc1)C(=O)[C@@H](C)C[NH+]2CCCCC2,Tolperisone,-8.488065,x0678,active-noncovalent
c1cc(cc2c1cc(c(c2)C(=O)[O-])O)O,"3,7-DIHYDROXYNAPHTHALENE-2-CARBOXYLIC ACID",-8.486043,x0195,active-noncovalent
CC(C)([C@H]1C[C@@]23C=C[C@@]1([C@H]4[C@@]25CC[N@@H+]([C@@H]3Cc6c5c(c(cc6)O)O4)CC7CC7)OC)O,Cyprenorphine,-8.485388,x0195,active-noncovalent
c1c(cc(c(c1I)Oc2cc(c(c(c2)I)[O-])I)I)C[C@@H](C(=O)[O-])[NH3+],Levothyroxine,-8.484230,x0195,active-noncovalent
CC[C@@H](C(C[C@@H](C)[NH+](C)C)(c1ccccc1)c2ccccc2)OC(=O)C,Methadyl acetate,-8.481861,x0195,active-noncovalent
CC[C@@H](C(C[C@@H](C)[NH+](C)C)(c1ccccc1)c2ccccc2)OC(=O)C,Betacetylmethadol,-8.481861,x0195,active-noncovalent
CC(C)n1c2c(c(n1)c3ccc4c(c3)nc(o4)N)c(ncn2)N,Sapanisertib,-8.479814,x0678,active-noncovalent
C[C@]12C[C@@H](C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(C(C(F)(F)F)(F)F)O)c5ccc(cc5)S(=O)(=O)C,Vilaprisan,-8.477801,x1077,active-noncovalent
c1cc2c(cc1O)c(c[nH]2)C[C@@H](C(=O)[O-])[NH3+],Oxitriptan,-8.476649,x0678,active-noncovalent
c1ccc2c(c1)cnnc2NN,Hydralazine,-8.476441,x0107,active-noncovalent
CCC(=O)C(C[C@@H](C)[NH+](C)C)(c1ccccc1)c2ccccc2,Methadone,-8.475481,x0195,active-noncovalent
C[C@](Cc1ccc(c(c1)O)O)(C(=O)[O-])[NH3+],Methyldopa,-8.474210,x1374,active-covalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5cccc(c5c4)N(=O)=O)O,Rubitecan,-8.473740,x0104,active-noncovalent
c1cc(ccc1N)Sc2ccc(cc2)N3C(=O)c4ccc(cc4C3=O)N,"5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE",-8.472511,x0104,active-noncovalent
C[C@@]12CC3C[C@@](C1)(CC(C3)(C2)[NH3+])C,Memantine,-8.472478,x1077,active-noncovalent
Cc1c(c2c(c(c1O)C)CCC(O2)(C)C)C,Chromanol,-8.471735,x0195,active-noncovalent
c1cc(c(cc1Cl)O)Oc2ccc(cc2Cl)Cl,Triclosan,-8.471461,x0161,active-noncovalent
COc1cc(cc(c1)OC)c2nc(c(c(n2)N)C[NH3+])c3ccc(cc3Cl)Cl,"5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine",-8.470547,x0161,active-noncovalent
c1cc(ccc1C[C@@H](C(=O)[O-])[NH3+])OP(=O)([O-])[O-],Phosphonotyrosine,-8.470440,x0678,active-noncovalent
Cc1ccc2c(c1)n3c(=O)c(c(n3c(n2)N(C)C)[O-])CC=C,Azapropazone,-8.467151,x0195,active-noncovalent
C1CC(=[NH2+])N(C1)Cc2c(c(=O)[nH]c(=O)[nH]2)Cl,Tipiracil,-8.466299,x0678,active-noncovalent
c1ccc2c(c1)c(=O)cc([nH]2)C(=O)[O-],Kynurenic Acid,-8.466244,x0678,active-noncovalent
CC(C)([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CC[N@@H+]([C@@H]3Cc6c5c(c(cc6)O)O4)CC7CC7)OC)O,Diprenorphine,-8.464994,x0195,active-noncovalent
c1ccc(cc1)C2=N[C@@H](C(=O)Nc3c2cc(cc3)Cl)O,Oxazepam,-8.463932,x0434,active-noncovalent
c1cc(c2c3c1C[C@@H]4[C@]5([C@]3(CC[N@@H+]4CC6CCC6)[C@@H](O2)[C@H](CC5)O)O)O,Nalbuphine,-8.463601,x0874,active-noncovalent
Cc1cc(no1)[N-]S(=O)(=O)c2ccc(cc2)N,Sulfamethoxazole,-8.463095,x0072,active-noncovalent
C[NH+]1CCC(CC1)c2c3ccccc3cc(=O)c4c2ccs4,Ketotifen,-8.461905,x0161,active-noncovalent
C[C@@H](CN1c2ccccc2Sc3c1cc(cc3)OC)C[NH+](C)C,Methotrimeprazine,-8.460957,x0104,active-noncovalent
C[C@@](c1ccccc1)(c2ccc(cc2)Cl)OCC[C@H]3CCC[N@@H+]3C,Clemastine,-8.460388,x0678,active-noncovalent
C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,Methylprednisolone,-8.458721,x1077,active-noncovalent
c1ccc(cc1)c2cc(c(c(c2)Br)[O-])Br,"3,5-dibromobiphenyl-4-ol",-8.457076,x0161,active-noncovalent
c1ccnc(c1)/C=C/2\C(=O)[NH+]=C(S2)N,"(5E)-2-Amino-5-(2-pyridinylmethylene)-1,3-thiazol-4(5H)-one",-8.456252,x0749,active-covalent
COc1ccc(cc1)CC(=O)N,2-(4-METHOXYPHENYL)ACETAMIDE,-8.454595,x0195,active-noncovalent
c1cc2c(ccc(c2nc1)[O-])N(=O)=O,Nitroxoline,-8.454420,x0195,active-noncovalent
c1cc2c(cc1OC(F)(F)F)sc(n2)N,Riluzole,-8.454394,x0195,active-noncovalent
Cc1c(n2ccccc2n1)c3ccnc(n3)NC(=O)C,"N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide",-8.451538,x0678,active-noncovalent
c1cc(ccc1c2c(n(cn2)C3CC[NH2+]CC3)c4ccnc(n4)N)F,SB220025,-8.451029,x0749,active-covalent
CCc1cc(c(cc1OC)C[C@H](C)[NH3+])OC,"2,5-Dimethoxy-4-ethylamphetamine",-8.451007,x0195,active-noncovalent
c1ccc(cc1)c2ccccc2C[NH3+],1-biphenyl-2-ylmethanamine,-8.449472,x1418,active-covalent
c1cc2c(cc1O)c(c[nH]2)CC[NH3+],Serotonin,-8.449264,x0195,active-noncovalent
c1cc2c(cc(nc2c(c1)C(F)(F)F)C(F)(F)F)[C@H]([C@H]3CCCC[NH2+]3)O,Mefloquine,-8.447909,x0195,active-noncovalent
CCC[N@@H+]1CCCC[C@H]1C(=O)Nc2c(cccc2C)C,Ropivacaine,-8.446188,x0195,active-noncovalent
Cc1c2ccc(cc2oc(=O)c1CCO)O,7-HYDROXY-4-METHYL-3-(2-HYDROXY-ETHYL)COUMARIN,-8.445297,x0195,active-noncovalent
c1ccc2c(c1)c(c[nH]2)C[C@@H](CO)[NH3+],2-Amino-3-(1h-Indol-3-Yl)-Propan-1-Ol,-8.444458,x0195,active-noncovalent
c1cc(ccc1C[C@H](C(=O)NO)[NH3+])I,Para-Iodo-D-Phenylalanine Hydroxamic Acid,-8.444391,x0830,active-covalent
C/C(=C\c1ccc(cc1)C(=O)[O-])/c2ccc3c(c2)C(CCC3(C)C)(C)C,Arotinoid acid,-8.444140,x0104,active-noncovalent
Cc1ccc(cc1)C(=O)N2CCC(CC2)Cc3ccccc3,N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE,-8.443148,x0946,active-noncovalent
[H]/N=c/1\nn/c(=N\[H])/c1=NNc2cc(ccc2)C(F)(F)F,5-imino-4-(3-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine,-8.441792,x0678,active-noncovalent
Cc1c(c2c(cn1)[C@@H](OC2)c3ccc(cc3)Cl)O,Cicletanine,-8.440985,x0195,active-noncovalent
c1ccc(cc1)/N=C/[C@H]2CCOC2=O,(3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one,-8.438836,x0749,active-covalent
c1ccc(cc1)C(=O)c2ccc(c(c2N(=O)=O)[O-])O,"(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE",-8.436135,x0770,active-covalent
C[NH+](C)C[C@@H]1CCOC1(c2ccccc2)c3ccccc3,Blarcamesine,-8.435296,x0072,active-noncovalent
Cc1cccc(c1)CN2CC[NH+](CC2)[C@H](c3ccccc3)c4ccc(cc4)Cl,Meclizine,-8.434520,x0104,active-noncovalent
Cn1c2ccc(cc2c(=O)n(c1=O)Cc3ccc(cc3)C(=O)[O-])C#CCc4ccccc4,"4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL",-8.433024,x0104,active-noncovalent
COC(=O)[C@H](c1ccccc1)[C@H]2CCCC[NH2+]2,Dexmethylphenidate,-8.432077,x0195,active-noncovalent
B(c1ccc(cc1)c2ccc(cc2)B(O)O)(O)O,"4,4'-Biphenyldiboronic Acid",-8.431700,x0195,active-noncovalent
C1C[C@H]2C[NH2+][C@@H](C[C@H]2C[C@H]1CCc3n[n-]nn3)C(=O)[O-],Tezampanel,-8.430841,x0107,active-noncovalent
CC1=C(C(CCC1=O)(C)C)/C=C/C(=C/C=C/C(=C/CO)/C)/C,4-Oxoretinol,-8.430619,x1077,active-noncovalent
CCc1c([nH]c2c1C(=O)[C@@H](CC2)C[NH+]3CCOCC3)C,Molindone,-8.429701,x1077,active-noncovalent
B1(c2ccc(cc2CO1)Cl)O,AN-2718,-8.428252,x0195,active-noncovalent
c1cc2c(ccc3c2c(c1)C(=O)NC3=O)N,"6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE",-8.426353,x0195,active-noncovalent
C[C@@H]1CN(C[C@@H]([NH2+]1)C)c2c(c(c3c(c2F)n(cc(c3=O)C(=O)[O-])C4CC4)N)F,Sparfloxacin,-8.425159,x0161,active-noncovalent
C[C@H]1Cn2c3c(ccc(c3C[N@@H+]1CC=C(C)C)Cl)[nH]c2=S,"5-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BE",-8.424280,x1077,active-noncovalent
C(CCCC[NH3+])CCC[NH3+],Octamethylenediamine,-8.423462,x1334,active-covalent
C[N@@]1[C@H](Nc2cc(c(cc2S1(=O)=O)S(=O)(=O)N)Cl)CCl,Methyclothiazide,-8.422181,x0749,active-covalent
B([C@@H]1CCCN1C(=O)[C@@H]2CCC[NH2+]2)(O)O,(2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYB,-8.420096,x0104,active-noncovalent
c1cc2n(c(=O)c1)C[C@H]3C[C@@H]2C[NH2+]C3,Cytisine,-8.417797,x0195,active-noncovalent
CC[N@H+](C)[C@@H](C)[C@@H](c1ccccc1)O,Etafedrine,-8.417681,x0195,active-noncovalent
C[C@@H]1C[C@@H]2[C@H](O2)/C=C\C=C\C(=O)Cc3c(c(cc(c3Cl)O)[O-])C(=O)O1,Radicicol,-8.417435,x1385,active-covalent
c1cc(c(c2c1[NH+]=C3NC(=O)CN3C2)Cl)Cl,Anagrelide,-8.416256,x0749,active-covalent
COc1c(ccc2c1cc(c3c2c4c(cc3C(=O)[O-])OCO4)N(=O)=O)O,"9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid",-8.415316,x0195,active-noncovalent
C[NH+]1CCN(CC1)c2ccccc2C/N=N\C(=S)N,(Z)-2-[2-(4-methylpiperazin-1-yl)benzyl]diazenecarbothioamide,-8.412063,x0830,active-covalent
c1cc2c(c(c1)NC(=O)Nc3cc([nH]n3)[C@@H]4CCC[NH2+]4)[C@@H]5CCCN5C2=O,"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-Y",-8.407955,x0678,active-noncovalent
CCCCNS(=O)(=O)c1ccccc1,N-Butyl-Benzenesulfonamide,-8.407525,x0678,active-noncovalent
c1cc(cc(c1)O)C[C@@H](C(=O)[O-])[NH3+],3-Tyrosine,-8.407487,x0830,active-covalent
C[C@@H](c1ccc2c(c1)nc(o2)c3ccc(cc3)Cl)C(=O)[O-],Benoxaprofen,-8.407418,x1077,active-noncovalent
CC[C@H](c1ccccc1)C(=O)Nc2ccncc2,(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE,-8.405595,x0749,active-covalent
c1cc2c(cc1C(F)(F)F)[C@@H]3C[C@H]2C[NH2+]C3,CP-601927,-8.400669,x0749,active-covalent
c1cc(sc1)C2(CCCCC2)[NH+]3CCCCC3,Tenocyclidine,-8.399853,x0354,active-noncovalent
c1ccc(cc1)C[C@@H]2Nc3cc(c(cc3S(=O)(=O)N2)S(=O)(=O)N)C(F)(F)F,Bendroflumethiazide,-8.397747,x0195,active-noncovalent
C[C@]12CC/C(=N\OCC[NH3+])/C[C@@H]1C(=O)C[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C,Istaroxime,-8.397587,x0161,active-noncovalent
c1cc2c(cc(c(c2nc1)O)I)I,Diiodohydroxyquinoline,-8.397536,x0195,active-noncovalent
c1cc(c(cc1C[C@@H](C(=O)[O-])[NH3+])F)O,3-Fluoro-L-tyrosine,-8.393539,x1374,active-covalent
Cc1cccc(c1)C[C@@H](C(=O)[O-])[NH3+],3-Methylphenylalanine,-8.392673,x1374,active-covalent
C1CCc2c(c(c(s2)NC(=O)C3CC3)C(=O)N)C1,"2-[(CYCLOPROPYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",-8.392258,x0195,active-noncovalent
COc1c2ccc(=O)oc2cc3c1cco3,Bergapten,-8.392231,x0195,active-noncovalent
C=CC[N@H+]1CC[C@]23CCCC[C@H]2[C@H]1Cc4c3cc(cc4)O,Levallorphan,-8.391128,x0072,active-noncovalent
c1cc(ccc1CC[NH3+])S(=O)(=O)F,4-(2-Aminoethyl)Benzenesulfonyl Fluoride,-8.389985,x0161,active-noncovalent
C[C@@]12[C@H](CC[C@@]3([C@@H]1[C@@H]([C@]45[C@H]3CC[C@H](C4)C(=C)C5)C(=O)[O-])OC2=O)O,GIBBERELLIN A4,-8.389585,x1311,active-covalent
c1cc(ccc1CCC2(OCCO2)Cn3ccnc3)Cl,"1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE",-8.386787,x0678,active-noncovalent
C[C@@H]1[C@H](OC(=[NH2+])N1)c2ccccc2,4-Methylaminorex,-8.385629,x0104,active-noncovalent
c1ccc(cc1)C[C@@H]([C@H](Cc2ccc3c(c2)OCO3)C(=O)[O-])C(=O)[O-],"2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid",-8.385226,x0831,active-covalent
C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2([C@H](C=O)O)O)CCC4=CC(=O)C=C[C@]34C,Prednisone,-8.384087,x0678,active-noncovalent
c1ccc(cc1)C(c2ccccc2)([C@H]3CCCC[NH2+]3)O,Pipradrol,-8.383217,x0967,active-noncovalent
c1cnccc1C(=O)NN,Isoniazid,-8.380651,x0540,active-noncovalent
CC(C)C(=O)Nc1ccc(c(c1)C(F)(F)F)N(=O)=O,Flutamide,-8.378767,x0195,active-noncovalent
C[C@@H](Cc1ccc(cc1)[123I])[NH2+]C(C)C,Iofetamine I-123,-8.378622,x0161,active-noncovalent
CCOCn1c(c(c(=O)[nH]c1=O)C(C)C)Cc2ccccc2,Emivirine,-8.377581,x1412,active-covalent
c1c2c(=O)[nH]cnc2n[nH]1,Allopurinol,-8.376930,x0678,active-noncovalent
c1cc(c(cc1C(F)(F)F)N(=O)=O)C(=O)C2C(=O)CCCC2=O,Nitisinone,-8.373479,x0749,active-covalent
c1ccc2c(c1)CCN3[C@@H]2CN(CC3=O)C(=O)C4CCCCC4,Praziquantel,-8.373052,x1093,active-noncovalent
CC(C)C[C@@H](C[N@@]1CCC[N@H+]2[C@H]1CCC2)[NH3+],"N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE",-8.372559,x0104,active-noncovalent
C(C(C(C(C(F)(F)Br)(F)F)(F)F)(F)F)(C(C(C(F)(F)F)(F)F)(F)F)(F)F,Perflubron,-8.372052,x0749,active-covalent
C[C@H]1Cc2c(c(=O)c3c(o2)cc(c(c3C(=O)[O-])O)O)[C@@H](O1)OC,"7,8-Dihydroxy-1-Methoxy-3-Methyl-10-Oxo-4,10-Dihydro-1h,3h-Pyrano[4,3-B]Chromene",-8.371123,x0195,active-noncovalent
c1cc(ccc1C[C@@H](C(=O)[O-])S)I,PD150606,-8.369014,x0749,active-covalent
Cn1c2cc(ccc2c3c1C(=O)NC4([C@@H]3C#N)CC[NH2+]CC4)Cl,"(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperid",-8.368329,x0195,active-noncovalent
CC(=O)OC1(CC[NH+](CC1)CCc2ccccc2)c3ccccc3,1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine,-8.366267,x0072,active-noncovalent
c1ccc(cc1)[C@](CC[NH+]2CCCC2)(C3CCCCC3)O,Procyclidine,-8.364244,x0195,active-noncovalent
C=CC[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2[C@H](C=C[C@H]3[C@H]1C5)O)O,Nalorphine,-8.363655,x1077,active-noncovalent
c1ccc(c(c1)C2=NCC(=O)Nc3c2cc(cc3)N(=O)=O)Cl,Clonazepam,-8.362827,x0072,active-noncovalent
COc1cc(ccc1O)c2ccc\3c(c2)NC(=O)/C3=C\c4ccc[nH]4,"(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-IN",-8.361881,x1077,active-noncovalent
c1ccc(cc1)CCCC[NH3+],4-Phenylbutylamine,-8.361356,x0161,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)[N@](C)c2ccnn2c3ccccc3,"N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide",-8.360682,x0195,active-noncovalent
CC(C)(CCl)C(=O)Nc1ccc(cc1)C(F)(F)F,"3-CHLORO-2,2-DIMETHYL-N-[4-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE",-8.358693,x0749,active-covalent
C[C@@H](c1ccc(cc1)F)/[NH+]=C\2/NC(=O)[C@](S2)(C)C(C)(C)O,(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,-8.357133,x0749,active-covalent
C[C@](c1ccccc1)(c2ccc(cc2)Cl)OCC[NH+](C)C,Chlorphenoxamine,-8.356419,x0072,active-noncovalent
c1cc(c(c2c1CC[NH2+]C2)Cl)Cl,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",-8.355127,x0104,active-noncovalent
C1CC[C@H]2[C@@H](C1)C[C@H]([NH2+]2)C(=O)[O-],Octahydroindole-2-Carboxylic Acid,-8.355081,x0678,active-noncovalent
c1cc(ccc1n2ccnc2)O,4-(1H-IMIDAZOL-1-YL)PHENOL,-8.354967,x0195,active-noncovalent
Cc1c(c(=O)n2c(n1)CCCC2)CC[NH+]3CCC(CC3)c4c5ccc(cc5on4)F,Risperidone,-8.354231,x0107,active-noncovalent
Cc1c2c([nH]cn2)ncn1,6-Methylpurine,-8.353774,x0678,active-noncovalent
CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C,Spironolactone,-8.350913,x0874,active-noncovalent
c1cc(ccc1C[C@H]2C(=O)N3CCC[C@H]3C(=O)N2)O,"(3s,8ar)-3-(4-Hydroxybenzyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",-8.350901,x0072,active-noncovalent
CC[NH2+][C@@H](C)Cc1cccc(c1)C(F)(F)F,Fenfluramine,-8.350566,x0195,active-noncovalent
CC[NH2+][C@@H](C)Cc1cccc(c1)C(F)(F)F,Dexfenfluramine,-8.350566,x0195,active-noncovalent
C(C(=O)[O-])N(C(=O)[O-])O,(Carboxyhydroxyamino)Ethanoic Acid,-8.349384,x0397,active-noncovalent
C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)Cc4ccccc4)NC(=O)[C@H]5C[N@H+]([C@@H]6Cc7c[nH]c8c7c(ccc8)C6=C5)C,Ergotamine,-8.346910,x0161,active-noncovalent
Cc1ccc(cc1OCc2ccncc2)OC,4-[(5-methoxy-2-methylphenoxy)methyl]pyridine,-8.346909,x0749,active-covalent
C#CC[NH2+][C@@H]1CCc2c1cc(cc2)O,5-Hydroxy-N-Propargyl-1(R)-Aminoindan,-8.345014,x0104,active-noncovalent
CC#C[C@H]1CC[C@H](N1C(=O)[C@H](C2CCCC2)[NH3+])C[NH3+],"(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-PROP-1-YN-1-YLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2",-8.344507,x0072,active-noncovalent
c1ccc(cc1)Cc2cnc(s2)N,"5-benzyl-1,3-thiazol-2-amine",-8.343583,x0072,active-noncovalent
c1cc2c(nc1)C(=C3CC[NH2+]CC3)c4ccc(cc4CC2)Cl,Desloratadine,-8.342944,x0072,active-noncovalent
Cn1c(ncn1)[C@H]2c3c4c(cc(cc4N[C@@H]2c5ccc(cc5)F)F)c(=O)[nH]n3,Talazoparib,-8.342268,x0195,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)[N@]2CCC[C@@H]2C(=O)[O-],Tosyl-D-Proline,-8.340429,x0749,active-covalent
CCn1c(=O)n(nn1)CC[N@@H+]2CC[C@@H]([C@@H](C2)C)N(c3ccccc3F)C(=O)COC,Brifentanil,-8.339855,x0072,active-noncovalent
C1CCC(CC1)C[C@@H](C(=O)[O-])[NH3+],Beta-Cyclohexyl-Alanine,-8.332220,x0195,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](c1cc(c(c(c1)Cl)N)Cl)O,Clenbuterol,-8.330451,x0104,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@H]4[C@H](O3)CO[P@@](=S)(O4)O)O)N,"Sp-Adenosine-3',5'-Cyclic-Monophosphorothioate",-8.329042,x0678,active-noncovalent
Cc1cc(nc(n1)O[C@H](C(=O)[O-])C(c2ccccc2)(c3ccccc3)OC)C,Ambrisentan,-8.328909,x0678,active-noncovalent
c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)N[C@@H](N2)C(Cl)Cl,Trichlormethiazide,-8.328909,x0195,active-noncovalent
C[C@@H](c1cccc(c1)O)[NH+](C)C,3-[(1s)-1-(Dimethylamino)Ethyl]Phenol,-8.327099,x0678,active-noncovalent
c1ccc2c(c1)C=Cc3ccccc3N2C(=O)N,Carbamazepine,-8.326951,x0072,active-noncovalent
COC(=O)[C@@H]1[C@H]2CC[C@H]([N@@H+]2CCCF)C[C@@H]1c3ccc(cc3)[123I],Ioflupane I-123,-8.326529,x0874,active-noncovalent
CC(=O)O[C@@H]1[C@@H](Sc2ccccc2N(C1=O)CC[NH+](C)C)c3ccc(cc3)OC,Diltiazem,-8.325207,x1077,active-noncovalent
C[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2CCC[C@H]3[C@H]1C5)O,Desomorphine,-8.324210,x1077,active-noncovalent
CC(=O)CCCCn1c(=O)c2c(ncn2C)n(c1=O)C,Pentoxifylline,-8.322370,x0104,active-noncovalent
COC(=O)C[C@@H]1C[C@H](NC1=O)COc2ccc(cc2)c3ccc(cc3)C(=[NH2+])NC(=O)OC,Lefradafiban,-8.322215,x0104,active-noncovalent
C[N@@H+]1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc4c3cc(cc4)OC,Dextromethorphan,-8.320422,x0874,active-noncovalent
c1cc(c(cc1Cl)Cl)CCC(=O)N=O,"(2E)-3-(2,4-DICHLOROPHENYL)-N-HYDROXYACRYLAMIDE",-8.316799,x0195,active-noncovalent
CC[C@H]1[C@H](COC1=O)Cc2cncn2C,Pilocarpine,-8.316508,x0195,active-noncovalent
c1cc(sc1)/C(=C/C(=O)C(F)(F)F)/O,Thenoyltrifluoroacetone,-8.314051,x0749,active-covalent
C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)[O-])NC(=O)N2,Biotin,-8.313080,x0678,active-noncovalent
CCC(=O)N(c1ccccc1)[C@@H]2CC[N@@H+](C[C@@H]2C)CCc3ccccc3,3-Methylfentanyl,-8.311404,x0946,active-noncovalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C,Eltanolone,-8.310772,x0072,active-noncovalent
c1cc(ccc1CCC(=O)[O-])N,4-Aminohydrocinnamic Acid,-8.310589,x0678,active-noncovalent
CCOC(=O)N1CCC(=C2c3ccc(cc3CCc4c2nccc4)Cl)CC1,Loratadine,-8.304543,x0434,active-noncovalent
COc1cc(cc(c1OC)OC)[C@@H]2c3cc4c(cc3[C@@H]([C@@H]5[C@@H]2C(=O)OC5)O)OCO4,Podofilox,-8.303778,x0161,active-noncovalent
c1cc(ccc1C(C(F)(F)F)(C(F)(F)F)O)NCC(F)(F)F,"1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL",-8.303535,x0195,active-noncovalent
CC[C@@]1(CCC(=O)NC1=O)c2ccc(cc2)N,Aminoglutethimide,-8.301993,x0195,active-noncovalent
Cc1cn(c(=O)[nH]c1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)([O-])[O-])F,"Phosphoric Acid Mono-[3-Fluoro-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-",-8.300789,x0072,active-noncovalent
C[NH+](C)C1(CCC2(CC1)c3c(c4cc(ccc4[nH]3)F)CCO2)c5ccccc5,Cebranopadol,-8.300319,x0072,active-noncovalent
c1ccc(cc1)[N@]2CC(=O)NS2(=O)=O,"1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE",-8.298386,x0678,active-noncovalent
c1[nH]c(=O)c2c3c(sc2n1)CCCC3,"5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE",-8.295583,x0195,active-noncovalent
CC12c3ccccc3C(c4c1cccc4)(OO2)CCC(=O)[O-],9-(2-carboxyethyl)-10-methylanthracene endoperoxide,-8.295489,x0830,active-covalent
CC(C)(C=C)c1cc2cc3c(cc2oc1=O)O[C@@H](C3)C(C)(C)O,"6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chro",-8.292443,x0749,active-covalent
COc1cc(cc(c1OC)OC)Cc2cnc(nc2N)N,Trimethoprim,-8.292109,x0967,active-noncovalent
c1[nH]c2c(n1)c(=S)[nH]cn2,Mercaptopurine,-8.290368,x0678,active-noncovalent
CCC(=O)N(c1ccccc1)C2CC[NH+](CC2)CCc3ccccc3,Fentanyl,-8.290323,x0072,active-noncovalent
c1ccc(cc1)NC(=O)[C@H]2CC(=O)N(C2)C3CCCCC3,(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE,-8.290104,x0749,active-covalent
C(C[C@@H](C(=O)[O-])[NH3+])CNC(=O)N,Citrulline,-8.288851,x0107,active-noncovalent
CC[C@@]1(Cc2cc3c(c(c2[C@H](C1)O[C@H]4C[C@@H]([C@@H]([C@@H](O4)C)O)[NH+](C)C)[O-])C(=O)c5c(cccc5[O-])C3=O)O,"10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-",-8.288523,x0161,active-noncovalent
C[C@H](C(=O)c1cccc(c1)Cl)[NH2+]C(C)(C)C,Bupropion,-8.288425,x0195,active-noncovalent
c1ccc(cc1)C(c2ccccc2)C(=O)[O-],Diphenylacetic Acid,-8.287976,x0195,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)Cc3ccccc3)C(=O)[O-])C,Benzylpenicillin,-8.287273,x0831,active-covalent
C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2([C@H](C=O)O)O)CCC4=CC(=O)C=C[C@]34C)O,Prednisolone,-8.286992,x0749,active-covalent
C[C@H]1C[C@]2([C@@H](CC[C@@]2(C(=O)C)OC(=O)C)[C@H]3[C@H]1[C@H]4CCC(=O)C=C4CC3)C,Norgestomet,-8.286314,x0749,active-covalent
C1[C@H]2[C@@H]([C@H](S1)CCCCC(=O)[O-])NC(=O)N2,"5-[(3AS,4R,6AR)-2-OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL]PENTANOIC ACID",-8.285969,x1077,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CCC2=O)OS(=O)(=O)[O-],Estrone sulfate,-8.285603,x0195,active-noncovalent
c1ccc2cnccc2c1,Isoquinoline,-8.284518,x0540,active-noncovalent
Cc1ccc2c(c1)CC[C@H](O2)C[P@@H](=O)[O-],"(6-METHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL)METHYLPHOSPHINATE",-8.284280,x0749,active-covalent
C[N@@+]1(CC[C@]23c4c5ccc(c4O[C@H]2C(=O)CC[C@]3([C@H]1C5)O)O)CC6CC6,Methylnaltrexone,-8.283707,x1077,active-noncovalent
c1ccc(cc1)c2c(c(c(o2)c3ccccc3)C(=O)[O-])C(=O)[O-],"2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID",-8.283481,x0434,active-noncovalent
c1c(cc(c2c1[nH]c(cc2=O)C(=O)[O-])Cl)Cl,"5,7-Dichlorokynurenic acid",-8.283470,x0678,active-noncovalent
C[C@@H](c1ccc(cc1)CC(C)C)C(=O)[O-],Dexibuprofen,-8.281713,x0749,active-covalent
C[C@@H](c1ccc(cc1)CC(C)C)C(=O)[O-],Ibuprofen,-8.281713,x0749,active-covalent
C[C@@H](C(=O)c1ccccc1)[NH3+],Cathinone,-8.281448,x0678,active-noncovalent
c1cc(cc2c1cc(cc2)S(=O)(=O)[O-])S(=O)(=O)[O-],"Naphthalene-2,6-disulfonic acid",-8.279241,x0749,active-covalent
C[C@]12CC[C@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C)O,Aetiocholanolone,-8.277693,x0072,active-noncovalent
C[N@H+]1[C@@H]2c3ccccc3C(=O)[C@H]1C4=C2C(=O)c5ccccc5C4=O,TU-100,-8.275042,x1093,active-noncovalent
C(C(=O)[O-])OP(=O)([O-])[O-],2-Phosphoglycolic Acid,-8.274786,x0397,active-noncovalent
c1(c(nc(c(n1)Cl)N)N)C(=O)NC(=[NH2+])N,Amiloride,-8.274187,x0397,active-noncovalent
c1ccc2c(c1)[nH]c(n2)C(=O)[O-],1h-Benoximidazole-2-Carboxylic Acid,-8.273639,x0678,active-noncovalent
C(C[NH3+])C/[NH+]=C(\N)/NO,Descarboxy-nor-N(Omega)-Hydroxy-L-Arginine,-8.270840,x0104,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC=C4[C@@]3(CC[C@@H](C4)OS(=O)(=O)[O-])C,Prasterone sulfate,-8.270839,x0749,active-covalent
COC(=O)Nc1[nH]c2cc(ccc2n1)C(=O)c3ccccc3,Mebendazole,-8.269169,x0195,active-noncovalent
CN(C)c1cccc2c1cccc2S(=O)(=O)N,Dansylamide,-8.268063,x0749,active-covalent
c1cc2c(cc(s2)C(=[NH2+])N)c(c1)I,4-Iodobenzo[B]Thiophene-2-Carboxamidine,-8.263539,x0195,active-noncovalent
c1ccc(c(c1)c2ccc(o2)C(=O)[O-])OC(F)(F)F,5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FUROIC ACID,-8.261178,x0749,active-covalent
Cc1cccn2c1nc(c(c2=O)CC[NH+]3CCC(CC3)c4c5ccc(cc5on4)F)C,Ocaperidone,-8.260574,x0107,active-noncovalent
CC(CC(=O)[O-])(CC(=O)[O-])O,Meglutol,-8.259262,x0397,active-noncovalent
CC(C)(C)C(=O)NNCc1ccccc1,Pivhydrazine,-8.258900,x0678,active-noncovalent
c1cc(ccc1C[C@H](C(=O)[O-])[NH3+])I,4-Iodo-D-phenylalanine,-8.258878,x1077,active-noncovalent
Cc1cc(c(cc1)/[NH+]=C/N(/C=[NH+]/c2c(cc(cc2)C)C)C)C,Amitraz,-8.258758,x0104,active-noncovalent
CCN(c1ccccc1C)C(=O)/C=C/C,Crotamiton,-8.258624,x0678,active-noncovalent
c1c(cc(c2c1c(c(cc2O)O)O)O)O,"naphthalene-1,2,4,5,7-pentol",-8.254675,x0397,active-noncovalent
c1[nH]c2c(n1)c(=O)[nH]cn2,Hypoxanthine,-8.254661,x0678,active-noncovalent
CC(C)n1c2c(c(n1)c3cccc(c3)O)c(ncn2)N,"3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL",-8.252977,x0434,active-noncovalent
C[C@@H]([C@@H](c1ccccc1)O)[NH2+]C,Ephedrine,-8.252539,x0195,active-noncovalent
c1ccc(cc1)NC(=S)N,N-Phenylthiourea,-8.252433,x0678,active-noncovalent
C[C@@H](Cc1ccc2c(c1)OCO2)[NH2+]C(C)C,"3,4-Methylenedioxy-N-isopropylamphetamine",-8.247872,x0161,active-noncovalent
c1ccc2c(c1)C=CCN=N2,Benzodiazepine,-8.247625,x0195,active-noncovalent
CC[NH2+][C@@H](C)Cc1ccc2c(c1)OCO2,Methylenedioxyethamphetamine,-8.243757,x0161,active-noncovalent
CC1(Cc2c(sc(n2)N3CCOCC3)C(=O)C1)C,"5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one",-8.240270,x0749,active-covalent
CC(C)(C)c1ccc(cc1)CN2CC[NH+](CC2)[C@H](c3ccccc3)c4ccc(cc4)Cl,Buclizine,-8.239141,x0104,active-noncovalent
CC(C)(C)[C@H](/C=C/c1ccc2c(c1)OCO2)O,Stiripentol,-8.238860,x0161,active-noncovalent
C[C@]12CCC(=O)C=C1[C@H](C[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3C[C@@H]5[C@]4(OC(O5)(C)C)[C@H](C=O)O)C)O)F,Flurandrenolide,-8.234793,x0874,active-noncovalent
C[C@@H](C(=O)[C@H]1CNc2c(c(=O)[nH]c(n2)N)N1)O,"L-erythro-7,8-dihydrobiopterin",-8.234267,x0195,active-noncovalent
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1([C@H](C=O)O)O)C)O)F)C,Dexamethasone,-8.233694,x0678,active-noncovalent
CC(C)(C)Nc1nc(c(s1)C(=O)c2ccccc2)N,"[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone",-8.233192,x0161,active-noncovalent
c1c(c(cc(c1Cl)Cl)Cl)OCC#CI,Haloprogin,-8.232437,x0195,active-noncovalent
c1c(c(cc(c1N2CC2)N(=O)=O)N(=O)=O)C(=O)N,Tretazicar,-8.231679,x0195,active-noncovalent
COc1cc2cnc-3c(c2cc1OC)Cc4c3cc5c(c4)OCO5,"2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM",-8.231147,x0749,active-covalent
B1(OCCO1)OCCCC[NH3+],"4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium",-8.229801,x0161,active-noncovalent
c1c(cc(c(c1Cl)NC2=[NH+]CCN2)Cl)N,Apraclonidine,-8.228703,x0678,active-noncovalent
Cc1ccc(c(c1)N(=O)=O)NCCC[NH3+],Epicept NP-1,-8.228505,x1334,active-covalent
C[C@H]1[C@@](OCC([NH2+]1)(C)C)(c2cccc(c2)Cl)O,Radafaxine,-8.227618,x0195,active-noncovalent
c1ccc(cc1)Cn2ccnc2,1-benzylimidazole,-8.226871,x0195,active-noncovalent
C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3[C@]24[C@H](O4)C[C@]5([C@H]3CC[C@@]56CCC(=O)O6)C)C(=O)OC,Eplerenone,-8.226517,x1077,active-noncovalent
C(CC(=O)[O-])CC(=O)[O-],Glutaric Acid,-8.225920,x0397,active-noncovalent
c1cc2cc(ccc2c(c1)O)O,"1,6-DIHYDROXY NAPHTHALENE",-8.225857,x0195,active-noncovalent
Cc1c(c(c(cn1)CO)C[NH3+])O,Pyridoxamine,-8.224558,x0540,active-noncovalent
C1CCC(CC1)C[C@@H](CO)[NH3+],1-Hydroxy-2-Amino-3-Cyclohexylpropane,-8.223312,x0195,active-noncovalent
c1cc(c2c(c1)OCCO2)N3CC[NH2+]CC3,Eltoprazine,-8.222124,x0195,active-noncovalent
c1cc(ncc1[C@H]2C[C@@H]3CC[C@H]2[NH2+]3)Cl,Epibatidine,-8.216853,x0749,active-covalent
CCOP(=O)(Cc1ccc(cc1)C)OCC,Diethyl 4-Methylbenzylphosphonate,-8.215959,x0434,active-noncovalent
CCC(=O)[C@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)C)C,Rimexolone,-8.215210,x0749,active-covalent
C[C@@]1(CC[C@H](C1(C)C)/C=C/C=C2C[C@H](C[C@@H](C2)O)O)CCC#CC(C(F)(F)F)(C(F)(F)F)O,"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifl",-8.214505,x0161,active-noncovalent
CC(C)(C)c1cc(n(n1)c2cccc(c2)N)NC(=O)Nc3ccccc3,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea,-8.214261,x0195,active-noncovalent
C[C@](Cc1ccc(cc1)O)(C(=O)[O-])[NH3+],Metyrosine,-8.213871,x0678,active-noncovalent
CC(C)(C)C(=O)Nc1cccnc1C(=O)Nc2nccs2,"3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE",-8.213244,x0195,active-noncovalent
C([C@@H]1[C@@H]([C@H](C2=Nc3c(=O)[nH]c(nc3N[C@@H]2O1)N)[S-])[S-])OP(=O)([O-])[O-],Molybdenum cofactor,-8.212620,x0678,active-noncovalent
c1cc(ncc1CN\2CCS/C2=N\C#N)Cl,"{(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide",-8.211166,x0749,active-covalent
C[C@H]([C@H](c1cnc2c(n1)c(=O)[nH]c(n2)N)O)O,Biopterin,-8.210232,x0397,active-noncovalent
C[NH2+]C[C@@H](c1cccc(c1)O)O,Phenylephrine,-8.209882,x0195,active-noncovalent
CC(=O)Nc1ccc(cc1)C(=O)Nc2ccccc2N,Tacedinaline,-8.209475,x1093,active-noncovalent
c1c(cc(c2c1[nH]c(c2CCC(=O)[O-])C(=O)[O-])Cl)Cl,Mdl-29951,-8.209234,x0749,active-covalent
CC[C@H](C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C3C[C@H](C(=C)[C@@H](C3)O)O)C,Becocalcidiol,-8.207868,x0874,active-noncovalent
c1cnc(nc1c2cc3c([nH]2)[C@H](CNC3=O)CCF)N,"(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3",-8.207827,x0831,active-covalent
C=C/C=N/[C@@H]1CCc2c1cccc2O,4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN,-8.204722,x0195,active-noncovalent
C[N+](C)(C)c1cccc(c1)C(C(F)(F)F)(O)O,"M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene",-8.201869,x0104,active-noncovalent
Cc1c(c(=O)n(n1C)c2ccccc2)N(C)C,Aminophenazone,-8.201104,x0749,active-covalent
CCOCn1c(c(c(=O)[nH]c1=O)C(C)C)SC2CCCCC2,"6-(cyclohexylsulfanyl)-1-(ethoxymethyl)-5-(1-methylethyl)pyrimidine-2,4(1H,3H)-d",-8.200170,x0874,active-noncovalent
CCCOc1ccc2c(c1)[nH]c(n2)NC(=O)OC,Oxibendazole,-8.198368,x1077,active-noncovalent
COc1ccc(cc1)C(=O)N2CCCC2=O,Aniracetam,-8.198207,x0749,active-covalent
Cc1ccc(cc1)CCC(=O)[O-],3-(P-Tolyl)Propionic Acid,-8.197846,x1392,active-covalent
CC1=CC[C@@H](CC1)[N@H+](C)CCC=C(C)C,S-azabisabolene,-8.197637,x0104,active-noncovalent
c1cc(ccc1C[NH3+])NC(=O)C(=O)[O-],"[[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid,",-8.196931,x1412,active-covalent
CC(C)CCC[C@](C)([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)O,20-hydroxycholesterol,-8.195089,x0104,active-noncovalent
c1cc(ccc1Sc2cc(c(cc2Cl)Cl)Cl)Cl,Tetrasul,-8.193975,x0161,active-noncovalent
C[NH+](C)Cc1nnc2n1-c3ccc(cc3[C@@H](N=C2)c4ccccc4)Cl,Adinazolam,-8.193320,x0195,active-noncovalent
Cc1cccc(c1OC[C@@H](C)[NH3+])C,"(2R)-1-(2,6-dimethylphenoxy)propan-2-amine",-8.193022,x0195,active-noncovalent
CCC1(C(=O)NCNC1=O)c2ccccc2,Primidone,-8.191757,x0678,active-noncovalent
CC[C@@H]([C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O)[NH2+]C(C)C,Procaterol,-8.190609,x1077,active-noncovalent
c1cn(cc(c1=O)[O-])C[C@@H](C(=O)[O-])[NH3+],Mimosine,-8.187805,x0107,active-noncovalent
c1ccc(c(c1)NCCC[NH3+])N(=O)=O,N-(3-AMINOPROPYL)-2-NITROBENZENAMINE,-8.187611,x0195,active-noncovalent
CC(C)c1c(c2cc(ccc2[nH]c1=O)F)OC#CC3CC3,4-[(CYCLOPROPYLETHYNYL)OXY]-6-FLUORO-3-ISOPROPYLQUINOLIN-2(1H)-ONE,-8.186555,x0195,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])SS(=O)(=O)[O-],S-sulphocysteine,-8.186016,x0397,active-noncovalent
CC(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@]4([C@H]3C[C@@H](C5=CC(=O)C=C[C@@]54C)F)F)O)C)OC(O2)(C)C,Fluocinonide,-8.184811,x1077,active-noncovalent
c1cc2c(cc(c(c2nc1)O)Cl)Cl,Chloroxine,-8.184093,x0195,active-noncovalent
c1cc(cc(c1)n2nc3c(=O)[nH]c(nc3n2)N)C(=O)[O-],"3-(5-amino-7-hydroxy-(1,2,3)triazolo(4,5-d)pyrimidin-2-yl)benzoic acid",-8.183857,x0749,active-covalent
CCc1ccc2c(c1)N(c3ccccc3S2)C[C@@H](C)C[NH+](C)C,Etymemazine,-8.183055,x0072,active-noncovalent
[H]/N=C\1/C=C(C(=O)C=C1[O-])C[C@@H](C(=O)[O-])[NH3+],"3-(4-Hydroxy-3-Imino-6-Oxo-Cyclohexa-1,4-Dienyl)-Alanine",-8.182240,x1418,active-covalent
c1cc(c(c(c1)Br)NC2=[NH+]CCN2)F,Romifidine,-8.182166,x0195,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@@]4([C@H](C=O)O)O)C)O)F,Fludrocortisone,-8.179886,x0678,active-noncovalent
C[C@@H]([C@@H](c1ccccc1)O)[NH+](C)C,DL-Methylephedrine,-8.179488,x0161,active-noncovalent
c1cc(c(c2c1CCC[NH2+]C2)Cl)Cl,"8,9-Dichloro-2,3,4,5-Tetrahydro-1h-Benzo[C]Azepine",-8.179276,x0749,active-covalent
c1ccc(cc1)c2cnc[nH]2,4-Phenyl-1h-Imidazole,-8.178530,x0678,active-noncovalent
c1cc(c(cc1N)O)C(=O)[O-],Aminosalicylic acid,-8.178270,x0678,active-noncovalent
C[C@H](Cc1ccccc1)[N@@H+](C)CC=C,N-METHYL-N-[(1R)-1-METHYL-2-PHENYLETHYL]PROP-2-EN-1-AMINE,-8.177457,x0072,active-noncovalent
C[C@@H]1C[N@](CC[NH2+]1)c2c(cc3c(c2OC)n(cc(c3=O)C(=O)[O-])C4CC4)F,Gatifloxacin,-8.175415,x0749,active-covalent
B1(c2ccc(cc2CO1)F)O,Tavaborole,-8.175386,x0195,active-noncovalent
CCc1c(c(nc(n1)N)N)c2ccccc2,"6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE",-8.175291,x0195,active-noncovalent
c1cc2c(cc(c(c2nc1)O)I)Cl,Clioquinol,-8.172704,x0195,active-noncovalent
CCC1=C[C@@H]2[C@H](C1)C[C@@]2(CC(=O)[O-])C[NH3+],Mirogabalin,-8.171089,x1334,active-covalent
CCC(=O)N(c1ccccc1)[C@@H]2CC[N@@H+](C[C@@H]2C)CCc3cccs3,3-Methylthiofentanyl,-8.170733,x1077,active-noncovalent
COC(=O)Nc1[nH]c2cc(ccc2n1)[S@](=O)c3ccccc3,Oxfendazole,-8.170349,x0195,active-noncovalent
c1c(cc(c(c1Sc2cc(cc(c2O)Cl)Cl)O)Cl)Cl,Bithionol,-8.169826,x0161,active-noncovalent
Cc1c(ssc1=S)c2cnccn2,Oltipraz,-8.167756,x0749,active-covalent
c1[nH]c2c(n1)c(ncn2)Br,6-bromopurine,-8.162199,x0678,active-noncovalent
C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)C[C@@H](C5=CC(=O)C=C[C@@]53C)F)F)O,Fluocinolone acetonide,-8.159698,x1077,active-noncovalent
CC[C@@]1(CCC(=O)NC1=O)c2ccccc2,Glutethimide,-8.159465,x0195,active-noncovalent
C(C(=O)[O-])N1C(=O)C(=O)N[C@@]1(C[NH3+])O,"(2R)-2-(aminomethyl)-2,4-dihydroxy-5-oxo-3-(2-oxoethyl)-2,5-dihydro-1h-imidazol-",-8.159104,x0397,active-noncovalent
CC(C)c1c(c2ccccn2n1)C(=O)C(C)C,Ibudilast,-8.158834,x0678,active-noncovalent
COc1ccc(cc1OC)CCC(=O)[O-],"3-(3,4-Dimethoxyphenyl)Propionic Acid",-8.157972,x0759,active-covalent
c1ccc(c(c1)/C=C/C(=O)C(=O)[O-])O,2-Hydroxybenzalpyruvate,-8.155440,x0749,active-covalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)N3C(=O)[C@H]([NH2+]C3(C)C)c4ccccc4)C(=O)[O-])C,Hetacillin,-8.155181,x0831,active-covalent
c1ccc(cc1)C(c2ccc(cc2)F)(c3ccc(cc3)F)C(=O)N,Senicapoc,-8.150712,x0072,active-noncovalent
CS(=O)(=O)Nc1cccc2c1nccc2,N-(QUINOLIN-8-YL)METHANESULFONAMIDE,-8.149688,x0195,active-noncovalent
Cc1c(c(no1)c2c(cccc2Cl)Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],Dicloxacillin,-8.149154,x0072,active-noncovalent
Cn1c2ccccc2ccc1=O,1-Methyl-2-quinolone,-8.149032,x0195,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\C(=O)[O-])/C)/C,Isotretinoin,-8.148855,x0830,active-covalent
C[C@@H](C(=O)c1nnc(o1)C(C)(C)C)[NH3+],"(2S)-2-AMINO-1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)PROPAN-1-ONE",-8.148833,x0195,active-noncovalent
[H]/N=c/1\nn/c(=N\[H])/c1=NNc2cc(ccc2)C(=O)[O-],3-(5-Amino-3-imino-3H-pyrazol-4-ylazo)-benzoic acid,-8.147835,x0749,active-covalent
COc1cc(nc(n1)OC)NS(=O)(=O)c2ccc(cc2)N,Sulfadimethoxine,-8.147144,x0195,active-noncovalent
C[C@H](C(=O)[O-])NS(=O)(=O)c1ccc(cc1)OC,N-[(4-methoxyphenyl)sulfonyl]-D-alanine,-8.146156,x0830,active-covalent
C[C@H](C[P@@](=O)([C@H](CC(=O)[O-])[NH3+])[O-])C(=O)[O-],3-[(1-Amino-2-Carboxy-Ethyl)-Hydroxy-Phosphinoyl]-2-Methyl-Propionic Acid,-8.144497,x0397,active-noncovalent
Cc1c2ccc(c(c2oc(=O)c1Br)Br)O,"3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE",-8.143710,x0195,active-noncovalent
C[C@@H](Cc1ccc2c(c1)OCO2)[NH3+],Tenamfetamine,-8.143455,x0195,active-noncovalent
c1cc2c(cc1Cl)[C@@](OC(=O)N2)(C#CC3CC3)C(F)(F)F,Efavirenz,-8.143311,x0195,active-noncovalent
C[C@@H](Cc1cc2c(c(c1)OC)OCO2)[NH3+],MMDA,-8.142098,x0195,active-noncovalent
CC(=CCn1cnc(=[NH2+])c2c1nc[nH]2)C,3-(3-Methyl-2-buten-1-yl)-3H-purin-6-amine,-8.141670,x0107,active-noncovalent
C[C@H]1C[C@H]2[C@@H]3CC[C@@H]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)CC4)C)O)C)C(=O)C,Medrysone,-8.141653,x1077,active-noncovalent
C[n+]1cccc(c1)OC(=O)N(C)C,Pyridostigmine,-8.139699,x0195,active-noncovalent
C[C@@H](c1ccccc1)N(C)C=O,N-Methyl-N-(Methylbenzyl)Formamide,-8.139530,x0678,active-noncovalent
Cc1cc(cc(c1CC2=[NH+]CCN2)C)C(C)(C)C,Xylometazoline,-8.139528,x0195,active-noncovalent
CC[C@@H]1[C@@H](/C=C/C(=O)[C@@H](C[C@@H]([C@@H]([C@H](C(=O)O1)C)O)C)C)C,"(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-",-8.138972,x0195,active-noncovalent
c1ccc(cc1)[C@@H]2CNc3c(c(nc(n3)N)N)N2,"2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine",-8.136619,x0678,active-noncovalent
c1cc(ccc1NC(=O)Nc2ccc(c(c2)Cl)Cl)Cl,Triclocarban,-8.136365,x1093,active-noncovalent
Cc1cc(c(c(c1)I)O)C(=O)Nc2ccc(c(c2)Cl)C(=[NH2+])N,N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE,-8.132529,x1334,active-covalent
c1c(c(=O)[nH]o1)C[C@@H](C(=O)[O-])[NH3+],(S)-DES-ME-AMPA,-8.132175,x0397,active-noncovalent
CC(C)(Cc1ccccc1Cl)[NH3+],Clortermine,-8.131664,x0678,active-noncovalent
Cn1c(=O)cc(c2c1c3c(cc2)OCO3)OC,"6-methoxy-9-methyl[1,3]dioxolo[4,5-h]quinolin-8(9H)-one",-8.131173,x0195,active-noncovalent
c1ccc(c(c1)C(=O)[O-])NC2CCCCC2,2-(cyclohexylamino)benzoic acid,-8.130783,x0749,active-covalent
CCC(=O)N(c1ccccc1)C2CC[NH+](CC2)C[C@H](C)c3ccccc3,-Methylfentanyl,-8.126843,x0072,active-noncovalent
c1ccnc(c1)C(=O)c2cnn3c2nccc3c4ccncc4,Ocinaplon,-8.126430,x0072,active-noncovalent
c1c(cc(c(c1I)[O-])I)C[C@@H](C(=O)[O-])[NH3+],"3,5-Diiodotyrosine",-8.125792,x0830,active-covalent
c1ccc(c(c1)C2=N[C@@H](C(=O)Nc3c2cc(cc3)Cl)O)Cl,Lorazepam,-8.123451,x0434,active-noncovalent
C([C@H](C(=O)[O-])O)C(=O)[O-],Malate Ion,-8.121599,x0397,active-noncovalent
C([C@H](C(=O)[O-])O)C(=O)[O-],Malate Like Intermediate,-8.121599,x0397,active-noncovalent
c1cc2c(cc1C(=[NH2+])N)nc[nH]2,5-Amidino-Benzimidazole,-8.119345,x0195,active-noncovalent
CCOC(=O)c1c(nn(c1C)c2ccc(cc2)OC)C,"1-(4-Methoxyphenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",-8.118567,x0749,active-covalent
CC[C@H](C)[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c2ccc(nc2C)C)C(=O)N3CCOCC3)C4Cc5ccccc5C4,Epelsiban,-8.117161,x0161,active-noncovalent
c1cc(ccc1CC(=O)C(=O)[O-])C(=[NH2+])N,Amido Phenyl Pyruvic Acid,-8.114545,x1077,active-noncovalent
C(C(CC(=O)[O-])O)C(=O)[O-],3-hydroxyglutaric acid,-8.112601,x0397,active-noncovalent
C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,"(3BETA)-CHOLEST-5-ENE-3,25-DIOL",-8.112440,x1077,active-noncovalent
c1ccc(cc1)C(c2ccccc2)(c3ccccc3Cl)n4ccnc4,Clotrimazole,-8.112062,x0678,active-noncovalent
c1cc(c(cc1[C@@H](C(=O)[O-])[NH3+])Cl)O,3-Chloro-4-Hydroxyphenylglycine,-8.111869,x1334,active-covalent
Cc1cc(=O)oc2c1ccc(c2)O,Hymecromone,-8.111824,x0195,active-noncovalent
CC1=C[C@H]2Cc3c(ccc(=O)[nH]3)[C@@]4(C1)[C@@H]2CCC[NH2+]4,Huperzine B,-8.111438,x0072,active-noncovalent
c1ccc(c(c1)c2nnc(s2)S(=O)(=O)N)Cl,"5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide",-8.110352,x0195,active-noncovalent
c1ccc2c(c1)C(=O)N[C@]2(c3ccc(c(c3)S(=O)(=O)N)Cl)O,Chlorthalidone,-8.109246,x0072,active-noncovalent
CC[C@H](C(C[C@@H](C)[NH+](C)C)(c1ccccc1)c2ccccc2)OC(=O)C,Alphacetylmethadol,-8.108759,x0195,active-noncovalent
CC(C)(C)Nc1c2cc(ccc2nc(n1)C(F)(F)F)c3cccc(c3)N,6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE,-8.108742,x0874,active-noncovalent
CCC[NH2+][C@H]1CCc2c(sc(n2)N)C1,Pramipexole,-8.107148,x0678,active-noncovalent
c1ccc(c(c1)N2C[C@H](CC2=O)C(=O)[O-])O,(3S)-1-(2-hydroxyphenyl)-5-oxopyrrolidine-3-carboxylic acid,-8.105787,x0830,active-covalent
COc1ccc2c(c1)c(ccn2)[C@@H]([C@H]3C[C@@H]4CC[N@H+]3C[C@@H]4C=C)O,Quinidine,-8.104474,x0104,active-noncovalent
c1c(nc[nH]1)C[C@@H](CO)[NH3+],Histidinol,-8.104052,x0397,active-noncovalent
c1ccc2c(c1)CC[C@@H]([C@@H]2O)[NH3+],"CIS-(1R,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL",-8.103767,x0195,active-noncovalent
C[C@@H](Cc1ccc2c(c1)OCO2)[NH2+]C,Midomafetamine,-8.103735,x0161,active-noncovalent
CC(C)(Cc1ccccc1)[NH3+],Phentermine,-8.102841,x0678,active-noncovalent
c1cc(ccc1c2cc(nn2c3ccc(cc3)S(=O)(=O)N)C(F)(F)F)Br,1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole,-8.101828,x0395,active-noncovalent
Cc1ccc(cc1)C(=O)N(CCC[NH3+])[C@@H](c2nc3cc(ccc3c(=O)n2Cc4ccccc4)Cl)C(C)C,Ispinesib,-8.100250,x1077,active-noncovalent
C[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2C(=O)CC[C@H]3[C@H]1C5)O,Hydromorphone,-8.099906,x1385,active-covalent
CC[C@@H](Cc1ccccc1)[NH3+],1-Benzyl-(R)-Propylamine,-8.099770,x0195,active-noncovalent
C=CCC/[NH+]=C\1/N=N[C@H](CS1)c2ccc(cc2)Cl,"BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE",-8.097694,x0195,active-noncovalent
Cc1c(c(=O)n(n1C)c2ccccc2)N(C)CS(=O)(=O)[O-],Metamizole,-8.097168,x1093,active-noncovalent
C[C@@]12CC[C@@H](C1(C)C)C[C@@]2(c3ccccc3)OCC[NH+](C)C,Deramciclane,-8.096269,x0354,active-noncovalent
CC(C)NC(=O)c1ccc(cc1)CNNC,Procarbazine,-8.094168,x0749,active-covalent
COc1cnc(nc1)[N-]S(=O)(=O)c2ccc(cc2)N,Sulfameter,-8.093465,x0072,active-noncovalent
CCC(=O)N(c1ccccc1)[C@@H]2CC[N@@H+](C[C@@H]2C)C[C@@H](c3ccccc3)O,Ohmefentanyl,-8.093194,x0161,active-noncovalent
c1ccc(cc1)S(=O)(=O)Nc2ccc3c(c2C(=O)[O-])CCCC3,"2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",-8.093086,x0161,active-noncovalent
C(=C\C(=O)[O-])\C(=O)[O-],Maleic Acid,-8.091616,x0397,active-noncovalent
c1ccc2c(c1)cccc2C[C@H](C(=O)[O-])N3C(=O)c4ccc(cc4C3=O)C(=O)[O-],"2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-c",-8.091177,x0107,active-noncovalent
C1CSS[C@@H]1CCCCC(=O)[O-],Thioctic acid tromethamine,-8.091139,x0678,active-noncovalent
C1CSS[C@@H]1CCCCC(=O)[O-],Lipoic acid,-8.091139,x0678,active-noncovalent
c1ccc(c(c1)C2c3ccc(cc3Oc4c2ccc(c4)O)O)C(=O)[O-],FLUORESCIN,-8.090793,x0830,active-covalent
c1cc(ccc1C[C@@H](C(=O)[O-])[NH3+])I,4-Iodo-L-phenylalanine,-8.090021,x0830,active-covalent
CS(=O)(=O)c1ccc(cc1)C(=[NH2+])N,4-(METHYLSULFONYL)BENZENECARBOXIMIDAMIDE,-8.088459,x0195,active-noncovalent
C[NH2+]CCc1ccccn1,Betahistine,-8.088276,x0397,active-noncovalent
C[C@@H]1[C@H](C[C@@H](O1)n2cnc3c2ncnc3N)OP(=O)([O-])[O-],"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",-8.087579,x0749,active-covalent
CC(C)c1ccc(cc1S(=O)(=O)C)C(=O)NC(=[NH2+])N,Cariporide,-8.086206,x0874,active-noncovalent
C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@]2([C@@]4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O,Fluorometholone,-8.086151,x1077,active-noncovalent
c1cc(c(cc1O)O)/C=C/C(=O)[O-],"2,4-Dihydroxy-Trans Cinnamic Acid",-8.084255,x0678,active-noncovalent
C[n+]1cnc2c(c1N)nc[nH]2,6-amino-1-methyl-7H-purin-1-ium,-8.083656,x0397,active-noncovalent
CC(C)(C)C#C/C=C/C[N@@H+](C)Cc1cccc2c1cccc2,Terbinafine,-8.082284,x0161,active-noncovalent
C[C@H](CC1CCCCC1)[NH2+]C,Propylhexedrine,-8.079041,x0195,active-noncovalent
[C@H]([C@H](C(=O)[O-])O)(C(=O)[O-])[NH3+],Beta-Hydroxyaspartic Acid,-8.078529,x0397,active-noncovalent
Cc1cc(=O)n(n1C)c2ccccc2,Dichloralphenazone,-8.075042,x0195,active-noncovalent
Cc1cc(=O)n(n1C)c2ccccc2,Antipyrine,-8.075042,x0195,active-noncovalent
[H]/N=c/1\nn/c(=N\[H])/c1=NNc2ccc(cc2)F,4-(4-fluoro-phenylazo)-5-imino-5H-pyrazol-3-ylamine,-8.074907,x0072,active-noncovalent
C[N@H+]1CCC[C@H](C1)CC2c3ccccc3Sc4c2cccc4,Metixene,-8.073361,x0072,active-noncovalent
c1cc(ccc1CCC(=O)[O-])O,Hydroxyphenyl Propionic Acid,-8.071903,x0830,active-covalent
C[C@@H]([C@H](c1ccccc1)O)[NH2+]C,Pseudoephedrine,-8.070702,x0195,active-noncovalent
C1CC=C(c2c(o[nH]c2=O)C1)C[C@@H](C(=O)[O-])[NH3+],"2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid",-8.070038,x1093,active-noncovalent
c1cc2c(c(c1)C(F)(F)F)[C@H]3CC[C@@H]2[C@@H]3[NH3+],"(1S,4R,9S)-5-(trifluoromethyl)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-9-amine",-8.066962,x0195,active-noncovalent
CC1=CC(=O)N2CC(=O)N(c3ccc(cc3[C@]2(O1)c4ccccc4)Cl)C,Ketazolam,-8.066148,x0195,active-noncovalent
c1ccc(cc1)C2(CCCC2)C[NH3+],1-(1-phenylcyclopentyl)methylamine,-8.065423,x0195,active-noncovalent
c1cc(oc1/C=N/N2CC(=O)NC2=O)N(=O)=O,Nitrofurantoin,-8.063862,x0749,active-covalent
c1ccc(c(c1)c2ccc(o2)C(=O)[O-])N(=O)=O,5-(2-NITROPHENYL)-2-FUROIC ACID,-8.063778,x1418,active-covalent
c1c(c(=O)[nH]o1)C(=O)[O-],3-hydroxyisoxazole-4-carboxylic acid,-8.063778,x0397,active-noncovalent
c1ccc(cc1)C[C@H](C(=O)[O-])[NH3+],D-Phenylalanine,-8.063537,x0195,active-noncovalent
C1[C@H]([C@@H]([C@H](C=C1C(=O)[O-])[NH3+])O)O,"3-Amino-4,5-Dihydroxy-Cyclohex-1-Enecarboxylate",-8.063437,x0426,active-noncovalent
CCc1cc(ccc1O)CC[NH3+],4-(2-aminoethyl)-2-ethylphenol,-8.062597,x0195,active-noncovalent
CC(C)(C)c1nnc(o1)C(=O)[C@@H]2CCC[NH2+]2,"2-Prolyl-5-Tert-Butyl-[1,3,4]Oxadiazole",-8.062145,x0161,active-noncovalent
CC[NH+](CC)CCNC(=O)c1ccc(cc1)N,Procainamide,-8.061700,x0434,active-noncovalent
Cc1cc(c(cc1C)N)N,"4,5-Dimethyl-1,2-Phenylenediamine",-8.061035,x1077,active-noncovalent
CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1[N+]4(CCCCC4)C)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C,Pancuronium,-8.059139,x0104,active-noncovalent
c1cc(c(c(c1)Cl)c2c3ccc(nn3cnc2=O)Sc4ccc(cc4F)F)Cl,Neflamapimod,-8.058599,x0749,active-covalent
CNC(=O)c1cccnc1,N-methylnicotinamide,-8.057701,x0678,active-noncovalent
CC[C@@H]1C[N@H+](CC[C@@]1(c2ccccc2)OC(=O)CC)C,Betameprodine,-8.056217,x0195,active-noncovalent
c1ccc(c(c1)c2ccccc2[S@](=O)[O-])O,"2'-HYDROXY-1,1'-BIPHENYL-2-SULFINIC ACID",-8.055464,x0678,active-noncovalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@](C4)(C)O)C)C,Ganaxolone,-8.054926,x0749,active-covalent
CC(C)[NH2+][C@@H]1CCn2c3c(cccc3[nH]c2=O)[C@H]1O,Zilpaterol,-8.051447,x0107,active-noncovalent
C1c2c(c(c(c(c2Cl)Cl)Cl)Cl)C(=O)O1,"4,5,6,7-Tetrachloro-3h-Isobenzofuran-1-One",-8.050623,x0195,active-noncovalent
Cc1cc(=O)n(c2c1c(ccc2OC)OC)C,"5,8-dimethoxy-1,4-dimethylquinolin-2(1H)-one",-8.049793,x0195,active-noncovalent
c1ccnc(c1)NS(=O)(=O)c2ccc(cc2)N,Sulfapyridine,-8.048029,x0678,active-noncovalent
C(C(CC(=O)[O-])C(=O)[O-])C(=O)[O-],Tricarballylic Acid,-8.044989,x0397,active-noncovalent
CC[NH2+][C@@H]1[C@H]2CC[C@H](C2)[C@H]1c3ccccc3,Fencamfamin,-8.044714,x0749,active-covalent
C[C@H]1Cc2ccccc2[N@]1NC(=O)c3ccc(c(c3)S(=O)(=O)N)Cl,"4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide",-8.040809,x0161,active-noncovalent
C[N@@H+]1CC[C@]23[C@@H](C1)[C@H](CC(=O)N2)c4cc(ccc4O3)Cl,Lortalamine,-8.040696,x0161,active-noncovalent
CC1(C(=O)NC(=O)NC1=O)c2ccc(cc2)Oc3ccccc3,"5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione",-8.040022,x0678,active-noncovalent
CCCSCc1cc(cc2c1nc([nH]c2=O)N)N,"2,6-Diamino-8-Propylsulfanylmethyl-3h-Quinazoline-4-One",-8.039555,x0749,active-covalent
CC(=O)NCCc1c2cc(ccc2[nH]c1I)OC,N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide,-8.039362,x0967,active-noncovalent
c1ccc(cc1)C[C@@H](CI)C(=O)[O-],2-Benzyl-3-Iodopropanoic Acid,-8.036414,x0397,active-noncovalent
c1ccc2c(c1)cc[nH]2,Indole,-8.035315,x0678,active-noncovalent
Cc1c(c(nc(n1)N)N)c2ccc(c(c2)Cl)Cl,Metoprine,-8.035050,x0678,active-noncovalent
c1ccc2cc(ccc2c1)S(=O)(=O)[O-],2-NAPHTHALENESULFONIC ACID,-8.033806,x0749,active-covalent
C1=C(C(=CC(=O)C1=O)[O-])C[C@@H](C(=O)[O-])[NH3+],6-hydroxydopa quinone,-8.031667,x0678,active-noncovalent
CC1=CC[C@H]2C[C@@H]1[C@@H](OC2(C)C)c3ccc(cc3)O,"4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",-8.031608,x1077,active-noncovalent
CCOC(=O)C(C)(C)Oc1ccc(cc1)Cl,Clofibrate,-8.030338,x0195,active-noncovalent
c1ccc2c(c1)c(c[nH]2)CC(=O)[O-],Indoleacetic acid,-8.028038,x0830,active-covalent
C[N@H+]1[C@H]2CC[C@@H]1[C@H]([C@H](C2)O)C(=O)OC,Methylecgonine,-8.027662,x0104,active-noncovalent
CCC(=O)C1(CC[NH+](CC1)C)c2cccc(c2)O,Ketobemidone,-8.026377,x0678,active-noncovalent
CCC(=O)C(C[C@@H](C)[NH+]1CCCCC1)(c2ccccc2)c3ccccc3,Dipipanone,-8.025624,x0195,active-noncovalent
CCN1c2cc(ccc2N(C(=O)c3c1nccc3)C)N(=O)=O,"6,11-DIHYDRO-11-ETHYL-6-METHYL-9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN-5-ONE",-8.024220,x0072,active-noncovalent
Cn1cnc2c1nc([nH]c2=O)N,9-Methylguanine,-8.023533,x0397,active-noncovalent
c1ccc(cc1)[C@H](C(=O)[O-])NC(=O)CCC(=O)[O-],N-Succinyl Phenylglycine,-8.022334,x0678,active-noncovalent
C[C@@H]1C[C@H]2[C@@H]3[C@@H](CC4=CC(=O)C=C[C@@]4([C@H]3[C@H](C[C@@]2([C@]1([C@H](C=O)O)O)C)O)C)Cl,Alclometasone,-8.019617,x0967,active-noncovalent
c1c2c([nH]c1Br)C(=O)NCC[C@@H]2C3=NC(=[NH2+])NC3=O,Hymenialdisine,-8.019303,x0874,active-noncovalent
c1c(c(cc2c1NCNS2(=O)=O)S(=O)(=O)N)C(F)(F)F,Hydroflumethiazide,-8.017550,x0749,active-covalent
c1cc(ccc1NS(=O)(=O)c2ccc3c(c2)C[NH2+]CC3)Cl,"N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",-8.016869,x1093,active-noncovalent
C[C@H]1[C@@H](OCC[NH2+]1)c2ccccc2,Phenmetrazine,-8.015677,x0161,active-noncovalent
Cc1cc(n(c(=O)c1)[O-])C2CCCCC2,Ciclopirox,-8.013767,x0678,active-noncovalent
c1cc(cnc1)C(=O)N,Nicotinamide,-8.013707,x0397,active-noncovalent
c1cnc(nc1c2csc(n2)N)N,"4-(2-amino-1,3-thiazol-4-yl)pyrimidin-2-amine",-8.013229,x0749,active-covalent
Cc1c2c(n(n1)C)N(C(=O)C=N[C@H]2c3ccccc3F)C,Zolazepam,-8.013073,x0434,active-noncovalent
c1cc(c(c(c1)Br)c2cc3cnc(nc3nc2N)N)Br,"6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine",-8.009518,x0107,active-noncovalent
COc1ccc2c(c1)c(ccn2)[C@H]([C@@H]3C[C@@H]4CC[N@H+]3C[C@@H]4C=C)O,Quinine,-8.007846,x0678,active-noncovalent
C[N@@H+](Cc1cc(cc(c1N)Br)Br)C2CCCCC2,Bromhexine,-8.006972,x0678,active-noncovalent
c1c(nc2c(=O)[nH]c(nc2n1)N)COP(=O)([O-])[O-],Pterin-6-Yl-Methyl-Monophosphate,-8.006639,x0397,active-noncovalent
CCC[C@H]1COc2ccsc2C(=[NH2+])N1,"(3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f][1,4]oxazepin-5(2H)-imine",-8.005352,x0749,active-covalent
Cc1cccc(c1OC[C@H](C)[NH3+])C,Mexiletine,-8.004562,x0195,active-noncovalent
C[C@H]1[C@@](CC[N@@H+](C1)[C@H]2CC[C@@](CC2)(c3ccc(cc3)F)C#N)(C(=O)[O-])c4ccccc4,Levocabastine,-8.003959,x1077,active-noncovalent
CC1=C(C(=O)C(=C(C1=O)Br)C(C)C)Br,Dibromothymoquinone,-8.003654,x0195,active-noncovalent
C[C@]12CCCCC[C@H]([C@@H]1[NH3+])Cc3c2cc(cc3)O,Dezocine,-8.003187,x1392,active-covalent
c1cc(ccc1CCC(=O)[O-])S(=O)(=O)N,3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID,-8.003050,x0830,active-covalent
C[C@H]1O[C@]2(C[NH+]3CCC2CC3)CS1,Cevimeline,-8.002839,x0195,active-noncovalent
c1cc(c(c(c1)F)CNC(=O)c2ccc(cc2)S(=O)(=O)N)F,"N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide",-8.000661,x0072,active-noncovalent
c1cc2n(c1)[C@@]3(CC(=O)NC3=O)C(=O)N(C2=O)Cc4ccc(cc4F)Br,Ranirestat,-8.000050,x0434,active-noncovalent
c1cc2cc(ccc2c(c1)N)S(=O)(=O)[O-],5-AMINO-NAPHTALENE-2-MONOSULFONATE,-7.999174,x0195,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@H]4[C@H](O3)CO[P@](=O)(O4)[O-])O)N,Cyclic adenosine monophosphate,-7.996620,x1385,active-covalent
c1c2c(c(=O)[nH]cn2)n[nH]1,"3H-pyrazolo[4,3-d]pyrimidin-7-ol",-7.996417,x0397,active-noncovalent
CCc1cc2c(cc1N3CCC(CC3)[NH+]4CCOCC4)C(c5c(c6ccc(cc6[nH]5)C#N)C2=O)(C)C,Alectinib,-7.994830,x0104,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])C(=O)[O-],Aspartic acid,-7.993051,x0397,active-noncovalent
c1cc(ccc1SC(P(=O)([O-])[O-])P(=O)([O-])[O-])Cl,Tiludronic acid,-7.992678,x0831,active-covalent
C[C@H](Cc1ccccc1)/N=C/C(Cl)(Cl)Cl,Amfecloral,-7.992058,x0749,active-covalent
C[C@](c1ccc(cc1)C(=O)[O-])(C(=O)[O-])[NH3+],4-(1-Amino-1-Carboxy-Ethyl)-Benzoic Acid,-7.990639,x0104,active-noncovalent
c1cc2c(c(c1)N(=O)=O)C=CC2=O,4-Nitro-Inden-1-One,-7.989002,x0195,active-noncovalent
c1cc(ccc1Oc2ccc(cc2O)Cl)Cl,Soneclosan,-7.988163,x0161,active-noncovalent
C[C@@H](Cc1cc(c(cc1OC)Br)OC)[NH3+],"4-Bromo-2,5-dimethoxyamphetamine",-7.987509,x0195,active-noncovalent
CS(=O)(=O)Nc1ccc(cc1Oc2ccccc2)N(=O)=O,Nimesulide,-7.985777,x0434,active-noncovalent
c1cc2c(cc1C(=O)N3CCOCC3)non2,CX717,-7.985219,x0749,active-covalent
Cc1nc(nn1c2cc(cc(c2)Cl)Cl)C(=O)[O-],"1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID",-7.984477,x0736,active-covalent
CCC[C@@](C)([C@H]1C[C@@]23C=C[C@@]1([C@H]4[C@@]25CC[N@@H+]([C@@H]3Cc6c5c(c(cc6)O)O4)C)OC)O,Etorphine,-7.983629,x0104,active-noncovalent
c1c(c(=O)[nH]c(=O)[nH]1)N(CCCl)CCCl,Uracil mustard,-7.982178,x1077,active-noncovalent
c1ccc(cc1)C[C@H](C(=O)[O-])NC(=O)C(=O)[O-],N-(carboxycarbonyl)-D-phenylalanine,-7.981539,x0678,active-noncovalent
c1cc(ccc1CC(=O)C(=O)[O-])O,3-(4-HYDROXY-PHENYL)PYRUVIC ACID,-7.981157,x0759,active-covalent
c1ccc(cc1)C[C@@H](CO)O,"3-Phenyl-1,2-Propandiol",-7.980884,x0195,active-noncovalent
C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1([C@H](C=O)O)O)C)O)F)C)F,Diflorasone,-7.979549,x0967,active-noncovalent
COc1ccc2ccc(cc2c1c3cnn(c3)S(=O)(=O)C)C(=[NH2+])N,7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide,-7.978664,x0195,active-noncovalent
C(CP(=O)([O-])[O-])C(=O)[O-],2-Carboxyethylphosphonic Acid,-7.976758,x0397,active-noncovalent
CC(C)Cn1cnc2c1c3ccccc3nc2N,Imiquimod,-7.976064,x0161,active-noncovalent
CCOc1ccc2c(c1)sc(n2)S(=O)(=O)N,Ethoxzolamide,-7.975399,x0678,active-noncovalent
CC(C)(C)NS(=O)(=O)c1ccc(cc1)c2ccc3c(c2)c([nH]n3)N,4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide,-7.975193,x1077,active-noncovalent
C[C@@H]([C@H]1[NH2+][C@H](C(=O)N1CC(=O)[O-])CN)N,"3,5-Dihydro-5-Methylidene-4h-Imidazol-4-On",-7.974502,x0830,active-covalent
[C@H]([C@@H](O)OP(=O)([O-])[O-])(C(=O)[O-])[NH3+],2-Amino-3-Hydroxy-3-Phosphonooxy-Propionic Acid,-7.974077,x0397,active-noncovalent
COc1ccc(cc1)/N=C/2\[C@H](C(=O)N(C2=O)Cc3ccccc3)c4ccccc4,"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",-7.972952,x1077,active-noncovalent
c1ccc2c(c1)c(no2)CS(=O)(=O)N,Zonisamide,-7.972009,x1311,active-covalent
C[C@@]12[C@H](C=C[C@@]3([C@@H]1[C@@H]([C@]45[C@H]3CC[C@](C4)(C(=C)C5)O)C(=O)[O-])OC2=O)O,Gibberellic acid,-7.969599,x1311,active-covalent
C[C@H]1CNC(=[NH2+])c2c(ccs2)O1,"(2S)-2-methyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine",-7.968589,x1077,active-noncovalent
c1c(c(cc(c1N(CCCl)CCCl)N(=O)=O)N(=O)=O)C(=O)N,"5-[Bis-2(Chloro-Ethyl)-Amino]-2,4-Dintro-Benzamide",-7.968035,x0195,active-noncovalent
C[C@@H](Cc1ccccc1)[NH3+],Dextroamphetamine,-7.967638,x0161,active-noncovalent
C[C@@H](Cc1ccccc1)[NH3+],Amphetamine,-7.967638,x0161,active-noncovalent
CC[C@@H]1Nc2cc(c(cc2C(=O)N1)S(=O)(=O)N)Cl,Quinethazone,-7.966033,x0749,active-covalent
CCN(c1ccccc1)C(=O)c2c(=O)c3c(cccc3Cl)n(c2[O-])C,Laquinimod,-7.963831,x0195,active-noncovalent
c1cc(ccc1n2c(c(cn2)C#N)N)Cl,5-amino-1-(4-chlorophenyl)-1H-pyrazole-4-carbonitrile,-7.963257,x0395,active-noncovalent
C(C(=O)[O-])(C(=O)[O-])O,Tartronate,-7.962155,x0397,active-noncovalent
C[C@@H]1Cc2ccccc2[N@]1NC(=O)c3ccc(c(c3)S(=O)(=O)N)Cl,Indapamide,-7.960424,x0195,active-noncovalent
c1cc(ccc1C(=[NH2+])N)NC(=O)Nc2ccc(cc2)Cl,1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea,-7.960353,x0678,active-noncovalent
Cc1ccccc1N2[C@H](Nc3cc(c(cc3C2=O)S(=O)(=O)N)Cl)C,Metolazone,-7.959642,x0104,active-noncovalent
Cn1c2c(c(=O)n(c1=O)C)n(c(n2)N3CC[NH2+]CC3)Cc4ccccc4,"7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE",-7.958889,x1386,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)Nc4cc(ccc4C(F)(F)F)C(F)(F)F)CC[C@@H]5[C@@]3(C=CC(=O)N5)C,Dutasteride,-7.954278,x0104,active-noncovalent
c1cc(c(cc1S(=O)(=O)N)N(=O)=O)N2CCCC2=O,3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide,-7.954195,x0749,active-covalent
C(CC[NH3+])C[C@H](C(=O)[O-])[NH3+],D-Lysine,-7.952079,x0397,active-noncovalent
c1ccnc(c1)c2cccc(n2)c3ccccn3,"2,2':6',2''-Terpyridine Platinum(Ii)",-7.951975,x0195,active-noncovalent
[C@@H]1([C@@H]([C@H](O[C@H]([C@@H]1O)O)C(=O)[O-])O)O,beta-D-glucuronic acid,-7.950293,x0397,active-noncovalent
CC(C)(C)n1c2c(c(n1)c3cccc(c3)O)c(ncn2)N,"3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol",-7.949100,x0434,active-noncovalent
C[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2[C@H](C=C[C@H]3[C@H]1C5)O)O,Morphine,-7.947979,x1077,active-noncovalent
C[C@H]1C[NH2+]CCc2c1cc(cc2)Cl,Lorcaserin,-7.946508,x0195,active-noncovalent
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)Cl)C,Mometasone,-7.946288,x0104,active-noncovalent
C[C@@]12[C@@H]([C@@H](C[C@@H](O1)n3c4ccccc4c5c3c6n2c7ccccc7c6c8c5C(=O)N[C@@H]8O)[NH2+]C)OC,7-Hydroxystaurosporine,-7.942410,x0195,active-noncovalent
c1c(cc(c(c1I)Oc2cc(c(c(c2)I)[O-])I)I)C[C@H](C(=O)[O-])[NH3+],Dextrothyroxine,-7.940776,x0195,active-noncovalent
Cn1c2ccccc2c(=O)c(c1[O-])[O-],"3,4-Dihydroxy-1-Methylquinolin-2(1h)-One",-7.939693,x0195,active-noncovalent
CCCc1c(c2cc(ccc2[nH]c1=O)Cl)[S@](=O)C3CCCCC3,6-Chloro-4-[(R)-cyclohexylsulfinyl]-3-propyl-2(1H)-quinolinone,-7.939434,x0874,active-noncovalent
C[C@H]1CC[C@@]2(CO[C@@H]([C@H]1[C@H]2C)c3ccc(cc3)O)CO,"4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL",-7.939384,x0749,active-covalent
c1ccc(cc1)c2ccc(cc2)c3cccc(c3)CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",-7.939239,x0874,active-noncovalent
c1ccc2c(c1)c(=O)cc(o2)[O-],4-hydroxycoumarin,-7.938272,x0195,active-noncovalent
c1cc(cc(c1)NC(=O)c2cccc(c2)F)c3[n-]nnn3,3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide,-7.937124,x0104,active-noncovalent
c1ccc(cc1)C[C@@H](C(=O)[O-])[NH3+],Phenylalanine,-7.936695,x0195,active-noncovalent
c1ccc(cc1)n2cc(cn2)C(=O)[O-],1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID,-7.936496,x0749,active-covalent
CC(=O)O[C@H]1CC[C@H]2[C@H]3Cc4ccc(c5c4[C@]2([C@H]1O5)CC[N@@H+]3C)OC,Acetyldihydrocodeine,-7.936257,x1077,active-noncovalent
C(C(=C(Cl)Cl)C(=O)[O-])P(=O)([O-])[O-],"3,3-Dichloro-2-Phosphonomethyl-Acrylic Acid",-7.933999,x0397,active-noncovalent
CC(C)c1cccc(c1OS(=O)(=O)[N-]C(=O)Cc2c(cc(cc2C(C)C)C(C)C)C(C)C)C(C)C,Avasimibe,-7.933449,x0161,active-noncovalent
CCc1c(c(nc(n1)N)N)C#CCc2cc(ccc2OC)OC,"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",-7.931183,x0072,active-noncovalent
c1cc(c(c(c1)Cl)CC(=O)NC(=[NH2+])N)Cl,Guanfacine,-7.930786,x0195,active-noncovalent
CCC[C@@H](C(=O)[O-])[NH2+]Cc1c(cnc(c1O)C)COP(=O)([O-])[O-],Vitamin B6 Complexed with 2-Amino-Pentanoic Acid,-7.927727,x0397,active-noncovalent
C[C@H](C(=O)[O-])NC(=O)c1ccccc1,N-BENZOYL-D-ALANINE,-7.927665,x0107,active-noncovalent
C[C@@H](CO)NC(=O)[C@H]1C[N@H+]([C@@H]2Cc3c[nH]c4c3c(ccc4)C2=C1)C,Ergometrine,-7.927420,x1077,active-noncovalent
CCOC(=O)c1ccc(cc1)N,Benzocaine,-7.925155,x0678,active-noncovalent
C[C@H](CC(=O)[O-])[C@@H](C(=O)[O-])[NH3+],3-Methylglutamic acid,-7.923613,x0397,active-noncovalent
CN(C)c1[nH]c2c(n1)c(c(c(c2Br)Br)Br)Br,"DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE",-7.920352,x0195,active-noncovalent
C[C@@H](Cc1cc(ccc1OC)OC)[NH3+],"2,5-Dimethoxyamphetamine",-7.920017,x1311,active-covalent
Cc1cc(cc(c1OC(C)(C)C(=O)[O-])C)/C=C/C(=O)c2ccc(cc2)SC,Elafibranor,-7.919868,x0072,active-noncovalent
C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OS(=O)(=O)[O-])C)C,Cholesterol sulfate,-7.918909,x0104,active-noncovalent
c1cc(ccc1c2csc(n2)N)O,"4-(2-amino-1,3-thiazol-4-yl)phenol",-7.917682,x0195,active-noncovalent
C[C@@H]([C@H](c1ccccc1)O)[NH3+],Cathine,-7.916599,x0104,active-noncovalent
C[N+](C)(C)CCCC[C@@H](C(=O)[O-])[NH3+],N-Trimethyllysine,-7.913313,x0678,active-noncovalent
c1cc(c(c(c1)O)O)c2c(cccc2Cl)Cl,"2',6'-Dichloro-Biphenyl-2,6-Diol",-7.910859,x0195,active-noncovalent
c12c(=O)[nH]c(nc1n[nH]n2)N,8-azaguanine,-7.909998,x0305,active-noncovalent
CCOc1ccc2c3c1O[C@@H]4[C@]35CC[N@@H+]([C@H](C2)[C@@H]5C=C[C@@H]4O)C,Ethylmorphine,-7.909685,x0678,active-noncovalent
c1ccc2c(c1)[nH]cn2,Benzimidazole,-7.909513,x0678,active-noncovalent
c1cc(c(c2c1nccn2)Br)NC3=[NH+]CCN3,Brimonidine,-7.909169,x1392,active-covalent
Cc1cccc2c1n3cnnc3s2,Tricyclazole,-7.908038,x0195,active-noncovalent
CC1=C(SCCO1)C(=O)Nc2ccccc2,Carboxin,-7.906460,x0749,active-covalent
c1c(cc(c(c1I)Oc2cc(c(c(c2)I)[O-])I)I)CC(=O)[O-],"3,3',5,5'-Tetraiodothyroacetic Acid",-7.905382,x0195,active-noncovalent
c12c(c(c(c(c1Br)Br)Br)Br)n[nH]n2,Tetrabromo-2-Benzotriazole,-7.904695,x0195,active-noncovalent
c1cc2c(c[nH]c2nc1)C[C@@H](C(=O)[O-])[NH3+],Nz2-Tryptophan,-7.903271,x0195,active-noncovalent
CCN(CC)C(=S)SSC(=S)N(CC)CC,Disulfiram,-7.901861,x0195,active-noncovalent
c1ccc(cc1)c2ccc(cc2)S(=O)(=O)[N@@]3Cc4ccccc4C[C@@H]3C(=O)[O-],"2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid",-7.900901,x0104,active-noncovalent
Cc1c(cc(c(=O)[nH]1)C#N)c2ccncc2,Milrinone,-7.899122,x1077,active-noncovalent
CC(=O)Nc1ccc(cc1)S(=O)(=O)[N-]c2ccc(cc2)N(=O)=O,Sulfanitran,-7.898918,x0195,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5ccccc5c4)O,Camptothecin,-7.896329,x0195,active-noncovalent
c1c(nc(cn1)Cl)N,2-Amino-6-Chloropyrazine,-7.895925,x0397,active-noncovalent
C1CCC(CC1)[NH2+]CCCS(=O)(=O)[O-],3-Cyclohexyl-1-Propylsulfonic Acid,-7.895701,x0678,active-noncovalent
CC1(CC(CC(N1[O-])(C)C)n2c(ccc2O)O)C,"1-(1-HYDROXY-2,2,6,6-TETRAMETHYLPIPERIDIN-4-YL)PYRROLIDINE-2,5-DIONE",-7.895074,x0195,active-noncovalent
c1ccc2c(c1)c(=O)[nH]c(n2)N,2-Aminoquinazolin-4(3h)-One,-7.894604,x0678,active-noncovalent
[C@H]([C@@H](O)OS(=O)(=O)[O-])(C(=O)[O-])[NH3+],2-Amino-3-Oxo-4-Sulfo-Butyric Acid,-7.894005,x0397,active-noncovalent
c1ccc(cc1)C[C@@H](CO)[NH3+],L-phenylalaninol,-7.893780,x0195,active-noncovalent
Cc1cccc2c1nc([nH]c2=O)CCC[N@H+]3CCC(=CC3)c4ccc(cc4)F,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quin",-7.892773,x0195,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3C[C@@H]5[C@]4(OC(O5)(C)C)C(=O)CCl)C)O)F,Halcinonide,-7.892338,x0161,active-noncovalent
CCCc1c(c2cc(ccc2[nH]c1=O)Cl)SC3CCCCC3,6-CHLORO-4-(CYCLOHEXYLSULFANYL)-3-PROPYLQUINOLIN-2(1H)-ONE,-7.889890,x0874,active-noncovalent
Cc1cc(=O)n([nH]1)c2ccccc2,Edaravone,-7.889587,x0195,active-noncovalent
CC(C)[N+](C)(CCC(c1ccccc1)(c2ccccc2)C(=O)N)C(C)C,Isopropamide,-7.889341,x0195,active-noncovalent
c1cc(cc(c1)Br)NC(=O)[C@H]2CC(=O)N(C2)C3CCCCC3,(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,-7.888378,x0749,active-covalent
C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)[C@H](C=O)O)C[C@@H](C5=CC(=O)C=C[C@]35C)F)O,Flunisolide,-7.887690,x0874,active-noncovalent
c1cc(ccc1C[C@]23CCCN2C(=O)C(=C3C#N)c4cc(cc(c4)Cl)Cl)C#N,"7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-p",-7.887212,x0434,active-noncovalent
CC(C)(Cc1ccc(cc1)Cl)[NH3+],Chlorphentermine,-7.885717,x0161,active-noncovalent
c1cn(c(=O)[nH]c1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)OP(=O)([O-])[O-])F,2'-fluoro-2'-deoxyuridine 3'-monophosphate,-7.885256,x0874,active-noncovalent
CS(=O)(=O)c1ccc(cc1)Nc2cc(nc3n2ncc3)Cl,"(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine",-7.883293,x0749,active-covalent
c1ccn2c(c1)nc3c2ncnc3NCCO,"2-(Pyrido[1,2-E]Purin-4-Yl)Amino-Ethanol",-7.882679,x0749,active-covalent
C(C[C@@H](C(=O)[O-])[NH3+])C[C@@H](C(=O)[O-])[NH3+],"2,6-Diaminopimelic Acid",-7.882129,x0107,active-noncovalent
B(c1cccc(c1)N)(O)O,M-Aminophenylboronic Acid,-7.881499,x0195,active-noncovalent
CN(c1ccc(cc1)O)C(=O)C(Cl)Cl,Diloxanide,-7.880745,x0195,active-noncovalent
Cc1c(c(=O)[nH]o1)C[C@@H](C(=O)[O-])[NH3+],(S)-AMPA,-7.879806,x0678,active-noncovalent
CCc1c(c(nc(n1)N)N)c2ccc(cc2)Cl,Pyrimethamine,-7.879348,x1077,active-noncovalent
c12c([nH]c(=O)[nH]c1=O)n[nH]n2,8-azaxanthine,-7.879091,x0678,active-noncovalent
CC[C@@H](C)SSc1[nH]ccn1,PX-12,-7.875203,x0749,active-covalent
CCCSc1ccc2c(c1)[nH]c(n2)NC(=O)OC,Albendazole,-7.874957,x1077,active-noncovalent
c1c(c(c(cc1Br)Br)N)C[NH2+][C@H]2CC[C@@H](CC2)O,Ambroxol,-7.873024,x1093,active-noncovalent
c1cc(cc2c1cc(cc2)C(=O)[O-])C(=O)[O-],"2,6-dicarboxynaphthalene",-7.871736,x0749,active-covalent
C[C@H](Cc1ccccc1)[NH2+]C,Levmetamfetamine,-7.871223,x0195,active-noncovalent
C[C@](c1ccccc1)(c2ccccn2)OCC[NH+](C)C,Doxylamine,-7.868533,x0072,active-noncovalent
C(=C(\[C@H](C(=O)[O-])O)/C(=O)[O-])\C(=O)[O-],4-Hydroxy-Aconitate Ion,-7.867841,x0397,active-noncovalent
Cc1cc2c(cc1C)nc[nH]2,"5,6-Dimethylbenzimidazole",-7.867279,x0195,active-noncovalent
c1cc2c(cc[nH]c2=O)c(c1)S(=O)(=O)[N@]3CCC[NH2+]CC3,Hydroxyfasudil,-7.867182,x1077,active-noncovalent
CCCC[N@@H+]1CCCC[C@H]1C(=O)Nc2c(cccc2C)C,Bupivacaine,-7.866196,x0874,active-noncovalent
Cc1cc2c(cc1S(=O)(=O)N3CC[NH+](CC3)C)S(=O)(=O)N[C@H](N2)C4CCCC4,"(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-",-7.865419,x0161,active-noncovalent
C[C@@H](Cc1ccccc1)[NH2+]C,Metamfetamine,-7.863082,x0195,active-noncovalent
C([C@H](C(=O)[O-])[NH3+])C(=O)N,D-Asparagine,-7.862980,x0397,active-noncovalent
Cc1cnc(s1)NC(=O)C2=C(c3ccccc3S(=O)(=O)[N@@]2C)O,Meloxicam,-7.862762,x0678,active-noncovalent
COc1cc(c(cc1C(=O)N[C@@H]2CC[NH2+]C[C@@H]2OC)Cl)N,Ticalopride,-7.862230,x0678,active-noncovalent
CC[NH2+][C@H]1C[C@@H](S(=O)(=O)c2c1cc(s2)S(=O)(=O)N)C,Dorzolamide,-7.861938,x1093,active-noncovalent
CN1CC[NH+](CC1)[C@H](c2ccccc2)c3ccc(cc3)Cl,Chlorcyclizine,-7.861389,x0195,active-noncovalent
c1ccc(c(c1)CC(=O)[O-])Nc2c(cccc2Cl)Cl,Diclofenac,-7.860729,x0107,active-noncovalent
CC[C@H](C)[C@H](C(=O)[O-])[NH2+]Cc1c(cnc(c1O)C)COP(=O)([O-])[O-],N-[O-Phosphono-Pyridoxyl]-Isoleucine,-7.859570,x0831,active-covalent
c1c(nc(cn1)Cl)N2CC[NH2+]CC2,MK-212,-7.856847,x0397,active-noncovalent
CCC(=O)N(c1ccccc1)[C@@H]2CC[N@@H+](C[C@@H]2CC=C)CCc3ccccc3,3-Allylfentanyl,-7.856302,x0874,active-noncovalent
C[C@H](C[C@@H](C(=O)[O-])[NH3+])C(=O)[O-],"2s,4r-4-Methylglutamate",-7.854684,x0397,active-noncovalent
c1cc2c(cc1C(=O)[O-])CC[C@H]3C2=NN([C@H]3C4CCCC4)c5ccc(c(c5)Cl)C#N,PF-03882845,-7.854643,x0072,active-noncovalent
C[N@H+]1C[C@H](C2=CC(=O)C(=O)C=C21)O,"(3S)-3-hydroxy-1-methyl-2,3-dihydro-1H-indole-5,6-dione",-7.853426,x0195,active-noncovalent
Cc1c(c(c(cn1)COP(=O)([O-])[O-])C[NH3+])O,Pyridoxamine-5'-Phosphate,-7.853054,x0397,active-noncovalent
CC(C)[NH+](CCc1c[nH]c2c1cc(cc2)OC)C(C)C,"5-Methoxy-N,N-diisopropyltryptamine",-7.852458,x0195,active-noncovalent
c1c(c(cc(c1F)F)F)[C@H]2CC[C@@H](C[C@@H]2[NH3+])[N@H+]3CCn4c(nnc4C(F)(F)F)C3,"(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)",-7.851545,x1077,active-noncovalent
C1C2CC3CC1CC(C2)(C3)[NH3+],Amantadine,-7.850710,x0354,active-noncovalent
Cc1cc(=O)oc2c1cccc2,4-METHYL-2H-CHROMEN-2-ONE,-7.850533,x0195,active-noncovalent
c1cc(ccc1C[C@@H](C=O)[NH3+])O,Tyrosinal,-7.850187,x1077,active-noncovalent
Cn1cnc2c1[n+](cnc2N)C,"3,9-Dimethyladenine",-7.848722,x0967,active-noncovalent
C[C@H](CCC=C(C)C)[C@H]1CC[C@@]2([C@@]1(CCC3=C2CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)C,Lanosterol,-7.848373,x1077,active-noncovalent
C[C@@H](CC(=O)[O-])[C@@H](C(=O)[O-])[NH3+],"(2S,3S)-2-azanyl-3-methyl-pentanedioic acid",-7.846585,x0397,active-noncovalent
CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)c5ccc(cc5)N(C)C)C)O,Mifepristone,-7.842813,x1077,active-noncovalent
c1ccc(cc1)c2ccccc2[S@](=O)[O-],"1,1'-BIPHENYL-2-SULFINIC ACID",-7.841554,x0195,active-noncovalent
c1ccc(c(c1)C2=NCC(=O)Nc3c2cc(cc3)Cl)Cl,Delorazepam,-7.841276,x0195,active-noncovalent
C[C@H](CCC(=O)[O-])[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,Chenodeoxycholic acid,-7.840150,x0946,active-noncovalent
c1ccc(cc1)C2(CCCCC2)[NH+]3CCCCC3,Phencyclidine,-7.840008,x0354,active-noncovalent
CC(=O)NS(=O)(=O)c1ccc(cc1)N,Sulfacetamide,-7.839550,x0678,active-noncovalent
C=CC[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2C(=O)CC[C@]3([C@H]1C5)O)O,Naloxone,-7.838502,x1077,active-noncovalent
c1ccc2c(c1)C(=O)C=C(C2=O)[O-],Lawsone,-7.837579,x0195,active-noncovalent
c1ccc(cc1)CN2C(=O)/C(=C/c3cccc(c3[O-])N(=O)=O)/SC2=S,(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE,-7.835010,x0072,active-noncovalent
c1cc2cccnc2c(c1)O,Oxyquinoline,-7.834648,x0195,active-noncovalent
C[C@H]1CN([C@@H](CN1C(=O)[C@](C)(C(F)(F)F)O)C)C(=O)c2ccc(cc2)C#N,"4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIP",-7.833167,x0161,active-noncovalent
COC(=O)c1ccc(cc1)c2ccc(cc2)C(=O)OC,Biphenyl dimethyl dicarboxylate,-7.832707,x0749,active-covalent
c1cc2c(cc1N)c(=O)[nH][nH]c2=O,Isoluminol,-7.832098,x0107,active-noncovalent
C(c1c(c(c(c(c1F)F)F)F)F)O,"2,3,4,5,6-Pentafluorobenzyl Alcohol",-7.832042,x0195,active-noncovalent
CC(=O)N1CCCC[C@H]1C(=O)[O-],1-ACETYL-2-CARBOXYPIPERIDINE,-7.831988,x0397,active-noncovalent
C[C@@]1(CC(=O)N(C1=O)C)c2ccccc2,Methsuximide,-7.831721,x0161,active-noncovalent
CC(C)c1cccc(c1OCOP(=O)([O-])[O-])C(C)C,Fospropofol,-7.830031,x0749,active-covalent
Cc1cccc2c1CCNC2=O,"3,4-Dihydro-5-Methyl-Isoquinolinone",-7.829390,x0195,active-noncovalent
CCOCCn1c2ccccc2nc1N3CCC[N@H+](CC3)C,Emedastine,-7.829353,x0434,active-noncovalent
c1ccc(cc1)[C@H]2C[C@@H]2[NH3+],Tranylcypromine,-7.828674,x0678,active-noncovalent
C[N@H+]1CCc2cc(c(cc2[C@@H]3[C@@H]1CCc4c3cccc4)O)Cl,Ecopipam,-7.827047,x0830,active-covalent
C[NH+](C)Cc1ccc2c(cc(c(c2n1)O)Cl)Cl,PBT-1033,-7.826399,x0874,active-noncovalent
C/C(=C/C(=O)[O-])/C(=O)[O-],Citraconic acid,-7.826240,x0397,active-noncovalent
C[C@@H]1C(=O)C[C@H](C1(C)C)CC(O)O,"(2s,4s)-Alpha-Campholinic Acid",-7.826180,x0195,active-noncovalent
CC(=O)NCCc1cnc[nH]1,N-ACETYLHISTAMINE,-7.823645,x1093,active-noncovalent
c1cc(ccc1NC(=O)NC2CCCCC2)I,N-Cyclohexyl-N'-(4-Iodophenyl)Urea,-7.823221,x0072,active-noncovalent
c1ccc(cc1)C(=O)Nc2cc(c(c(c2)Br)[O-])Br,"N-(3,5-dibromo-4-hydroxyphenyl)benzamide",-7.823116,x0830,active-covalent
c1c[nH]c2c1cc(c(c2)O)O,"3h-Indole-5,6-Diol",-7.823091,x0678,active-noncovalent
CC(C)NNC(=O)c1ccncc1,Iproniazid,-7.823040,x0749,active-covalent
CC(=O)O[C@@H]1C[C@]2([C@@H](CCC2=O)C3=C1[C@@]4(c5c(coc5C3=O)C(=O)O[C@@H]4COC)C)C,Wortmannin,-7.822913,x0195,active-noncovalent
c1cc(ccc1CCO)F,4-Fluorophenethyl Alcohol,-7.822380,x0678,active-noncovalent
C[C@](Cc1ccc(c(c1)O)O)(C(=O)[O-])NN,Carbidopa,-7.821371,x0678,active-noncovalent
CC[C@]1([C@H](C1(Cl)Cl)C)C(=O)N[C@H](C)c2ccc(cc2)Cl,Carpropamide,-7.820664,x0749,active-covalent
C[C@H](/C(=c\1/[nH]/c(=C\c2c[nH]c3c2c(ccc3)N)/c(=O)n1CC(=O)[O-])/[NH3+])O,"{(4Z)-2-[(1R,2R)-1-Amino-2-hydroxypropyl]-4-[(4-amino-1H-indol-3-yl)methylene]-5",-7.820184,x0072,active-noncovalent
C[C@H](CN1c2ccccc2Sc3c1cc(cc3)C#N)C[NH+](C)C,Cyamemazine,-7.819659,x0161,active-noncovalent
c1ccc2c(c1)ccc(=O)o2,Coumarin,-7.819531,x0195,active-noncovalent
Cc1ccc2c(c1)nc[nH]2,5-methylbenzimidazole,-7.819118,x0678,active-noncovalent
Cc1cc2c(cc1C)nc3c(n2)c(=O)[nH]c(=O)[nH]3,Lumichrome,-7.818331,x0749,active-covalent
c1[nH]c2c(n1)c(ncn2)N,Adenine,-7.817648,x0678,active-noncovalent
Cc1ccnc2c1NC(=O)c3cccnc3N2C4CC4,Nevirapine,-7.817565,x0195,active-noncovalent
C([C@H](C(=O)[O-])O)OP(=O)([O-])[O-],3-phospho-D-glyceric acid,-7.817548,x0397,active-noncovalent
c1ccc(c(c1)C(=O)Nc2ccc(cc2)S(=O)(=O)N)[S-],N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE,-7.817204,x0072,active-noncovalent
c1c(cc(c2c1C(=O)C(=O)CC2=O)[O-])O,Flaviolin,-7.816840,x0195,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CC[C@@H]2O)OS(=O)(=O)N,Estradiol sulfamate,-7.816764,x0195,active-noncovalent
CC[n+]1c(c(c(c(c1C(=O)[O-])C(=O)[O-])c2ccccc2Cl)C(=O)OC(C)C)C,"2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridini",-7.814970,x1386,active-covalent
CC(C)(C)C1CCC(CC1)C2=C(C(=O)c3ccccc3C2=O)[O-],BW-A 58C,-7.814486,x1334,active-covalent
CN(C)c1cccc2c1cccc2S(=O)(=O)[O-],5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID),-7.814426,x0831,active-covalent
COc1cccc(c1)N2C=Cc3cc(sc3S2(=O)=O)S(=O)(=O)N,AL6528,-7.811002,x0104,active-noncovalent
C[NH+]1CCC(CC1)N(Cc2cccs2)c3ccccc3,Thenalidine,-7.810107,x1077,active-noncovalent
c1csc2c1[nH]cc(c2=O)C(=O)N[C@H]3C[NH+]4CCC3CC4,Pumosetrag,-7.809350,x0749,active-covalent
CS(=O)(=O)CC[C@@H](C(=O)[O-])[NH3+],S-Dioxymethionine,-7.809021,x0397,active-noncovalent
c1ccnc(c1)c2ccccn2,"lambda-bis(2,2'-bipyridine)imidazole ruthenium (II)",-7.807874,x0195,active-noncovalent
c1cc(ccc1CC[NH3+])O,Tyramine,-7.807739,x0678,active-noncovalent
c1cn(cn1)CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],Zoledronic acid,-7.805415,x0397,active-noncovalent
c1cc(c(cc1C[C@@H](C(=O)[O-])[NH3+])O)O,Levodopa,-7.803472,x1374,active-covalent
Cc1ccc(c(c1)S(=O)(=O)[O-])N2CC[NH2+]CC2,Caldaret,-7.803284,x0678,active-noncovalent
Cc1ccccc1c2n[nH]c(=S)n2N,"4-AMINO-5-(2-METHYLPHENYL)-2,4-DIHYDRO-3H-1,2,4-TRIAZOLE-3-THIONE",-7.802868,x0195,active-noncovalent
CCc1ccc(cc1)NC(=O)P(=O)([O-])[O-],ISO24,-7.802248,x0830,active-covalent
Cc1c(n(nc1C(=O)NN2CCCCC2)c3ccc(cc3Cl)Cl)c4ccc(cc4)Cl,Rimonabant,-7.800844,x0161,active-noncovalent
c1ccnc(c1)C2=NCC(=O)Nc3c2cc(cc3)Br,Bromazepam,-7.799737,x0195,active-noncovalent
c1ccc(cc1)C2=NCC(=O)Nc3c2cc(cc3)N(=O)=O,Nitrazepam,-7.799504,x0072,active-noncovalent
c1cc(c(c(c1)O)O)C(=O)[O-],"2,3-Dihydroxy-Benzoic Acid",-7.798022,x0397,active-noncovalent
CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)C,Lupeol,-7.797742,x0946,active-noncovalent
C(C(=O)C(=O)[O-])P(=O)([O-])[O-],Phosphonopyruvate,-7.795211,x0397,active-noncovalent
Cc1cccc2c1nc([nH]c2=O)N,2-Amino-8-Methylquinazolin-4(3h)-One,-7.793961,x0195,active-noncovalent
Cc1cccc(c1NC(=O)[C@@H](C)[NH3+])C,Tocainide,-7.792863,x0195,active-noncovalent
c1cc(ccc1S(=O)(=O)Nc2ccc(cc2C(=O)[O-])Br)Cl,5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID,-7.790303,x0678,active-noncovalent
c1[nH]c2c(n1)c(nc(n2)F)Cl,6-Chloro-2-fluoropurine,-7.789034,x0678,active-noncovalent
C([C@@H](C(=O)[O-])OP(=O)([O-])[O-])F,3-Fluoro-2-(Phosphonooxy)Propanoic Acid,-7.787158,x0397,active-noncovalent
[C@H]([C@@H](C(=O)[O-])O)(C(=O)[O-])O,D-tartaric acid,-7.783849,x0397,active-noncovalent
C[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2[C@H](CC[C@H]3[C@H]1C5)O)O,Dihydromorphine,-7.782769,x0874,active-noncovalent
C[C@@H](c1cc(nc2c1CCCC2=O)C(=O)[O-])O,8-Hydroxy-4-(1-Hydroxyethyl)Quinoline-2-Carboxylic Acid,-7.782599,x0195,active-noncovalent
C1[C@@H]([C@H]([C@@H](O[C@@H]1C(=O)[O-])O)O)O,4-Deoxy-D-Glucuronic Acid,-7.777595,x0397,active-noncovalent
c1cc(ccc1[N@]2CCCCS2(=O)=O)S(=O)(=O)N,Sulthiame,-7.777538,x0749,active-covalent
c1cc(c(cc1O)O)C(=O)[O-],"2,4-Dihydroxybenzoic Acid",-7.777531,x0678,active-noncovalent
Cn1c2c(c(=O)n(c1=O)C)n(cn2)CC3OCCO3,Doxofylline,-7.777446,x0749,active-covalent
c1cc(cnc1)CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],Risedronic acid,-7.776007,x0397,active-noncovalent
c1ccc(cc1)CC(=O)NC(=O)N,Phenacemide,-7.775181,x0195,active-noncovalent
Cn1c[n+](c2c1[C@@H]([NH2+][C@@H](N2)N)O)C,"7,9-Dimethylguanine",-7.773215,x0104,active-noncovalent
C[NH+](C)CC[C@](c1ccccc1)(c2ccccc2Cl)O,Clofedanol,-7.769453,x0195,active-noncovalent
C(/C(=C/C(=O)[O-])/C(=O)[O-])C(=O)[O-],Aconitate Ion,-7.768332,x0397,active-noncovalent
c1cc(ccc1C[NH3+])F,4-Fluorobenzylamine,-7.767799,x0678,active-noncovalent
CCCC/[NH+]=C(\N)/NO,2-butyl-1-hydroxyguanidine,-7.767578,x0195,active-noncovalent
c1[nH]c2c(n1)c(ncn2)N3CCOCC3,6-MORPHOLIN-4-YL-9H-PURINE,-7.766863,x0749,active-covalent
c1ccc2c(c1)cccc2N(c3ccccc3C(=O)[O-])C(=O)C(=O)[O-],"Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid",-7.766557,x0708,active-covalent
c1ccc(c(c1)/C=C/C(=O)[O-])O,trans-2-hydroxycinnamic acid,-7.765436,x0195,active-noncovalent
C[C@@]12CC[C@]3(CCC(C[C@H]3[C@H]1C(=O)C=C4[C@]2(CC[C@@H]5[C@@]4(C=C(C(=O)C5(C)C)C#N)C)C)(C)C)C(=O)OC,Bardoxolone methyl,-7.765179,x0072,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])SCP(=O)([O-])[O-],S-Methyl Phosphocysteine,-7.764889,x0397,active-noncovalent
c1ccc(cc1)C[C@H](C(=O)[O-])NC(=O)NO,D-[(N-Hydroxyamino)Carbonyl]Phenylalanine,-7.764501,x1385,active-covalent
CC(C)(C)c1cc(n(n1)c2ccccc2)NC(=O)Nc3ccc(cc3)Cl,"N-[(3Z)-5-Tert-butyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-ylidene]-N'-(4-chlorophen",-7.763075,x1093,active-noncovalent
B(c1cccc(c1)N(=O)=O)(O)O,3-Nitrophenylboronic Acid,-7.762524,x0195,active-noncovalent
CCNC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(CCCC1(C)C)C,N-Ethyl Retinamide,-7.762279,x0104,active-noncovalent
CCOC(=O)C(=O)N1CCCCC1,Ethyl Oxo(Piperidin-1-Yl)Acetate,-7.761250,x0195,active-noncovalent
Cc1cc2c(cc1S(=O)(=O)N3CC[NH+](CC3)C)S(=O)(=O)N[C@H](C2)C4CCCC4,"(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-",-7.759610,x0161,active-noncovalent
C[C@H]1CCCC[C@@]1(c2cccs2)[NH+]3CCCCC3,Gacyclidine,-7.759554,x0830,active-covalent
c1c(nc2c(=O)[nH]c(nc2n1)N)CO,6-Hydroxymethylpterin,-7.759462,x0397,active-noncovalent
c1ccc2c(c1)C(=O)N(C2=O)[C@H]3CCC(=O)NC3=O,Thalidomide,-7.758467,x0195,active-noncovalent
C=C(C(=O)[O-])OP(=O)([O-])[O-],Phosphoenolpyruvate,-7.757468,x0397,active-noncovalent
C1COCc2c1c(c(s2)NC(=O)C(=O)[O-])C(=O)[O-],"2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",-7.757082,x1478,active-covalent
Cc1cc(cc(c1Oc2c(c(nc(n2)Nc3ccc(cc3)C#N)N)Br)C)C#N,Etravirine,-7.754365,x0434,active-noncovalent
c1[nH]c2c(=S)[nH]c(nc2n1)N,Tioguanine,-7.753992,x0540,active-noncovalent
c1cc(cc(c1)Br)[C@H]2N(C(=O)CS2)c3cc(ccc3O)Cl,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",-7.748663,x0195,active-noncovalent
C[C@@H]([C@@H](C(=O)[O-])[NH3+])C(=O)[O-],threo-3-methyl-L-aspartic acid,-7.748417,x0426,active-noncovalent
C[N@@]1c2c(oc(=O)n(c2=O)c3ccccn3)-c4ccccc4S1(=O)=O,Droxicam,-7.748305,x0195,active-noncovalent
CCCCCCCNC=O,N-Heptylformamide,-7.748182,x0749,active-covalent
c1nc2c(nc(nc2n1[C@H]3CC[C@H](O3)CO)Cl)N,2-Chlorodideoxyadenosine,-7.747760,x1334,active-covalent
Cc1c(sc(n1)C)c2ccnc(n2)N,"4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine",-7.746389,x0749,active-covalent
C1=CC(=O)N(C1=O)COCN2C(=O)C=CC2=O,"1-[Pyrrol-1-Yl-2,5-Dione-Methoxymethyl]-Pyrrole-2,5-Dione",-7.743571,x0749,active-covalent
Cc1ccc(cc1)OCC[P@@H](=O)[O-],2-(4-METHYLPHENOXY)ETHYLPHOSPHINATE,-7.742419,x0678,active-noncovalent
C1CC[NH+](CC1)C2CC[NH2+]CC2,4-Piperidino-Piperidine,-7.741867,x0195,active-noncovalent
C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)[C@H](C=O)O)C[C@@H](C5=CC(=O)C=C[C@@]53C)F)Cl)Cl,Fluclorolone acetonide,-7.741850,x0874,active-noncovalent
Cc1c(scn1)CCCl,Clomethiazole,-7.740016,x0195,active-noncovalent
c1cc(c2c3c1C[C@@H]4[C@]5([C@]3(CC[N@@H+]4CC6CC6)[C@@H](O2)C(=O)CC5)O)O,Naltrexone,-7.736509,x1077,active-noncovalent
CC(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@]4([C@H]3CCC5=CC(=O)C=C[C@@]54C)F)O)C)OC6(O2)CCCC6,Amcinonide,-7.735654,x0161,active-noncovalent
c1cc(ccc1[C@@H]([C@@H](C(=O)[O-])O)O)F,"(2S,3S)-3-(4-fluorophenyl)-2,3-dihydroxypropanoic acid",-7.731906,x0678,active-noncovalent
C1[C@@H](Nc2c(=O)[nH]c(nc2N1)N)C=O,"6-Hydroxymethyl-7,8-Dihydropterin",-7.731676,x0195,active-noncovalent
Cc1cc(=O)oc2c1ccc(c2)N,7-AMINO-4-METHYL-CHROMEN-2-ONE,-7.731665,x0195,active-noncovalent
C[C@@H](C=C(c1cccs1)c2cccs2)[NH+](C)C,Dimethylthiambutene,-7.731600,x0305,active-noncovalent
Cc1cc(nc(n1)n2c(cc(n2)C)OC)OC,Epirizole,-7.729853,x0434,active-noncovalent
Cc1cccc(c1OCC(=O)[O-])C,"(2,6-Dimethylphenoxy)acetic acid",-7.729612,x0678,active-noncovalent
c1ccc(cc1)CCNN,Phenelzine,-7.728145,x0195,active-noncovalent
Cc1cc(cc(c1Oc2ccc(c(c2)C(C)C)O)C)n3c(=O)[nH]c(=O)cn3,"2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5",-7.724475,x0678,active-noncovalent
c1cc(ccc1/C=C(\C(=O)[O-])/F)O,(E)-2-Fluoro-P-Hydroxycinnamate,-7.722515,x1385,active-covalent
c1ccc(cc1)CC[NH3+],Phenethylamine,-7.722284,x0195,active-noncovalent
c1nc(nc(=O)n1[C@H]2C[C@@H]([C@H](O2)CO)O)N,Decitabine,-7.721965,x0967,active-noncovalent
CCC(=O)N(c1ccccc1)C2CC[NH+](CC2)[C@@H](C)Cc3ccccc3,-Methylfentanyl,-7.721523,x1077,active-noncovalent
C1CC[N@@H+]2C[C@@H]3C[C@H]([C@H]2C1)C[N@@H+]4[C@H]3CCCC4,Sparteine,-7.721165,x0678,active-noncovalent
COc1ccc2c(c1)[nH]cn2,5-Methoxybenzimidazole,-7.721054,x0678,active-noncovalent
c1c[nH]c2c1cc(c(c2)NC(=O)C(=O)[O-])C(=O)[O-],6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid,-7.720443,x0749,active-covalent
C/C=C(\C)/C=C/C1=C(CCCC1(C)C)C,"1,3,3-trimethyl-2-[(1E,3E)-3-methylpenta-1,3-dien-1-yl]cyclohexene",-7.718019,x0195,active-noncovalent
C1CCC(CC1)(CC(=O)[O-])C[NH3+],Gabapentin,-7.716552,x0678,active-noncovalent
c1cc2c(cc1Cl)NC(=O)Nc3cncc(n3)OCCCCCO2,"18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZAC",-7.713855,x1385,active-covalent
Cc1c(c2c(n1C)C(=O)C=C(C2=O)OC)COc3ccc(cc3)N(=O)=O,"5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione",-7.707971,x0195,active-noncovalent
Cn1c2ccccc2c(c(c1=O)C(=O)N(C)c3ccccc3)[O-],Roquinimex,-7.707769,x1392,active-covalent
CC1=NS(=O)(=O)c2cc(ccc2N1)Cl,Diazoxide,-7.707629,x0678,active-noncovalent
CC(=O)O[C@H](c1ccc(cc1C(=O)[O-])N)C(=O)OC,METHYL(2-ACETOXY-2-(2-CARBOXY-4-AMINO-PHENYL))ACETATE,-7.705448,x1478,active-covalent
CCOC(=O)c1c2n(cn1)-c3ccc(cc3C(=O)N(C2)C)F,Flumazenil,-7.704267,x0678,active-noncovalent
Cc1c(n(c(n1)[C@H](C)[NH3+])CC(=O)[O-])O,4-Methylidene-5-One,-7.704143,x0107,active-noncovalent
C[NH2+][C@@]1(CCCCC1=O)c2ccccc2Cl,Esketamine,-7.702714,x0072,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C,Finasteride,-7.701688,x1077,active-noncovalent
[C@H]1([C@H](C(=C(O[C@H]1O)C(=O)[O-])O)O)O,"4,5-Dehydro-L-Iduronic Acid",-7.697611,x0397,active-noncovalent
c1cc(ccc1C[C@H](C(=O)[O-])[NH3+])O,D-Tyrosine,-7.696136,x1077,active-noncovalent
CCS(=O)(=O)c1ccc2c(c1)nc(o2)c3ccc4ccccc4c3,Ezutromid,-7.695350,x0104,active-noncovalent
C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)[NH2+]C)O)[NH2+]C)O)O,Spectinomycin,-7.693339,x0195,active-noncovalent
C[C@@H](Cc1ccc(cc1)O)[NH3+],Hydroxyamphetamine,-7.693278,x0161,active-noncovalent
CCCc1c2c(cc3c1oc(cc3=O)C(=O)[O-])c(=O)cc(n2CC)C(=O)[O-],Nedocromil,-7.689206,x0749,active-covalent
B(CCc1ccccc1)(O)O,Phenylethane Boronic Acid,-7.689205,x0749,active-covalent
CCC(=O)N(c1ccccc1)C2CC[NH+](CC2)C[C@@H](c3ccccc3)O,Beta-hydroxyfentanyl,-7.689091,x0874,active-noncovalent
C/C=C/1\[C@@H]2Cc3c(ccc(=O)[nH]3)[C@]1(CC(=C2)C)[NH3+],Huperzine A,-7.687847,x0072,active-noncovalent
Cc1cnc(cn1=O)C(=O)[O-],Acipimox,-7.687257,x0397,active-noncovalent
C(/C(=C(\C(=O)[O-])/O)/C(=O)[O-])C(=O)[O-],(S)-oxalosuccinic acid,-7.687056,x0397,active-noncovalent
c1cc2c[nH]nc2c(c1)N(=O)=O,7-Nitroindazole,-7.685583,x0195,active-noncovalent
C1Cc2c(n[nH]c2c3[n-]nnn3)C1,MK-0354,-7.681265,x0397,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])OS(=O)(=O)[O-],O-Sulfo-L-Serine,-7.681209,x0397,active-noncovalent
c1ccc(cc1)C[C@H](CS)C(=O)[O-],2-Thiomethyl-3-Phenylpropanoic Acid,-7.679974,x0678,active-noncovalent
Cc1ccc(c(c1)N[C@@H](c2c(cccc2Cl)Cl)C(=O)N)C(=O)C,"ALPHA-(2,6-DICHLOROPHENYL)-ALPHA-(2-ACETYL-5-METHYLANILINO)ACETAMIDE",-7.679875,x0104,active-noncovalent
c1cc2c(cc1Cl)[nH]c(=O)o2,Chlorzoxazone,-7.677007,x0678,active-noncovalent
C[C@H](CCC(=O)[O-])[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,Deoxycholic acid,-7.676250,x0830,active-covalent
C([C@@H](C(=O)[O-])[NH3+])SCC(=O)[O-],Carbocisteine,-7.675538,x0397,active-noncovalent
c1ccc2c(c1)C(=O)C(=O)N2,Isatin,-7.675142,x0195,active-noncovalent
c1ccc(cc1)C2(C(=O)NC(=O)NC2=O)[NH+]3CCC(CC3)CCO,"5-[4-(2-Hydroxyethyl)-1-piperidinyl]-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione",-7.675106,x0387,active-noncovalent
c1ccc2c(c1)[C@@H](S[C@H](O2)[NH3+])O,"2-Amino-4h-1,3-Benzoxathiin-4-Ol",-7.672568,x0195,active-noncovalent
c1ccc(c(c1)C(=O)[O-])N(c2cccc3c2cc(cc3)O)C(=O)C(=O)[O-],2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID,-7.672386,x0708,active-covalent
COc1cccc(c1c2cc3cnc(nc3nc2N)N)OC,"6-(2,6-DIMETHOXYPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,7-DIAMINE",-7.670734,x0830,active-covalent
Cc1ncc(c(n1)N)C[NH3+],5-(Aminomethyl)-2-Methylpyrimidin-4-Amine,-7.669811,x0397,active-noncovalent
c1c(c(=O)[nH]c(=O)n1[C@H]2C[C@@H]([C@H](O2)CO)O)F,Floxuridine,-7.669107,x0195,active-noncovalent
C1CCC(CC1)(C#N)N2CCCCC2,1-Piperidinocyclohexanecarbonitrile,-7.668975,x0749,active-covalent
[H]/N=c/1\nn/c(=N\[H])/c1=NNc2c(cccc2)C(F)(F)F,5-Imino-4-(2-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine,-7.668834,x0678,active-noncovalent
CC(C)c1ccc(cc1)N,Para-Isopropylaniline,-7.667021,x0678,active-noncovalent
CC1=CC[C@@H](CC1)[NH+](C)C,"(4r)-7aza-7,8-Dihydrolimonene",-7.666269,x0678,active-noncovalent
C[NH+](C)CC[C@H](c1ccc(cc1)Br)c2ccccn2,Brompheniramine,-7.664710,x0749,active-covalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/CO)/C)/C,Vitamin A,-7.664129,x0104,active-noncovalent
c1ccc(cc1)CCCC(=O)[O-],Phenylbutyric acid,-7.664060,x0678,active-noncovalent
C1C[NH2+]Cc2c1c(=O)[nH]o2,Gaboxadol,-7.662099,x0678,active-noncovalent
C[C@@H]([C@@H]([C@H]1CN=c2c(=N1)c(=O)[nH]c(n2)N)O)O,"Quinonoid 7,8-Tetrahydrobiopterin",-7.660017,x0397,active-noncovalent
COc1cc(ccc1O)C(=O)OC,Methyl vanillate,-7.659404,x0161,active-noncovalent
c1ccc(cc1)C[C@@H](C(=O)[O-])O,Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,-7.659377,x0830,active-covalent
CC1(Cc2c(c(ncn2)N)C(=O)C1)C,"4-amino-7,7-dimethyl-7,8-dihydroquinazolin-5(6H)-one",-7.656579,x0195,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)[NH3+])C(=O)[O-])C,Ampicillin,-7.656118,x1093,active-noncovalent
CC[NH+](CC)[C@@H](C)C=C(c1cccs1)c2cccs2,Diethylthiambutene,-7.654969,x0305,active-noncovalent
C[N+](C)(C)CCCCCC[N+](C)(C)C,Hexamethonium,-7.654933,x0749,active-covalent
c1ccc(cc1)[C@@H]2C[C@H]2[NH3+],"(1R,2S)-2-Phenylcyclopropanaminium",-7.653600,x0195,active-noncovalent
c1ccc(cc1)/C=C/CN2CC[NH+](CC2)C(c3ccccc3)c4ccccc4,Cinnarizine,-7.647291,x0946,active-noncovalent
c1cc(c(c2c1nsn2)NC3=[NH+]CCN3)Cl,Tizanidine,-7.645987,x0195,active-noncovalent
c1ccn2c(c1)[nH+]cc2CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],Minodronic acid,-7.645850,x0831,active-covalent
c1cc2c(cccc2S(=O)(=O)[O-])c(c1)N,5-aminonaphthalene-1-sulfonic acid,-7.642004,x0195,active-noncovalent
CCc1ccc(cc1)NS(=O)(=O)[O-],(4-ETHYLPHENYL)SULFAMIC ACID,-7.640641,x0678,active-noncovalent
CC[C@H](C(=O)[O-])[NH3+],Alpha-Aminobutyric Acid,-7.640092,x0397,active-noncovalent
Cn1c(cc(n1)c2ccccc2)NS(=O)(=O)[O-],1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID,-7.640003,x0161,active-noncovalent
C[C@H]1[C@H](OC(=O)N1Cc2cc(ccc2c3cc(c(cc3OC)F)C(C)C)C(F)(F)F)c4cc(cc(c4)C(F)(F)F)C(F)(F)F,Anacetrapib,-7.639530,x0104,active-noncovalent
C[C@H](CC1CCCC1)[NH2+]C,Cyclopentamine,-7.639247,x0678,active-noncovalent
c1cc(cc(c1)O)C2=CC(=O)NS2(=O)=O,"5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE",-7.633510,x0195,active-noncovalent
Cc1ccc(cc1)C(=O)N(CCC[NH3+])[C@H](c2nc3c(c(ns3)C)c(=O)n2Cc4ccccc4)C(C)C,AZD-4877,-7.633217,x0434,active-noncovalent
C([C@H](C(=O)[O-])[NH3+])Cl,3-Chloroalaninate,-7.632918,x0397,active-noncovalent
CC[C@@H](c1cccc(c1)O)[C@@H](C)C[NH+](C)C,Tapentadol,-7.632641,x0946,active-noncovalent
C(CC(=O)[O-])[C@@H](C(=O)[O-])[NH3+],Glutamic acid,-7.631398,x0397,active-noncovalent
c1ccc(c(c1)C(=O)[O-])NC(=O)C(=O)[O-],2-(Oxalyl-Amino)-Benzoic Acid,-7.630916,x0195,active-noncovalent
Cc1cc(cc(c1OCCCc2cc(no2)C)C)c3nc(on3)C(F)(F)F,Pleconaril,-7.628827,x0104,active-noncovalent
Cc1[nH]c(=O)c2cccc(c2n1)O,NU1025,-7.628617,x0195,active-noncovalent
CC(C)C[C@@H](C1(CCC1)c2ccc(cc2)Cl)[NH+](C)C,Sibutramine,-7.627319,x0195,active-noncovalent
C[C@]1(OC[C@@H]2[C@H](O1)[C@@H]([C@H]([C@@H](O2)OC)O)O)C(=O)[O-],"Methyl 4,6-O-[(1R)-1-carboxyethylidene]-beta-D-galactopyranoside",-7.627043,x0397,active-noncovalent
C[N@+]1(CC[C@]23c4c5ccc(c4O[C@H]2C(=O)CC[C@]3([C@H]1C5)O)O)CC=C,N-Methylnaloxonium,-7.626315,x1385,active-covalent
Cc1c(c(c(cn1)COP(=O)([O-])[O-])C[NH2+][C@H]([C@H](C)O)C(=O)[O-])O,N-Pyridoxyl-Threonine-5-Monophosphate,-7.626047,x0749,active-covalent
CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)C(=O)[O-],Betulinic Acid,-7.624409,x0874,active-noncovalent
c1cc(ccc1C(=[NH2+])N)OCCCCCOc2ccc(cc2)C(=[NH2+])N,Pentamidine,-7.623391,x0967,active-noncovalent
c1ccc(cc1)c2ccc(cc2)c3cc(cc(c3)C(=O)[O-])C(=O)N,"5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid",-7.622393,x0072,active-noncovalent
CC(C)(C)c1cc(ccc1O)O,"2-tert-butylbenzene-1,4-diol",-7.620463,x0195,active-noncovalent
c1cc(ccc1O)O,Hydroquinone,-7.618016,x0678,active-noncovalent
CC[N+](CC)(CC)CC[C@@](c1ccccc1)(C2CCCCC2)O,Tridihexethyl,-7.616778,x0072,active-noncovalent
C[C@H](CCC=C(C)C)[NH2+]C,Isometheptene,-7.615142,x0195,active-noncovalent
C[NH+](C)C[C@@H](c1ccc(cc1)O)C2(CCCCC2)O,Desvenlafaxine,-7.611884,x0749,active-covalent
CC[C@@H](Cc1c(cc(c(c1I)N)I)I)C(=O)[O-],Iopanoic acid,-7.611565,x0749,active-covalent
C[C@H](c1ccc(cc1)Cl)c2cc(cc(c2[O-])N(=O)=O)N(=O)=O,"2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL",-7.608840,x0072,active-noncovalent
C[P@](=O)(CC[C@H](C(=O)[O-])[NH3+])[O-],2-Amino-4-(Hydroxymethyl-Phosphinyl)Butanoic Acid,-7.608689,x0397,active-noncovalent
c1cc(c(cc1[C@H](C[NH3+])O)O)O,Norepinephrine,-7.607880,x0104,active-noncovalent
CC[C@H]1C(=O)NC2(S1)CC[NH+](CC2)C,NGX267,-7.607117,x0104,active-noncovalent
c1ccc(c(c1)C(=O)O)[O-],Magnesium salicylate,-7.606682,x0678,active-noncovalent
c1ccc(c(c1)C(=O)O)[O-],Choline magnesium trisalicylate,-7.606682,x0678,active-noncovalent
COc1cc(ccc1O)CC=C,Eugenol,-7.606231,x0161,active-noncovalent
c1c(cc(c(c1C(=O)[O-])O)I)I,"2-HYDROXY-3,5-DIIODOBENZOIC ACID",-7.606040,x1386,active-covalent
CC(C)(C)c1c(c(=O)[nH]s1)C[C@@H](C(=O)[O-])[NH3+],THIO-ATPA,-7.605993,x1077,active-noncovalent
C=C1CC[C@]2([C@H]3Cc4ccc(c5c4[C@]2([C@H]1O5)CC[N@@H+]3CC6CC6)O)O,Nalmefene,-7.604344,x0434,active-noncovalent
COc1ccc(cc1O)/C=C/C(=O)[O-],(2E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid,-7.604026,x0749,active-covalent
c1ccc(cc1)CC(=O)[O-],Phenylacetic acid,-7.601032,x0678,active-noncovalent
C[C@@H](Cc1ccc(cc1)OC)[NH3+],4-Methoxyamphetamine,-7.598653,x0195,active-noncovalent
c1cc(c(cc1Br)NC(=O)Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F)c3n[n-]nn3,NS-3728,-7.594941,x0967,active-noncovalent
c1[nH]c2c(n1)c(=O)[nH]c(n2)N,Guanine,-7.594061,x0678,active-noncovalent
C[C@@H](C12CC3CC(C1)CC(C3)C2)[NH3+],Rimantadine,-7.592239,x0195,active-noncovalent
C(C(=O)[O-])C(=O)[O-],Strontium malonate,-7.591541,x0397,active-noncovalent
C(C(=O)[O-])C(=O)[O-],Malonate Ion,-7.591541,x0397,active-noncovalent
C(C(=O)[O-])C(=O)[O-],Malonic acid,-7.591541,x0397,active-noncovalent
c1ccc(cc1)c2c(nc3c(n2)c(nc(n3)N)N)N,Triamterene,-7.588733,x1385,active-covalent
CC(=O)Oc1ccccc1C(=O)[O-],Acetylsalicylic acid,-7.586169,x0678,active-noncovalent
Cc1c(c(nc(n1)N)N)C#CC(C)(C)c2cc(c(c(c2)OC)OC)OC,"6-methyl-5-[3-methyl-3-(3,4,5-trimethoxyphenyl)but-1-yn-1-yl]pyrimidine-2,4-diam",-7.585330,x0195,active-noncovalent
B(c1ccc(cc1)C(=O)[O-])(O)O,4-Carboxyphenylboronic Acid,-7.583461,x0195,active-noncovalent
c1cc(sc1)C[C@@H](C(=O)[O-])[NH3+],Beta(2-Thienyl)Alanine,-7.580446,x0195,active-noncovalent
C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@H]3[C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)C)F,Paramethasone,-7.579543,x1077,active-noncovalent
C[C@@H](Cc1ccccc1)[NH+]2CCC(CC2)N(c3ccccc3)C(=O)C,-Methylacetylfentanyl,-7.579217,x0072,active-noncovalent
CC(=O)N[C@@H](Cc1ccccc1)C(=O)C(F)(F)F,"1,1,1-TRIFLUORO-3-ACETAMIDO-4-PHENYL BUTAN-2-ONE(N-ACETYL-L-PHENYLALANYL TRIFLUO",-7.575854,x0195,active-noncovalent
C[NH+](C)CCCC[C@@H](C(=O)[O-])[NH3+],N-Dimethyl-Lysine,-7.575563,x1418,active-covalent
CCc1ccc(c(c1C)C(=O)[O-])NS(=O)(=O)c2ccc(cc2)F,3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID,-7.574533,x1392,active-covalent
CC[N+](C)(C)Cc1ccccc1Br,Bretylium,-7.573410,x0195,active-noncovalent
c1cc2c(cc1S(=O)(=O)N3CCSCC3)C[NH2+][C@H](C2)CF,"(3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN-4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOL",-7.571821,x0946,active-noncovalent
c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)NC=N2,Chlorothiazide,-7.570635,x0195,active-noncovalent
Cc1ccc(c(c1)O)C(C)C,Thymol,-7.570327,x0749,active-covalent
c1cc(ccc1CO)C(=[NH2+])N,4-(Hydroxymethyl)Benzamidine,-7.570267,x1077,active-noncovalent
c1cc(ccc1/N=N/C2=c3cc(ccc3=NC2=O)Br)S(=O)(=O)N,4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide,-7.568878,x0161,active-noncovalent
c1cc2c(c(c1)N)C(=O)N(C2=O)[C@H]3CCC(=O)NC3=O,Pomalidomide,-7.565386,x0195,active-noncovalent
c1cc2c(cc1F)[C@@]3(CCO2)C(=O)NC(=O)N3,Sorbinil,-7.561558,x0678,active-noncovalent
Cc1[nH]c(=O)c2c(n1)CCSC2,"2-methyl-3,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one",-7.560843,x0195,active-noncovalent
Cn1cnc(c1Sc2c3c(nc[nH]3)ncn2)N(=O)=O,Azathioprine,-7.558165,x1077,active-noncovalent
C=C[C@H](C(=O)[O-])[NH3+],"2-Ammoniobut-3-Enoate, 2-Amino-3-Butenoate",-7.556477,x0397,active-noncovalent
c1[nH]c2c(n1)c(nc(n2)Br)Cl,2-Bromo-6-chloro-purine,-7.555106,x0397,active-noncovalent
CC(C)[C@@]12[C@@H](O1)[C@H]3[C@@]4(O3)[C@]5(CCC6=C([C@@H]5C[C@H]7[C@]4([C@@H]2O)O7)COC6=O)C,Triptolide,-7.553959,x0749,active-covalent
c1cc2c(c(c1)OP(=O)([O-])[O-])NCCC2,RU79073,-7.551728,x0830,active-covalent
CC(=O)CC[C@@H](C(=O)[O-])[NH3+],5-Oxo-L-Norleucine,-7.550528,x0107,active-noncovalent
C=C1[C@H](C[C@@H]([C@H]1CO)O)n2cnc3c2nc([nH]c3=O)N,Entecavir,-7.550159,x0874,active-noncovalent
C=CS(=O)(=O)Oc1ccccc1,phenyl ethenesulfonate,-7.548808,x0195,active-noncovalent
c1cc(ccc1[C@H](C(=O)[O-])[NH3+])O,D-4-hydroxyphenylglycine,-7.548680,x0830,active-covalent
c1cc(ccc1[C@H](C(=O)[O-])[NH3+])O,4-Hydroxyphenylglycine,-7.548680,x0830,active-covalent
Cn1c2ccc(cc2c(=O)s1)S(=O)(=O)N,"1-Methyl-3-Oxo-1,3-Dihydro-Benzo[C]Isothiazole-5-Sulfonic Acid Amide",-7.546547,x0195,active-noncovalent
C[C@@H]([C@H](C(=O)[O-])[NH3+])C(=O)[O-],(3S)-3-methyl-D-aspartic acid,-7.543386,x0397,active-noncovalent
COC(=O)c1ccccc1O,Methyl salicylate,-7.543220,x0195,active-noncovalent
c1c(n(=O)c(nc1N2CCCCC2)N)N,Minoxidil,-7.543031,x0195,active-noncovalent
c1cc(cc(c1)n2nc3c(=O)[nH]c(nc3n2)N)C(=O)NCc4cc(cc(c4)Cl)Cl,"3-(5-amino-7-hydroxy-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(3,5-dichlorobenzyl",-7.540393,x0749,active-covalent
COC(=O)[C@@H]1CS[C@]2(N1C(=O)c3c2cccc3)c4ccccc4,"(R)-(+) 5(9BH)-OXO-9B-PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-3-CARBOXYLIC ACI",-7.539513,x0831,active-covalent
C[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2[C@H](C=C[C@H]3[C@H]1C5)O)OC,Codeine,-7.539073,x1077,active-noncovalent
c1cc(cc(c1)O)C(=O)NCC(=O)[O-],3-Hydroxyhippuric acid,-7.538335,x0749,active-covalent
CC(=O)Oc1cc(ccc1C(=O)[O-])C(F)(F)F,Triflusal,-7.536491,x0161,active-noncovalent
c1ccc2c(c1)cccc2[C@@H](O)P(=O)([O-])[O-],DPI59,-7.536218,x0678,active-noncovalent
c1(c(=O)[nH]on1)C(=O)[O-],"4-Hydroxy-1,2,5-oxadiazole-3-carboxylic acid",-7.535817,x0397,active-noncovalent
c1ccc(c(c1)C(=O)[O-])O[P@@H](=O)[O-],2-[(Dioxidophosphoranyl)oxy]benzoate,-7.533795,x0678,active-noncovalent
Cc1cn(c(=O)[nH]c1=O)[C@@H]2[C@@H]([C@H]([C@@H](O2)CO)O)F,Clevudine,-7.533670,x1077,active-noncovalent
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)F)C,Clobetasol,-7.533046,x0072,active-noncovalent
Cc1cc(cc(c1Cl)C)O,Chloroxylenol,-7.532886,x0195,active-noncovalent
c1cc2c(cc1N(=O)=O)cn[nH]2,5-Nitroindazole,-7.531814,x1077,active-noncovalent
c1cc2ccc(nc2c(c1)OP(=O)([O-])[O-])C#N,RU79072,-7.531803,x0195,active-noncovalent
C=C[C@@H](CCC(=O)[O-])[NH3+],Vigabatrin,-7.525628,x0107,active-noncovalent
C[C@@H]([C@@H](c1ccccc1)O)[NH3+],Phenylpropanolamine,-7.524961,x0195,active-noncovalent
C([C@@H]([C@@H](C(=O)[O-])O)C(=O)[O-])C(=O)[O-],Isocitric Acid,-7.524197,x0397,active-noncovalent
C/C/1=C\CC[C@@]2([C@@H](O2)[C@@H]3[C@@H](CC1)C(=C)C(=O)O3)C,Parthenolide,-7.524172,x1077,active-noncovalent
CC[N+](C)(CC)CCC[n+]1c2cc(ccc2c3ccc(cc3c1c4ccccc4)N)N,Propidium,-7.523794,x0195,active-noncovalent
Cc1nc(c(c(n1)Cl)[NH+]=C2NCCN2)OC,Moxonidine,-7.523081,x0195,active-noncovalent
c1cc2c(c(c1)N(=O)=O)[nH]nc2Br,3-Bromo-7-Nitroindazole,-7.522428,x0195,active-noncovalent
C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@H]6[C@@]5(CC[C@@H](C6)O)C)C)C)OC1,Smilagenin,-7.519355,x1077,active-noncovalent
C(CC(=O)[O-])C(=O)C(=O)[O-],Oxogluric acid,-7.517095,x0397,active-noncovalent
c1ccc(cc1)C[C@H](CN(=O)=O)C(=O)[O-],(2R)-2-benzyl-3-nitropropanoic acid,-7.516711,x1093,active-noncovalent
C#CCO[C@H]1C[NH+]2CCC1CC2,Talsaclidine,-7.511095,x0195,active-noncovalent
c1cc(cc(c1)Cl)[C@@H]2/C(=N\c3ccc(c(c3)C(=O)[O-])Cl)/C(=O)NC2=O,SB-409513,-7.510377,x1458,active-covalent
C[C@@H](C[C@](C#N)(c1ccccc1)C(C)C)[NH+](C)C,Isoaminile,-7.508497,x0195,active-noncovalent
C(CCO)C[C@H](C(=O)[O-])[NH3+],6-hydroxy-D-norleucine,-7.508027,x0397,active-noncovalent
C[C@H](/C=C/C=C(/C)\[C@H]1C[NH2+][C@@H]([C@H]1CC(=O)[O-])C(=O)[O-])C(=O)[O-],Domoic Acid,-7.507018,x0831,active-covalent
c1cc(ccc1[C@@H](C(=O)[O-])O)O,(2S)-hydroxy(4-hydroxyphenyl)ethanoic acid,-7.505554,x1334,active-covalent
CC(C)C[C@H](C(=O)NO)[N@@](Cc1ccccc1)[P@](=O)(C)c2ccccc2,N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHIN,-7.505178,x0678,active-noncovalent
Cc1cc(c2ccccc2c1OP(=O)([O-])[O-])OP(=O)([O-])[O-],Kappadione,-7.504925,x0195,active-noncovalent
CN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C,Neostigmine,-7.501215,x0195,active-noncovalent
c1ccc(cc1)CC(=O)C(=O)[O-],Phenylpyruvic acid,-7.499963,x0195,active-noncovalent
c1cc(ccc1C(=O)NCC(=O)[O-])N,Aminohippuric acid,-7.499182,x1077,active-noncovalent
Cc1cn(c(=O)[nH]c1=O)[C@@H]2C[C@H]3[C@@H](O2)CO[C@](O3)(c4ccccc4)P(=O)([O-])[O-],Dpb-T,-7.498197,x1077,active-noncovalent
C[C@@H](CN1CC(=O)NC(=O)C1)[NH+]2CC(=O)NC(=O)C2,Dexrazoxane,-7.498163,x0678,active-noncovalent
c1c[nH]c2c1nc([nH]c2=O)N,9-Deazaguanine,-7.497011,x0678,active-noncovalent
C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC)C,Artemether,-7.496870,x0195,active-noncovalent
c1c2c(cc(c1N(=O)=O)N(=O)=O)[nH]c(=O)c(=O)[nH]2,FG-9041,-7.496219,x0749,active-covalent
C1C2CC3CC1CC(C2)C3,Adamantane,-7.495760,x0354,active-noncovalent
c1ccc(cc1)CNC=O,N-Benzylformamide,-7.494650,x0678,active-noncovalent
c1c(c(nc(=O)n1[C@@H]2C=C[C@@H](O2)CO)N)F,Elvucitabine,-7.489977,x0195,active-noncovalent
c1cc(ccc1C(=[NH2+])N)O[C@@H]2CO[C@H]3[C@@H]2OC[C@@H]3Oc4ccc(cc4)C(=[NH2+])N,"2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL",-7.488112,x0395,active-noncovalent
C[C@H](Cc1ccccc1O)C(=O)[O-],Trans-O-Hydroxy-Alpha-Methyl Cinnamate,-7.485261,x0678,active-noncovalent
C1=C(O[C@H]([C@@H]([C@H]1O)O)O)C(=O)[O-],"4,5-Dehydro-D-Glucuronic Acid",-7.484820,x0397,active-noncovalent
c1c2c(c(c(c1F)N3C[C@H]4[C@H](C3)OCC[NH2+]4)C#N)n(cc(c2=O)C(=O)[O-])C5CC5,Finafloxacin,-7.483934,x0104,active-noncovalent
c1c(cc(c(c1Cl)[O-])Cl)c2cc(c(c(c2)Cl)[O-])Cl,"3,5,3',5'-Tetrachloro-Biphenyl-4,4'-Diol",-7.483101,x0161,active-noncovalent
c1cc(c(cc1C=O)O)O,Protocatechualdehyde,-7.482390,x0195,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@H](CO3)OP(=O)([O-])[O-])O)N,5-(6-Amino-9h-Purin-9-Yl)-4-Hydroxytetrahydrofuran-3-Yl Dihydrogen Phosphate,-7.481488,x1077,active-noncovalent
c1cc2c(cc1)C(=O)C(=C(C2=O)[C@H]3CC[C@@H](CC3)c4ccc(cc4)Cl)[O-],Atovaquone,-7.480928,x0678,active-noncovalent
CC(=O)Nc1ccc(cc1N[C@@H]([NH3+])N)C(=O)[O-],4-(Acetylamino)-3-Guanidinobenzoic Acid,-7.479623,x0195,active-noncovalent
C[S@@](=O)CC[C@@H](C(=O)[O-])[NH3+],L-methionine (S)-S-oxide,-7.478869,x0397,active-noncovalent
C[S@@](=O)CC[C@@H](C(=O)[O-])[NH3+],L-methionine (R)-S-oxide,-7.478869,x0397,active-noncovalent
CCc1c([nH]n(c1=O)c2n[n-]nn2)C,"4-ethyl-5-methyl-2-(1H-tetrazol-5-yl)-1,2-dihydro-3H-pyrazol-3-one",-7.474237,x0678,active-noncovalent
[H]/N=C(\Cc1ccccc1)/C(=O)[O-],Phenyldehydroalanine,-7.474085,x1374,active-covalent
c1cc(ccc1/C=C/C(=O)[O-])C(=O)[O-],4-Carboxycinnamic Acid,-7.472637,x0749,active-covalent
CC(C)(C)c1cc(n(n1)C)NC(=O)Nc2ccc(cc2)Cl,1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea,-7.472637,x0104,active-noncovalent
c1nc2c(=O)[nH]c(nc2n1[C@H]3[C@@H]([C@H]4[C@H](O3)CO[P@](=O)(O4)[O-])O)N,Cyclic GMP,-7.472118,x0678,active-noncovalent
C[C@H](Cn1cnc2c1ncnc2N)O,R-9-(2-hydroxypropyl)adenine,-7.471846,x0540,active-noncovalent
CN(C)c1ccc(cc1)C(=C2C=CC(=[N+](C)C)C=C2)c3ccc(cc3)N(C)C,Gentian violet cation,-7.469940,x0161,active-noncovalent
CC(C)c1cccc(c1O)C(C)C,Propofol,-7.469593,x1418,active-covalent
C[n+]1ccccc1CN=O,Pralidoxime,-7.469566,x0678,active-noncovalent
CC(C(=O)[O-])C(=O)[O-],Methylmalonic Acid,-7.467208,x0397,active-noncovalent
C1[C@H]2[C@@H]([C@@H](S1)CCCCC=O)NC(=O)N2,"5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL",-7.466056,x0749,active-covalent
Cc1cc(cc(c1)S(=O)(=O)c2cccc(c2C#N)N)C,"2-AMINO-6-(3,5-DIMETHYLPHENYL)SULFONYLBENZONITRILE",-7.465624,x0072,active-noncovalent
CC(C)C1=NCCc2c1cc(cc2)NC(=O)c3ccc4cc(ccc4c3)C(=[NH2+])N,"6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidi",-7.465271,x0874,active-noncovalent
c1ccc(cc1)[C@@H](CCCl)O,(1R)-3-chloro-1-phenylpropan-1-ol,-7.465263,x0195,active-noncovalent
c1ncn(n1)C(=[NH2+])N,"1,2,4-Triazole-Carboxamidine",-7.460563,x0397,active-noncovalent
c1ccc2c(c1)cco2,Benzofuran,-7.459019,x0195,active-noncovalent
CC[C@H]1C(=O)Nc2ccc(cc2N1C(=O)OC(C)C)F,"ISOPROPYL (2S)-2-ETHYL-7-FLUORO-3-OXO-3,4-DIHYDROQUINOXALINE-1(2H)-CARBOXYLATE",-7.456979,x0195,active-noncovalent
CCc1cc(ccn1)C(=S)N,Ethionamide,-7.455378,x0195,active-noncovalent
CC[C@@H](C(C[C@H](C)[NH+](C)C)(c1ccccc1)c2ccccc2)OC(=O)C,Levacetylmethadol,-7.453006,x0195,active-noncovalent
C1CCC(C1)N(C=O)C2CCC2,N-Cyclopentyl-N-Cyclobutylformamide,-7.451046,x0195,active-noncovalent
Cc1c2c(nc(n1)N)CCSC2,"4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine",-7.450269,x0195,active-noncovalent
C1C[NH2+]CCC1CCCC=O,4-PIPERIDIN-4-YLBUTANAL,-7.449667,x0749,active-covalent
CC1(CCC(c2c1ccc(c2)NC(=O)c3ccc(cc3)C(=O)[O-])(C)C)C,Tamibarotene,-7.449089,x0104,active-noncovalent
c1cc(ccc1C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])N(Cc2ccc3c(n2)c(=O)[nH]c(n3)N)C(=O)/C=C/c4c(ncn4[C@H]5[C@@H]([C@@H]([C@H](O5)COP(=O)([O-])[O-])O)O)C(=O)N,"Beta-Dadf, Msa, Multisubstrate Adduct Inhibitor",-7.448990,x0967,active-noncovalent
CCC(=O)OC1(CC[NH+](CC1)C)c2ccccc2,Desmethylprodine,-7.445733,x0072,active-noncovalent
C/C(=C(\C#N)/C(=O)Nc1ccc(cc1)c2ccccc2)/O,(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide,-7.445292,x0749,active-covalent
C1[C@H](NC(=O)NC1=O)C(=O)[O-],Dihydroorotic Acid,-7.443055,x0397,active-noncovalent
CC[N@H+](C)[C@@H](C)C=C(c1cccs1)c2cccs2,Ethylmethylthiambutene,-7.437001,x0072,active-noncovalent
c1cc2cccnc2c(c1)[O-],Indium In-111 oxyquinoline,-7.436671,x0195,active-noncovalent
CC[C@H](C(=O)[O-])OP(=O)([O-])[O-],2-(Phosphonooxy)Butanoic Acid,-7.436153,x0397,active-noncovalent
C1[C@H]([C@@H](C(=C[C@]1(C(=O)[O-])O)F)O)O,2-Anhydro-3-Fluoro-Quinic Acid,-7.436120,x0397,active-noncovalent
C[NH+](C)C[C@@H](c1ccc(cc1)OC)C2(CCCCC2)O,Venlafaxine,-7.435339,x1392,active-covalent
c1cc(oc1/C=N/NC(=O)N)N(=O)=O,Nitrofural,-7.432948,x0678,active-noncovalent
COc1c(c(c(c(c1F)F)C(=O)N)F)F,"2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide",-7.430866,x0195,active-noncovalent
c1c(c(=O)[nH]c(=O)n1[C@H]2C[C@@H]([C@H](O2)CO)O)C(F)(F)F,Trifluridine,-7.429812,x0072,active-noncovalent
c1cc2c(cc1O)sc(n2)S(=O)(=O)N,"6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE",-7.429472,x1077,active-noncovalent
CC[N+](C)(C)c1cccc(c1)O,Edrophonium,-7.427729,x0104,active-noncovalent
C[C@H]1CC(C[C@@H]1C)(CC(=O)[O-])C[NH3+],Atagabalin,-7.427536,x1418,active-covalent
C1CCC(CC1)[NH2+]CCS(=O)(=O)[O-],N-cyclohexyltaurine,-7.424162,x0830,active-covalent
C1(C(C(C(C(C1(F)F)(F)F)(F)F)(F)F)(F)F)(C(C(F)(F)F)(C(F)(F)F)C(F)(F)F)F,Perfluoro tert-butylcyclohexane,-7.422782,x1311,active-covalent
CC(=O)Nc1ccc(cc1)O,Acetaminophen,-7.421527,x0678,active-noncovalent
C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O,Gallium citrate Ga 67,-7.419847,x0397,active-noncovalent
C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O,Citric acid,-7.419847,x0397,active-noncovalent
c1c[nH]c2c(c1=O)c(c3n2c(ncc3)N)c4ccnc(n4)N,Variolin B,-7.419272,x1385,active-covalent
CO[C@H]1Cc2c(n(c(=O)c(=O)o2)O)C=C1,"2,4-Dihydroxy-7-(Methyloxy)-2h-1,4-Benzoxazin-3(4h)-One",-7.418249,x0195,active-noncovalent
CC(C)Oc1cc(ccc1C2=[NH+][C@H]([C@H](N2C(=O)N3CC[NH2+]CC3)c4ccc(cc4)Cl)c5ccc(cc5)Cl)OC,"Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimida",-7.418068,x1077,active-noncovalent
C[C@@H](c1ccccc1)NN,Mebanazine,-7.417472,x0195,active-noncovalent
C#Cc1c[nH]c(=O)[nH]c1=O,Eniluracil,-7.416646,x0678,active-noncovalent
C1C2CC3CC1CC(C2)C3=O,Adamantanone,-7.411266,x0678,active-noncovalent
c1ccc(cc1)c2ccc(cc2)c3ccc(cc3)c4ccccc4,p-Quaterphenyl,-7.409986,x0104,active-noncovalent
CCOC(=O)c1cccc(c1)N,Tricaine,-7.405404,x0195,active-noncovalent
c1cc(c(cc1Cl)C(=O)Nc2cc(c(c(c2)Br)[O-])Br)Cl,"2,5-dichloro-N-(3,5-dibromo-4-hydroxyphenyl)benzamide",-7.403969,x0830,active-covalent
c1c(nc[nH]1)CC[NH3+],Histamine,-7.402808,x0397,active-noncovalent
CC(C)Nc1cc(nc2n1ncc2C#N)Cl,"5-chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile",-7.402708,x0195,active-noncovalent
c1cc(ccc1CC[NH3+])S(=O)(=O)N,4-(2-AMINOETHYL)BENZENESULFONAMIDE,-7.401299,x0195,active-noncovalent
C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)[C@H](C=O)O)CCC5=CC(=O)C=C[C@]35C)O,Desonide,-7.401280,x0874,active-noncovalent
COc1cc(c(c(c1)OC)/C=C/2\c3ccccc3NC2=O)OC,IC261,-7.401141,x0195,active-noncovalent
Cc1ccc(c(c1)N[C@@H](c2c(cccc2Br)Br)C(=O)N)C(=O)C,"(2-ACETYL-5-METHYLANILINO)(2,6-DIBROMOPHENYL)ACETAMIDE",-7.400417,x0195,active-noncovalent
c1cc2c(cc1F)[C@@]3(CC(=O)NC3=O)C(=O)N(C2=O)Cc4ccc(cc4F)Br,(R)-minalrestat,-7.399339,x0434,active-noncovalent
CCOCn1c(c(c(=O)[nH]c1=O)C(C)C)Cc2cc(cc(c2)C)C,"6-(3',5'-DIMETHYLBENZYL)-1-ETHOXYMETHYL-5-ISOPROPYLURACIL",-7.396886,x0874,active-noncovalent
c1ccc(c(c1)C(=O)NO)O,Salicylhydroxamic Acid,-7.396714,x0195,active-noncovalent
C[NH+](C)CCO[C@@H](c1ccc(cc1)Cl)c2ccccn2,Carbinoxamine,-7.396145,x0749,active-covalent
C[NH+](C)[C@H]1[C@@H]2[C@H]([C@H]3[C@H](C(=O)c4c(cccc4[O-])C3=C)C(=O)[C@@]2(C(=O)C(=C1[O-])C(=O)N)O)O,Metacycline,-7.396066,x0831,active-covalent
c1c(cc(c2c1c(=O)[nH][nH]c2=O)N)N,"3,5-Diaminophthalhydrazide",-7.395670,x0107,active-noncovalent
CCC(=O)O[C@@]1(CC[N@@H+](C[C@H]1C)C)c2ccccc2,Betaprodine,-7.394290,x0104,active-noncovalent
c1cc2c(cc1F)[C@]3(C[C@H](O2)C(=O)N)C(=O)NC(=O)N3,"(S,R)-fidarestat",-7.391781,x0195,active-noncovalent
c1ccc2c(c1)C[C@H](C(=O)N2)NC(=O)c3cc4cc(sc4[nH]3)Cl,"2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-",-7.391034,x0195,active-noncovalent
c1ccc(cc1)C2=N[C@@H](C(=O)Nc3c2cc(cc3)Cl)C(=O)[O-],Clorazepic acid,-7.387878,x0161,active-noncovalent
c1c(cc(cc1O)O)[C@@H](C(=O)[O-])[NH3+],"(2r)-Amino(3,5-Dihydroxyphenyl)Acetic Acid",-7.387761,x0434,active-noncovalent
CC(C)C[C@@H]1C[N@@H+]2CCc3cc(c(cc3[C@H]2CC1=O)OC)OC,Tetrabenazine,-7.385639,x0195,active-noncovalent
C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)F)C)F,Ulobetasol,-7.385544,x1077,active-noncovalent
CCC#C[C@@H](C)[C@]1(C(=O)NC(=O)N(C1=O)C)CC=C,Methohexital,-7.383235,x1077,active-noncovalent
C(CCC(=O)[O-])CC[NH3+],Aminocaproic acid,-7.383017,x0734,active-covalent
c1cc(c(cc1/C=C/C(=O)[O-])O)O,"3,4-Dihydroxycinnamic Acid",-7.382650,x0678,active-noncovalent
CCCc1ccccc1N,2-Propyl-Aniline,-7.379566,x0678,active-noncovalent
CC(=O)Nc1ccc(cc1)C(=O)NC(C)(C)C,CP1-1189,-7.379025,x0749,active-covalent
[C@@H]1([C@H]([C@H](O[C@H]([C@@H]1O)O)C(=O)[O-])O)O,beta-D-Galactopyranuronic acid,-7.376772,x0397,active-noncovalent
C[C@H](/C(=c\1/[nH]/c(=C\c2c[nH]c3c2cccc3)/c(=O)n1CC(=O)[O-])/[NH3+])O,"[2-(1-amino-2-hydroxy-propyl)-4-(1H-indol-3-ylmethylene)-5-oxo-4,5-dihydro-imida",-7.374801,x0195,active-noncovalent
CC1(CC(CC(C1)(C)[NH3+])(C)C)C,Neramexane,-7.374457,x0354,active-noncovalent
c1c[nH]c2c1c(=O)[nH]c(n2)N,7-Deazaguanine,-7.373170,x0195,active-noncovalent
c1c([nH]c(=O)[nH]c1=O)CC(=O)[O-],6-Carboxymethyluracil,-7.370897,x0397,active-noncovalent
CCN(CC)C(=O)c1cccc(c1)C,Diethyltoluamide,-7.370422,x0161,active-noncovalent
C[C@H]1Cn2c3c(cc(cc3[nH]c2=S)Cl)C[N@@H+]1CC=C(C)C,"4-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BE",-7.369449,x1077,active-noncovalent
CC(C)[C@@]12[C@@H](O1)[C@H]3[C@@]4(O3)[C@]5(CCC6=C([C@@]5(C[C@H]7[C@]4([C@@H]2O)O7)O)COC6=O)C,PG-701,-7.369381,x0195,active-noncovalent
Cn1c2c(c(=O)n(c1=O)C)[nH]c(n2)N,8-Aminotheophylline,-7.369127,x0195,active-noncovalent
C(COCC[NH3+])[C@@H](C(=O)[O-])[NH3+],2-Amino-4-(2-Amino-Ethoxy)-Butyric Acid,-7.368794,x0397,active-noncovalent
CCN(CC)C(=O)[C@H]1[C@@H]([C@H](C[C@@H](O1)C(=O)[O-])[NH3+])NC(=O)C,"5-N-Acetyl-4-Amino-6-Diethylcarboxamide-4,5-Dihydro-2h-Pyran-2-Carboxylic Acid",-7.367639,x1077,active-noncovalent
c1cc(ccc1C(=O)NCCO)Cl,N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE,-7.367277,x0678,active-noncovalent
C[C@H](C(=O)[O-])OP(=O)([O-])[O-],L-Phospholactate,-7.366311,x0397,active-noncovalent
CN1(=O)CC[C@]23c4c5ccc(c4O[C@H]2[C@H](C=C[C@H]3[C@H]1C5)O)OC,Codeine-N-oxide,-7.365364,x0678,active-noncovalent
c1ccc(cc1)NCCS(=O)(=O)[O-],2-Phenylamino-Ethanesulfonic Acid,-7.364672,x1093,active-noncovalent
CC1(CC(CC(N1[O-])(C)C)OC(=O)C2CC2)C,OT-551,-7.362073,x0195,active-noncovalent
C[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2C(=O)CC[C@H]3[C@H]1C5)OC,Hydrocodone,-7.361645,x0678,active-noncovalent
c1cc(ccc1/C=C/C(=O)[O-])O,para-Coumaric Acid,-7.358415,x0678,active-noncovalent
C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)OC)O)O)O,alpha-L-methyl-fucose,-7.356846,x0397,active-noncovalent
C[C@@H]1c2cc(ccc2C(=O)N(Cc3c(c(n(n3)C)C#N)-c4cc(c(nc4)N)O1)C)F,Lorlatinib,-7.354625,x0874,active-noncovalent
C[C@H](C[NH+]1CCOCC1)C(c2ccccc2)(c3ccccc3)C(=O)N4CCCC4,Dextromoramide,-7.352647,x0678,active-noncovalent
B(c1ccccc1)(O)O,Phenyl Boronic Acid,-7.352579,x0195,active-noncovalent
Cc1cc(cc(c1)C(=O)N(C(C)(C)C)NC(=O)c2ccc3c(c2C)OCCO3)C,"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBO",-7.349293,x0195,active-noncovalent
Cc1cccc(c1O)CC=C,2-Allyl-6-Methyl-Phenol,-7.347103,x0195,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)[O-])/C)/C,Tretinoin,-7.345068,x0104,active-noncovalent
C[C@@H]1[C@](C1(Cl)Cl)(C(=O)N[C@@H](C)c2ccc(cc2)Br)[S@@](=O)C,"2,2-Dichloro-1-methanesulfinyl-3-methyl-cyclopropanecarboxylic acid [1-(4-bromo-",-7.344211,x0749,active-covalent
CC[C@](C)(C(=O)[O-])[NH3+],D-Isovaline,-7.344193,x0397,active-noncovalent
CC1=CC[C@@H](CC1)C(=C)C,(4R)-limonene,-7.342541,x0195,active-noncovalent
c1[nH]c2c(n1)[nH]c(=O)[nH]c2=O,Xanthine,-7.341512,x0678,active-noncovalent
CC(C)(C)c1ccc(cc1)S(=O)(=O)[O-],4-TERT-BUTYLBENZENESULFONIC ACID,-7.339198,x0749,active-covalent
C[N@H+]1CC[C@]23C[C@@H](CC[C@]2([C@H]1Cc4c3c(c(cc4)OC)OC)O)O,Drotebanol,-7.335996,x1077,active-noncovalent
c1c([nH]cn1)/C=C/C(=O)[O-],trans-urocanic acid,-7.334667,x0195,active-noncovalent
Cc1cc(c(cc1OC)C[C@H](C)[NH3+])OC,"4-Methyl-2,5-dimethoxyamphetamine",-7.334440,x0946,active-noncovalent
C[NH2+]CCCC[C@@H](C(=O)[O-])[NH3+],N-Methyl-Lysine,-7.334429,x0830,active-covalent
CC(C)(C)OC(=O)NN(C)C#N,TERT-BUTYL 2-CYANO-2-METHYLHYDRAZINECARBOXYLATE,-7.334331,x0678,active-noncovalent
C=c1c(=O)/c(=C\[O-])/c(c[nH]1)COP(=O)([O-])[O-],Pyridoxal phosphate,-7.330033,x0397,active-noncovalent
c1ccc(c(c1)CS)I,2-Iodobenzylthio Group,-7.329430,x0195,active-noncovalent
C(C(C(F)(F)F)(F)F)(C(C(F)(F)F)(F)F)(F)F,Perflenapent,-7.329278,x0195,active-noncovalent
CN(C)/N=N/c1c(nc[nH]1)C(=O)N,Dacarbazine,-7.328555,x1077,active-noncovalent
C[C@@H]1CC[C@H]2[C@H]([C@@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)O)C,Artenimol,-7.328520,x0195,active-noncovalent
C1[C@H]2[C@@H]([C@@H](S1)CCCC(=O)[O-])NC(=O)N2,"4-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Butyricacid",-7.328464,x1077,active-noncovalent
c1ccc(cc1)CCC(=O)[O-],3-phenylpropionic acid,-7.328450,x0195,active-noncovalent
C[C@H]1CC[C@@H]([C@H](C1)O)C(C)C,(+)-menthol,-7.327931,x0195,active-noncovalent
CC(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],N-Acetyl-L-Glutamate,-7.327812,x0397,active-noncovalent
C[C@@H]([C@@H](c1ccc(c(c1)O)O)O)[NH3+],Levonordefrin,-7.326422,x0434,active-noncovalent
CCCc1cc(=O)[nH]c(=S)[nH]1,Propylthiouracil,-7.320730,x1382,active-covalent
C[C@@H](Cc1csc(n1)N)C=O,2-Methyl-3-(2-Aminothiazolo)Propanal,-7.317004,x0397,active-noncovalent
CCn1cc(c(=O)c2c1nc(cc2)C)C(=O)[O-],Nalidixic acid,-7.316710,x0195,active-noncovalent
c1cc2c(c(sc2nc1)C(=O)[O-])OCC(=O)[O-],"3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID",-7.315426,x0195,active-noncovalent
C[n+]1cccc(c1)C(=O)N,Trigonellamide,-7.315037,x0195,active-noncovalent
CC(C)(Cc1ccccc1)[NH2+]C,Mephentermine,-7.310733,x0161,active-noncovalent
c1cn(c(=O)nc1N)[C@@H]2CO[C@@H](O2)CO,Troxacitabine,-7.309044,x0195,active-noncovalent
C[C@@H](Cc1ccccc1)C(=O)[O-],DEAMINO-METHYL-PHENYLALANINE,-7.308984,x0678,active-noncovalent
CC[C@@]1(C(=O)NC(=O)N(C1=O)C)c2ccccc2,Methylphenobarbital,-7.308652,x1418,active-covalent
COc1c(ccc(c1Cl)N)C(=O)N[C@@H]2CC[N@@H+]3CCC[C@H]2C3,Renzapride,-7.307933,x0678,active-noncovalent
c1cc(cnc1)CO,Nicotinyl alcohol,-7.306850,x0426,active-noncovalent
C[C@]1(OC[C@@H]2[C@H](O1)[C@@H]([C@H]([C@@H](O2)O)O)O)C(=O)[O-],"4,6-O-(1-Carboxyethylidene)-Beta-D-Glucose",-7.305534,x0397,active-noncovalent
c1ccc(c(c1)C(=O)[O-])C(=O)[O-],Phthalic Acid,-7.305440,x0678,active-noncovalent
C[C@@H]([C@H](c1cc(ccc1OC)OC)O)[NH3+],Methoxamine,-7.302982,x1077,active-noncovalent
C[C@]1(c2cccc(c2C(=O)[C@H]3[C@@H]1[C@@H]([C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)O)[O-])O,Oxytetracycline,-7.301876,x0749,active-covalent
CCCCCC[C@@H](C)NC=O,N-1-methylheptylformamide,-7.301714,x0749,active-covalent
c1ccc2c(c1)C(=O)NS2(=O)=O,Saccharin,-7.298658,x0678,active-noncovalent
C[C@H](Cc1ccccc1)NN,Pheniprazine,-7.295744,x0195,active-noncovalent
Cn1c2c(c(=O)n(c1=O)C)nc[nH]2,Theophylline,-7.292322,x0678,active-noncovalent
Cn1c2c(c(=O)n(c1=O)C)nc[nH]2,Oxtriphylline,-7.292322,x0678,active-noncovalent
Cn1c2c(c(=O)n(c1=O)C)nc[nH]2,Aminophylline,-7.292322,x0678,active-noncovalent
Cc1[nH+]cc(n1C[C@H](C)O)N(=O)=O,Secnidazole,-7.290377,x0195,active-noncovalent
c1cc2c[nH]nc2cc1N(=O)=O,6-Nitroindazole,-7.285499,x0678,active-noncovalent
c1cn2c(nc1=O)O[C@@H]3[C@H]2O[C@@H]([C@H]3O)CO,Cyclouridine,-7.283973,x0397,active-noncovalent
c12c([nH]c(=O)[nH]1)[nH]c(=O)[nH]c2=O,Uric acid,-7.283333,x0678,active-noncovalent
CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF,Fluticasone propionate,-7.283143,x1077,active-noncovalent
CC(C)[NH+](CC[C@](c1ccccc1)(c2ccccn2)C(=O)N)C(C)C,Disopyramide,-7.282314,x0195,active-noncovalent
c1ccc(cc1)[C@@H](C#N)O,(S)-HYDROXY(PHENYL)ACETONITRILE,-7.280184,x0678,active-noncovalent
c1ccc(c(c1)C=O)OP(=O)([O-])[O-],RU78262,-7.277938,x0678,active-noncovalent
c1c(nc(c(=O)[nH]1)C(=O)N)F,Favipiravir,-7.276232,x0397,active-noncovalent
C1CC(=O)N[C@@H]1C(=O)N2CSC[C@H]2C(=O)[O-],Pidotimod,-7.273022,x0749,active-covalent
c1cc2c(cc1S(=O)(=O)N)CCC2,indane-5-sulfonamide,-7.272014,x0195,active-noncovalent
C(C(=O)C(=O)[O-])S(=O)(=O)[O-],Sulfopyruvate,-7.268673,x0397,active-noncovalent
c1cc(ccc1C=O)O,P-Hydroxybenzaldehyde,-7.266864,x0678,active-noncovalent
Cn1cc[nH]c1=S,Methimazole,-7.266704,x0678,active-noncovalent
c1cc(cnc1)C(=O)[O-],Niacin,-7.265731,x0397,active-noncovalent
CCC(=O)N(c1ccccc1)[C@@H]2C[C@H]([N@@H+](C[C@@H]2C)CCc3ccccc3)C,Phenaridine,-7.262793,x0072,active-noncovalent
C[C@H](/C(=c\1/[nH]/c(=C\c2ccc(cc2)O)/c(=O)n1CC(=O)[O-])/[NH3+])O,Chromophore (Gly-Tyr-Gly),-7.262269,x0397,active-noncovalent
CCCC[C@H](C(=O)[O-])[NH3+],D-norleucine,-7.261909,x0397,active-noncovalent
CC(=O)Nc1ccc(cc1NC(=O)C[NH3+])C(=O)[O-],4-(Acetylamino)-3-[(Aminoacetyl)Amino]Benzoic Acid,-7.259489,x1187,dimer-interface
c1cc(ccc1OCCO)Cl,Chlorophetanol,-7.254825,x0161,active-noncovalent
c1cc(c(cc1CC[NH3+])O)O,Dopamine,-7.254482,x0104,active-noncovalent
CO/C=C\[C@@H](C(=O)[O-])[NH3+],L-2-amino-4-methoxy-cis-but-3-enoic acid,-7.253308,x0397,active-noncovalent
c1ccc2=NC(N=c2c1)[NH3+],2H-Benzimidazol-2-amine,-7.252685,x0195,active-noncovalent
Cc1cccn2c1ncc(c2=O)c3[n-]nnn3,Pemirolast,-7.250249,x0195,active-noncovalent
CC(C)[C@@H]([C@H](C(=O)[O-])O)C(=O)[O-],3-Isopropylmalic Acid,-7.249776,x0397,active-noncovalent
CCOC(=O)c1cnc([nH]c1=O)N,ethyl 2-amino-4-hydroxypyrimidine-5-carboxylate,-7.246047,x0195,active-noncovalent
CC[C@]1(C(=O)N(C(=O)N1)C)c2ccccc2,Mephenytoin,-7.243958,x0434,active-noncovalent
CCOC(=O)n1ccn(c1=S)C,Carbimazole,-7.243903,x0195,active-noncovalent
Cc1ccc(cc1C)N,"3,4-Dimethylaniline",-7.242476,x0678,active-noncovalent
CC(=O)Nc1nc2c(s1)C(=O)NCCC2,"N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-[1,3]THIAZOLO[5,4-C]AZEPIN-2-YL)ACETAMIDE",-7.242461,x0195,active-noncovalent
[C@@H]([C@H](C(=O)[O-])O)(C(=O)[O-])O,L-tartaric acid,-7.242224,x0397,active-noncovalent
C(CC(=O)N)[C@@H](C(=O)[O-])[NH3+],L-Glutamine,-7.241982,x0107,active-noncovalent
c1ccc(c(c1)C(=O)[O-])O,Salicylic acid,-7.241326,x1093,active-noncovalent
COc1cc(ccc1O)/C=C/C(=O)[O-],Ferulic acid,-7.238907,x0195,active-noncovalent
CCCC(=O)SCC[N+](C)(C)C,Butyrylthiocholine,-7.236776,x0749,active-covalent
c1ccc(cc1)C[C@@H](C(=O)[O-])NC(=O)NO,L-[(N-Hydroxyamino)Carbonyl]Phenylalanine,-7.233534,x0161,active-noncovalent
C[N@H+]1CCC=C(C1)C(=O)OC,Arecoline,-7.232696,x0104,active-noncovalent
c1cc(c(c(c1C(=O)[O-])N)O)Cl,2-AMINO-4-CHLORO-3-HYDROXYBENZOIC ACID,-7.231819,x0397,active-noncovalent
CC(C)(C)OC(=O)Nc1cccnc1C(=O)Nc2nccs2,"TERT-BUTYL {2-[(1,3-THIAZOL-2-YLAMINO)CARBONYL]PYRIDIN-3-YL}CARBAMATE",-7.231666,x0195,active-noncovalent
c1ccc(cc1)C(=O)C(=O)[O-],Benzoylformic Acid,-7.227210,x0678,active-noncovalent
Cc1c(c(c(cn1)CO)CO)O,Pyridoxine,-7.223303,x0426,active-noncovalent
C[C@H](CCC(=O)[O-])[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,Ursodeoxycholic acid,-7.220377,x0104,active-noncovalent
c1cc(ccc1[C@@H]2CO2)N(=O)=O,(R)-4-Nitrostyrene oxide,-7.219937,x0195,active-noncovalent
C1=C[C@@H]([C@H](C(=C1)C(=O)[O-])[NH3+])O,"(2s,3s)-Trans-2,3-Dihydro-3-Hydroxyanthranilic Acid",-7.219549,x0426,active-noncovalent
CSCC[C@H](C(=O)[O-])[NH3+],D-Methionine,-7.217588,x0397,active-noncovalent
c1cc2c(cccc2S(=O)(=O)N)c(c1)O,5-hydroxynaphthalene-1-sulfonamide,-7.214425,x0195,active-noncovalent
C[C@H]([C@H]([C@H]1CNc2c(c(=O)[nH]c(n2)N)N1)O)O,"6S-5,6,7,8-Tetrahydrobiopterin",-7.214097,x0397,active-noncovalent
C[C@H](C(=O)[O-])[NH3+],D-Alanine,-7.213622,x0397,active-noncovalent
c1ccc(cc1)C[C@@H](C(=O)[O-])NC(=O)N,D-[(Amino)Carbonyl]Phenylalanine,-7.212943,x0397,active-noncovalent
C[C@@](c1ccccc1)(C(=O)[O-])O,(S)-atrolactic acid,-7.210797,x1392,active-covalent
C=CCNc1ccccc1,N-Allyl-Aniline,-7.207365,x0195,active-noncovalent
CCC1(C(=O)NC(=O)N(C1=O)C)CC,Metharbital,-7.205359,x0678,active-noncovalent
c1ccc2c(c1)C=C[C@](O2)(C(=O)[O-])O,(2S)-2-HYDROXY-2H-CHROMENE-2-CARBOXYLIC ACID,-7.204971,x0830,active-covalent
CC1(CCC(c2c1cc(c(c2Cl)O)C(=O)Nc3cc(c(c(c3)F)C(=O)[O-])F)(C)C)C,IRX-5183,-7.204479,x0104,active-noncovalent
CC(=C)[C@@H]1CC[C@@]2([C@H](C1)O2)C,"(4R)-limonene 1,2-epoxide",-7.204408,x0195,active-noncovalent
C(CC[NH3+])C[C@@H](C(=O)[O-])[NH3+],L-Lysine,-7.202809,x0397,active-noncovalent
c1ccc(cc1)n2c(nnn2)N,Fenamole,-7.201094,x0195,active-noncovalent
c1ccc2c(c1)C=C[C@@H]([C@@H]2O)O,"(1R, 2S)-cis 1,2 dihydroxy-1,2-dihydronaphthalene",-7.200811,x0195,active-noncovalent
COc1ccccc1/C=C\C(=O)C(=O)[O-],4-(2-METHOXYPHENYL)-2-OXOBUT-3-ENOIC ACID,-7.200565,x0874,active-noncovalent
C(CC[NH2+]CCC[NH3+])C[NH3+],Spermidine,-7.199936,x1093,active-noncovalent
C(CSC(F)(F)F)[C@@H](C(=O)[O-])[NH3+],Trifluoromethionine,-7.198627,x0708,active-covalent
c1ccc(cc1)C[NH3+],Benzylamine,-7.197380,x0678,active-noncovalent
C[C@@H](CCCC(C)(C)O)C=C,"2,6-Dimethyl-7-Octen-2-Ol",-7.196761,x0749,active-covalent
CC(C)NC(=[NH2+])NO,1-hydroxy-2-isopropylguanidine,-7.196707,x0104,active-noncovalent
C[C@](C(=O)Nc1cccc2c1C(=O)c3c(ccs3)CS2(=O)=O)(C(F)(F)F)O,KW-7158,-7.195967,x0195,active-noncovalent
c1cn(c(=O)[nH]c1=O)[C@H]2C[C@@H]([C@H](O2)CO)O,2'-Deoxyuridine,-7.195349,x0874,active-noncovalent
CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C,Butalbital,-7.193576,x0195,active-noncovalent
c1ccc(cc1)NC(=O)ON,N-[(Aminooxy)Carbonyl]Aniline,-7.188769,x0195,active-noncovalent
C/C=C/C(=C/[C@@]1(C(=C(C(=O)S1)C)[O-])C)/C,"(5R)-4-HYDROXY-3,5-DIMETHYL-5-[(1E,3E)-2-METHYLPENTA-1,3-DIENYL]THIOPHEN-2(5H)-O",-7.186824,x0161,active-noncovalent
CCOC(=O)c1c([nH]nc1C)C,"3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",-7.185022,x0540,active-noncovalent
c1ccc(cc1)CS(=O)(=O)[O-],Benzylsulfinic Acid,-7.184757,x0678,active-noncovalent
Cc1cccnc1,3-Methylpyridine,-7.183367,x0397,active-noncovalent
Cc1nc2c(=O)[nH]c(nc2o1)N,8-Methyl-9-Oxoguanine,-7.182127,x0195,active-noncovalent
Cc1cc(cc(c1O)C)C(=O)Nc2cc(c(c(c2)Br)[O-])Br,"N-(3,5-dibromo-4-hydroxyphenyl)-4-hydroxy-3,5-dimethylbenzamide",-7.181430,x0072,active-noncovalent
c1cc(c(cc1C(F)(F)F)N(=O)=O)C(=C2C(=O)CCCC2=O)[O-],"2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE",-7.181240,x1093,active-noncovalent
Cc1cn(c(=O)[nH]c1=O)[C@H]2C=C[C@H](O2)CO,Stavudine,-7.180764,x0874,active-noncovalent
C(CC[NH3+])C[C@@H](C(=O)N)[NH3+],"2,6-Diamino-Hexanoic Acid Amide",-7.177758,x0104,active-noncovalent
C1C/C(=N\c2n[n-]nn2)/CC(=O)C1,3-(1H-tetrazol-5-ylamino)cyclohex-2-en-1-one,-7.176019,x0678,active-noncovalent
CCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)C(=O)CCl,Clobetasol propionate,-7.175142,x1077,active-noncovalent
CCC(C)(C)C(=O)C(=O)N1CCC[C@H]1C(=O)[O-],GPI-1485,-7.174813,x0749,active-covalent
C=CCc1ccccc1O,2-Allylphenol,-7.173183,x0195,active-noncovalent
C(CC[NH+]=C(N)N)C[NH3+],Agmatine,-7.168641,x1374,active-covalent
c1cc(c(cc1C[C@@H](C(=O)[O-])[NH3+])N(=O)=O)[O-],Meta-Nitro-Tyrosine,-7.166180,x0830,active-covalent
c1ccc2c(c1)c(c[nH]2)OS(=O)(=O)[O-],3-SULFOOXY-1H-INDOLE,-7.163273,x0749,active-covalent
c1nc(c2c(n1)n(cn2)[C@@H]3C=C[C@@H]([C@H]3O)O)N,"(1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)Adenine",-7.161386,x0195,active-noncovalent
Cn1cnc2c1c(=O)n(c(=O)n2C)C,Caffeine,-7.160553,x0195,active-noncovalent
c1cc(c(cc1N)C(=O)[O-])O,Mesalazine,-7.158207,x0397,active-noncovalent
C[C@@H]1Cc2cc3c(cc2C(=NN1C(=O)C)c4ccc(cc4)N)OCO3,Talampanel,-7.157860,x0161,active-noncovalent
c1c(c(=O)[nH]c(=O)n1C[C@@H](C(=O)[O-])[NH3+])F,Fluoro-Willardiine,-7.157616,x0678,active-noncovalent
CN(C)c1ccc(cc1)C(=O)[O-],4-(DIMETHYLAMINO)BENZOIC ACID,-7.157005,x0195,active-noncovalent
C(CCC(=O)[O-])C[C@@H](C(=O)[O-])[NH3+],2-Aminopimelic Acid,-7.155433,x1418,active-covalent
c1ccc(cc1)CCO,Phenylethyl alcohol,-7.153935,x0195,active-noncovalent
c1cc(ccc1[C@@H](C#N)O)O,(2s)-Hydroxy(4-Hydroxyphenyl)Ethanenitrile,-7.152297,x0195,active-noncovalent
Cc1cn(c(=O)[nH]c1=O)[C@H]2C[C@@H]([C@H](O2)CO)O,Thymidine,-7.148470,x0195,active-noncovalent
C[NH2+][C@]1(CCCCC1=O)c2ccccc2Cl,Ketamine,-7.146005,x0072,active-noncovalent
CCCn1c2c(c(=O)[nH]c1=O)nc[nH]2,Enprofylline,-7.145932,x0397,active-noncovalent
c1cc(c(c(c1)F)F)CO,"2,3-Difluorobenzyl Alcohol",-7.141989,x0195,active-noncovalent
C1[C@@H]([C@H](C=C(O1)C(=O)[O-])O)O,"2,6-Anhydro-3-Deoxy-D-Erythro-Hex-2-Enonic Acid",-7.138594,x0397,active-noncovalent
C[Si](C)(C)[C@H](CC(=O)[O-])C(=O)[O-],3-Trimethylsilylsuccinic Acid,-7.136160,x1493,active-covalent
C[C@H](c1ccccc1)O,(R)-1-phenylethanol,-7.135807,x0195,active-noncovalent
c1cc(c(cc1O)CC(=O)[O-])O,"2-(3,6-DIHYDROXYPHENYL)ACETIC ACID",-7.135596,x0397,active-noncovalent
Cc1cn(c(=O)[nH]c1=O)[C@H]2C[C@@H]([C@H](O2)CO)F,Alovudine,-7.133937,x0195,active-noncovalent
[H]/N=C/COP(=O)([O-])[O-],2-Amino-Vinyl-Phosphate,-7.132102,x0397,active-noncovalent
C[C@H]1CC[C@H]2[C@@]13CC(C[C@@H]3C=C2C(=O)[O-])(C)C,"(1S,3aS,5aR,8aS)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentale",-7.131256,x0831,active-covalent
Cc1ccc(cc1C)O,"3,4-Dimethylphenol",-7.127916,x0678,active-noncovalent
c1c(c(=O)[nH]c(=O)n1C[C@@H](C(=O)[O-])[NH3+])I,Iodo-Willardiine,-7.126901,x0397,active-noncovalent
CC1(C2CCC(O1)(CC2)C)C,Eucalyptol,-7.124851,x0354,active-noncovalent
c1ccc(cc1)C(=[NH2+])N,Benzamidine,-7.124781,x0678,active-noncovalent
C[C@@H]1CCCN(C1)C(=O)C,(3r)-1-Acetyl-3-Methylpiperidine,-7.121165,x0195,active-noncovalent
C[NH+](C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(c4C(=O)[C@H]3C(=O)[C@@]2(C(=O)C(=C1[O-])C(=O)N)O)[O-])N(C)C,Minocycline,-7.120826,x0104,active-noncovalent
C([C@@H](C(=O)[O-])N)/[N+](=[NH+]/[O-])/[O-],Alanosine,-7.120152,x0397,active-noncovalent
c1cc(cnc1)CS,3-(Mercaptomethylene)Pyridine,-7.117760,x0195,active-noncovalent
C1[C@@H](CC[C@H](C1)C(=O)[O-])C[NH3+],Tranexamic acid,-7.117168,x0426,active-noncovalent
c1c(c(=O)[nH]c(=O)n1[C@H]2C[C@@H]([C@H](O2)CO)O)I,Idoxuridine,-7.116411,x1077,active-noncovalent
CSc1[nH]c2c(n1)c(c(c(c2Br)Br)Br)Br,"S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE",-7.115298,x0195,active-noncovalent
C(C[C@@H](C(=O)[O-])[NH3+])C=O,4-Carboxy-4-Aminobutanal,-7.114931,x0397,active-noncovalent
C(C[C@@H](C(=O)[O-])[NH3+])C=O,Glutamyl Group,-7.114931,x0397,active-noncovalent
CSCC[C@H]([NH3+])P(=O)([O-])[O-],Methionine Phosphonate,-7.114700,x0397,active-noncovalent
c1ccc(cc1)c2c(c(=O)[nH]c(n2)N)Br,2-Amino-5-Bromo-6-Phenylpyrimidin-4-Ol,-7.113606,x0195,active-noncovalent
CC(C)Cn1c2c(c(=O)n(c1=O)C)[nH]cn2,3-isobutyl-1-methyl-7H-xanthine,-7.113242,x0195,active-noncovalent
c1cc(c(cc1F)F)CO,"2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene",-7.110918,x0195,active-noncovalent
C[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)[O-],1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid,-7.110713,x0831,active-covalent
CCOc1ccc(cc1)NC(=O)C,Phenacetin,-7.108883,x0195,active-noncovalent
c1ccc(cc1)COC=O,Formic Acid Benzyl Ester,-7.106264,x0195,active-noncovalent
c1c(cc(c(c1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N,Diclofenamide,-7.105409,x0195,active-noncovalent
CC(=O)N1CCC(CC1)NC(=O)NC23CC4CC(C2)CC(C4)C3,AR-9281,-7.104700,x1077,active-noncovalent
CSC[C@@H](C(=O)[O-])[NH3+],S-Methylcysteine,-7.103190,x1077,active-noncovalent
C[N@@]1C(=C(c2c(ccs2)S1(=O)=O)O)C(=O)Nc3ccccn3,Tenoxicam,-7.101867,x0195,active-noncovalent
c1cc(cc(c1)I)CO,3-Iodo-Benzyl Alcohol,-7.101763,x0195,active-noncovalent
c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)NCN2,Hydrochlorothiazide,-7.101425,x0749,active-covalent
C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)[O-],Captopril,-7.100540,x0831,active-covalent
C[C@H]([C@H](C(=O)[O-])[NH3+])N,"D-ERITHRO-2,3-DIAMINO-BUTYRIC ACID",-7.098596,x0397,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])C(C(=O)[O-])C(=O)[O-],Gamma-Carboxy-Glutamic Acid,-7.095986,x0397,active-noncovalent
c1cc(ccc1O)I,p-Iodophenol,-7.093729,x0678,active-noncovalent
c1cc(c(c(c1)O)N)C(=O)[O-],3-hydroxyanthranilic acid,-7.089893,x0397,active-noncovalent
CC[NH2+][C@]1(CCCCC1=O)c2cccs2,Tiletamine,-7.089738,x1382,active-covalent
C[C@@H](Cc1cc(c(c(c1)OC)OC)OC)[NH3+],"3,4,5-Trimethoxyamphetamine",-7.086974,x0195,active-noncovalent
c1cc(c(cc1CC(=O)[O-])O)O,"2-(3,4-Dihydroxyphenyl)Acetic Acid",-7.086059,x0830,active-covalent
C[C@@H](Cn1cnc2c1ncnc2N)O,S-9-(2-hydroxypropyl)adenine,-7.083193,x0426,active-noncovalent
c1c(c(nc(=O)n1[C@@H]2CS[C@@H](O2)CO)N)F,Emtricitabine,-7.082219,x0397,active-noncovalent
COc1c(c(=O)c(c([nH]1)C(Cl)(Cl)Cl)Cl)Cl,4-O-Demethylpenclomedine,-7.081570,x0195,active-noncovalent
Cc1c(c(c(c[n+]1C)COP(=O)([O-])[O-])C=O)O,N-Methyl-Pyridoxal-5'-Phosphate,-7.081129,x0397,active-noncovalent
CC(C)(C)c1c([nH]cn1)/C=c\2/c(=O)[nH]/c(=C\c3ccccc3)/c(=O)[nH]2,Plinabulin,-7.080822,x1334,active-covalent
c1ccc(c(c1)C(=O)N)O,Salicylamide,-7.078387,x0195,active-noncovalent
C(CSC(F)F)[C@@H](C(=O)[O-])[NH3+],Difluoromethionine,-7.077248,x0678,active-noncovalent
C[C@@]12CC[C@@H](C1(C)C)CC2=S,Thiocamphor,-7.076839,x0354,active-noncovalent
c1ccc(cc1)C(=O)NO,Benzhydroxamic Acid,-7.073057,x0195,active-noncovalent
C(C(C(F)(F)F)(F)F)(C(F)(F)F)(F)F,Perflubutane,-7.072898,x0195,active-noncovalent
c1c2c([nH]c1C(=O)[O-])-c3c(cc(nc3C(=O)C2=O)C(=O)[O-])C(=O)[O-],Pyrroloquinoline Quinone,-7.071880,x0195,active-noncovalent
C(=C(/C(=O)[O-])\O)\C(=O)[O-],Oxaloacetate Ion,-7.070899,x0397,active-noncovalent
CN(C)c1ccc(cc1)c2c(ncnc2N)C#Cc3ccc(nc3)N4CCOCC4,5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4,-7.070848,x0305,active-noncovalent
CCC1(C(=O)[C@@H](CNC1=O)C)CC,Methyprylon,-7.069792,x0678,active-noncovalent
CCCC[N+](CCCC)(CCCC)CCCC,Tetrabutylammonium Ion,-7.069019,x0072,active-noncovalent
c1ccc(cc1)C(c2ccccc2)([C@@H]3CC[N@@H+](C3)CCc4ccc5c(c4)CCO5)C(=O)N,Darifenacin,-7.063828,x1077,active-noncovalent
CC(C)C[C@H]([NH3+])P(=O)([O-])[O-],Leucine Phosphonic Acid,-7.059947,x0397,active-noncovalent
C[C@H]([C@@H](c1nccs1)[NH3+])O,"(1s,2s)-1-Amino-1-(1,3-Thiazol-2-Yl)Propan-2-Ol",-7.059248,x1093,active-noncovalent
C1CC1([NH3+])P(=O)([O-])[O-],1-Aminocyclopropylphosphonate,-7.058842,x0397,active-noncovalent
C1CCC(CC1)C[NH3+],Aminomethylcyclohexane,-7.057826,x1093,active-noncovalent
Cc1c(cc(cc1N(=O)=O)N(=O)=O)C(=O)N,Zoalene,-7.057245,x0104,active-noncovalent
C[N@@H+]1CC[C@@]23C=C[C@@H](C[C@@H]2Oc4c3c(ccc4OC)C1)O,Galantamine,-7.056937,x1385,active-covalent
C[C@@H]1C(=O)O[C@@H]2[C@]1([C@@]34C(=O)O[C@H]5[C@]3([C@H]2O)[C@@]6([C@@H]([C@H]5O)C(C)(C)C)[C@H](C(=O)O[C@H]6O4)O)O,ginkgolide-C,-7.054410,x0946,active-noncovalent
COc1cc(c(cc1Br)OC)CC[NH3+],"4-Bromo-2,5-dimethoxyphenethylamine",-7.053773,x1077,active-noncovalent
Cc1ccc(c(c1)N)O,2-Amino-P-Cresol,-7.052740,x0195,active-noncovalent
C1[C@H](C[NH2+][C@@H]1C(=O)[O-])O,Hydroxyproline,-7.051167,x0397,active-noncovalent
CC1=C(C(C(=C(N1)C)C(=O)OC)c2ccccc2N(=O)=O)C(=O)OC,Nifedipine,-7.047341,x0831,active-covalent
c1cn(c(=O)nc1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,Gemcitabine,-7.046522,x0195,active-noncovalent
COc1ccc(cc1)C(=C(c2ccc(cc2)OC)Cl)c3ccc(cc3)OC,Chlorotrianisene,-7.043087,x0749,active-covalent
Cc1ccccn1,Picoplatin,-7.040344,x0195,active-noncovalent
C[N@@]1C(=C(c2ccccc2S1(=O)=O)O)C(=O)Nc3ccccn3,Piroxicam,-7.037559,x0195,active-noncovalent
C[C@@H]1CC[C@H]([C@@H](C1)O)C(C)C,Levomenthol,-7.037339,x0195,active-noncovalent
CC1=CC=CC(=C)[C@H]1[NH3+],2-Chloro-6-Methyl-Aniline,-7.036787,x1382,active-covalent
c1cc(sc1)CCCC(=O)[O-],4-(2-Thienyl)Butyric Acid,-7.035312,x0678,active-noncovalent
C1CC(=O)N2[C@H]1NC(=O)C2,Dimiracetam,-7.034143,x0678,active-noncovalent
C[Se]C[C@@H](C(=O)[O-])[NH3+],Methylselenocysteine,-7.034014,x0397,active-noncovalent
CC(C)[C@@H](C(=O)N1CCCC1)[NH3+],2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One,-7.031631,x0104,active-noncovalent
c1c[nH]c2c1ncnc2N,9-Deazaadenine,-7.030487,x0540,active-noncovalent
C#CC1(CCCCC1)OC(=O)N,Ethinamate,-7.030241,x0354,active-noncovalent
CCC1(C(=O)NC(=O)NC1=O)C2=CCCCCC2,Heptabarbital,-7.029195,x0678,active-noncovalent
c1c(c(c[nH]c1=O)Cl)[O-],Gimeracil,-7.029076,x0678,active-noncovalent
CC1=C([C@@](SC1=O)(C)/C=C(\C)/C=C)[O-],"4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One",-7.027461,x0161,active-noncovalent
c1cc(c(nc1)C(=O)[O-])C(=O)[O-],Quinolinic Acid,-7.027446,x0397,active-noncovalent
C[C@]12CCC/C(=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)/[C@@H]1CC[C@@H]2C#CC#CC(C)(C)O,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-",-7.020599,x0072,active-noncovalent
C(CC(=O)NO)[C@@H](C(=O)[O-])[NH3+],Glutamine hydroxamate,-7.019590,x0397,active-noncovalent
c1cc(ccc1CO)Br,Para-Bromobenzyl Alcohol,-7.019146,x0195,active-noncovalent
c1c(cc(c(c1N(=O)=O)[O-])O)N(=O)=O,"3,5-Dinitrocatechol",-7.017367,x0397,active-noncovalent
CC(C)C[C@@](C)(C(=O)[O-])[NH3+],2-Methylleucine,-7.016713,x0397,active-noncovalent
C([C@H](C(=O)[O-])OP(=O)([O-])[O-])O,2-phospho-D-glyceric acid,-7.016144,x0397,active-noncovalent
C[n+]1c(cc[nH]c1=O)N,3-Methylcytosine,-7.014339,x0678,active-noncovalent
CC(=O)N[C@@H](CO)C(=O)[O-],N-Acetyl-Serine,-7.013788,x0397,active-noncovalent
CN1[C@H](S(=O)(=O)CCC1=O)c2ccc(cc2)Cl,Chlormezanone,-7.013259,x0678,active-noncovalent
c1cc(c(nc1)C(=O)[O-])CP(=O)([O-])[O-],3-(Phosphonomethyl)Pyridine-2-Carboxylic Acid,-7.012524,x0397,active-noncovalent
C[C@H]1[C@H]2[C@H]([C@@H]([C@@]34[C@]25C(=O)O[C@@H]3[C@@H]([C@H]([C@@]46[C@H](C(=O)O[C@H]6O5)O)C(C)(C)C)O)O)OC1=O,ginkgolide-M,-7.010036,x0946,active-noncovalent
c1c(c(=O)[nH]c(=O)n1[C@H]2CCCO2)F,Tegafur,-7.008922,x0195,active-noncovalent
c1c(c(=O)[nH]c(=O)n1[C@H]2CCCO2)F,Tegafur-uracil,-7.008922,x0195,active-noncovalent
c1c[nH]c2c1nc[nH]c2=O,9-Deazahypoxanthine,-7.008268,x0397,active-noncovalent
CC(C)OCCn1c2cc[nH]c2c(=O)[nH]c1=S,Verdiperstat,-7.003990,x0749,active-covalent
COc1cc(cc(c1O)OC)C(=O)OC,SYRINGATE,-7.003550,x0161,active-noncovalent
C([C@@H](C(=O)[O-])N)[NH3+],3-Amino-Alanine,-7.002242,x0397,active-noncovalent
CCCC[C@H]([NH3+])P(=O)([O-])[O-],Norleucine Phosphonate,-7.001636,x0397,active-noncovalent
CN(C)C(=[NH2+])NC(=[NH2+])N,Metformin,-6.999578,x0195,active-noncovalent
C[C@@]1(C(=O)NC(=O)N(C1=O)C)C2=CCCCC2,Hexobarbital,-6.998093,x0072,active-noncovalent
c1ccc(cc1)CC=O,Phenylacetaldehyde,-6.996418,x0195,active-noncovalent
C1C[C@H]2C(=O)NCC(=O)N2C1,"(8ar)-Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",-6.993780,x0195,active-noncovalent
C[C@@]12[C@H]3[C@@H]4[C@H]([C@H]([C@@]1(C[C@@H]5[C@]2(O5)C(=O)O3)O)C(=O)O4)C(C)(C)O,Picrotoxin,-6.989843,x1311,active-covalent
CC(C)SC(=[NH2+])N,S-Isopropyl-Isothiourea,-6.988349,x0195,active-noncovalent
C[C@H]([C@H](C(=O)[O-])[NH3+])O,D-Threonine,-6.987926,x0397,active-noncovalent
C1CCC(CC1)[NH3+],Cyclohexylammonium Ion,-6.987208,x0678,active-noncovalent
C[C@@H]([C@@H](c1cccc(c1)O)O)[NH3+],Metaraminol,-6.980960,x0946,active-noncovalent
CCS(=O)(=O)CCn1c([nH+]cc1N(=O)=O)C,Tinidazole,-6.980910,x0195,active-noncovalent
C[C@@H]1[C@H](C[C@@H](O1)n2ccc(=O)[nH]c2=O)O,"2',5'-Dideoxyuridine",-6.980674,x1077,active-noncovalent
C[C@H](C[NH+](C)C)[C@@](C)(Cc1ccc(cc1)Cl)O,Clobutinol,-6.979883,x0946,active-noncovalent
c1[nH]c(=O)c2c(n1)n(cn2)[C@H]3CC[C@H](O3)CO,Didanosine,-6.978282,x0874,active-noncovalent
Cc1ccc(c(c1)N)C,"2,5-Xylidine",-6.978009,x0195,active-noncovalent
CC1=C(C(=O)C(=C(C1=O)C)C)C,Duroquinone,-6.976719,x0195,active-noncovalent
CN(C)C(=O)C(CC[NH+]1CCC(CC1)(c2ccc(cc2)Cl)O)(c3ccccc3)c4ccccc4,Loperamide,-6.976212,x1077,active-noncovalent
C1CN[P@](=O)(OC1)N(CCCl)CCCl,Cyclophosphamide,-6.974492,x0678,active-noncovalent
c1ccc(cc1)[C@H](C(=O)[O-])S(=O)(=O)[O-],RU79256,-6.970413,x0678,active-noncovalent
Cn1cnc(=[NH2+])c2c1nc[nH]2,3-Methyladenine,-6.969131,x0426,active-noncovalent
C(CC(=O)N)[C@H](C(=O)[O-])[NH3+],D-Glutamine,-6.966459,x0397,active-noncovalent
C1C[C@H]([NH2+]C1)C(=O)[O-],Proline,-6.964620,x0397,active-noncovalent
C(C[NH+]=C(N)N)CO,Guanidine-3-propanol,-6.964151,x0195,active-noncovalent
c1ccc(cc1)[C@@H](C(=O)[O-])O,(S)-Mandelic acid,-6.961865,x0434,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5ccc(cc5c4[Si](C)(C)C(C)(C)C)O)O,AR-67,-6.961268,x0161,active-noncovalent
CCOC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)C(=O)OCCl,Loteprednol etabonate,-6.956453,x1077,active-noncovalent
c1cc(ccc1C(F)(F)F)[O-],4-(trifluoromethyl)phenol,-6.956327,x0195,active-noncovalent
C[NH+](C)[C@H]1[C@@H]2C[C@@H]3[C@@H](c4c(ccc(c4C(=O)[C@@H]3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)[O-])O)[O-])Cl)O,Demeclocycline,-6.954122,x0831,active-covalent
CC(=O)Nc1c(cc(cc1O)C(=O)[O-])N,4-(ACETYLAMINO)-5-AMINO-3-HYDROXYBENZOIC ACID,-6.950950,x0749,active-covalent
c1(c(c(c(c(c1Br)Br)Br)Br)Br)[O-],Pentabromophenol,-6.949751,x0195,active-noncovalent
CCCCCCCC(=O)[O-],Caprylic acid,-6.941590,x0830,active-covalent
c1ccc(cc1)OP(=O)([O-])[O-],Phenylphosphate,-6.941041,x0830,active-covalent
c1ccc(c(c1)C(=O)[O-])N,Anthranilic acid,-6.940486,x0195,active-noncovalent
CN(CC(=O)[O-])C(=[NH2+])N,Creatine,-6.936517,x0107,active-noncovalent
Cc1cccc(c1)O,M-Cresol,-6.935145,x0678,active-noncovalent
c1ccc2c(c1)n(=O)c(nn2=O)N,Tirapazamine,-6.933386,x0195,active-noncovalent
c1c(ncn1c2[n-]nnn2)C[C@@H](C=O)[NH3+],Tetrazolyl Histidine,-6.931595,x0749,active-covalent
C1[C@@H]2N(C1=O)[C@H](/C(=C/CO)/O2)C(=O)[O-],Clavulanic acid,-6.930803,x0678,active-noncovalent
C1[C@H]([C@@H](C(=O)C[C@]1(C(=O)[O-])O)O)O,3-Dehydroquinic Acid,-6.929134,x0397,active-noncovalent
[H]/N=C(\CC)/C1=N[C@H](CS1)C(=O)[O-],"(4s)-2-[(1e)-1-Aminoprop-1-Enyl]-4,5-Dihydro-1,3-Thiazole-4-Carboxylic Acid",-6.929056,x0830,active-covalent
c1cc(ccc1[C@H]2CO2)N(=O)=O,(S)-4-Nitrostyrene oxide,-6.928142,x0195,active-noncovalent
C1[C@H](NC(=O)S1)C(=O)[O-],Oxothiazolidinecarboxylic acid,-6.924533,x0397,active-noncovalent
CNc1c(c(=O)[nH]c(n1)N)N(=O)=O,6-Methylamino-5-Nitroisocytosine,-6.921386,x0397,active-noncovalent
C[C@@]12CC[C@@H](C1(C)C)C[NH2+]2,"(1r,4s)-2-Azabornane",-6.918400,x0354,active-noncovalent
C1CCC(CC1)NC=O,Cyclohexylformamide,-6.917302,x0195,active-noncovalent
c1ccc(cc1)C(C(=O)[O-])C(=O)[O-],RU78191,-6.916422,x0678,active-noncovalent
COC(=O)CCC(=O)C[NH3+],Methyl aminolevulinate,-6.915980,x0161,active-noncovalent
CC(=C)[C@H]1Cc2c(ccc3c2O[C@@H]4COc5cc(c(cc5[C@@H]4C3=O)OC)OC)O1,Rotenone,-6.911138,x0874,active-noncovalent
C[C@@]12CC[C@@H](C1(C)C)C[C@@H]2O,Borneol,-6.910866,x0354,active-noncovalent
COc1cc(ccc1O)C=C,2-Methoxy-4-Vinyl-Phenol,-6.910066,x0195,active-noncovalent
C1[C@H](CC(=O)C(=O)[C@@H]1O)C(=O)[O-],3-Dehydroshikimate,-6.909518,x0397,active-noncovalent
C1CCC(CC1)CCC(=O)[O-],Cyclohexane Propionic Acid,-6.908438,x0678,active-noncovalent
CC(C)(C)c1c(c(=O)[nH]o1)C[C@@H](C(=O)[O-])[NH3+],"(2S)-2-Ammonio-3-[5-(2-methyl-2-propanyl)-3-oxido-1,2-oxazol-4-yl]propanoate",-6.906281,x0749,active-covalent
C[C@@H]([C@H](C(=O)[O-])[NH3+])OP(=O)([O-])[O-],Phosphonothreonine,-6.905437,x0397,active-noncovalent
CC(=O)Oc1ccc2c3c1O[C@@H]4[C@]35CC[N@@H+]([C@H](C2)[C@@H]5C=C[C@@H]4OC(=O)C)C,Diamorphine,-6.905259,x0072,active-noncovalent
C([C@@H](C(=O)[O-])NC(=O)N)C(=O)[O-],N-Carbamoyl-L-Aspartate,-6.904584,x0397,active-noncovalent
C(=C/C(=O)[O-])\C(=O)[O-],Fumaric Acid,-6.902456,x0397,active-noncovalent
c1cc(c(cc1N(=O)=O)N(=O)=O)Cl,Dinitrochlorobenzene,-6.898301,x0195,active-noncovalent
C(=O)(C(=O)[O-])C(=O)[O-],Alpha-Ketomalonic Acid,-6.889739,x0397,active-noncovalent
C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,Decamethonium,-6.889684,x0749,active-covalent
CO[Si](C)(C)O[Si](C)(C)C,Simethicone,-6.889395,x0161,active-noncovalent
CCCCC[C@H](C)NC=O,(R)-N-(1-Methyl-Hexyl)-Formamide,-6.887155,x0104,active-noncovalent
CCC[C@@H](C)C1(C(=O)NC(=S)NC1=O)CC=C,Thiamylal,-6.882651,x1077,active-noncovalent
CCN(CC)C(=O)N1CC[NH+](CC1)C,Diethylcarbamazine,-6.881789,x0104,active-noncovalent
C(CC[NH3+])C[NH3+],Putrescine,-6.881141,x0678,active-noncovalent
COc1cc(ccc1O)OO,4-Hydroperoxy-2-Methoxy-Phenol,-6.877448,x0195,active-noncovalent
C[C@@]1([C@@H]2CC[C@@H](C2)C1(C)C)[NH2+]C,Mecamylamine,-6.875599,x0354,active-noncovalent
COc1cccc(c1)C(=O)N,3-Methoxybenzamide,-6.874501,x0195,active-noncovalent
C[C@@]([C@H](CC(=O)[O-])C(=O)[O-])(C(=O)[O-])O,Alpha-Methylisocitric Acid,-6.874001,x0397,active-noncovalent
c1cc(ccc1NC[S@@](=O)[O-])S(=O)(=O)c2ccc(cc2)NC[S@@](=O)[O-],Sulfoxone,-6.871513,x0161,active-noncovalent
C(CON)[C@@H](C(=O)[O-])[NH3+],Canaline,-6.868639,x0397,active-noncovalent
C(C[C@@H](C(=O)[O-])[NH3+])C[NH3+],Ornithine,-6.867640,x0426,active-noncovalent
CCN(CC)c1cc(nc2n1ncn2)C,Trapidil,-6.866957,x0195,active-noncovalent
CC(C)C[C@@H](C(=O)NO)[NH3+],L-Leucyl-Hydroxylamine,-6.866472,x0104,active-noncovalent
[C@@H]1(C(=O)[N-]C(=O)N1)NC(=O)N,Alcloxa,-6.866361,x0397,active-noncovalent
CC(=O)Nc1c(cc(cc1O)C(=O)[O-])N(=O)=O,4-(ACETYLAMINO)-3-HYDROXY-5-NITROBENZOIC ACID,-6.865570,x0195,active-noncovalent
C1CN1P(=S)(N2CC2)N3CC3,Thiotepa,-6.864407,x0678,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])S(=O)(=O)[O-],Cysteinesulfonic Acid,-6.864200,x0397,active-noncovalent
CC(C)Cc1c(nccn1)OC,2-Isobutyl-3-Methoxypyrazine,-6.863948,x0397,active-noncovalent
C(CC[NH3+])CC(=O)[O-],Delta-Amino Valeric Acid,-6.863568,x0107,active-noncovalent
c1cc2c(cc1C[C@@H]([C@H](Cc3ccc4c(c3)OCO4)C(=O)[O-])C(=O)[O-])OCO2,"2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid",-6.863161,x0831,active-covalent
c1cc(c(c(c1)O)O)C(=O)N,"Trencam-3,2-Hopo",-6.862690,x0107,active-noncovalent
c1ccc(cc1)[C@@H]2CO2,R-Styrene Oxide,-6.858549,x0195,active-noncovalent
C(C=O)[C@H](C(=O)[O-])[NH3+],Aspartate Semialdehyde,-6.857247,x1077,active-noncovalent
CC[C@@H](C(=O)N)N1CCCC1=O,Etiracetam,-6.857013,x0678,active-noncovalent
CC[C@@H](C(=O)N)N1CCCC1=O,Levetiracetam,-6.857013,x0678,active-noncovalent
C[N@H+]1CCc2cc(c3cc2[C@@H]1Cc4ccc(cc4)Oc5c6c(cc(c5O)OC)CC[N+]([C@@H]6Cc7ccc(c(c7)O3)O)(C)C)OC,Tubocurarine,-6.856276,x0161,active-noncovalent
Cn1c(=O)n2cnc(c2nn1)C(=O)N,Temozolomide,-6.853195,x0195,active-noncovalent
C1CCC(C1)(C(=O)[O-])[NH3+],Cycloleucine,-6.851056,x0689,active-covalent
Cn1c2c(c(=O)[nH]c(=O)[nH]2)[nH]c1=O,9-Methyl Uric Acid,-6.851008,x0195,active-noncovalent
COc1cc(cc(c1O)OC)/C=C/C(=O)[O-],SINAPINATE,-6.849241,x0678,active-noncovalent
c1c(cc(cc1Cl)Cl)Cl,"1,3,5-Trichloro-Benzene",-6.846482,x0195,active-noncovalent
CC(C)C[C@H](C(=O)[O-])[NH2+]C,N-Methylleucine,-6.844419,x0397,active-noncovalent
CSCC[C@@H](C(=O)[O-])[NH3+],Methionine,-6.843937,x0397,active-noncovalent
CS(=O)(=O)c1cc(c(cc1Cl)c2cc(c(cc2Cl)S(=O)(=O)C)Cl)Cl,"4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL",-6.843736,x0874,active-noncovalent
C[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2[C@H](CC[C@]3([C@H]1C5)O)O)O,Hydromorphinol,-6.842316,x0874,active-noncovalent
Cc1ccc(cc1c2ccc(cc2)C(=O)Nc3cccc(c3)C#N)c4nnc(o4)C,"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxa",-6.841299,x0104,active-noncovalent
Cc1ccc(c(c1)O)O,"4-Methyl-1,2-Benzenediol",-6.840804,x0195,active-noncovalent
COc1c(c(nc(c1Cl)OC)C(Cl)(Cl)Cl)Cl,Penclomedine,-6.839565,x0195,active-noncovalent
CC(=O)CCC(=O)[O-],Laevulinic Acid,-6.838971,x0397,active-noncovalent
c1cn(c(=O)nc1N)[C@@H]2CS[C@@H](O2)CO,Lamivudine,-6.838600,x0830,active-covalent
C1[C@H]([C@@H](C=C[C@]1(C(=O)[O-])O)O)O,"2,3-Anhydro-quinic acid",-6.838379,x0397,active-noncovalent
CC(=O)N1CCC[C@H]1C(=O)[O-],N-Acetylproline,-6.837784,x0397,active-noncovalent
COc1cc(ccc1O)CO,Vanillyl alcohol,-6.836990,x0195,active-noncovalent
C[C@@]1([C@@H]2CC[C@@H](C2)C1(C)C)[NH2+]C,Dexmecamylamine,-6.836729,x0354,active-noncovalent
Cc1ccc(cc1)O,P-Cresol,-6.833539,x0678,active-noncovalent
COc1cc(ccc1O)C(=O)[O-],Vanillic acid,-6.831812,x0195,active-noncovalent
C1CC(=O)N[C@@H]1C(=O)[O-],Pidolic acid,-6.830359,x0397,active-noncovalent
CC[C@]1(CC(=O)NC1=O)C,Ethosuximide,-6.826540,x0678,active-noncovalent
CC1=[NH+]C(=[NH2+])C(=C)C=N1,4-Imino-5-Methidyl-2-Methylpyrimidine,-6.825720,x1077,active-noncovalent
Cc1cn(c(=O)[nH]c1=O)[C@@H]2C[C@H]([C@@H](O2)CO)O,Telbivudine,-6.824641,x1385,active-covalent
Cc1cc[nH]c1,5-Methylpyrrole,-6.820171,x0678,active-noncovalent
Cc1[nH+]cc(n1CCO)N(=O)=O,Metronidazole,-6.818151,x0195,active-noncovalent
c1cc(c(c(c1)F)S(=O)(=O)N)F,"2,6-Difluorobenzenesulfonamide",-6.816015,x0195,active-noncovalent
c1cc(ccc1C[NH3+])S(=O)(=O)N,Mafenide,-6.814958,x0161,active-noncovalent
C(C[NH3+])[C@@H](C(=O)[O-])[NH3+],"L-2,4-diaminobutyric acid",-6.811644,x0397,active-noncovalent
CC[C@]1(C(=O)N(C(=O)O1)C)C,Paramethadione,-6.809840,x0678,active-noncovalent
c1(c(c(c(c(c1Br)N)Br)C(=O)[O-])Br)C(=O)[O-],"5-amino-2,4,6-tribromobenzene-1,3-dicarboxylic acid",-6.809451,x1478,active-covalent
CCC[C@@H](C)C1(C(=O)NC(=O)NC1=O)CC=C,Secobarbital,-6.798752,x1077,active-noncovalent
C[C@@H](C[C@@H](C(=O)[O-])[NH3+])CF,(4s)-5-Fluoro-L-Leucine,-6.798565,x0195,active-noncovalent
CC[C@@H](C)[C@@H](C(=O)[O-])[NH3+],Allo-Isoleucine,-6.793243,x1077,active-noncovalent
C[75Se]CC[C@@H](C(=O)[O-])[NH3+],Selenomethionine Se-75,-6.791201,x0397,active-noncovalent
C[Se]CC[C@@H](C(=O)[O-])[NH3+],Selenomethionine,-6.791201,x0397,active-noncovalent
c1cn(c(=O)nc1N)[C@H]2CC[C@H](O2)CO,Zalcitabine,-6.789504,x0967,active-noncovalent
C[C@@H]1NC(=[NH+]C(=[NH+]1)N(C)C)N,Imeglimin,-6.788079,x1077,active-noncovalent
CC[C@@H](C)c1nccs1,2-(Sec-Butyl)Thiazole,-6.787253,x0195,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])[S@](=O)[O-],3-sulfino-L-alanine,-6.786350,x0397,active-noncovalent
c1cn2c(n1)[C@@H]([C@H]([C@@H](C2)O)O)O,Xylose-Derived Imidazole,-6.777059,x0397,active-noncovalent
C[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2C(=O)CC[C@]3([C@H]1C5)O)O,Oxymorphone,-6.776961,x1334,active-covalent
C(OC(C(F)(F)F)C(F)(F)F)F,Sevoflurane,-6.775061,x0678,active-noncovalent
Cc1cc(c(cc1Cl)Cl)S(=O)(=O)c2c(cc(cc2N(=O)=O)C(F)(F)F)N(=O)=O,"2-[(2,4-DICHLORO-5-METHYLPHENYL)SULFONYL]-1,3-DINITRO-5-(TRIFLUOROMETHYL)BENZENE",-6.774424,x0874,active-noncovalent
CCC(=O)N(c1ccccc1)C2(CC[NH+](CC2)CCc3cccs3)COC,Sufentanil,-6.774042,x1392,active-covalent
C([C@@H](C(=O)[O-])O)S(=O)(=O)[O-],(R)-2-Hydroxy-3-Sulfopropanoic Acid,-6.773255,x0397,active-noncovalent
Cn1cnc2c1c(=O)[nH]c(=O)n2C,Theobromine,-6.771730,x0678,active-noncovalent
c1ccc(cc1)[C@H](C(=O)[O-])O,(R)-Mandelic acid,-6.769610,x0678,active-noncovalent
c1(n[nH]c(=S)s1)N,"5-amino-1,3,4-thiadiazole-2-thiol",-6.764985,x0397,active-noncovalent
C1=C([C@@H](NC(=[NH+]1)O)O)F,"5-Fluoro-4-(S)-Hydroxy-3,4-Dihydropyrimidine",-6.764815,x0678,active-noncovalent
CC[C@H](C)[C@@H](C(=O)[O-])[NH3+],Isoleucine,-6.761021,x0426,active-noncovalent
C[C@@H]1CC(=O)C=C([C@]12C(=O)c3c(cc(c(c3O2)Cl)OC)OC)OC,Griseofulvin,-6.760086,x0161,active-noncovalent
CC(=O)OC[C@@H](C(=O)[O-])[NH3+],O-acetyl-L-serine,-6.757511,x0397,active-noncovalent
CC(C)C[C@H](C(=O)[O-])[NH3+],D-Leucine,-6.756269,x0397,active-noncovalent
c1c(cc(c(c1NC(=O)C(=O)[O-])Cl)NC(=O)C(=O)[O-])C#N,Lodoxamide,-6.754840,x0195,active-noncovalent
C[C@@]12CC[C@@H](C1(C)C)CC2=O,Camphor,-6.752044,x0354,active-noncovalent
C(C(=O)[O-])[NH+]=C(N)N,Glycocyamine,-6.751967,x0107,active-noncovalent
C1CC(=O)N(C1)CC(=O)N,Piracetam,-6.751506,x0195,active-noncovalent
CC1=CC[C@@](CC1)(C(C)C)O,Terpinen-4-ol,-6.751224,x0195,active-noncovalent
C[C@H]1C[C@@H](c2cc(sc2S1(=O)=O)S(=O)(=O)N)[NH2+]C,"(4s-Trans)-4-(Methylamino)-5,6-Dihydro-6-Methyl-4h-Thieno(2,3-B)Thiopyran-2-Sulf",-6.748824,x1093,active-noncovalent
c1[nH]c2c(=O)[nH]c(nc2n1)Br,2-Bromo-6-Hydroxy-Purine,-6.746253,x0195,active-noncovalent
C[C@@]12[C@H]3CC[C@@H]([C@@]1(C(=O)OC2=O)C)O3,Cantharidin,-6.741804,x0678,active-noncovalent
Cc1c(c(ncn1)C)C(=O)N2CCC(CC2)(C)[N@H+]3CC[N@@]([C@H](C3)C)[C@@H](COC)c4ccc(cc4)C(F)(F)F,Vicriviroc,-6.740479,x0104,active-noncovalent
CC(C)[C@@H]([C@@H](C(=O)[O-])[NH3+])O,Beta-Hydroxyleucine,-6.740348,x0397,active-noncovalent
C(CC(=O)[O-])[C@@H](C(=O)[O-])NC(=O)N,Carglumic acid,-6.738369,x0397,active-noncovalent
CO[C@H]1[C@@H]([C@H]([C@@H](O[C@@H]1C(=O)[O-])O)O)O,4-O-methyl-beta-D-glucuronic acid,-6.736392,x0397,active-noncovalent
Cc1c(cccc1F)N,3-Fluoro-2-Methyl-Aniline,-6.734136,x0354,active-noncovalent
CCC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)OC(=O)C)[NH+]5CCCCC5)C)C)[N+]6(CCCCC6)CC=C,Rapacuronium,-6.733075,x0104,active-noncovalent
C1[C@H]([C@@H]2[C@H](O1)[C@H](CO2)ON(=O)=O)ON(=O)=O,Isosorbide dinitrate,-6.730387,x0195,active-noncovalent
c1cc(nc(c1)C(=O)[O-])C(=O)[O-],Dipicolinic Acid,-6.730226,x0397,active-noncovalent
c1cc(ccc1C(=O)[O-])N,Aminobenzoic acid,-6.729932,x0678,active-noncovalent
c1cc(cc(c1)Cl)O,3-Chlorophenol,-6.729534,x0678,active-noncovalent
c1ccc(cc1)C(=O)[O-],Benzoic acid,-6.727146,x0195,active-noncovalent
C=C1C=NC(=[NH+]C1=[NH2+])C(F)(F)F,4-Imino-5-Methidyl-2-Trifluoromethylpyrimidine,-6.726896,x0387,active-noncovalent
c1ccc(c(c1)O)Br,o-Bromophenol,-6.726497,x0678,active-noncovalent
C[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2C(=O)CC[C@]3([C@H]1C5)O)OC,Oxycodone,-6.725407,x0678,active-noncovalent
c1cn(c(=O)nc1N)[C@H]2/C(=C/F)/[C@@H]([C@H](O2)CO)O,Tezacitabine,-6.722871,x0195,active-noncovalent
c1cc(cc(c1)N)C(=O)[O-],Gabaculine,-6.720776,x0678,active-noncovalent
CC1=C([C@@](SC1=O)(C)/C=C/C=C)[O-],"(5R)-5-[(1E)-BUTA-1,3-DIENYL]-4-HYDROXY-3,5-DIMETHYLTHIOPHEN-2(5H)-ONE",-6.714650,x0397,active-noncovalent
CC1(C2CCC1(CC2)C)C,Camphane,-6.711880,x0354,active-noncovalent
CC(=O)Nc1ccc(cc1)S(=O)(=O)Cl,N-acetylsulfanilyl chloride,-6.709066,x0749,active-covalent
c1cc(c(cc1[S-])C(=O)[O-])N(=O)=O,5-Mercapto-2-Nitro-Benzoic Acid,-6.706492,x0195,active-noncovalent
c1cc(c(cc1C(=O)[O-])O)O,"3,4-Dihydroxybenzoic Acid",-6.704190,x0195,active-noncovalent
Cc1ccc(c(c1)N(=O)=O)[O-],2-Nitro-P-Cresol,-6.703740,x0195,active-noncovalent
CSCC[C@H]([NH3+])[P@H](=O)[O-],Methionine Phosphinate,-6.703384,x0397,active-noncovalent
c1c(c(c([nH]1)C[NH3+])CC(=O)[O-])CCC(=O)[O-],Porphobilinogen,-6.700338,x1311,active-covalent
Cc1c(c(c(cn1=O)COP(=O)([O-])[O-])C=O)O,Pyridoxal-5'-Phosphate-N-Oxide,-6.694534,x0397,active-noncovalent
CC(C)C[C@@H](CC(=O)[O-])C[NH3+],Pregabalin,-6.694026,x0426,active-noncovalent
C[N@@H+](CC(=O)[O-])C(N)N,(Diaminomethyl-Methyl-Amino)-Acetic Acid,-6.692634,x0397,active-noncovalent
[C@@H]1([C@@H]([C@@H](O[C@H]([C@@H]1O)O)C(=O)[O-])O)O,alpha-L-iduronic acid,-6.690486,x0397,active-noncovalent
C(C(=O)[O-])[NH+](CC(=O)[O-])CC(=O)[O-],Nitrilotriacetic Acid,-6.687152,x0397,active-noncovalent
CC(C)(C)NC(=O)[C@@H]1CCCC[NH2+]1,PIPERIDINE-2-CARBOXYLIC ACID TERT-BUTYLAMIDE,-6.686109,x0195,active-noncovalent
Cc1c(c(c(cn1)COP(=O)([O-])[O-])C[NH2+][C@@](C)(CCC(=O)[O-])C(=O)[O-])O,N-PYRIDOXYL-2-METHYL-L-GLUTAMIC ACID-5'-MONOPHOSPHATE,-6.685467,x0749,active-covalent
CC(C)C[C@]1(C[C@@H]([C@@H](N1C(=O)c2ccc(cc2)C(C)(C)C)c3nccs3)C(=O)[O-])C(=O)[O-],"(2S,4S,5R)-1-(4-TERT-BUTYLBENZOYL)-2-ISOBUTYL-5-(1,3-THIAZOL-2-YL)PYRROLIDINE-2,",-6.681684,x0831,active-covalent
c1cc(cc(c1)N(=O)=O)N(=O)=O,Dinitrophenylene,-6.678761,x0195,active-noncovalent
C(CC(=O)[O-])C(=O)C[NH3+],Aminolevulinic acid,-6.677773,x0426,active-noncovalent
c1cc(ccc1F)S(=O)(=O)N,4-Flourobenzenesulfonamide,-6.677448,x0678,active-noncovalent
C1C[C@H](CN=C1)[NH3+],"(3s)-2,3,4,5-Tetrahydropyridin-3-Amine",-6.676554,x0426,active-noncovalent
C[C@H](CCC(=O)[O-])[C@H]1CC[C@@H]2[C@@]1(C(=O)C[C@H]3[C@H]2C(=O)C[C@H]4[C@@]3(CCC(=O)C4)C)C,Dehydrocholic acid,-6.675861,x0104,active-noncovalent
C1COCCN1CC[NH3+],N-Aminoethylmorpholine,-6.674809,x0397,active-noncovalent
CCCC(CCC)C(=O)[O-],Valproic acid,-6.672935,x0397,active-noncovalent
C[N@H+]1[C@H]2CC[C@@H]1[C@H]([C@H](C2)O)C(=O)[O-],Ecgonine,-6.672307,x0678,active-noncovalent
C[C@]12CC[C@H](C1(C)C)CC2=O,(S)-camphor,-6.672303,x0678,active-noncovalent
C(CC=O)C[C@@H](C(=O)[O-])[NH3+],2-Amino-6-Oxo-Hexanoic Acid,-6.669080,x1386,active-covalent
C(C(=O)[O-])P(=O)([O-])[O-],Phosphonoacetic Acid,-6.665718,x0397,active-noncovalent
CC(C)C[C@@H](C(=O)[O-])[NH3+],Leucine,-6.664870,x0397,active-noncovalent
C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)Cc4ccccc4)NC(=O)[C@@H]5C[C@@H]6c7cccc8c7c(c[nH]8)C[C@H]6[N@@H+](C5)C,Dihydroergotamine,-6.664672,x0161,active-noncovalent
c1ccc(cc1)[S@](=O)[O-],Benzenesulfinic acid,-6.664037,x0678,active-noncovalent
CCSC(=[NH2+])N,S-Ethylisothiourea,-6.663584,x0195,active-noncovalent
c1cc(ccc1CC(=O)[O-])N(=O)=O,2-(4-NITROPHENYL)ACETIC ACID,-6.663364,x0195,active-noncovalent
COc1ccccc1O,Guaiacol,-6.662649,x0678,active-noncovalent
C(CCO)C[C@@H](C(=O)[O-])[NH3+],6-hydroxy-L-norleucine,-6.662601,x0397,active-noncovalent
c1ccc(c(c1)O)Cl,2-Chlorophenol,-6.661001,x0678,active-noncovalent
C[C@@H]1C(=O)O[C@@H]2[C@]1([C@@]34C(=O)O[C@H]5[C@]3(C2)[C@@]6([C@@H]([C@H]5O)C(C)(C)C)[C@H](C(=O)O[C@H]6O4)O)O,ginkgolide-J,-6.659510,x0874,active-noncovalent
c1ccnc(c1)C(=O)[O-],Zinc picolinate,-6.658438,x1382,active-covalent
Cc1cccc(c1O)O,"3-methyl-benzene-1,2-diol",-6.657676,x0195,active-noncovalent
CCNc1nc(nc(n1)Cl)NC(C)C,"2-CHLORO-4-ISOPROPYLAMINO-6-ETHYLAMINO -1,3,5-TRIAZINE",-6.656612,x0195,active-noncovalent
c1c(c(=O)[nH]c(=O)n1C[C@@H](C(=O)[O-])[NH3+])Br,Bromo-Willardiine,-6.656386,x0830,active-covalent
CC(=O)N[C@@H](CS)C(=O)[O-],Acetylcysteine,-6.654838,x0397,active-noncovalent
c1c(cn[nH]1)I,4-Iodopyrazole,-6.653956,x1077,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])OP(=O)([O-])[O-],Dexfosfoserine,-6.650231,x0397,active-noncovalent
CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(c(c(c2)C(C)(C)C)O)C(C)(C)C,Probucol,-6.645323,x0161,active-noncovalent
c1cc(ccc1C(=O)[O-])O,P-Hydroxybenzoic Acid,-6.644961,x0195,active-noncovalent
[H]/N=C/1\[C@@H](C(=O)C2=C(C1=O)[C@H]([C@@]3([N@]2C[C@H]4[C@@H]3[NH2+]4)OC)COC(=O)N)C,Mitomycin,-6.644881,x1311,active-covalent
c1c(c([nH]c(=O)n1)N)F,Flucytosine,-6.641623,x0397,active-noncovalent
CC(=O)Nc1ccc(cc1NC(=O)CO)C(=O)[O-],4-(Acetylamino)-3-[(Hydroxyacetyl)Amino]Benzoic Acid,-6.638350,x1187,dimer-interface
CC(=O)c1ccc(c(c1)OC)O,Apocynin,-6.638061,x0161,active-noncovalent
CC(C)([C@H](C(=O)[O-])[NH3+])S,Penicillamine,-6.635518,x0397,active-noncovalent
Cc1c(scn1)CCO,4-Methyl-5-Hydroxyethylthiazole,-6.634696,x0195,active-noncovalent
C(C(=O)N)C(=O)[O-],3-Amino-3-Oxopropanoic Acid,-6.634367,x0397,active-noncovalent
C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O)[NH3+])O)O)O,Glucosamine,-6.631167,x0195,active-noncovalent
CCCC[C@@H](C=O)[NH3+],1-Amino-1-Carbonyl Pentane,-6.630626,x1077,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])SO,S-Hydroxycysteine,-6.628985,x0397,active-noncovalent
CCC1(C(=O)NC(=O)NC1=O)c2ccccc2,Barbexaclone,-6.628639,x0195,active-noncovalent
CCC1(C(=O)NC(=O)NC1=O)c2ccccc2,Phenobarbital,-6.628639,x0195,active-noncovalent
CC(=O)Nc1c(c(c(c(c1I)N(C)C(=O)C)I)C(=O)[O-])I,Metrizoic acid,-6.628449,x1418,active-covalent
c1(c([nH]c(=O)[nH]c1=O)N)N,"5,6-Diaminouracil",-6.623201,x1077,active-noncovalent
COc1cccc(c1OP(=O)([O-])[O-])C=O,RU78300,-6.622682,x0195,active-noncovalent
CC(C)(C(=O)[O-])NC(=O)c1ccc2c(c1)n3c(c2C4CCCCC4)-c5ccccc5OCC3,"N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-ME",-6.620663,x0434,active-noncovalent
CCCC[C@H]1CC[S@](=O)C1,3-Butylthiolane 1-Oxide,-6.620502,x0195,active-noncovalent
CCOP(=O)([O-])[O-],Ethyl Dihydrogen Phosphate,-6.618809,x0397,active-noncovalent
C[P@@](=O)([O-])Oc1ccc(cc1)N(=O)=O,METHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER,-6.617151,x0195,active-noncovalent
CCC[C@@H](C(=O)[O-])[NH3+],Norvaline,-6.616121,x0397,active-noncovalent
c1c(cc(cc1F)F)N,"3,5-Difluoroaniline",-6.610943,x0678,active-noncovalent
Cc1c(c(c(cn1)COP(=O)([O-])[O-])C[NH2+][C@@H](C)P(=O)([O-])[O-])O,{1-[(3-Hydroxy-Methyl-5-Phosphonooxy-Methyl-Pyridin-4-Ylmethyl)-Amino]-Ethyl}-Ph,-6.607976,x0830,active-covalent
COc1ccc(cc1)[S@](=O)[O-],4-methoxybenzenesulfinate,-6.605054,x0195,active-noncovalent
C(C(CO)OP(=O)([O-])[O-])O,Glycerol-2-Phosphate,-6.604873,x0397,active-noncovalent
[C@H](C(=O)[O-])(C(F)(F)F)[NH3+],Trifluoroalanine,-6.604339,x0397,active-noncovalent
C(CCC[NH3+])CC[NH3+],"1,6-Diaminohexane",-6.601397,x1077,active-noncovalent
C1[C@H]2N1C(=O)NC2=[NH2+],Imexon,-6.598052,x0104,active-noncovalent
C[C@@H](C(=O)[O-])NC(=O)C,N-Acetylalanine,-6.594541,x0397,active-noncovalent
C[C@@H]([C@@H]([C@H]1CNc2c(c(=O)[nH]c(n2)N)N1)O)O,Sapropterin,-6.594530,x1077,active-noncovalent
CN1CC(=O)NC1=[NH2+],Creatinine,-6.591959,x1077,active-noncovalent
C=CCNc1nc(nc(n1)N2CC[NH+](CC2)C(c3ccc(cc3)F)c4ccc(cc4)F)NCC=C,Almitrine,-6.584793,x0161,active-noncovalent
CC(=CC[C@@H]1[C@@](O1)(C)[C@]2([C@@H](C(=O)CC[C@@]2(C)O)OC)O)C,Ovalicin,-6.584764,x0830,active-covalent
CC(=O)Nc1ccc(cc1N)C(=O)[O-],4-(Acetylamino)-3-Amino Benzoic Acid,-6.583210,x0749,active-covalent
[C@@H](C(F)(F)F)(OC(F)F)Cl,Isoflurane,-6.580067,x0195,active-noncovalent
CC(=O)c1ccccc1,Acetophenone,-6.579109,x0161,active-noncovalent
CC(=O)Nc1ccc(cc1)C(=O)[O-],Acedoben,-6.577055,x0749,active-covalent
CC(C)C[C@H](C(=O)OC)N(C(=O)C)O,2-(ACETYL-HYDROXY-AMINO)-4-METHYL-PENTANOIC ACID METHYL ESTER,-6.574590,x0678,active-noncovalent
C1C[NH2+]CC(=C1)C(=O)[O-],Guvacine,-6.571605,x0397,active-noncovalent
Cc1nccn1C,"2,3-Dimethylimidazolium Ion",-6.570694,x0195,active-noncovalent
Cc1c[nH]c(=O)[nH]c1=O,Thymine,-6.569574,x0678,active-noncovalent
C1[C@@H]([C@H]([C@@H]([NH2+]1)CO)O)O,"2-Hydroxymethyl-Pyrrolidine-3,4-Diol",-6.567926,x0397,active-noncovalent
COc1ccc(cc1)O,Mequinol,-6.567737,x0195,active-noncovalent
C[C@@H]1C(=O)O[C@@H]2[C@]1([C@@]34C(=O)O[C@H]5[C@]3(C2)[C@@]6([C@@H](C5)C(C)(C)C)[C@H](C(=O)O[C@H]6O4)O)O,Ginkgolide A,-6.567110,x0874,active-noncovalent
C(CC[NH3+])CC[NH3+],"Pentane-1,5-Diamine",-6.565961,x0195,active-noncovalent
c1ccc(cc1)CO,Benzyl alcohol,-6.565585,x0195,active-noncovalent
c1ccc(c(c1)N)F,2-Fluoroaniline,-6.556680,x0678,active-noncovalent
C(CCO)CC(=O)[O-],5-hydroxyvaleric acid,-6.554106,x0107,active-noncovalent
C(=C(/C(=O)[O-])\O)\O,3-Hydroxypyruvic Acid,-6.550343,x0397,active-noncovalent
C(CCC(=O)[O-])CCC(=O)[O-],Pimelic Acid,-6.548163,x0397,active-noncovalent
c1ccc(cc1)N,Aniline,-6.547737,x0678,active-noncovalent
c1c(n(cn1)P(=O)([O-])[O-])C[C@@H](C(=O)[O-])[NH3+],Nd1-Phosphonohistidine,-6.543983,x0734,active-covalent
Cc1cnc(nc1N)C,"2,5-Dimethylpyrimidin-4-Amine",-6.542530,x0397,active-noncovalent
C=C(CCP(=O)([O-])[O-])C=O,(3-Formyl-but-3-Enyl)-Phosphonic Acid,-6.539027,x0397,active-noncovalent
c1c(cc(cc1O)O)O,Phloroglucinol,-6.537689,x0678,active-noncovalent
CC(=O)O[C@H]1[C@H]([C@@H]2[C@]([C@H](CCC2(C)C)O)([C@@]3([C@@]1(O[C@@](CC3=O)(C)C=C)C)O)C)O,Colforsin,-6.535344,x0967,active-noncovalent
CCCCCCC(=O)N,Heptanamide,-6.534652,x0104,active-noncovalent
Cc1cc(c(c(c1)C=O)OP(=O)([O-])[O-])C=O,RU78299,-6.534353,x0736,active-covalent
CSCC[C@@H](C(=O)[O-])NC(=O)[O-],N-Carboxymethionine,-6.531823,x0107,active-noncovalent
Cc1c(cc(cc1N(=O)=O)N(=O)=O)N(=O)=O,Trinitrotoluene,-6.531733,x0195,active-noncovalent
c1ccc(c(c1)CO)N,2-Aminobenzyl alcohol,-6.530681,x0195,active-noncovalent
CC[C@H](C)C1(C(=O)NC(=O)NC1=O)CC=C,Talbutal,-6.528949,x0104,active-noncovalent
C[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2[C@H](CC[C@H]3[C@H]1C5)O)OC,Dihydrocodeine,-6.528854,x0305,active-noncovalent
CC1(C(=O)Nc2c(=O)[nH]c(nc2N1)N)C,"7,8-dihydro-7,7-dimethyl-6-hydroxypterin",-6.526858,x1386,active-covalent
C([C@H](C(=O)[O-])[NH3+])S,D-Cysteine,-6.523105,x0397,active-noncovalent
c1ccc(c(c1)O)O,"1,2-Dihydroxybenzene",-6.522794,x0678,active-noncovalent
CC(C)(C)c1cc(c(cc1NC(=O)c2c[nH]c3ccccc3c2=O)O)C(C)(C)C,Ivacaftor,-6.520783,x1093,active-noncovalent
C[N+](C)(C)C[C@@H](CC(=O)[O-])O,Levocarnitine,-6.519732,x0830,active-covalent
C[N+](C)(C)C[C@@H](CC(=O)[O-])O,(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium,-6.519732,x0830,active-covalent
CC(=O)NCc1c(c(c(c(c1I)NC(=O)C)I)C(=O)[O-])I,Iodamide,-6.516819,x0830,active-covalent
CC(C)c1cc(c(c(c1)C(C)C)S(=O)(=O)N[C@@H](Cc2cccc(c2)C(=[NH2+])N)C(=O)N3CCN(CC3)C(=O)CC[NH3+])C(C)C,"[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Be",-6.515148,x0104,active-noncovalent
Cc1c[nH]nc1,Fomepizole,-6.513643,x0678,active-noncovalent
c1c(c(=O)[nH]c(=O)[nH]1)I,5-Iodouracil,-6.508505,x0678,active-noncovalent
CC[C@H](CCC(=O)[O-])[NH3+],4-Amino Hexanoic Acid,-6.507660,x0426,active-noncovalent
C1[C@H]([NH2+]CS1)C(=O)[O-],L-thioproline,-6.506055,x0397,active-noncovalent
c1c[nH+]cc(c1N)N,Amifampridine,-6.505768,x0354,active-noncovalent
c1ccc(cc1)C(P(=O)([O-])[O-])P(=O)([O-])[O-],RU78783,-6.503935,x0678,active-noncovalent
C[C@@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)[O-])Cn3ccnn3,Tazobactam,-6.503598,x1412,active-covalent
[C@@H]1([C@@H]([C@H](O[C@@H]([C@H]1O)O)C(=O)[O-])O)O,D-Mannuronic Acid,-6.503077,x0397,active-noncovalent
C([C@@H](CO)C(=O)[O-])[NH3+],Beta-3-Serine,-6.498003,x0397,active-noncovalent
C[N@]1C(=C(c2c(cc(s2)Cl)S1(=O)=O)O)C(=O)Nc3ccccn3,Lornoxicam,-6.496785,x0195,active-noncovalent
Cc1c(c(c(cn1)COP(=O)([O-])[O-])C[NH2+]CC(=O)[O-])O,N-Pyridoxyl-Glycine-5-Monophosphate,-6.490295,x0540,active-noncovalent
C1C[C@@H]2C[C@H]1CC2=O,Norcamphor,-6.489439,x0195,active-noncovalent
CCC[C@@H](C)C1(C(=O)NC(=O)NC1=O)CC,Pentobarbital,-6.486618,x0195,active-noncovalent
CC(C)(CO)C(=O)C(=O)[O-],2-Dehydropantoate,-6.485159,x0397,active-noncovalent
C[C@@H]1C(=O)O[C@@H]2[C@]1([C@@]34C(=O)O[C@H]5[C@]3([C@H]2O)[C@@]6([C@@H](C5)C(C)(C)C)[C@H](C(=O)O[C@H]6O4)O)O,ginkgolide-B,-6.482668,x0946,active-noncovalent
C1CNc2c(c(=O)c2=O)N(C1)CCP(=O)([O-])[O-],Perzinfotel,-6.476309,x1311,active-covalent
[H]/N=C(/CC)\CCC(=O)[O-],(4e)-4-Aminohex-4-Enoic Acid,-6.476119,x0759,active-covalent
C1[C@@H]2[C@@H](C=C[C@]1(C[C@H](O2)C(=O)[O-])C(=O)[O-])O,"(1R,3S,5S,8R)-8-Hydroxy-2-oxabicyclo[3.3.1]non-6-ene-3,5-dicarboxylic acid",-6.474741,x0397,active-noncovalent
CC(C)c1c(nccn1)OC,2-Methoxy-3-Isopropylpyrazine,-6.468586,x0397,active-noncovalent
CC(=O)Nc1c(cc(c(c1I)C(=O)[O-])I)I,Acetrizoic acid,-6.461906,x0195,active-noncovalent
CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)[O-])C,Sulbactam,-6.461625,x0678,active-noncovalent
C1CC1(C(=O)[O-])[NH3+],1-Aminocyclopropanecarboxylic Acid,-6.460526,x1077,active-noncovalent
c1cc(cc(c1)N(=O)=O)CC(=O)[O-],2-(3-NITROPHENYL)ACETIC ACID,-6.460202,x1385,active-covalent
C([C@H](CS)[NH3+])C(=O)[O-],Beta-3-Cysteine,-6.457094,x0397,active-noncovalent
CSSC[C@@H](C(=O)[O-])[NH3+],S-Methyl Thiocysteine Group,-6.455029,x0830,active-covalent
C/C(=C(/C(=O)[O-])\[NH3+])/O,2-Amino-3-Ketobutyric Acid,-6.451915,x0397,active-noncovalent
CC(=O)N[C@H]1CCc2cc(c(c(c2-c3c1cc(=O)c(cc3)OC)OC)OC)OC,Colchicine,-6.450075,x0874,active-noncovalent
[C@@H](C(F)(F)F)(OC(F)F)F,Desflurane,-6.448938,x0195,active-noncovalent
[O-][Si]([O-])([O-])O[Si]([O-])([O-])[O-],Kaolin,-6.447465,x1382,active-covalent
c1(c(=O)[nH]c(nc1[O-])N)N,"2,5-Diaminopyrimidin-4,6-diol",-6.445490,x0397,active-noncovalent
Cc1c(scn1)CCOP(=O)([O-])[O-],4-Methyl-5-Hydroxyethylthiazole Phosphate,-6.445377,x0678,active-noncovalent
c1c(cc(c(c1Br)[O-])Br)Br,"2,4,6-Tribromophenol",-6.442406,x0195,active-noncovalent
CN(C)C1=[NH+][C@@H]2[C@H]([C@@H]([C@H]([C@@H]2O1)CO)O)O,Allosamizoline,-6.441592,x0195,active-noncovalent
CC[C@H](C)C1(C(=O)NC(=O)NC1=O)CC,Butabarbital,-6.430714,x0104,active-noncovalent
C[Si]1(O[Si](O[Si](O[Si](O[Si](O1)(C)C)(C)C)(C)C)(C)C)C,Cyclomethicone 5,-6.427023,x0774,active-covalent
CSCC[C@H](C(=O)[O-])NC(=O)N,N-Carbamyl-D-Methionine,-6.426527,x0107,active-noncovalent
c1c(cc(cc1F)S(=O)(=O)N)F,"3,5-Difluorobenzenesulfonamide",-6.425664,x0195,active-noncovalent
[H]/N=C(\CC)/C(=O)[O-],Z-Dehydrobutyrine,-6.419198,x0397,active-noncovalent
C[NH+](CCCl)CCCl,Mechlorethamine,-6.419176,x0104,active-noncovalent
c1cc(ccc1N)S(=O)(=O)N,Sulfanilamide,-6.414182,x0678,active-noncovalent
c1ccc(cc1)I,Iodophenyl,-6.410590,x0678,active-noncovalent
C/C=C\C(=O)C(=O)[O-],2-Oxo-3-Pentenoic Acid,-6.408948,x0397,active-noncovalent
c1cc(ccc1C(=O)[O-])Cl,p-Chlorobenzoic acid,-6.408443,x0195,active-noncovalent
C1CCN(CC1)C=O,N-Formylpiperidine,-6.406695,x0195,active-noncovalent
CC1(C(=O)N(C(=O)O1)C)C,Trimethadione,-6.405789,x0195,active-noncovalent
CS(=O)(=O)Nc1ccc(cc1)C(=O)[O-],4-[(METHYLSULFONYL)AMINO]BENZOIC ACID,-6.404823,x0195,active-noncovalent
c1ccc(c(c1)N)O,2-Aminophenol,-6.397197,x0678,active-noncovalent
c1c(occ(c1=O)[O-])CO,Kojic acid,-6.397096,x0397,active-noncovalent
C1[C@@H](O1)C[C@@H](C(=O)[O-])[NH3+],3-Oxiran-2ylalanine,-6.392528,x1402,active-covalent
C([C@H](C(=O)[O-])[NH3+])O,D-Serine,-6.391307,x0397,active-noncovalent
CC(C)/N=c\1/cc-2n(c3ccccc3nc2cc1Nc4ccc(cc4)Cl)c5ccc(cc5)Cl,Clofazimine,-6.391025,x0161,active-noncovalent
C[C@@]12CC[C@]3(CCC(C[C@H]3[C@H]1C(=O)C=C4[C@]2(CC[C@@H]5[C@@]4(C=C(C(=O)C5(C)C)C#N)C)C)(C)C)C(=O)[O-],Bardoxolone,-6.384450,x1077,active-noncovalent
C=c1c(=O)/c(=C\[O-])/c(c[nH]1)CO,Pyridoxal,-6.384388,x1093,active-noncovalent
CC(C)C[C@]1(C[C@@H]([C@@H](N1C(=O)c2ccc(cc2)C(F)(F)F)c3cccs3)C(=O)[O-])C(=O)[O-],"(2S,4S,5R)-2-ISOBUTYL-5-(2-THIENYL)-1-[4-(TRIFLUOROMETHYL)BENZOYL]PYRROLIDINE-2,",-6.380241,x1077,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])SS,S-Mercaptocysteine,-6.377731,x0397,active-noncovalent
CC[C@@H](C)C(=O)[O-],2-Methylbutanoic Acid,-6.372119,x0397,active-noncovalent
CSCCC(=O)C(=O)[O-],4-(Methylsulfanyl)-2-Oxobutanoic Acid,-6.372084,x0397,active-noncovalent
CC(=O)SC[C@@H](C(=O)[O-])[NH3+],S-Acetyl-Cysteine,-6.371180,x0397,active-noncovalent
C(CC(=O)[O-])C[NH3+],gamma-Aminobutyric acid,-6.370827,x0397,active-noncovalent
CC(C)(C)[C@@H](C(=O)NC)[NH3+],"2-Amino-N,3,3-Trimethylbutanamide",-6.370217,x0946,active-noncovalent
c1(c(=O)[nH]sn1)C(=O)[O-],"4-oxo-4,5-dihydro-1,2,5-thiadiazole-3-carboxylic acid",-6.368380,x0397,active-noncovalent
Cn1ccc(nc1=O)N,1-Methylcytosine,-6.368200,x0678,active-noncovalent
C1CSC(=[NH+]1)N,2-Aminothiazoline,-6.367793,x1077,active-noncovalent
C(C(F)(F)F)(C(F)(F)F)(F)F,Perflutren,-6.367108,x0195,active-noncovalent
CCOC(=O)C[C@@H](C(=O)OCC)SP(=S)(OC)OC,Malathion,-6.365399,x1077,active-noncovalent
C[NH2+]CC(=O)[O-],Sarcosine,-6.365326,x0397,active-noncovalent
C[C@H](C(C)(C)C)O[P@@H](=O)C,"(1R)-1,2,2-trimethylpropyl (R)-methylphosphinate",-6.361247,x0678,active-noncovalent
C[N+]1(CCC[C@H]1C(=O)[O-])C,L-proline betaine,-6.356004,x0678,active-noncovalent
c1ccc(cc1)O,Phenol,-6.355002,x0678,active-noncovalent
C[C@@H]1CC=N[C@H]1C(=O)[O-],4-Methyl-Pyrroline-5-Carboxylic Acid,-6.354576,x1478,active-covalent
C([C@@H]1[C@H]([C@@H]([C@@H]([C@@H](O1)F)F)O)O)O,2-deoxy-2-fluoro-alpha-D-mannosyl fluoride,-6.351585,x0195,active-noncovalent
CC1(CCC(=O)N1C)C,"1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine",-6.346446,x0195,active-noncovalent
c1cc[nH]c(=S)c1,2-Pyridinethiol,-6.342711,x0678,active-noncovalent
CCO[P@@](=O)([O-])OP(=O)([O-])[O-],Ethyl Dihydrogen Diphosphate,-6.340615,x0397,active-noncovalent
CC[C@](C)([C@H](C(=O)[O-])O)O,"2,3-Dihydroxy-Valerianic Acid",-6.340594,x0397,active-noncovalent
COc1ccc(cc1)C(=O)[O-],P-Anisic Acid,-6.339252,x0195,active-noncovalent
C[C@H]1[C@H]([C@H]([C@@H]([C@H](O1)O)O)O)O,beta-L-fucose,-6.338554,x0397,active-noncovalent
c1c(ncs1)C(=O)[O-],"1,3-Thiazole-4-Carboxylic Acid",-6.335241,x0689,active-covalent
CC(C)OP(=O)([O-])[O-],Phosphorylisopropane,-6.332303,x0397,active-noncovalent
c1cc(ccc1N(=O)=O)OP(=O)([O-])[O-],4-Nitrophenyl Phosphate,-6.331973,x0749,active-covalent
Cc1ncc(c(n1)N)CO,4-Amino-5-Hydroxymethyl-2-Methylpyrimidine,-6.331808,x1077,active-noncovalent
COC[C@@]1(C(=O)C2CC[NH+]1CC2)CO,APR-246,-6.325886,x0354,active-noncovalent
c1cc(cc(c1)O)O,Resorcinol,-6.319438,x0678,active-noncovalent
C[C@@H]1C[C@H]([NH2+][C@H]1C(=O)[O-])N(C)[O-],5-(Hydroxy-Methyl-Amino)-3-Methyl-Pyrrolidine-2-Carboxylic Acid,-6.318424,x0705,active-covalent
C([C@@H](C(=O)[O-])[NH3+])[SeH],Selenocysteine,-6.311335,x1077,active-noncovalent
C(CS)[C@@H](C(=O)[O-])[NH3+],2-Amino-4-Mercapto-Butyric Acid,-6.308956,x0689,active-covalent
C1=C(O[C@H]([C@H]([C@H]1O)O)O)C(=O)[O-],4-Deoxy-D-Mannuronic Acid,-6.305320,x0397,active-noncovalent
C[C@@H]1C[C@@H]([NH2+][C@H]1C(=O)[O-])S(=O)(=O)[O-],3-Methyl-5-Sulfo-Pyrrolidine-2-Carboxylic Acid,-6.303784,x0397,active-noncovalent
C[NH+]1[C@@H]2CC[C@H]1CC(=O)C2,Tropinone,-6.302260,x0354,active-noncovalent
CCCCCCC(=O)[O-],Heptanoic Acid,-6.299717,x0397,active-noncovalent
c1cc(c(cc1N(=O)=O)O)[O-],4-Nitrocatechol,-6.293223,x0195,active-noncovalent
Cc1cc2c(c(c1OC)O)[C@@H]3[C@@H]4[C@H]5c6c(c7c(c(c6OC(=O)C)C)OCO7)[C@@H]([N@]4[C@H]([C@H](C2)[N@@H+]3C)O)COC(=O)[C@@]8(CS5)c9cc(c(cc9CC[NH2+]8)O)OC,Trabectedin,-6.292303,x1249,active-noncovalent
CCC1(C(=O)NC(=O)NC1=O)CCC(C)C,Amobarbital,-6.290393,x0874,active-noncovalent
Cc1cc(ccc1[C@H]2C[C@H](CCN2C(=O)N(C)[C@H](C)c3cc(cc(c3)C(F)(F)F)C(F)(F)F)[NH+]4CCN(CC4)C(=O)C)F,Casopitant,-6.290189,x0104,active-noncovalent
C(CO)[C@@H](C(=O)[O-])[NH3+],L-Homoserine,-6.284571,x0397,active-noncovalent
CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc1ccccc1Cl)Cc2ccccc2Cl,Ambenonium,-6.281774,x0107,active-noncovalent
C[C@H]([C@@H](C(=O)[O-])[NH3+])N,"L-threo-2,3-diamino-butyric acid",-6.280921,x0397,active-noncovalent
C1[C@@H]([C@H](CO[C@@H]1C(=O)[O-])O)O,"4,5-Dihydroxy-Tetrahydro-Pyran-2-Carboxylic Acid",-6.280810,x0397,active-noncovalent
C(CC(=O)[O-])C(=O)CF,5-Fluorolevulinic Acid,-6.280064,x0397,active-noncovalent
Cc1ccccc1,Toluene,-6.273493,x0195,active-noncovalent
C[C@H]1[C@H](O1)P(=O)([O-])[O-],Fosfomycin,-6.271924,x0397,active-noncovalent
C[C@@H](C(=O)[O-])[NH3+],Alanine,-6.264976,x0397,active-noncovalent
C1C=CCO[C@H]2[C@H]1O[C@@H]3C[C@H]4[C@@H](C=C[C@H]5[C@H](O4)C/C=C\[C@@H]([C@H](O5)CO)O)O[C@H]3[C@@H]2O,"(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-",-6.263030,x1077,active-noncovalent
CCn1c(ccc1O)O,"1-Ethyl-Pyrrolidine-2,5-Dione",-6.262587,x0678,active-noncovalent
CC(C)(CO)[C@H](C(=O)[O-])O,"2,4-Dihydroxy-3,3-Dimethyl-Butyrate",-6.257701,x0397,active-noncovalent
C[C@@H]1C[C@H]([NH2+][C@H]1C(=O)[O-])N[O-],5-Hydroxyamino-3-Methyl-Pyrrolidine-2-Carboxylic Acid,-6.254636,x0397,active-noncovalent
C1C[C@H]([NH2+][C@@H]1CC(=O)[O-])C(=O)[O-],"(2s,5s)-5-Carboxymethylproline",-6.253024,x0195,active-noncovalent
C[C@@]12C[C@H]([C@@H](C1(C)C)CC2=O)O,5-Exo-Hydroxycamphor,-6.251203,x0354,active-noncovalent
[C@@H]([C@@H](C(=O)[O-])S)(C(=O)[O-])S,Succimer,-6.250427,x0397,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])n1c(=O)[n-]c(=O)o1,Quisqualate,-6.245317,x0195,active-noncovalent
c1cc(c(cc1CC(=O)[O-])N(=O)=O)[O-],2-(4-HYDROXY-3-NITROPHENYL)ACETIC ACID,-6.238655,x1418,active-covalent
c1ccn(=O)c(c1)[S-],Pyrithione,-6.231613,x0678,active-noncovalent
C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)OC(=O)CCC(=O)[O-])C)(C)C(=O)[O-],Carbenoxolone,-6.229280,x0434,active-noncovalent
C[NH+](C)C[C@H]1CCCC[C@@]1(c2cccc(c2)OC)O,Tramadol,-6.227813,x0395,active-noncovalent
Cc1c(c(=O)cco1)[O-],Gallium maltolate,-6.223444,x0397,active-noncovalent
c1c(o[nH]c1=O)C[NH3+],Muscimol,-6.222374,x0708,active-covalent
C(C(=O)[O-])N(C=O)O,Hadacidin,-6.222205,x0397,active-noncovalent
C1C(=O)[N-]C(=O)S1,"2,4-thiazolidinedione",-6.221619,x0397,active-noncovalent
C[C@H](C[NH3+])C(=O)[O-],Beta-Amino Isobutyrate,-6.219296,x0397,active-noncovalent
C/C(=C\C=C\C=C(\C=C\C=C(\C(=O)[O-])/C)/C)/C=C/C=C(/C(=O)[O-])\C,Transcrocetinate,-6.219119,x0395,active-noncovalent
[C@H](C(OC(F)F)(F)F)(F)Cl,Enflurane,-6.215681,x0195,active-noncovalent
Cc1c(c(=O)ccn1C)[O-],Deferiprone,-6.215428,x0195,active-noncovalent
C1CCC(CC1)O,Cyclohexanol,-6.213742,x0678,active-noncovalent
CCOP(=S)(O)OCC,"O,O-DIETHYL HYDROGEN THIOPHOSPHATE",-6.211982,x1077,active-noncovalent
C1CC(=NC1)C(=O)[O-],"3,4-Dihydro-2h-Pyrrolium-5-Carboxylate",-6.211822,x0689,active-covalent
C(CCCBr)CCO,6-Bromo-1-hexanol,-6.211179,x0195,active-noncovalent
C(CC(=O)[O-])CO,Sodium oxybate,-6.211149,x0397,active-noncovalent
C(CC(=O)[O-])CO,gamma-Hydroxybutyric acid,-6.211149,x0397,active-noncovalent
C1CNCCNCCCNCCNC1,Cu-Cyclam,-6.209218,x0749,active-covalent
c1c[nH+]ccc1N,Dalfampridine,-6.206439,x0678,active-noncovalent
CC(C)N(C(=O)C(=O)[O-])O,N-Hydroxy-N-Isopropyloxamic Acid,-6.206164,x0689,active-covalent
B(CCCC)(O)O,1-Butane Boronic Acid,-6.206142,x0195,active-noncovalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)O,Pseudotropine,-6.203678,x0678,active-noncovalent
CC(C)[C@@H](C(=O)[O-])[NH3+],Valine,-6.202316,x0689,active-covalent
CC(C)C1(C(=O)NC(=O)NC1=O)CC=C,Aprobarbital,-6.201305,x1077,active-noncovalent
c1cc(oc1CO)C=O,5-(hydroxymethyl)-2-furaldehyde,-6.187746,x0195,active-noncovalent
C1C[C@@H]([NH2+]C1)C(=O)[O-],D-Proline,-6.183886,x0397,active-noncovalent
c1cc(ccc1N(=O)=O)[O-],P-Nitrophenol,-6.183648,x0195,active-noncovalent
c1cc(c(cc1N(=O)=O)N(=O)=O)[O-],"2,4-Dinitrophenol",-6.177756,x0195,active-noncovalent
C(C=O)P(=O)([O-])[O-],Phosphonoacetaldehyde,-6.174208,x0397,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)[O-],Para-Toluene Sulfonate,-6.172543,x0161,active-noncovalent
C[N+](C)(C)CCOC(=O)N,Carbamoylcholine,-6.171899,x0678,active-noncovalent
C[C@H]1[C@H]([C@H]([C@@H]([C@H](O1)O)OC)O)O,2-O-methyl fucose,-6.171655,x0397,active-noncovalent
CCCCC1(C(=O)NC(=O)NC1=O)CC,Butobarbital,-6.171080,x0874,active-noncovalent
C1[NH+]2CN3CN1CN(C2)C3,Methenamine,-6.170158,x0354,active-noncovalent
c1cc(ccc1CCCCc2ccc(cc2)C(F)(F)P(=O)([O-])[O-])C(F)(F)P(=O)([O-])[O-],[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Ph,-6.164916,x0107,active-noncovalent
Cc1cc(cc(c1O[C@H](Cc2ccccc2)C(=O)[O-])C)c3c4ccccc4c(c5c3c(c(s5)C)C)Br,Ertiprotafib,-6.161595,x0107,active-noncovalent
CC(C)OP(=O)(OC(C)C)F,Isoflurophate,-6.160890,x0397,active-noncovalent
C(C(F)(F)F)OCC(F)(F)F,Flurothyl,-6.159462,x0195,active-noncovalent
CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1[NH+]4CCCCC4)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C,Vecuronium,-6.159317,x0104,active-noncovalent
C[C@@H](C[N+](C)(C)C)OC(=O)C,Methacholine,-6.149840,x0195,active-noncovalent
C[C@@H](C[N+](C)(C)C)OC(=O)N,Bethanechol,-6.148996,x0678,active-noncovalent
C(C(=O)NO)OP(=O)([O-])[O-],Phosphoglycolohydroxamic Acid,-6.148524,x0397,active-noncovalent
Cc1c[nH]cn1,4-Methylimidazole,-6.145905,x0678,active-noncovalent
C1[C@@H](C(=O)NC1=O)[NH3+],(S)-Aspartimide,-6.145794,x0397,active-noncovalent
C(C[C@@H](C(=O)[O-])[NH3+])CO,5-Hydroxy Norvaline,-6.142746,x0830,active-covalent
CC(C)C(=O)C(=O)[O-],alpha-Ketoisovalerate,-6.141923,x0397,active-noncovalent
C1COC(=O)[C@@H]1[NH3+],Homoserine Lactone,-6.135716,x0195,active-noncovalent
CCC[C@@H](C)C1(C(=O)NC(=S)NC1=O)CC,Thiopental,-6.134953,x0874,active-noncovalent
CC(C)CC(=O)C(=O)[O-],2-Oxo-4-Methylpentanoic Acid,-6.131216,x0689,active-covalent
c1c(c(=O)[nH]c(=O)[nH]1)F,Fluorouracil,-6.128564,x0678,active-noncovalent
CC(C)(C(=O)[O-])[NH3+],Alpha-Aminoisobutyric Acid,-6.127037,x0397,active-noncovalent
C(C[NH3+])C(=O)[O-],Beta-Alanine,-6.126671,x0426,active-noncovalent
C1[C@@H](C(=O)NC(=O)N1)I,"(5S)-5-Iododihydro-2,4(1H,3H)-pyrimidinedione",-6.126539,x0678,active-noncovalent
[C@H]([C@@H](C(=O)N)O)(C(=O)[O-])[NH3+],beta-Hydroxyasparagine,-6.126353,x0426,active-noncovalent
CCCC(CCC)C(=O)N,Valpromide,-6.121942,x0874,active-noncovalent
C=C[C@@H](C(=O)[O-])[NH3+],Vinylglycine,-6.116640,x0397,active-noncovalent
CC(=O)OCC[N+](C)(C)C,Acetylcholine,-6.115171,x0161,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])O,Serine,-6.114371,x0397,active-noncovalent
[C@@H]1(C(=O)NC(=O)N1)NC(=O)N,Allantoin,-6.096950,x0397,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])C(=O)N,Asparagine,-6.092141,x0397,active-noncovalent
[C@@H]1([C@@H]([C@@H]([C@H]([C@@H]([C@@H]1Cl)Cl)Cl)Cl)Cl)Cl,Lindane,-6.085452,x0072,active-noncovalent
CCC1(C(=O)NC(=O)NC1=O)CC,Barbital,-6.082006,x0354,active-noncovalent
C([C@@H]1[C@@H]([C@@H]([C@H](C(=O)O1)O)O)O)O,D-Galctopyranosyl-1-On,-6.078040,x0678,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])S,Cysteine,-6.072908,x1077,active-noncovalent
C[C@H]([C@@H](C(=O)[O-])[NH3+])O,Threonine,-6.072842,x0397,active-noncovalent
c1c(c(cc(c1C(=O)[O-])C(=O)[O-])C(=O)[O-])C(=O)[O-],Pyromellitic Acid,-6.070957,x1478,active-covalent
C(C(F)F)C(F)(F)F,Pentafluoropropane,-6.070294,x0195,active-noncovalent
c1c(cc(c(c1N(=O)=O)[O-])N(=O)=O)N(=O)=O,Picric acid,-6.070100,x0397,active-noncovalent
COC(=O)/C=C/C(=O)OC,Dimethyl fumarate,-6.069678,x0749,active-covalent
C1[C@@H]([C@H]([C@H](C=C1CO)[NH3+])O)O,"1-Amino-2,3-Dihydroxy-5-Hydroxymethyl Cyclohex-5-Ene",-6.068528,x0161,active-noncovalent
c1cc2c(c[nH]c2c(c1)NS(=O)(=O)c3ccc(cc3)S(=O)(=O)N)Cl,Indisulam,-6.062252,x0104,active-noncovalent
c1cc2c(cc1S(=O)(=O)[O-])cc(cc2S(=O)(=O)[O-])S(=O)(=O)[O-],Naphthalene Trisulfonate,-6.061737,x1418,active-covalent
CC(=O)N[C@@H](CCSC)C(=O)[O-],N-Acetylmethionine,-6.060469,x0397,active-noncovalent
C([C@H](C[P@@H](=O)[O-])F)[NH3+],Lesogaberan,-6.060042,x0397,active-noncovalent
CCCCCON=O,Amyl Nitrite,-6.057952,x0678,active-noncovalent
C/C(=C/C(=O)[O-])/O,Acetoacetic Acid,-6.053140,x0397,active-noncovalent
C(C(=O)[O-])[NH3+],Glycine,-6.051857,x0397,active-noncovalent
CC(C)C[C@H](C(=O)NO)C(=O)[O-],1-Hydroxyamine-2-Isobutylmalonic Acid,-6.047060,x0397,active-noncovalent
C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@@H]3c4cc5c(cc4[C@H]([C@@H]6[C@@H]3COC6=O)c7cc(c(c(c7)OC)O)OC)OCO5)O)O,Etoposide,-6.047008,x0678,active-noncovalent
C[C@@H](CC1CC1)C=O,2-Cyclopropylmethylenepropanal,-6.046959,x0195,active-noncovalent
C1C[C@H]([C@@H]2[C@@H]([C@@H](C[N@H+]2C1)O)O)O,Tridolgosir,-6.040407,x0195,active-noncovalent
Cc1c([nH]c(=O)[nH]c1=O)CCCO,6-Hydroxypropylthymine,-6.039154,x0107,active-noncovalent
c1cc([nH]c1)C(=O)[O-],Pyrrole-2-Carboxylate,-6.038464,x0397,active-noncovalent
C[N+](C)(C)CC(=O)[O-],Glycine betaine,-6.036696,x0397,active-noncovalent
C[N+](C)(C)CC(=O)[O-],"N,N,N-trimethylglycinium",-6.036696,x0397,active-noncovalent
C[N+](C)(C)CC(=O)[O-],Chloral betaine,-6.036696,x0397,active-noncovalent
C1CCC(=O)CC1,Cyclohexanone,-6.033341,x0678,active-noncovalent
C1CC(=O)N[C@@H]1C=O,5-Oxo-Pyrrolidine-2-Carbaldehyde,-6.031752,x0397,active-noncovalent
C[NH+](C)C1=CCC2=C(c3ccc(cc3OC2=C1)N(C)C)c4ccc(cc4C(=O)[O-])N5C(=O)C=CC5=O,Tmr,-6.030475,x0434,active-noncovalent
C#C[C@@H](C(=O)[O-])[NH3+],L-2-amino-3-butynoic acid,-6.028115,x0397,active-noncovalent
CCCC(=O)[O-],Butyric Acid,-6.025297,x0397,active-noncovalent
c1c[nH]nc1,Pyrazole,-6.021192,x0397,active-noncovalent
CCCCC[C@@H](C=C)O,(S)-oct-1-en-3-ol,-6.020276,x0195,active-noncovalent
C[NH+]1CCN(CC1)C(=O)[O-],4-Methylpiperazin-1-Yl Carbonyl Group,-6.019269,x0104,active-noncovalent
C1COCC[NH+]1CCS(=O)(=O)[O-],2-(N-Morpholino)-Ethanesulfonic Acid,-6.017156,x0678,active-noncovalent
c1c(cc(cc1C(=O)[O-])C(=O)[O-])C(=O)[O-],"1,3,5-BENZENETRICARBOXYLIC ACID",-6.008542,x0397,active-noncovalent
C(=O)(C(=O)[O-])[O-],Oxalic Acid,-6.006968,x0397,active-noncovalent
C[C@@]1(OC[C@@H]2[C@@H](O1)[C@@H]([C@@H]([C@@H](O2)O)O)O)C(=O)[O-],"[4,6-O-(1-CARBOXYETHYLIDENE)-BETA-D-MANNOSE]",-6.000655,x0195,active-noncovalent
CC(=O)OP(=O)([O-])[O-],Acetylphosphate,-5.996526,x0397,active-noncovalent
CC(C)[C@H](C(=O)[O-])NC(=O)N,N-Carbamyl-D-Valine,-5.993633,x0104,active-noncovalent
Cn1ccnc1,1-Methylimidazole,-5.993622,x0397,active-noncovalent
S1SSSSSSS1,Technetium Tc-99m sulfur colloid,-5.975908,x0195,active-noncovalent
S1SSSSSSS1,Octasulfur,-5.975908,x0195,active-noncovalent
c1c([nH]c(=O)[nH]c1=O)C(=O)[O-],Orotic Acid,-5.968839,x0397,active-noncovalent
CC(C)CCC(=O)[O-],4-Methyl Valeric Acid,-5.967275,x0397,active-noncovalent
C(CCCO)CCO,"Hexane-1,6-Diol",-5.964829,x0195,active-noncovalent
CCN(CC)[P@](=O)([O-])OCC,ETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE,-5.961185,x0397,active-noncovalent
C(CC(=O)[O-])C(=O)[O-],Succinic acid,-5.959443,x0397,active-noncovalent
C[NH+](C)CC(=O)[O-],"N,N-dimethylglycine",-5.951606,x0107,active-noncovalent
CC[C@]1(C[C@@H](c2c(c(c3c(c2[O-])C(=O)c4c(cccc4OC)C3=O)[O-])[C@H]1C(=O)OC)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)[NH+](C)C)O,4-Methoxy-E-Rhodomycin T,-5.951217,x0072,active-noncovalent
CCCCC(=O)OC[C@H](CO[P@@](=S)(OCC[N+](C)(C)C)S)OC(=O)CCCC,"1,2-Di-N-Pentanoyl-Sn-Glycero-3-Dithiophosphocholine",-5.949663,x0072,active-noncovalent
C[C@@H]1C[C@@H]([NH2+][C@H]1C(=O)[O-])N,5-Amino-3-Methyl-Pyrrolidine-2-Carboxylic Acid,-5.948622,x0397,active-noncovalent
c1c2c(c-3cc(c(=O)c(c3oc2c(c(c1I)[O-])I)I)I)c4c(c(c(c(c4Cl)Cl)Cl)Cl)C(=O)[O-],Rose bengal,-5.948451,x0831,active-covalent
CC[Si](C)(C)C,Ethyl-Trimethyl-Silane,-5.947805,x0678,active-noncovalent
CC(C)OP(=O)OC(C)C,Diisopropylphosphono Group,-5.938944,x0397,active-noncovalent
CC/C(=N\C)/C(=O)[O-],N-Methyldehydrobutyrine,-5.918810,x1402,active-covalent
CCOC(=O)c1ccc(nc1)C#Cc2ccc3c(c2)C(CCS3)(C)C,Tazarotene,-5.918032,x1077,active-noncovalent
C[C@H](C(=O)[O-])NC(=O)N,N-Carbamoyl-Alanine,-5.913508,x0397,active-noncovalent
C(CP(=O)([O-])[O-])N(C=O)O,[2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid,-5.892597,x0397,active-noncovalent
CC[N+](C)(C)CCCS(=O)(=O)[O-],Ethyl Dimethyl Ammonio Propane Sulfonate,-5.882131,x0749,active-covalent
c1([nH]c(=O)[nH]c(=O)n1)C(=O)[O-],Oteracil,-5.875919,x0397,active-noncovalent
C(C[NH3+])C(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],Pamidronic acid,-5.871498,x0397,active-noncovalent
CCN1C(=O)C=CC1=O,N-Ethylmaleimide,-5.871104,x0195,active-noncovalent
C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O)O)O)OS(=O)(=O)[O-])O,O4-Sulfonylgalactose,-5.868514,x0397,active-noncovalent
CC[C@](/C=C/Cl)(C#C)O,Ethchlorvynol,-5.865373,x0708,active-covalent
C1[C@@H]([C@@H]2[C@H](O1)[C@@H](CO2)ON(=O)=O)O,Isosorbide mononitrate,-5.864551,x0678,active-noncovalent
C[C@@H]1/C=C/C(=O)NC/C=C/C(=C/[C@H](CC(=O)Cc2nc(co2)C(=O)N3CCC=C3C(=O)O[C@@H]1C(C)C)O)/C,Virginiamycin M1,-5.864255,x0161,active-noncovalent
C1[C@H]([NH2+]CS1)C(=O)[O-],Timonacic,-5.857564,x0397,active-noncovalent
c1[nH]ncn1,"1,2,4-Triazole",-5.856149,x0107,active-noncovalent
CCC(=O)C(=O)[O-],2-Oxobutanoic Acid,-5.855773,x0397,active-noncovalent
C[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O)O)O)[NH3+],"4,6-dideoxy-4-amino-alpha-D-glucose",-5.854641,x0708,active-covalent
CC(=O)N(CCOP(=O)([O-])[O-])Br,N-Bromoacetyl-Aminoethyl Phosphate,-5.854582,x0397,active-noncovalent
CC(C)C[C@H](CS)C(=O)[O-],2-(Thiomethylene)-4-Methylpentanoic Acid,-5.851783,x1386,active-covalent
C[C@@H](C(=O)NCC(=O)[O-])S,Tiopronin,-5.850543,x1402,active-covalent
C[C@H](CC(C)C)[NH3+],Leucine - Reduced Carbonyl,-5.845722,x1093,active-noncovalent
c1cc(ccc1c2cc(n3c(n2)c(cn3)C#Cc4ccc(nc4)N)C(F)(F)F)C(F)(F)F,Decoglurant,-5.844538,x0434,active-noncovalent
C(=O)([O-])P(=O)([O-])[O-],Foscarnet,-5.842930,x0397,active-noncovalent
CCOP(=O)OCC,Diethylphosphono Group,-5.840910,x0397,active-noncovalent
C(P(=O)([O-])[O-])P(=O)([O-])[O-],Technetium Tc-99m medronate,-5.840721,x0397,active-noncovalent
CC(C)OP(=O)(C)OC(C)C,Methylphosphonic Acid Diisopropyl Ester,-5.832283,x0397,active-noncovalent
CCN(CC)C(=S)S,Ditiocarb,-5.822183,x0195,active-noncovalent
C(CN(C=O)O)CP(=O)([O-])[O-],Fosmidomycin,-5.811556,x0397,active-noncovalent
C12C(NC(=O)N1)NC(=O)N2,Glycoluril,-5.806830,x0397,active-noncovalent
CC(C)[C@H](C(=O)NO)[NH3+],Hydroxyaminovaline,-5.805089,x0946,active-noncovalent
CCCCC[NH3+],Amylamine,-5.799589,x0678,active-noncovalent
c1c(c(=O)[nH]c(=O)[nH]1)N,"5-Amino-1h-Pyrimidine-2,4-Dione",-5.788424,x0678,active-noncovalent
c1cc(ncc1Cl)NC(P(=O)([O-])[O-])P(=O)([O-])[O-],"[{(5-Chloro-2-Pyridinyl)Amino} Methylene]-1,1-Bisphosphonate",-5.784945,x0831,active-covalent
C1[C@H]([C@@H](CSS1)O)O,"(4S,5S)-1,2-dithiane-4,5-diol",-5.774488,x0195,active-noncovalent
CC(C)CC(=O)[O-],Isovaleric Acid,-5.773857,x0689,active-covalent
CCC(=O)CCC(C)(C)O,6-Hydroxy-6-Methyl-Heptan-3-One,-5.768620,x0104,active-noncovalent
CCN(CC)C(=O)[C@H]1C[N@H+]2CCc3cc(c(cc3[C@@H]2C[C@@H]1OC(=O)C)OC)OC,Benzquinamide,-5.759775,x1077,active-noncovalent
CC(=O)/N=c\1/n(nc(s1)S(=O)(=O)N)C,Methazolamide,-5.754275,x0195,active-noncovalent
[H]/N=C(\C)/C(=O)[O-],2-Iminiopropanoate,-5.745897,x0397,active-noncovalent
[H]/N=C(\C)/C(=O)[O-],"2,3-Didehydroalanine",-5.745897,x0397,active-noncovalent
B1(OCCO1)O,"1,3,2-Dioxaborolan-2-Ol",-5.740666,x0195,active-noncovalent
CO[C@H]1[C@@H]([C@H]([C@H](O[C@@H]1C(=O)[O-])O)O)O,4-O-methyl-alpha-D-glucuronic acid,-5.739815,x0397,active-noncovalent
C1=CNC(=O)N[C@H]1O,"(4S)-4-hydroxy-3,4-dihydro-2(1H)-pyrimidinone",-5.739654,x0678,active-noncovalent
C1C[C@@H](OC1)C(=O)[O-],Tetrahydrofuran-2-Carboxylic Acid,-5.736467,x0397,active-noncovalent
c1c[nH]c(=O)[nH]c1=O,Uracil,-5.734784,x0678,active-noncovalent
CC1([NH2+][C@@H](CS1)C(=O)[O-])C,"2,2-Dimethylthiazolidine-4-Carboxylic Acid;(Dmt)Thiazolidine",-5.732477,x1478,active-covalent
C1[C@H]([C@@H]([C@H](ON1)CO)O)O,Tetrahydrooxazine,-5.731580,x0397,active-noncovalent
C1COCC[NH+]1CCCS(=O)(=O)[O-],3[N-Morpholino]Propane Sulfonic Acid,-5.726455,x0104,active-noncovalent
CCCCC(=O)[O-],N-Valeric Acid,-5.724632,x0689,active-covalent
C1[C@@H]([C@H](CSS1)O)O,"(4R,5R)-1,2-dithiane-4,5-diol",-5.713419,x0195,active-noncovalent
C[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)O)O)[NH3+],"4,6-dideoxy-4-amino-beta-D-glucopyranoside",-5.709976,x0107,active-noncovalent
CSCC(=O)[O-],[Methylthio]Acetate,-5.708950,x0397,active-noncovalent
c1(c([nH]c(=O)[nH]c1=O)N(=O)=O)N,5-Amino 6-Nitro Uracil,-5.702998,x0678,active-noncovalent
CC(=O)NCCCS(=O)(=O)[O-],Acamprosate,-5.700923,x0397,active-noncovalent
C(C(=O)[O-])(NC(=O)N)NC(=O)N,Allantoate,-5.689588,x0397,active-noncovalent
CCOP(=O)(OCC)OCC,Triethyl Phosphate,-5.688455,x0195,active-noncovalent
C(=[NH2+])(N)N,Guanidine,-5.680868,x0104,active-noncovalent
C1[C@@H]([C@H]([C@@H]([C@H]([NH2+]1)CO)O)O)O,Duvoglustat,-5.679975,x0397,active-noncovalent
C1[C@H]([C@H](O[C@@H]([C@H]1O)CO)O)[NH3+],3-Deoxy-D-Glucosamine,-5.679798,x0195,active-noncovalent
C[C@H](C(=O)[O-])O,Ammonium lactate,-5.675188,x0397,active-noncovalent
C[C@H](C(=O)[O-])O,D-Lactic acid,-5.675188,x0397,active-noncovalent
C[C@H](C(=O)[O-])O,Potassium lactate,-5.675188,x0397,active-noncovalent
C[C@H](C(=O)[O-])O,Lactic acid,-5.675188,x0397,active-noncovalent
CC(C)(CS(=O)(=O)[O-])N(Cl)Cl,Auriclosene,-5.670508,x0678,active-noncovalent
N([P@@](=O)([O-])OP(=O)([O-])[O-])P(=O)([O-])[O-],(Diphosphono)Aminophosphonic Acid,-5.665191,x0397,active-noncovalent
CCCOC(=O)C,Propyl acetate,-5.656629,x0195,active-noncovalent
C/C(=N\C)/C(=O)[O-],N-Methyl-Alpha-Beta-Dehydroalanine,-5.653899,x0689,active-covalent
C1C[N@@H+]2C[C@@H]([C@H]([C@@H]([C@H]2[C@H]1O)O)O)O,Castanospermine,-5.653402,x1077,active-noncovalent
C([C@@H](C(=O)N)[NH3+])S,Cysteinamide,-5.646763,x0104,active-noncovalent
C[Se]CC(=O)[O-],[Methylseleno]Acetate,-5.633389,x0107,active-noncovalent
C1CCC(CC1)N,Satraplatin,-5.630394,x0678,active-noncovalent
[C@@H](C(F)(F)F)(Cl)Br,Halothane,-5.628587,x0678,active-noncovalent
C1CNC(=O)NC1=O,"3,4-Dihydrouracil",-5.626685,x0397,active-noncovalent
[O-]P(=O)([O-])OP(=O)([O-])[O-],Ferric pyrophosphate,-5.626267,x0397,active-noncovalent
[O-]P(=O)([O-])OP(=O)([O-])[O-],Pyrophosphoric acid,-5.626267,x0397,active-noncovalent
[O-]P(=O)([O-])OP(=O)([O-])[O-],Technetium Tc-99m pyrophosphate,-5.626267,x0397,active-noncovalent
c1cc(c(cc1N(=O)=O)OS(=O)(=O)[O-])[O-],"N,4-Dihydroxy-N-Oxo-3-(Sulfooxy)Benzenaminium",-5.623071,x0397,active-noncovalent
C[C@@]1([C@@H](CO[P@](=O)(O[P@@](=O)(O1)[O-])[O-])O)CO,"2c-Methyl-D-Erythritol 2,4-Cyclodiphosphate",-5.622752,x0678,active-noncovalent
CC(=O)Nc1c(c(c(c(c1I)NC(=O)C)I)C(=O)[O-])I,Diatrizoate,-5.603374,x0195,active-noncovalent
C(CCO)C[NH3+],4-Hydroxybutan-1-Aminium,-5.603105,x0708,active-covalent
CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],Etidronic acid,-5.594781,x0397,active-noncovalent
OP(=O)(O)[O-],"Sodium phosphate, monobasic",-5.593920,x0397,active-noncovalent
OP(=O)(O)[O-],Monopotassium phosphate,-5.593920,x0397,active-noncovalent
CC(C)C(=O)[O-],Isobutyric acid,-5.586948,x0397,active-noncovalent
C(CO)C(=O)[O-],3-Hydroxy-Propanoic Acid,-5.586916,x0397,active-noncovalent
CC(=O)Nc1c(c(c(c(c1I)C(=O)[O-])I)C(=O)NC)I,Iothalamic acid,-5.586296,x0967,active-noncovalent
C[N+](C)(C)c1ccc(cc1)CNC(=O)c2cc3cc(ccc3n2Cc4cccc(c4)C(=[NH2+])N)OCc5ccccc5,[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl,-5.581244,x0104,active-noncovalent
CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(c(c(c2)C(C)(C)C)OC(=O)CCC(=O)[O-])C(C)(C)C,Succinobucol,-5.575253,x0072,active-noncovalent
CCCCP(=O)([O-])[O-],Butylphosphonate,-5.564268,x0397,active-noncovalent
CN1CCCC1=O,Methyl pyrrolidone,-5.550745,x1187,dimer-interface
C1[C@H]([C@@H]2[C@H](O1)[C@H](CO2)O)O,Isosorbide,-5.546425,x0678,active-noncovalent
CN(C)c1nc(nc(n1)N(C)C)N(C)C,Altretamine,-5.540484,x0195,active-noncovalent
CC(=O)Nc1nnc(s1)S(=O)(=O)N,Acetazolamide,-5.539082,x0195,active-noncovalent
C[C@@H](C(=O)[O-])[NH+](C)C,"N,N-Dimethyl-L-Alanine",-5.536486,x0107,active-noncovalent
CC[N+](CC)(CC)CC,Tetraethylammonium,-5.535480,x0354,active-noncovalent
C[N+](C)(C)CCS,2-(Trimethylammonium)Ethyl Thiol,-5.514043,x0195,active-noncovalent
C[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O)O)O)O,alpha-D-quinovopyranose,-5.512943,x0104,active-noncovalent
C(C(=O)[O-])Br,2-Bromoacetyl Group,-5.510002,x0397,active-noncovalent
[O-]P(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-],Triphosphoric acid,-5.508282,x0397,active-noncovalent
C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O)O)O)[NH3+])O,4-Deoxy-4-Amino-Beta-D-Glucose,-5.504643,x0708,active-covalent
C(C(=O)[O-])N,Magnesium glycinate,-5.502959,x0397,active-noncovalent
C(C(=O)[O-])N,Aluminum zirconium octachlorohydrex gly,-5.502959,x0397,active-noncovalent
C(C(=O)[O-])N,Ferrous bisglycinate,-5.502959,x0397,active-noncovalent
C[N+](C)(C)CCOP(=O)([O-])[O-],"N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium",-5.491971,x0678,active-noncovalent
C1[C@H](C(=O)NO1)[NH3+],Cycloserine,-5.486466,x1077,active-noncovalent
CCCC[NH3+],Butylamine,-5.485808,x0678,active-noncovalent
CCOC(=O)C(=O)C,Ethyl pyruvate,-5.484655,x0397,active-noncovalent
C1[C@@H]([C@H]([C@@H](C[NH2+]1)O)O)CO,Afegostat,-5.476012,x0397,active-noncovalent
CC(C)C[N@@]([C@@H](CCCCNC(=O)[C@H](C(c1ccccc1)c2ccccc2)NC(=O)OC)CO)S(=O)(=O)c3ccc(cc3)N,PPL-100,-5.473522,x0104,active-noncovalent
C1[C@H]([C@H]([C@@H]([C@H]([NH2+]1)CO)O)O)O,1-deoxymannojirimycin,-5.472977,x0678,active-noncovalent
C/C=C/C(=O)[O-],Butenoic Acid,-5.472266,x0426,active-noncovalent
C(=[NH2+])(N)NO,N-hydroxyguanidine,-5.470361,x0195,active-noncovalent
c1cnc[n-]1,Tetra(Imidazole)Diaquacopper (Ii),-5.469964,x0540,active-noncovalent
CC(=O)C(=O)[O-],Pyruvic acid,-5.448891,x0689,active-covalent
C[C@H]([C@](C)(C[NH3+])O)O,"(2s,3r)-1-Amino-2-Methylbutane-2,3-Diol",-5.445054,x0708,active-covalent
Cc1ccc2c(c1)C(=O)[C@]3(C2=O)[C@@H]([C@@H]([C@@H](O3)c4ccc(c(c4)Cl)Cl)C(=O)Nc5ccc(cc5)c6csnn6)C(=O)[O-],Bilh 434,-5.440731,x0434,active-noncovalent
c1cnc[nH]1,Imidazole,-5.434227,x0540,active-noncovalent
[O-]P(=O)([O-])F,Sodium fluorophosphate,-5.433599,x0397,active-noncovalent
[O-]P(=O)([O-])F,Monofluorophosphate ion,-5.433599,x0397,active-noncovalent
COC(C(Cl)Cl)(F)F,Methoxyflurane,-5.431319,x0195,active-noncovalent
CC(=O)NCC(=O)[O-],Acetylamino-Acetic Acid,-5.415166,x0689,active-covalent
OP(=O)([O-])[O-],Dihydrogenphosphate,-5.408278,x0397,active-noncovalent
OP(=O)([O-])[O-],Phosphoric acid,-5.408278,x0397,active-noncovalent
OP(=O)([O-])[O-],Dipotassium phosphate,-5.408278,x0397,active-noncovalent
C[C@@H]1C[C@@H]([C@H]([C@H](O1)O)O)O,"4,6-Dideoxyglucose",-5.399846,x0678,active-noncovalent
COCCOCCOC,Diglyme,-5.387523,x0195,active-noncovalent
C([C@H](C=O)O)O,Dihydroxyacetone,-5.386980,x0397,active-noncovalent
C([C@H](C=O)O)O,D-glyceraldehyde,-5.386980,x0397,active-noncovalent
[H]/N=C(\C)/C(=O)N,2-Aminoprop-2-Enamide,-5.383672,x1077,active-noncovalent
C(=O)C(=O)[O-],Glyoxylic acid,-5.381461,x0397,active-noncovalent
C(C(=O)[O-])O,Glycolic acid,-5.380449,x0397,active-noncovalent
CCC(=O)[O-],Propanoic acid,-5.374838,x0397,active-noncovalent
C1CC(=O)OC1,gamma-butyrolactone,-5.370160,x0195,active-noncovalent
C([C@H]1[C@@H]([C@H]([C@@H](O1)O)O)O)O,Alpha-L-Arabinose,-5.364061,x0434,active-noncovalent
CO[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O,Methyl alpha-galactoside,-5.361551,x0397,active-noncovalent
CC(C)[C@@H](CO)[NH3+],L-valinol,-5.355181,x0107,active-noncovalent
CC(C)(C)OC=O,Tert-Butyloxycarbonyl Group,-5.353163,x0678,active-noncovalent
C(C(=O)[O-])(Cl)Cl,Dichloroacetic acid,-5.345966,x0397,active-noncovalent
C1C[C@H]([NH2+]C1)CN,(2s)-Pyrrolidin-2-Ylmethylamine,-5.338181,x1418,active-covalent
C[C@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H]([N@H+](CCO2)Cc3[nH]c(=O)n(n3)P(=O)([O-])[O-])c4ccc(cc4)F,Fosaprepitant,-5.334058,x0107,active-noncovalent
[C@H]1([C@H]([C@@H](O[C@@H]([C@H]1O)F)O)O)O,"(3R,4R,5S,6R)-6-Fluoro-3,4,5-trihydroxytetrahydro-2H-pyran-2-olate",-5.333362,x0397,active-noncovalent
CCOC(=O)NC,Methyl-Carbamic Acid Ethyl Ester,-5.330009,x0195,active-noncovalent
C(C(=O)NO)P(=O)([O-])[O-],Phosphonoacetohydroxamic Acid,-5.320944,x0397,active-noncovalent
C(CC=O)CC=O,Glutaral,-5.318900,x0195,active-noncovalent
C1[C@H]([C@H]([C@H]([C@@H](O1)O)O)O)O,beta-D-Ribopyranose,-5.316902,x0678,active-noncovalent
C[C@H]([C@@H](CO)[NH3+])O,Reduced Threonine,-5.311022,x0104,active-noncovalent
C(CC(=O)NO)CP(=O)([O-])[O-],N-Hydroxy-4-Phosphono-Butanamide,-5.290582,x0397,active-noncovalent
C=CC(=O)[O-],Acrylic Acid,-5.281290,x0397,active-noncovalent
C(C[NH3+])CS(=O)(=O)[O-],Tramiprosate,-5.272611,x0397,active-noncovalent
CCCCC=O,Pentanal,-5.272313,x0195,active-noncovalent
C(CS(=O)(=O)[O-])CS(=O)(=O)[O-],Eprodisate,-5.264083,x0397,active-noncovalent
C1[C@H]([C@H]([C@H](O[C@@H]1O)CO)O)O,2-Deoxy-Beta-D-Galactose,-5.262959,x0708,active-covalent
C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O)[NH3+])O)O)O,2-Deoxy-2-Aminogalactose,-5.254015,x0397,active-noncovalent
C(COP(=O)([O-])[O-])[NH3+],Phosphorylcolamine,-5.248846,x0397,active-noncovalent
CC(C)CCO,Isoamyl alcohol,-5.241287,x0678,active-noncovalent
C(C(=O)[O-])ON,Aminooxyacetic acid,-5.235770,x0107,active-noncovalent
N(=O)(=O)[O-],Potassium nitrate,-5.230078,x0397,active-noncovalent
N(=O)(=O)[O-],Gallium nitrate,-5.230078,x0397,active-noncovalent
C[N+](C)(C)CC=O,"[Formylmethyl]Trimethyl-Ammonium, N,N,N-Trimethylammonium Acetaldehyde",-5.220707,x0678,active-noncovalent
CC[N+](CC)(CC)CCOc1cccc(c1OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC,Gallamine triethiodide,-5.219904,x0434,active-noncovalent
C1CCOCC1,Tetrahydropyran,-5.214960,x0195,active-noncovalent
C1[C@H]([C@@H]([C@@H](C=C1C(=O)[O-])OP(=O)([O-])[O-])O)O,Shikimate-3-Phosphate,-5.212574,x0107,active-noncovalent
CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1N4CC[N+](CC4)(C)C)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)N6CC[N+](CC6)(C)C)C,Pipecuronium,-5.206237,x0305,active-noncovalent
CC(=O)[O-],Sodium acetate,-5.200050,x0397,active-noncovalent
CC(=O)[O-],Acetic acid,-5.200050,x0397,active-noncovalent
CC(=O)[O-],Calcium acetate,-5.200050,x0397,active-noncovalent
CC(=O)[O-],Magnesium acetate tetrahydrate,-5.200050,x0397,active-noncovalent
C[C@@]1(C([C@H](CO1)O)(O)O)O,"(2r,4s)-2-Methyl-2,3,3,4-Tetrahydroxytetrahydrofuran",-5.194246,x0104,active-noncovalent
[O-]P=O,Hypophosphite,-5.184584,x0397,active-noncovalent
CC(C)(C)c1ccc(cc1)[C@H](CCC[NH+]2CCC(CC2)C(c3ccccc3)(c4ccccc4)O)O,Terfenadine,-5.181167,x0072,active-noncovalent
C1[C@@H]([C@H]([C@H]([C@H]([NH2+]1)CO)O)O)O,Migalastat,-5.181073,x0678,active-noncovalent
COP(=S)(O)OC,DIMETHYL THIOPHOSPHATE,-5.167266,x1077,active-noncovalent
C([C@@H]1[C@H]([C@@H]([C@@H]([C@@H](O1)O)F)O)O)O,2-deoxy-2-fluoro--D-mannose,-5.156820,x0195,active-noncovalent
C([C@@H]1[C@H]([C@@H]([C@@H](O1)CP(=O)([O-])[O-])O)O)OP(=O)([O-])[O-],"D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate",-5.155500,x0749,active-covalent
C(P(=O)([O-])[O-])S,Mercaptomethyl Phosphonate,-5.151906,x0397,active-noncovalent
[2H]C([2H])([2H])[N+](CCO)(C([2H])([2H])[2H])C([2H])([2H])[2H],Methyl-D9-choline,-5.148651,x0678,active-noncovalent
C[N+](C)(C)CCO,Choline,-5.148651,x0678,active-noncovalent
C[C@@H]1[C@H](CC[C@@H](O1)O)O,"2,3-Dideoxyfucose",-5.121422,x0305,active-noncovalent
C(=O)(O)[O-],Potassium bicarbonate,-5.120637,x0397,active-noncovalent
C(=O)(O)[O-],Sodium bicarbonate,-5.120637,x0397,active-noncovalent
C([C@H]1[C@@H]([C@H]([C@H](O1)O)O)O)O,Beta-L-Arabinose,-5.118839,x0195,active-noncovalent
CCCC(=O)N,Butyramide,-5.115891,x1077,active-noncovalent
C1[C@H]([C@@H]([C@H]([C@H](O1)O)O)O)O,alpha-D-Xylopyranose,-5.112770,x0678,active-noncovalent
CN1C(=O)[C@@]2([C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)NC1=O,"8,9,10-trihydroxy-7-hydroxymethyl-3-methyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-",-5.112457,x1392,active-covalent
C1CNCC[NH2+]1,Piperazine,-5.079155,x0354,active-noncovalent
OP(=S)(O)OP(=O)([O-])[O-],Thiopyrophosphate,-5.068804,x0397,active-noncovalent
C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O)F)O)O)O,2-deoxy-2-fluoro--D-galactose,-5.060860,x0354,active-noncovalent
C[C@@H](CC(C)(C)O)O,"(4r)-2-Methylpentane-2,4-Diol",-5.058070,x0195,active-noncovalent
C(CS(=O)(=O)[O-])[NH3+],Taurine,-5.055941,x0397,active-noncovalent
CO[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)C=S)O)O)O,"Methyl(6s)-1-Thio-L-Manno-Hexodialdo-6,2-Pyranoside",-5.038953,x0678,active-noncovalent
CCNC(=O)OC,Ethyl-Carbamic Acid Methyl Ester,-5.030568,x1382,active-covalent
C1[C@@H]([C@H]([C@@H]([C@]2([C@@H]1O2)CO)O)O)O,Oxiranpseudoglucose,-5.029800,x0708,active-covalent
C(C(F)(F)F)F,Norflurane,-5.026167,x0195,active-noncovalent
C1[C@@H]2[C@@H]([C@H](O1)[C@H]([C@H](O2)O)OS(=O)(=O)[O-])O,"3,6-Anhydro-D-Galactose-2-Sulfate",-5.022995,x1392,active-covalent
C=C(CO)Br,2-Bromo-2-Propene-1-Ol,-5.015962,x1093,active-noncovalent
C(C(F)(F)F)O,Trifluoroethanol,-5.010293,x1093,active-noncovalent
C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)O)OC)O)O,6-deoxy-2-O-methyl-alpha-L-galactopyranose,-5.005239,x0678,active-noncovalent
C=C(CCO)Br,3-Bromo-3-buten-1-ol,-4.998981,x0195,active-noncovalent
Cc1ccccc1c2cc(ncc2N(C)C(=O)C(C)(C)c3cc(cc(c3)C(F)(F)F)C(F)(F)F)N4CC[NH+](CC4)C,Netupitant,-4.996645,x0678,active-noncovalent
CCOC(=O)N,Urethane,-4.994659,x1077,active-noncovalent
C[N+](C)([11CH3])CCO,Choline C-11,-4.983122,x0678,active-noncovalent
C[N+](C)([11CH3])CCO,Choline C 11,-4.983122,x0678,active-noncovalent
C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)O)O)O)O,Alpha-L-Fucose,-4.964927,x0397,active-noncovalent
C[C@H](C(=O)C)O,(R)-acetoin,-4.961293,x0397,active-noncovalent
C[C@@H](C[NH3+])O,F-Loop of Vitamin B12,-4.931261,x0397,active-noncovalent
C(CCO)CO,"1,4-Butanediol",-4.927987,x0678,active-noncovalent
C[N+](CO)(CO)CO,Tris-Hydroxymethyl-Methyl-Ammonium,-4.919984,x0397,active-noncovalent
CC(=O)C(=O)N,Pyruvamide,-4.916672,x0397,active-noncovalent
c1(c(c(c(c(c1C(=O)[O-])C(=O)[O-])C(=O)[O-])C(=O)[O-])C(=O)[O-])C(=O)[O-],Benzene Hexacarboxylic Acid,-4.916650,x1348,active-covalent
C(CS(=O)(=O)[O-])NCl,N-chlorotaurine,-4.913523,x0397,active-noncovalent
CC(C)(C(=O)[O-])Oc1ccc(cc1)NC(=O)Nc2cc(cc(c2)Cl)Cl,"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",-4.911766,x1093,active-noncovalent
C(C(F)(F)F)(C(F)(F)F)(O)O,Hexafluoroacetone Hydrate,-4.904966,x0354,active-noncovalent
CCOP(=O)(C(=Cc1cc(c(c(c1)C(C)(C)C)O)C(C)(C)C)P(=O)(OCC)OCC)OCC,SR12813,-4.884092,x0072,active-noncovalent
C(=O)(N)[O-],Carbamic Acid,-4.882571,x0397,active-noncovalent
CC[C@@H](C)[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@@H]4C[C@@H]5c6cccc7c6c(c[nH]7)C[C@H]5[N@@H+](C4)C)O,Epicriptine,-4.869617,x0104,active-noncovalent
C(C(CO)(CO)[NH3+])O,Tromethamine,-4.866799,x0397,active-noncovalent
CSC[S@@](=O)C,Methyl Methylsulfinylmethyl Sulfide,-4.864301,x0397,active-noncovalent
C[C@@H]1[C@H](C[C@@H]([C@H](O1)O)O)O,Tyvelose,-4.863531,x0678,active-noncovalent
C[P@@H](=O)[O-],Methylphosphinate,-4.831707,x0397,active-noncovalent
C[P@@H](=O)[O-],Methylphosphinic Acid,-4.831707,x0397,active-noncovalent
CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@@H]4C[C@@H]5c6cccc7c6c(c[nH]7)C[C@H]5[N@@H+](C4)C)O,Dihydroergocornine,-4.826613,x0104,active-noncovalent
CC(C)(C(Cl)(Cl)Cl)O,Chlorobutanol,-4.820621,x0354,active-noncovalent
C(C=S)[NH3+],2-Thioethenamine,-4.807543,x0387,active-noncovalent
CC1OC(OC(O1)C)C,Paraldehyde,-4.794878,x0195,active-noncovalent
C[C@@H]1[C@@H](C[C@H]([C@H](O1)O)O)O,Abequose,-4.783498,x0678,active-noncovalent
C(P(=O)([O-])[O-])(P(=O)([O-])[O-])(Cl)Cl,Clodronic acid,-4.777125,x0397,active-noncovalent
[O-]P(=O)([O-])[O-],Calcium Phosphate,-4.761452,x0397,active-noncovalent
C([C@H](CS)O)O,Monothioglycerol,-4.757840,x0397,active-noncovalent
C([C@H](CS)S)O,Dimercaprol,-4.745041,x0678,active-noncovalent
C1C[C@]2([C@H]([C@@H]([C@H]([C@@H]1[NH2+]2)O)O)O)O,"(1S,2R,3S,4R,5S)-8-AZABICYCLO[3.2.1]OCTANE-1,2,3,4-TETROL",-4.720242,x0708,active-covalent
C(=O)([O-])[O-],Sodium carbonate,-4.711005,x0397,active-noncovalent
C(=O)([O-])[O-],Bismuth subcarbonate,-4.711005,x0397,active-noncovalent
C(=O)([O-])[O-],Magnesium carbonate,-4.711005,x0397,active-noncovalent
C(=O)([O-])[O-],Lanthanum carbonate,-4.711005,x0397,active-noncovalent
C(=O)([O-])[O-],Calcium carbonate,-4.711005,x0397,active-noncovalent
C[C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O)O)O)O,Beta-D-Fucose,-4.700359,x0195,active-noncovalent
C(C(Cl)(Cl)Cl)OP(=O)([O-])[O-],Triclofos,-4.690480,x0830,active-covalent
C[C@H]1[C@H]([C@H]([C@@H]([C@H](O1)OC)O)O)O,beta-L-methyl-fucose,-4.678061,x0195,active-noncovalent
[C@@H]1([C@@H]([C@H]([C@H]([C@@H]([C@H]1OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-])O,"Inositol-(1,3,4,5,6)-Pentakisphosphate",-4.668451,x0387,active-noncovalent
C[C@H](CCl)Cl,"1,2-Dichloro-Propane",-4.653594,x0678,active-noncovalent
C(=O)C(Cl)(Cl)Cl,Trichloroacetaldehyde,-4.642591,x0678,active-noncovalent
CCN=O,Nitrosoethane,-4.638287,x0397,active-noncovalent
C[C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)O)O)O)O,Alpha-D-Fucose,-4.608924,x0195,active-noncovalent
CC[NH2+]C,Methylethylamine,-4.599305,x1093,active-noncovalent
C1COCCO1,"1,4-Diethylene Dioxide",-4.596065,x0195,active-noncovalent
c1ccc(c(c1)/N=N/c2c(cc3cc(cc(c3c2O)Nc4nc(nc(n4)N)N)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-],Reactive Red 1 Dye,-4.591265,x0161,active-noncovalent
C(C(=O)N)[NH3+],Glycinamid,-4.583603,x0104,active-noncovalent
C[C@@H](C(=O)C)O,(S)-acetoin,-4.569004,x0397,active-noncovalent
C1COC1=O,Propiolactone,-4.556714,x0195,active-noncovalent
SSSSS,Pentasulfide-Sulfur,-4.547755,x0195,active-noncovalent
CCC(=O)N,Propionamide,-4.538956,x0397,active-noncovalent
CC(C)(c1ccc(cc1)[C@H](CCC[NH+]2CCC(CC2)C(c3ccccc3)(c4ccccc4)O)O)C(=O)[O-],Fexofenadine,-4.532675,x0104,active-noncovalent
C(=N[NH3+])(N)N,Pimagedine,-4.528815,x0397,active-noncovalent
C(C(CON(=O)=O)(CON(=O)=O)CON(=O)=O)ON(=O)=O,Pentaerythritol tetranitrate,-4.514275,x0678,active-noncovalent
C(C(CO)O)O,Glycerin,-4.513509,x0397,active-noncovalent
[C@H]1([C@@H]([C@H]([C@@H]([C@H]([C@@H]1OP(=O)([O-])[O-])O)OP(=O)([O-])[O-])OP(=O)([O-])[O-])O)O,"1D-myo-inositol 1,4,5-trisphosphate",-4.505332,x0397,active-noncovalent
C(C(Cl)(Cl)Cl)(O)O,Chloral hydrate,-4.502693,x0354,active-noncovalent
CC[C@@H](C)O,2-Butanol,-4.501529,x0678,active-noncovalent
C1[C@@H](O1)CCl,Sevelamer,-4.491785,x0195,active-noncovalent
CC(=O)CCO,4-Hydroxy-2-Butanone,-4.486339,x0678,active-noncovalent
[C@@H]1([C@@H]([C@H]([C@@H]([C@H]([C@@H]1O)O)O)O)O)O,scyllo-inositol,-4.486026,x0104,active-noncovalent
CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@@H]4C[C@@H]5c6cccc7c6c(c[nH]7)C[C@H]5[N@@H+](C4)C)O,Dihydro-alpha-ergocryptine,-4.468582,x0434,active-noncovalent
C/C=C/C=O,Crotonaldehyde,-4.451875,x0195,active-noncovalent
C(CS)[NH3+],Cysteamine,-4.426373,x1093,active-noncovalent
CCCCO,Butyl alcohol,-4.420505,x0195,active-noncovalent
OCl(=O)(=O)=O,Perchlorate,-4.414036,x0195,active-noncovalent
COCCOC,"1,2-Dimethoxyethane",-4.385652,x0195,active-noncovalent
C[C@H]([C@H](C)O)O,"(R,R)-2,3-Butanediol",-4.366899,x0104,active-noncovalent
C(CCl)Cl,Ethylene Dichloride,-4.365752,x0195,active-noncovalent
CCOCCO,2-Ethoxyethanol,-4.347944,x0195,active-noncovalent
C([C@@H]1[C@H]([C@@H]([C@H](O1)O)O)O)O,alpha-D-arabinofuranose,-4.347450,x0107,active-noncovalent
CC(C)(C#N)O,Acetone Cyanohydrin,-4.344299,x0708,active-covalent
C=CS(=O)(=O)[O-],Vinylsulphonic Acid,-4.342831,x0397,active-noncovalent
C(CO)[NH3+],Ethanolamine,-4.329275,x0397,active-noncovalent
C[C@@H](CBr)O,1-Bromopropane-2-Ol,-4.321112,x0678,active-noncovalent
C(CS(=O)(=O)[O-])S,Coenzyme M,-4.320788,x0397,active-noncovalent
C[N+](C)(C)C,Tetramethylammonium Ion,-4.317239,x0678,active-noncovalent
CCS(=O)(=O)[O-],Ethanesulfonic Acid,-4.296731,x0397,active-noncovalent
[O-]Cl(=O)(=O)=O,Potassium perchlorate,-4.296506,x0195,active-noncovalent
C(=O)[O-],Formic acid,-4.286236,x1478,active-covalent
B(O)(O)O,Boric acid,-4.270734,x0195,active-noncovalent
CC(=O)O[C@@H]1[C@@H]([C@H]([C@]2(CS[C@]([C@@H]1O2)(C(=O)N)O)C(=O)[O-])OP(=O)([O-])[O-])[NH3+],Tagetitoxin,-4.266921,x0874,active-noncovalent
C[C@@H](CCO)O,"(S)-butane-1,3-diol",-4.256177,x0397,active-noncovalent
CC(=O)C=O,Pyruvaldehyde,-4.250336,x0397,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)Nc2ccc(cc2)O)/C)/C,Fenretinide,-4.246811,x0104,active-noncovalent
C(Br)(Br)Br,Bromoform,-4.223693,x0195,active-noncovalent
C[C@H](CO)O,(R)-Propylene glycol,-4.206204,x0397,active-noncovalent
C[C@H](CO)O,Propylene glycol,-4.206204,x0397,active-noncovalent
CN(C)C=O,"N,N-dimethylformamide",-4.171321,x0397,active-noncovalent
[O-]S(=O)(=S)[O-],Thiosulfuric acid,-4.166615,x0397,active-noncovalent
CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4C[N@H+]([C@@H]5Cc6c7c(cccc7[nH]c6Br)C5=C4)C)O,Bromocriptine,-4.156972,x0434,active-noncovalent
C(=C/O)\C=O,Malonaldehyde,-4.145633,x0678,active-noncovalent
C[C@@H](C=O)O,Lactaldehyde,-4.144826,x0397,active-noncovalent
C1[C@@H]([C@H]([C@@H]([C@H](O1)O)O)O)O,L-Xylopyranose,-4.144556,x0195,active-noncovalent
[H]/N=C/C[NH3+],2-Aminoethanimidic Acid,-4.135004,x0678,active-noncovalent
C(CO)CO,"1,3-Propandiol",-4.127461,x0678,active-noncovalent
CC1([C@]2(C(=O)/C(=C/c3ccc(cc3)/C=C\4/C(=O)[C@@]5(C([C@H]4CC5)(C)C)CS(=O)(=O)[O-])/[C@@H]1CC2)CS(=O)(=O)[O-])C,Ecamsule,-4.113447,x0104,active-noncovalent
[C@H]1([C@H]([C@@H]([C@H]([C@H]([C@H]1OP(=O)([O-])[O-])O)OP(=O)([O-])[O-])OP(=O)([O-])[O-])O)O,"(1s,3s,4s)-1,3,4-Triphospho-Myo-Inositol",-4.112311,x0397,active-noncovalent
C(Cl)(Cl)Cl,Chloroform,-4.067810,x0195,active-noncovalent
C[C@@H](CO)O,"(S)-propane-1,2-diol",-4.033866,x0397,active-noncovalent
CC(C)(C)[NH2+]CC(=O)Nc1cc(c2c(c1[O-])C(=O)[C@@H]3[C@@H](C2)C[C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)N(C)C,Tigecycline,-4.031444,x0072,active-noncovalent
C(=O)(N)NO,Hydroxyurea,-4.018385,x0397,active-noncovalent
CC(=O)N,Acetamide,-4.006875,x0397,active-noncovalent
CC(C)(C)O,2-Methyl-2-Propanol,-4.002501,x0678,active-noncovalent
CCOC(=O)NC(=[NH2+])c1ccc(cc1)OCc2cccc(c2)COc3ccc(cc3)C(C)(C)c4ccc(cc4)O,Amelubant,-3.981787,x1249,active-noncovalent
CC[N+]#C,Ethyl Isocyanide,-3.957986,x0195,active-noncovalent
CC(=O)NO,Acetohydroxamic acid,-3.917711,x0397,active-noncovalent
C[C@H]1CO1,Poloxalene,-3.878845,x0195,active-noncovalent
CC[C@@]1(C[C@H]2C[C@@](c3c(c4ccccc4[nH]3)CC[N@@H+](C2)C1)(c5cc6c(cc5OC)[N@@]([C@@H]7[C@]68CC[N@H+]9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)OC)O)OC(=O)C)CC)C)C(=O)OC)O,Vinblastine,-3.862822,x0072,active-noncovalent
C(=O)(N)N,Carbamide peroxide,-3.808804,x0397,active-noncovalent
[14C](=O)(N)N,Urea C-14,-3.808804,x0397,active-noncovalent
C(=O)(N)N,Urea,-3.808804,x0397,active-noncovalent
[13C](=O)(N)N,Urea C-13,-3.808804,x0397,active-noncovalent
CCCO,Propyl alcohol,-3.764220,x1093,active-noncovalent
COCCO,2-Methoxyethanol,-3.711877,x0104,active-noncovalent
CS(=O)(=O)F,Methanesulfonyl Fluoride,-3.693915,x0195,active-noncovalent
C(CS)O,Mercaptoethanol,-3.693842,x0678,active-noncovalent
[O-]S(=O)(=O)[O-],Magaldrate,-3.684703,x0397,active-noncovalent
[O-]S(=O)(=O)[O-],Ferric sulfate,-3.684703,x0397,active-noncovalent
[O-]S(=O)(=O)[O-],Zinc sulfate,-3.684703,x0397,active-noncovalent
[O-]S(=O)(=O)[O-],Potassium alum,-3.684703,x0397,active-noncovalent
[O-]S(=O)(=O)[O-],Aluminum sulfate,-3.684703,x0397,active-noncovalent
[O-]S(=O)(=O)[O-],Cupric sulfate,-3.684703,x0397,active-noncovalent
[O-]S(=O)(=O)[O-],Sodium sulfate,-3.684703,x0397,active-noncovalent
[O-]S(=O)(=O)[O-],Barium sulfate,-3.684703,x0397,active-noncovalent
[O-]S(=O)(=O)[O-],Sulfuric acid,-3.684703,x0397,active-noncovalent
[O-]S(=O)(=O)[O-],Magnesium sulfate,-3.684703,x0397,active-noncovalent
CS(=O)C,Dimethyl sulfoxide,-3.647074,x0195,active-noncovalent
CC(C)Oc1ccc(cc1)NC(=O)N2CCN(CC2)c3c4cc(c(cc4ncn3)OCCC[NH+]5CCCCC5)OC,Tandutinib,-3.580071,x1249,active-noncovalent
[C@H]1([C@H]([C@@H]([C@@H]([C@@H]([C@H]1OP(=O)([O-])[O-])OP(=O)([O-])[O-])O)OP(=O)([O-])[O-])OP(=O)([O-])[O-])O,"(1s,3r,4r,6s)-1,3,4,6-Tetrapkisphosphate",-3.568758,x0387,active-noncovalent
CC(C)O,Isopropyl alcohol,-3.556877,x0397,active-noncovalent
[C@@H]1([C@@H]([C@@H]([C@@H]([C@H]([C@@H]1OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-])O)OP(=O)([O-])[O-])O,"Inositol 1,3,4,5-Tetrakisphosphate",-3.425946,x1418,active-covalent
CCO,Ethanol,-3.181034,x0397,active-noncovalent
C(=[N-])=[N-],Calcium carbimide,-3.127760,x0678,active-noncovalent
II,Iodine,-3.096936,x0195,active-noncovalent
[C@@H]1([C@@H]([C@@H]([C@@H]([C@H]([C@@H]1OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-],D-Myo-Inositol-Hexasulphate,-3.096339,x0831,active-covalent
C(#N)N,Cyanamide,-3.083759,x1093,active-noncovalent
CN([C@@H](CC(=O)[O-])C(=O)[O-])C(=O)c1cc(ccc1NS(=O)(=O)c2ccc3ccccc3c2)OS(=O)(=O)c4ccc5ccccc5c4,(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Ben,-3.044909,x0678,active-noncovalent
C=NN,Methyldiazene,-3.009922,x0195,active-noncovalent
CON,Methoxyamine,-2.995533,x0195,active-noncovalent
O[SiH3],Silanol,-2.943021,x0678,active-noncovalent
CC[C@@H](C)[C@H](C(=O)N[C@@H](CCC(=[NH2+])N)C(=O)NCc1ccc(cc1)C(=[NH2+])N)NS(=O)(=O)Cc2cccc(c2)C(=O)[O-],3-({1-[3-CARBAMIMIDOYL-1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-PROPYLCARBAMOYL]-2-ME,-2.932678,x0104,active-noncovalent
C[N+]1(CCc2cc(c3cc2[C@@H]1Cc4ccc(cc4)Oc5c6c(cc(c5OC)OC)CC[N+]([C@@H]6Cc7ccc(c(c7)O3)OC)(C)C)OC)C,Metocurine iodide,-2.786572,x0395,active-noncovalent
C[N+]1(CCc2cc(c3cc2[C@@H]1Cc4ccc(cc4)Oc5c6c(cc(c5OC)OC)CC[N+]([C@@H]6Cc7ccc(c(c7)O3)OC)(C)C)OC)C,Metocurine,-2.786572,x0395,active-noncovalent
CCCCCc1ccc(cc1)C(=O)N(Cc2ccc(cc2)c3ccc(cc3)CC(=O)OC)C4CC[NH+](CC4)Cc5[nH]ccn5,N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl),-2.730119,x0305,active-noncovalent
CCOC(=O)N1CCN(CC1)C(=O)[C@H](Cc2cccc(c2)C(=[NH2+])N)NS(=O)(=O)c3c(cc(cc3C(C)C)C(C)C)C(C)C,WX-UK1,-2.721390,x0434,active-noncovalent
ClCl,Chlorine,-2.507327,x0678,active-noncovalent
N(=O)[O-],Nitrous acid,-2.463639,x0397,active-noncovalent
N(=O)[O-],Nitrite,-2.463639,x0397,active-noncovalent
OCl,Hypochlorite,-2.274491,x0195,active-noncovalent
C=O,Formaldehyde,-2.257424,x1187,dimer-interface
CC[C@@H]1[C@@](C(=O)/C(=C\2/[C@@H](C[C@@](O2)([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)C)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)[N@@H+](C)C(C)C)O)C)C)/C)(C)OC,Mitemcinal,-2.212711,x0395,active-noncovalent
C[NH3+],Methylamine,-2.191734,x0678,active-noncovalent
COc1ccc(cc1)c2c(c3c(ncnc3o2)N)c4ccc(cc4)NC(=O)Nc5cc(ccc5F)C(F)(F)F,"1-{4-[4-Amino-6-(4-methoxyphenyl)furo[2,3-d]pyrimidin-5-yl]phenyl}-3-[2-fluoro-5",-2.140457,x0887,dimer-interface
CCCCCc1ccc(cc1)C(=O)Nc2ccc(cc2)S(=O)(=O)[N@](CC[NH+]3CCOCC3)[C@H](C(C)C)C(=O)NO,SC-74020,-2.118213,x0072,active-noncovalent
N#N,Nitrogen,-2.060159,x1187,dimer-interface
O=O,Oxygen,-2.024048,x1187,dimer-interface
[N]=O,Nitric Oxide,-1.972872,x0195,active-noncovalent
CC[C@@]1(C[C@@H]2C[C@@](c3c(c4ccccc4[nH]3)CC[N@@H+](C2)C1)(c5cc6c(cc5OC)[N@@]([C@@H]7[C@]68CC[N@H+]9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)N)O)O)CC)C)C(=O)OC)O,Vindesine,-1.920384,x0072,active-noncovalent
OO,Hydrogen peroxide,-1.894065,x0195,active-noncovalent
CCC1=C[C@H]2C[C@@](c3c(c4ccccc4[nH]3)C[N@H+](C2)C1)(c5cc6c(cc5OC)N([C@@H]7[C@]68CC[N@H+]9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)OC)O)OC(=O)C)CC)C)C(=O)OC,Vinorelbine,-1.844963,x0072,active-noncovalent
c1ccc2c(c1)nnn2C(Cc3ccc(cc3)C(F)(F)P(=O)([O-])[O-])(Cc4ccc(cc4)C(F)(F)P(=O)([O-])[O-])c5ccc(c(c5)F)F,"{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-",-1.826099,x0395,active-noncovalent
CC(C)[C@H]1C(=O)O[C@@H](C(=O)N([C@H](C(=O)O[C@@H](C(=O)N([C@H](C(=O)O[C@@H](C(=O)N1C)C(C)C)C(C)C)C)C(C)C)C(C)C)C)C(C)C,Fusafungine,-1.319222,x1249,active-noncovalent
C[C@H](C(C)C)[C@]1(CC[C@@]2([C@H]3CC[C@H]4[C@]5(COC[C@]4(C3=CC[C@]2([C@@H]1C(=O)[O-])C)C[C@H]([C@@H]5OC[C@@](C)(C(C)(C)C)[NH3+])n6c(ncn6)c7ccncc7)C)C)C,MK-3118,-0.996608,x0305,active-noncovalent
CC(C)N1CCN(C1=O)c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@H]5OC[C@](O5)(Cn6cncn6)c7ccc(cc7F)F,Pramiconazole,-0.117467,x0769,active-covalent
Cc1cc(nc2c1cccc2OCc3c(ccc(c3Cl)S(=O)(=O)[N@@]4CCC[C@H]4C(=O)NCCCNC(=O)c5ccc(cc5)C(=[NH2+])N)Cl)C,Anatibant,0.098183,x0967,active-noncovalent
Cc1nc(cs1)CN2CCN(C2=O)[C@@H](C(C)C)C(=O)N[C@@H](Cc3ccccc3)[C@@H](C[N@@](CC(C)C)S(=O)(=O)c4ccc(cc4)CN=O)O,OXIMINOARYLSULFONAMIDE,0.513231,x0305,active-noncovalent
CC(C)(CO[P@](=O)([O-])O[P@](=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)n2cnc3c2ncnc3N)O)OP(=O)([O-])[O-])[C@H](C(=O)NCCC(=O)NCCSC(=O)C[C@H](C[N+](C)(C)C)O)O,(R)-carnitinyl-CoA betaine,0.547900,x0305,active-noncovalent
CC[C@@]1(Cc2cc3c(c(c2[C@H](C1)O[C@H]4C[C@@H]([C@@H]([C@@H](O4)C)O[C@@H]5C[C@@H]([C@H]([C@@H](O5)C)O[C@H]6CCC(=O)[C@H](O6)C)O)[NH+](C)C)[O-])C(=O)c7c(cccc7[O-])C3=O)O,10-{4-Dimethylamino-5-[4-Hydroxy-6-Methyl-5-(6-Methyl-5-Oxo-Tetrahydro-Pyran-2-Y,0.881968,x0305,active-noncovalent
Cc1c(c2c3c4c1O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]([C@H](/C=C/C=C(\C(=O)/N=c(\c2O)/c5=NC6(CC[NH+](CC6)CC(C)C)Nc35)/C)C)O)C)O)C)OC(=O)C)C)OC)C)O,Rifabutin,1.365795,x0967,active-noncovalent
c1ccc(cc1)C(=O)N[C@@H](CCC(=O)[O-])C(=O)N[C@@H](Cc2ccc(cc2)C(F)(F)P(=O)([O-])[O-])C(=O)N[C@@H](Cc3ccc(cc3)C(F)(F)P(=O)([O-])[O-])C(=O)N,(4S)-5-[[(2S)-1-[[(2S)-1-Amino-3-[4-[difluoro(phosphono)methyl]phenyl]-1-oxoprop,1.715150,x0967,active-noncovalent
C[C@@H]1CC[C@]2(CCCCO2)O[C@@H]1[C@@H](C)C[C@@H]([C@@H]3C(=C)[C@H]([C@H]4[C@H](O3)CC[C@]5(O4)CC[C@@H](O5)/C=C/[C@@H](C)[C@@H]6CC(=C[C@@]7(O6)[C@@H](CC[C@H](O7)C[C@](C)(C(=O)[O-])O)O)C)O)O,"9,10-Deepithio-9,10-Didehydroacanthifolicin",2.694110,x1249,active-noncovalent
c1cc(ccc1C[C@@H](C(=O)NCCCCCC(=O)N[C@@H](CS)C(=O)N)NC(=O)[C@@H](CC(=O)[O-])NC(=O)Cc2ccc(cc2)C(F)(F)P(=O)([O-])[O-])C(F)(F)P(=O)([O-])[O-],4-[[(2S)-1-[[6-[(1-Amino-1-oxo-3-sulfanylpropan-2-yl)amino]-6-oxohexyl]amino]-3-,2.950443,x1249,active-noncovalent
c1ccc(cc1)C2(CCC(CC2)O[P@](=O)([O-])OC[C@@H](C[N@](CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-])c3ccccc3,Gadofosveset trisodium,3.360783,x0305,active-noncovalent
CC(C)[C@@H](C(=O)NC)NC(=O)[C@@H]([C@@H]([C@H]([C@H](C(=O)N[C@@H](C(C)C)C(=O)NC)OCc1ccc(cc1)c2ccsc2)O)O)OCc3ccc(cc3)c4ccsc4,Inhibitor Bea409,4.413773,x0967,active-noncovalent
C[NH+](C)C1CCN(CC1)C(=O)c2ccc(cc2)NC(=O)Nc3ccc(cc3)c4nc(nc(n4)N5CCOCC5)N6CCOCC6,Gedatolisib,4.922265,x0689,active-covalent
c1ccc(cc1)COC(=O)N[C@H](CC2CCCCC2)C(=O)C(=O)N[C@@H](CCC[NH+]=C(N)N)C(=O)N[C@@H](CCC(=O)[O-])C(=O)N[C@@H](CC3CCCCC3)C(=O)[O-],(4S)-5-[[(1S)-1-Carboxy-2-cyclohexylethyl]amino]-4-[[(2S)-2-[[(3R)-4-cyclohexyl-,5.112056,x0887,dimer-interface
C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5CC[C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)C)C)C)O)O,Digitoxin,5.699810,x0786,active-covalent
C(CC[NH2+]CCCNC(=O)CNC(=O)[C@H](CSSC[C@@H](C(=O)NCC(=O)NCCC[NH2+]CCCC[NH3+])NC(=O)CC[C@H](C(=O)[O-])[NH3+])NC(=O)CC[C@H](C(=O)[O-])[NH3+])C[NH3+],Glutathionylspermidine Disulfide,5.953060,x1249,active-noncovalent
C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Digoxin,6.022221,x0786,active-covalent
C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)COS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])COS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-],Sucrosofate,6.867441,x1249,active-noncovalent
C[C@H]1/C=C/[C@H](C[C@@H]([C@H]([C@H]2CC(=CC(=O)O2)C[C@@H](C/C(=C/C=C/C(=O)O[C@@H]([C@H](/C=C/[C@@H](C[C@@H]1OC)OC)C)[C@@H](C)[C@H]([C@@H](C)CCC(=O)[C@H](C)[C@@H](CCC(=O)[O-])OC)OC)/C)OC)C)OC)OC,Reidispongiolide C,7.054211,x0887,dimer-interface
CC[C@@H](C)n1c(=O)n(cn1)c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@H]5CO[C@](O5)(Cn6cncn6)c7ccc(cc7Cl)Cl,Itraconazole,9.927263,x0354,active-noncovalent
C[C@H]1[C@@H](C[C@@]2(C([C@H]([C@H](O2)[C@H](C[C@@H]([C@H](C)[C@@H]([C@H](C)/C=C(\C)/C(=C/C=C/C(=C\C#N)/C)/C)O)O)OC)OP(=O)([O-])[O-])(C)C)O[C@H]1C/C=C/c3coc(n3)[C@@H](C)CCNC(=O)[C@H]([C@H]([C@H](COC)[NH+](C)C)O)O)O,Calyculin A,10.283638,x0354,active-noncovalent
C[C@H]1/C=C/[C@H](C[C@@H]([C@H]([C@H]2CC(=CC(=O)O2)C[C@@H](C/C(=C/C=C/C(=O)O[C@@H]([C@H](/C=C/[C@@H](C[C@@H]1OC)OC)C)[C@@H](C)[C@H]([C@@H](C)CCC(=O)[C@H](C)[C@@H](C/C=C/N(C)C=O)OC)OC)/C)OC)C)OC)OC,Reidispongiolide A,10.983375,x0769,active-covalent
CC[C@@H]([C@H](C)O)n1c(=O)n(cn1)c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@H]5C[C@](OC5)(Cn6cncn6)c7ccc(cc7F)F,Posaconazole,11.375507,x1351,active-covalent
C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OP(=O)(C)C)C)/C)O)OC)C)C)/C)OC,Ridaforolimus,11.833998,x0771,active-covalent
C[N@+]1(CCc2cc(c(c(c2[C@@H]1Cc3cc(c(c(c3)OC)OC)OC)OC)OC)OC)CCCOC(=O)CCC(=O)OCCC[N@@+]4(CCc5cc(c(c(c5[C@@H]4Cc6cc(c(c(c6)OC)OC)OC)OC)OC)OC)C,Doxacurium,12.667004,x0354,active-noncovalent
C[N@+]1(CCc2cc(c(cc2[C@H]1Cc3cc(c(c(c3)OC)OC)OC)OC)OC)CCCOC(=O)CC/C=C/CCC(=O)OCCC[N@@+]4(CCc5cc(c(cc5[C@H]4Cc6cc(c(c(c6)OC)OC)OC)OC)OC)C,Mivacurium,13.461238,x0731,active-covalent
CC(C)C[C@@H](C(=O)N[C@@H](CCCNC(=[NH2+])N)C(=O)N1CCC[C@H]1C(=O)NNC(=O)N)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc3c[nH]c4c3cccc4)NC(=O)[C@H](Cc5c[nH]cn5)NC(=O)[C@@H]6CCC(=O)N6,Goserelin,17.005493,x0705,active-covalent
CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Cyclosporine,17.463869,x0769,active-covalent
CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=[NH2+])N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc3c[nH]c4c3cccc4)NC(=O)[C@H](Cc5c[nH]cn5)NC(=O)[C@@H]6CCC(=O)N6,Leuprolide,19.207775,x0354,active-noncovalent
CC(C)C[C@@H](C(=O)N[C@@H](CCC[NH+]=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](Cc4ccc(cc4)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc5c[nH]c6c5cccc6)NC(=O)[C@H](Cc7c[nH]cn7)NC(=O)[C@@H]8CCC(=O)N8,Nafarelin,19.356564,x0354,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C=C/C=C(/C=C/C=C(/C=C/C2=C(CCCC2(C)C)C)\C)\C)/C)/C,Beta carotene,19.490948,x1385,active-covalent
CC1=C(C(C[C@@H](C1)O)(C)C)/C=C/C(=C/C=C/C(=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/[C@H]2C(=C[C@@H](CC2(C)C)O)C)/C)/C,Lutein,20.639858,x0749,active-covalent
Cc1ccc(c2c1oc-3c(c(=O)c(c(c3n2)C(=O)N[C@H]4[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]5CCCN5C(=O)[C@H](NC4=O)C(C)C)C)C)C(C)C)C)N)C)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C,Dactinomycin,21.179607,x0692,active-covalent
Cc1ccc(cc1NC(=O)c2cccc(c2)NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6c5c(cc(c6)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])C(=O)Nc7ccc(c8c7c(cc(c8)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-],Suramin,22.229818,x1358,active-covalent
CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)Nc2ccc(cc2)[C@@H]3CC[C@H](N3c4ccc(cc4)C(C)(C)C)c5ccc(cc5)NC(=O)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,Ombitasvir,25.866055,x1412,active-covalent
C/C(=C\C=C\C=C(\C=C\C=C(\C=C\[C@@]12O[C@@]1(C[C@H](CC2(C)C)O)C)/C)/C)/C=C/C=C(/C=C/[C@@]34O[C@@]3(C[C@H](CC4(C)C)O)C)\C,Violaxanthin,26.124060,x1385,active-covalent
C[C@@H](C(=O)N[C@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c2c1cccc2)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc3c[nH]c4c3cccc4)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc5c[nH]c6c5cccc6)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc7c[nH]c8c7cccc8)C(=O)NCCO)NC(=O)[C@@H](CC(C)C)NC(=O)CNC(=O)[C@H](C(C)C)NC=O,Gramicidin D,32.317139,x0705,active-covalent
C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2c1cccc2)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)[O-])C(=O)N[C@@H](Cc3ccccc3)C(=O)N)NC(=O)[C@H](Cc4ccc(cc4)OS(=O)(=O)[O-])NC(=O)[C@H](CC(=O)[O-])NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]5CCC(=O)N5)O,Ceruletide,37.533073,x0786,active-covalent
C[C@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=[NH2+])N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCNC(=O)N)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc3cccnc3)NC(=O)[C@@H](Cc4ccc(cc4)Cl)NC(=O)[C@@H](Cc5ccc6ccccc6c5)NC(=O)C,Cetrorelix,58.040688,x1385,active-covalent
CC[C@H](C)CCCCC(=O)N[C@@H](CC[NH2+]CS(=O)(=O)[O-])C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC[NH2+]CS(=O)(=O)[O-])C(=O)N[C@@H]1CCNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](NC1=O)CC[NH2+]CS(=O)(=O)[O-])CC(C)C)CC(C)C)CC[NH2+]CS(=O)(=O)[O-])CC[NH2+]CS(=O)(=O)[O-])[C@@H](C)O,Colistimethate,77.974121,x0749,active-covalent
